{"peak early diastolic mitral flow velocity": 96.49919679829777, "peak early diastolic mitral annular velocity": 98.32872151206284, "global left ventricular longitudinal systolic strain": 68.43853760869376, "heart failure and reduced ejection fraction": 54.29615964201736, "left anterior descending coronary artery occlusion": 33.88043218984708, "scale prospective randomized multicenter trial paradigm": 34.70388248210277, "heart failure or coronary heart disease": 21.156386809679958, "heart rate and aortic blood flow": 20.018005568939763, "valve plasty and annular size reduction": 10.578193404839979, "diastolic pressure and myocardial oxygen consumption": 11.406422934782293, "stress echocardiography and cardiopulmonary exercise testing": 11.818586171647645, "time interval between local myocyte depolarization": 11.293477396615692, "filling time by controlling heart rate": 10.50343818521192, "kidney infection or urinary tract infection": 10.85923192840347, "oxygen uptake and higher metabolic exercise": 10.85923192840347, "heart failure and mechanical support devices": 10.925413501340316, "preserved left ventricular ejection fraction": 191.19473627345553, "early diastolic mitral flow velocity": 77.60890397999714, "left ventricular assist device implantation": 54.29615964201736, "left ventricular diastolic end diameter": 52.890967024199895, "chronic advanced heart failure patients": 52.890967024199895, "annular size reduction by surgery": 30.292555871519134, "clinical practice guidelines grading system": 27.14807982100868, "restrictive red blood cell transfusion": 26.2585954630298, "red blood cell transfusion strategy": 25.666995627085992, "low left ventricular ejection fraction": 26.2585954630298, "identified strong reliable mortality predictors": 27.788275773627106, "recapitulates conserved developmental chromatin remodeling": 29.302331292585837, "conserved developmental chromatin remodeling events": 28.376256930251298, "left bundle branch block pattern": 25.022506961174706, "preserved left ventricular ejection fractions": 27.475277641840094, "novel heart failure mice model": 24.5584579093617, "left ventricular assist device use": 25.458499170684053, "acute right ventricular pressure overload": 26.805332443971604, "vascular endothelial growth factor blockade": 27.14807982100868, "assessing left ventricular filling pressure": 27.14807982100868, "stable severe systolic heart failure": 25.869634659999043, "early transmitral blood flow velocity": 26.066736408667207, "early diastolic mitral annulus velocity": 26.445483512099948, "estimating pulmonary capillary wedge pressure": 27.475277641840094, "tricuspid annular plane systolic excursion": 26.978741640895166, "undergoing left ventricular assist device": 26.805332443971604, "shortens left ventricular ejection time": 26.445483512099948, "impaired cardiac metabolic gene expression": 26.978741640895166, "impaired cardiac energy metabolism gene": 26.445483512099948, "cardiac energy metabolism gene expression": 26.805332443971604, "using cardiac magnetic resonance t1": 25.666995627085992, "cardiac magnetic resonance t1 mapping": 26.066736408667207, "cardiac magnetic resonance t1 time": 25.458499170684053, "outperformed left ventricular ejection fraction": 27.788275773627106, "+9.2 \u00b1 9.5 % increase": 21.995855469099116, "restoring mitochondrial oxidative phosphorylation capacity": 29.302331292585837, "isolated coronary artery bypass grafting": 26.627651657837788, "pathological cardiac gene expression programme": 27.63347422770988, "using trichrome blue histologic analysis": 26.627651657837788, "induced pulmonary artery systolic pressure": 26.978741640895166, "impaired right ventricular pump function": 26.627651657837788, "targeted pulmonary arterial hypertension medication": 28.376256930251298, "increased vascular endothelial growth factor": 27.31353375335079, "vascular endothelial growth factor protein": 26.978741640895166, "left bundle branch block type": 24.31473624010461, "improved left ventricular filling pressure": 26.978741640895166, "left ventricular filling pressure response": 26.978741640895166, "proximal left anterior descending artery": 26.627651657837788, "acute ischemic right heart failure": 25.458499170684053, "mean \u00b1 sd testosterone levels": 24.31473624010461, "reduced left ventricular ejection fraction": 26.978741640895166, "single center retrospective observational study": 27.788275773627106, "receiving ventricular assist device support": 27.14807982100868, "acute autonomic nervous system modulation": 26.805332443971604, "relative appendicular lean mass index": 26.066736408667207, "symptomatic chronic advanced heart failure": 26.978741640895166, "myocardial infarction heart failure patients": 27.31353375335079, "large idiopathic dilated cardiomyopathy cohort": 27.63347422770988, "obese body mass index categories": 25.022506961174706, "overweight body mass index strata": 25.24379655959928, "decreased mitochondrial energy production precede": 28.08825559713665, "reduced mitochondrial complex v activity": 26.627651657837788, "provided left ventricular function assessment": 27.475277641840094, "using cardiopulmonary exercise testing guide": 27.31353375335079, "cardiopulmonary exercise testing guide exercise": 27.788275773627106, "prospective randomized multicenter trial paradigm": 28.08825559713665, "hypertensive heart disease by angiotensin": 16.08319946638296, "acute kidney injury during spironolactone": 16.08319946638296, "isolated hr reduction by ivabradine": 15.400197376251594, "extracorporeal membrane oxygenation as bridge": 16.485166585104054, "recent onset af at risk": 13.589462839586087, "systolic heart failure after pressure": 15.640041845200326, "respiratory gas analysis at baseline": 15.521780795999426, "limited mortality at hospital discharge": 10.578193404839979, "independent association between spironolactone use": 11.293477396615692, "cardiac dysfunction during insulin resistance": 10.990111056736037, "compelling improvement after device implantation": 11.17592997776536, "free probability after catheter ablation": 10.651060663135116, "association between frailty and risk": 5.173926931999809, "readmission after discharge among patients": 5.3957483281790335, "events as subjects without psoriasis": 5.173926931999809, "controls during this same time": 4.91169158187234, "association between race and outcomes": 5.213347281733442, "patients as control without exercise": 5.173926931999809, "evaluations at baseline and months": 5.0916998341368105, "left ventricular ejection fraction": 611.0039800964173, "estimated glomerular filtration rate": 227.65278500799158, "left ventricular assist device": 117.88059796493616, "chronic obstructive pulmonary disease": 104.26694563466883, "preserved left ventricular ejection": 82.13438600667517, "left bundle branch block": 73.45537986148159, "right ventricular contractile reserve": 83.41355650773507, "diastolic mitral annular velocity": 80.78014899071769, "hour cumulative urine volume": 57.74997870400277, "left ventricular assist devices": 59.50611210291889, "vascular endothelial growth factor": 61.10039800964172, "standard cardiac rehabilitation care": 62.087123183997704, "standard criteria cardiac transplant": 62.087123183997704, "early diastolic mitral flow": 57.12265135759811, "diastolic mitral flow velocity": 58.94029898246808, "peak early diastolic mitral": 57.12265135759811, "end stage heart failure": 54.35785135834435, "low left ventricular ejection": 38.90357798416738, "proteins alter chromatin structure": 40.733598673094484, "receive cardiac resynchronization therapy": 42.888531910354565, "left ventricular ejection fractions": 41.067193003337586, "diastolic mitral valve tethering": 40.03601113787953, "posteriorly displaced papillary muscles": 42.312773619359916, "left ventricular filling pressure": 40.390074495358846, "pulmonary capillary wedge pressure": 40.733598673094484, "showed good diagnostic performance": 40.733598673094484, "annular plane systolic excursion": 40.03601113787953, "pulmonary arterial systolic pressure": 41.39141545599847, "proximal left anterior descending": 40.390074495358846, "ejection fraction \u226435 %": 36.23856757222956, "ventricular assist device implantation": 42.01375274084768, "left ventricular ejection time": 39.29353265497872, "angiotensin converting enzyme inhibitors": 42.604242652540464, "cardiac magnetic resonance postcontrast": 42.312773619359916, "cardiac magnetic resonance t1": 38.90357798416738, "heart magnetic resonance imaging": 40.03601113787953, "ventricular longitudinal systolic strain": 42.604242652540464, "predicting adverse cv events": 38.49998580266851, "left ventricular diastolic function": 41.067193003337586, "mitochondrial oxidative phosphorylation capacity": 44.70371991106144, "coronary artery bypass grafting": 39.670741401945925, "channel mrna splice variants": 38.49998580266851, "acute right heart failure": 37.19692367250728, "angiotensin converting enzyme inhibitor": 42.312773619359916, "multivariate logistic regression analysis": 42.888531910354565, "left ventricular diastolic end": 39.29353265497872, "ventricular diastolic end diameter": 40.733598673094484, "angiotensin receptor neprilysin inhibitor": 42.888531910354565, "major public health problem": 38.08176757173207, "ischemic heart failure samples": 39.29353265497872, "early rhythm control therapy": 38.49998580266851, "acute care transfer policy": 37.64782321346018, "chronic advanced heart failure": 39.29353265497872, "advanced heart failure patients": 39.670741401945925, "myocardial infarction heart failure": 41.067193003337586, "primary study end point": 36.23856757222956, "heart failure disease management": 40.03601113787953, "failure disease management programs": 41.067193003337586, "hospital adverse events averted": 19.835370700972963, "national patient safety initiatives": 20.533596501668793, "cachectic heart failure patients": 20.018005568939763, "heart failure show preserved": 19.249992901334256, "mild clinical diastolic dysfunction": 20.533596501668793, "congestive heart failure exacerbation": 20.853389126933767, "clinical practice guidelines grading": 20.695707727999235, "practice guidelines grading system": 20.366799336547242, "restrictive red blood cell": 18.82391160673009, "red blood cell transfusion": 18.82391160673009, "blood cell transfusion strategy": 19.835370700972963, "term mortality rates compared": 19.45178899208369, "relative risk among trials": 18.82391160673009, "data supporting iron use": 18.363844965370397, "right ventricular assist devices": 20.018005568939763, "modern acute heart failure": 18.82391160673009, "baseline glomerular filtration rate": 20.533596501668793, "identified strong reliable mortality": 20.695707727999235, "strong reliable mortality predictors": 20.695707727999235, "acute heart failure randomized": 19.64676632748936, "heart failure randomized trial": 19.64676632748936, "renal function end point": 18.363844965370397, "cardiac chromatin identifies nucleolin": 21.00687637042384, "heart failure involves changes": 19.64676632748936, "conserved developmental chromatin remodeling": 21.85082700268063, "developmental chromatin remodeling events": 21.444265955177283, "conducted extensive functional characterization": 22.230620618901686, "displayed severe developmental impairment": 21.444265955177283, "limited data regarding risk": 19.040883785866036, "data regarding risk factors": 19.040883785866036, "present study population comprised": 20.366799336547242, "proportional hazards regression modeling": 21.302121326270232, "coronary artery bypass surgery": 19.64676632748936, "increased systolic blood pressure": 20.195037247679423, "bundle branch block pattern": 19.040883785866036, "improved outcomes among patients": 20.018005568939763, "term mortality as patients": 18.82391160673009, "interaction term analysis showed": 20.018005568939763, "day readmission rates using": 19.040883785866036, "produce different hospital rankings": 20.533596501668793, "rm interventions included home": 19.64676632748936, "interventions included home telemonitoring": 21.582993312716134, "chronic heart failure induced": 19.45178899208369, "rapid right ventricular pacing": 19.64676632748936, "pump sternal sparing approach": 19.45178899208369, "pump dysfunction requiring pump": 19.835370700972963, "dysfunction requiring pump replacement": 21.00687637042384, "type natriuretic peptide levels": 19.835370700972963, "involving ventricular assist devices": 20.695707727999235, "congestive heart failure declined": 20.195037247679423, "determined chf visit rates": 18.82391160673009, "congestive heart failure visits": 19.835370700972963, "heart failure visits declined": 19.45178899208369, "normal systolic ventricular function": 20.695707727999235, "low systemic vascular resistance": 20.018005568939763, "abnormal liver texture changes": 19.64676632748936, "chronic heart failure promotes": 19.64676632748936, "heart failure promotes restoration": 20.366799336547242, "protective effects via stimulation": 20.366799336547242, "novel heart failure mice": 18.363844965370397, "heart failure mice model": 18.363844965370397, "using simple experimental procedures": 20.695707727999235, "predict heart failure risk": 18.82391160673009, "prevalent coronary heart disease": 20.018005568939763, "simpler laboratory report model": 19.835370700972963, "temporary right ventricular support": 20.533596501668793, "chronic decompensated heart failure": 20.533596501668793, "right ventricular assist device": 19.835370700972963, "ventricular assist device use": 19.45178899208369, "selected cardiac surgery patients": 20.195037247679423, "used speckle tracking echocardiography": 21.00687637042384, "acute right ventricular pressure": 20.018005568939763, "right ventricular pressure overload": 20.533596501668793, "left ventricular midpapillary level": 20.533596501668793, "varying regional strain contributions": 20.853389126933767, "size reduction by surgery": 18.59846183625364, "successful mitral valve plasty": 19.64676632748936, "grade 4/6 holosystolic murmur": 19.45178899208369, "underwent mitral valve plasty": 19.45178899208369, "preserved mitral valve opening": 19.64676632748936, "mitral filling flow volume": 18.82391160673009, "limited mitral valve opening": 19.249992901334256, "diastolic mitral leaflet motions": 20.018005568939763, "after aggressive medical treatment": 20.366799336547242, "heart failure clinic outpatients": 20.018005568939763, "available outpatient models use": 19.835370700972963, "model included blood urea": 18.59846183625364, "included blood urea nitrogen": 19.249992901334256, "demonstrated excellent risk stratification": 21.582993312716134, "resources within health systems": 19.835370700972963, "median left ventricular ejection": 20.018005568939763, "uncontrolled hypertension identify patients": 21.71846385680694, "demonstrated high internal consistency": 21.00687637042384, "internal consistency among patients": 20.533596501668793, "offers excellent prognostic ability": 20.533596501668793, "interleukin receptor family member": 20.366799336547242, "left ventricular systolic dysfunction": 20.853389126933767, "lowest cardiovascular event rate": 20.018005568939763, "highest cardiovascular event rate": 20.195037247679423, "sst2 measurement identifies patients": 20.695707727999235, "soluble guanylate cyclase altered": 20.195037247679423, "maximal ventricular power index": 19.835370700972963, "right heart filling pressures": 19.45178899208369, "right ventricular fractional area": 20.195037247679423, "echocardiographic score allowed prediction": 21.582993312716134, "lv assist device implantations": 19.64676632748936, "symptomatic systolic heart failure": 20.366799336547242, "diagnosed systolic heart failure": 20.018005568939763, "baseline serum creatinine level": 19.835370700972963, "% confidence interval 0.77": 18.82391160673009, "incident systolic heart failure": 19.835370700972963, "endothelial growth factor blockade": 20.366799336547242, "growth factor blockade prevents": 19.835370700972963, "myocardial infarction heart contributes": 21.156386809679958, "adrenergic receptor blocker therapy": 20.533596501668793, "revealed reduced cardiac diameters": 20.366799336547242, "b act via activation": 17.316494385166266, "heart failure via activation": 19.249992901334256, "oxidase inhibition preserves left": 20.195037247679423, "inhibition improves cardiomyocyte bioenergetics": 22.230620618901686, "stable severe systolic heart": 19.249992901334256, "severe systolic heart failure": 19.45178899208369, "early transmitral blood flow": 19.249992901334256, "transmitral blood flow velocity": 19.835370700972963, "early diastolic mitral annulus": 19.64676632748936, "diastolic mitral annulus velocity": 20.195037247679423, "estimating pulmonary capillary wedge": 20.695707727999235, "decompensated systolic heart failure": 20.695707727999235, "detecting normal filling pressures": 20.366799336547242, "arterial systolic pressure relationship": 21.156386809679958, "right ventricular contractile function": 21.00687637042384, "tricuspid annular plane systolic": 20.018005568939763, "type natriuretic peptide assessment": 20.533596501668793, "downward regression line shift": 19.64676632748936, "fractional flow reserve measurements": 20.695707727999235, "positron emission tomography imaging": 20.695707727999235, "emission tomography imaging showed": 20.366799336547242, "competitive collateral growth patterns": 21.00687637042384, "selective heart rate reduction": 19.64676632748936, "preoperative serum albumin levels": 20.195037247679423, "% confidence interval 0.290": 19.040883785866036, "instituting mechanical circulatory support": 21.582993312716134, "underwent aortic valve surgery": 19.64676632748936, "patients underwent lvad implantation": 20.695707727999235, "transcatheter aortic valve procedure": 20.695707727999235, "bioprosthetic aortic valve replacement": 21.00687637042384, "population within cardiac rehabilitation": 21.302121326270232, "increased right grip strength": 19.45178899208369, "acute heart failure complicating": 20.018005568939763, "complicating precapillary pulmonary hypertension": 22.35185995553072, "major right ventricle overload": 19.64676632748936, "right ventricle overload leads": 19.64676632748936, "arterial tonometry study tested": 19.835370700972963, "radial artery tonometry variables": 20.195037247679423, "reconstructed aortic pressure curve": 20.533596501668793, "right atrial mass removal": 18.59846183625364, "right atrium mass presented": 19.040883785866036, "brief hypothermic circulatory arrest": 20.695707727999235, "advanced chronic organ failure": 19.64676632748936, "median body mass index": 17.863897858016276, "relative minimal detectable change": 20.366799336547242, "failure risk among patients": 19.040883785866036, "secondary outcome measures related": 20.366799336547242, "vasopressin receptor antagonist therapy": 21.156386809679958, "beneficial new therapeutic approach": 20.533596501668793, "healthy heart muscle cells": 18.82391160673009, "heart muscle cells developed": 19.249992901334256, "evoked spontaneous cardiac dysfunction": 21.00687637042384, "converting enzyme inhibitors intolerance": 21.302121326270232, "past decades several studies": 19.249992901334256, "beta blockers decrease mortality": 20.018005568939763, "causes myocardial insulin resistance": 20.695707727999235, "box class o-1 signaling": 18.11928378611478, "impaired cardiac metabolic gene": 19.835370700972963, "cardiac metabolic gene expression": 20.195037247679423, "impaired cardiac energy metabolism": 20.366799336547242, "cardiac energy metabolism gene": 19.64676632748936, "energy metabolism gene expression": 20.195037247679423, "neonatal rat ventricular cardiomyocytes": 21.156386809679958, "chronic insulin exposure reduced": 20.018005568939763, "optimal combined treatment measure": 20.366799336547242, "multivariable hierarchical regression models": 21.85082700268063, "level prescription rates ranged": 19.835370700972963, "adjusted median rate ratio": 18.82391160673009, "angiotensin receptor blockers therapy": 20.853389126933767, "reduced ejection fraction exists": 20.018005568939763, "cardiotoxicity among older patients": 20.533596501668793, "adjuvant setting improves outcomes": 20.366799336547242, "chf among older patients": 18.363844965370397, "older breast cancer patients": 19.249992901334256, "mortality among postmenopausal women": 20.695707727999235, "proportional hazards models adjusted": 20.695707727999235, "higher dash diet scores": 18.11928378611478, "extended criteria cardiac transplantation": 21.444265955177283, "extended criteria cardiac transplant": 20.695707727999235, "undergoing isolated heart transplant": 20.695707727999235, "criteria cardiac transplant recipients": 21.00687637042384, "criteria cardiac transplant survival": 20.695707727999235, "advanced heart failure therapy": 19.64676632748936, "heart failure readmission quality": 20.195037247679423, "failure readmission quality improvement": 21.156386809679958, "readmission quality improvement initiative": 21.582993312716134, "hospital quality improvement initiative": 21.156386809679958, "heart failure nurse practitioner": 20.018005568939763, "myocardial extracellular matrix accumulation": 21.85082700268063, "estimate myocardial extracellular matrix": 21.302121326270232, "using cardiac magnetic resonance": 20.018005568939763, "magnetic resonance t1 mapping": 19.45178899208369, "cardiac magnetic resonance imaging": 20.366799336547242, "magnetic resonance imaging including": 20.695707727999235, "resonance imaging including t1": 19.64676632748936, "imaging including t1 mapping": 19.249992901334256, "magnetic resonance t1 time": 18.82391160673009, "right ventricular ejection fraction": 20.533596501668793, "recommend cardiac resynchronization therapy": 21.71846385680694, "end systolic volume index": 18.59846183625364, "rat metabolic risk model": 18.363844965370397, "important metabolic risk factors": 20.018005568939763, "preserved ejection fraction development": 21.156386809679958, "high muscle strip stiffness": 19.040883785866036, "rats developed heart failure": 19.249992901334256, "systolic mitral annulus velocity": 20.018005568939763, "containing chronic heart failure": 20.018005568939763, "receiving implantable cardioverter defibrillator": 22.35185995553072, "refractory congestive heart failure": 20.533596501668793, "diuretic resistant volume overload": 20.366799336547242, "transplant ineligible patients receiving": 21.302121326270232, "severe right ventricular dysfunction": 20.695707727999235, "stage congestive heart failure": 19.64676632748936, "ii receptor blocker use": 18.11928378611478, "demonstrated superior reverse remodeling": 21.302121326270232, "certain dialysis patients demonstrated": 21.00687637042384, "sodium dash diet improves": 18.59846183625364, "dietary sodium restriction improves": 20.533596501668793, "parametrized diastolic filling formalism": 21.302121326270232, "connected elevated resistin levels": 20.366799336547242, "mouse model lacking murine": 18.82391160673009, "model lacking murine resistin": 19.45178899208369, "increased cardiac mrna levels": 19.45178899208369, "cell adhesion genes compared": 19.249992901334256, "treated breast cancer patients": 19.64676632748936, "patients maintaining sinus rhythm": 20.195037247679423, "larger randomized control studies": 20.195037247679423, "mitochondrial oxidative stress induced": 21.00687637042384, "restoring mitochondrial oxidative phosphorylation": 22.470604477709323, "significant cardioprotection via inhibition": 21.71846385680694, "isolated coronary artery bypass": 19.835370700972963, "heart failure \u226490 days": 17.863897858016276, "developed acute kidney injury": 19.45178899208369, "% confidence interval 1.38": 18.82391160673009, "paediatric heart failure concern": 20.018005568939763, "new onset heart failure": 18.11928378611478, "targeting specific effector molecules": 20.853389126933767, "% intermediate frail according": 19.64676632748936, "acute heart failure trials": 18.82391160673009, "adverse event rates remain": 18.82391160673009, "selecting appropriate end points": 20.018005568939763, "faster turnaround times provided": 20.018005568939763, "measuring heart failure care": 19.249992901334256, "inhibition halts heart failure": 19.64676632748936, "pathological cardiac gene expression": 20.695707727999235, "cardiac gene expression programme": 20.195037247679423, "activating transcription factor networks": 21.302121326270232, "promoting transcriptional pause release": 21.156386809679958, "abrogate pathological gene expression": 20.853389126933767, "quantify myocardial t1 changes": 19.64676632748936, "similar left ventricular tissue": 19.835370700972963, "using trichrome blue histologic": 19.835370700972963, "trichrome blue histologic analysis": 20.366799336547242, "quantify diffuse myocardial changes": 20.533596501668793, "myocardial delayed enhancement imaging": 21.00687637042384, "induced pulmonary artery systolic": 20.195037247679423, "pulmonary artery systolic pressure": 20.366799336547242, "diagnosed pulmonary arterial hypertension": 21.444265955177283, "chronic thromboembolic pulmonary hypertension": 21.980222113472074, "impaired right ventricular pump": 19.835370700972963, "right ventricular pump function": 19.835370700972963, "stable targeted pulmonary arterial": 20.366799336547242, "targeted pulmonary arterial hypertension": 21.302121326270232, "pulmonary arterial hypertension medication": 21.582993312716134, "arterial hypertension medication underwent": 21.582993312716134, "remained independent prognostic markers": 21.156386809679958, "regulates cardiac sodium current": 20.018005568939763, "systolic human heart failure": 19.249992901334256, "increases alternative mrna splicing": 20.533596501668793, "human induced pluripotent stem": 19.64676632748936, "induced pluripotent stem cell": 19.45178899208369, "receptor potential cation channel": 20.195037247679423, "potential cation channel m7": 19.040883785866036, "intrinsic left ventricular dysfunction": 21.00687637042384, "chronic pulmonary arterial hypertension": 21.156386809679958, "characteristics yielded hazard ratios": 20.853389126933767, "requires new prevention strategies": 20.366799336547242, "stable heart failure patients": 19.45178899208369, "secondary outcomes included markers": 20.533596501668793, "competing priorities impact prescribing": 21.156386809679958, "primary care clinicians caring": 19.64676632748936, "increased vascular endothelial growth": 20.853389126933767, "endothelial growth factor protein": 20.195037247679423, "volume conductance catheter system": 20.366799336547242, "coronary artery ligation augmented": 20.366799336547242, "bundle branch block type": 18.363844965370397, "block electrical activation sequence": 20.695707727999235, "slows myofiber shortening velocity": 20.366799336547242, "lower body mass index": 17.596684375279292, "lower fat mass index": 17.316494385166266, "greater antecedent weight loss": 19.64676632748936, "lean body mass ratio": 17.316494385166266, "increased body mass index": 18.59846183625364, "ivabradine increased exercise capacity": 21.00687637042384, "improved left ventricular filling": 20.195037247679423, "ventricular filling pressure response": 20.853389126933767, "abnormal exercise hemodynamic status": 20.695707727999235, "simple validated clinical tool": 19.64676632748936, "left anterior descending artery": 19.835370700972963, "simple clinical prediction rule": 19.835370700972963, "japanese heart failure patients": 19.835370700972963, "congestive heart failure patients": 20.195037247679423, "diminished cyclic adenosine monophosphate": 21.444265955177283, "augmented cyclic guanosine monophosphate": 21.302121326270232, "fluorescence resonance energy transfer": 21.00687637042384, "stimulation via catecholamine infusions": 21.156386809679958, "synthesis via nitric oxide": 18.82391160673009, "intracellular antiadrenergic therapeutic strategy": 22.470604477709323, "using linear mixed models": 18.59846183625364, "implantable cardiac arrhythmia devices": 21.00687637042384, "total cost per patient": 17.863897858016276, "severe heart failure appears": 19.249992901334256, "skeletal muscle sarcomere structure": 20.533596501668793, "systemic adverse events evaluation": 20.366799336547242, "accepted peak oxygen consumption": 20.018005568939763, "refractory right heart failure": 19.64676632748936, "after percutaneous coronary revascularization": 21.980222113472074, "extra corporeal membrane oxygenation": 20.695707727999235, "acute ischemic right heart": 18.82391160673009, "ischemic right heart failure": 19.249992901334256, "first acute myocardial infarction": 20.195037247679423, "linked administrative health data": 20.195037247679423, "mean \u00b1 sd testosterone": 17.863897858016276, "\u00b1 sd testosterone levels": 18.363844965370397, "incremental shuttle walk test": 19.45178899208369, "testosterone group showed improvements": 21.00687637042384, "tendency toward lower mitral": 19.249992901334256, "transforming growth factor beta": 19.835370700972963, "anterior descending coronary artery": 20.533596501668793, "descending coronary artery occlusion": 20.695707727999235, "cell differentiation toward cardiomyocyte": 21.444265955177283, "optimizing cardiac progenitor function": 21.00687637042384, "displayed permanent periodic breathing": 21.00687637042384, "stable coronary artery disease": 19.64676632748936, "improve cardiac autonomic balance": 20.195037247679423, "time domain heart rate": 17.863897858016276, "domain heart rate variability": 19.45178899208369, "power spectral analysis indicated": 20.195037247679423, "improves cardiac autonomic balance": 20.366799336547242, "chronic systolic heart failure": 19.64676632748936, "patients underwent device implantation": 21.00687637042384, "stage heart failure supported": 19.45178899208369, "pediatric mechanical cardiac support": 20.695707727999235, "receiving ventricular assist device": 20.533596501668793, "ventricular assist device support": 20.195037247679423, "patients receiving extracorporeal membrane": 21.582993312716134, "receiving extracorporeal membrane oxygenation": 21.980222113472074, "extracorporeal membrane oxygenation membrane": 21.85082700268063, "membrane oxygenation membrane support": 20.853389126933767, "ecmo+vad group included patients": 20.018005568939763, "sensitive outcome change scores": 19.835370700972963, "using standardized nursing terminologies": 21.302121326270232, "standardized nursing terminologies makes": 21.302121326270232, "retrospective descriptive research design": 21.444265955177283, "future prospective experimental research": 21.302121326270232, "influences cardiac hypertrophic response": 21.302121326270232, "cardiac plasma membrane levels": 19.64676632748936, "first month after discharge": 19.040883785866036, "better outcomes among patients": 19.64676632748936, "adrenergic receptor blockade reduces": 20.695707727999235, "total myosin binding protein": 19.249992901334256, "mutant ri\u03b1 proteins demonstrated": 20.018005568939763, "myocardium displays altered expression": 21.00687637042384, "autonomic nervous system activity": 20.195037247679423, "acute autonomic nervous system": 19.64676632748936, "autonomic nervous system modulation": 20.533596501668793, "related congestive heart failure": 20.018005568939763, "developing congestive heart failure": 20.533596501668793, "chf predictive model performed": 19.64676632748936, "right heart circulatory failure": 19.835370700972963, "foster collaborative research initiatives": 21.444265955177283, "class angiotensin receptor neprilysin": 20.853389126933767, "receptor neprilysin inhibitor composed": 21.00687637042384, "angiotensin receptor antagonist valsartan": 21.444265955177283, "preserved ejection fraction outcomes": 20.695707727999235, "ejection fraction outcomes trial": 20.018005568939763, "guided clinical trial design": 19.249992901334256, "reduced skeletal muscle mass": 19.249992901334256, "underwent cardiopulmonary exercise testing": 21.582993312716134, "single tertiary referral centre": 19.835370700972963, "skeletal muscle mass assessed": 19.45178899208369, "relative appendicular lean mass": 19.835370700972963, "appendicular lean mass index": 19.249992901334256, "low skeletal muscle mass": 18.363844965370397, "skeletal muscle mass correlated": 19.835370700972963, "skeletal muscle mass t": 17.863897858016276, "sarcopenic range muscle wasting": 19.835370700972963, "performed confirmatory factor analysis": 21.00687637042384, "used exploratory factor analysis": 20.018005568939763, "showed excellent fit indices": 19.249992901334256, "concentric left ventricular hypertrophy": 21.156386809679958, "outcome data among groups": 18.59846183625364, "lower systolic blood pressure": 19.45178899208369, "elevated cardiac filling pressures": 20.366799336547242, "heart failure patients undergoing": 20.195037247679423, "undergoing either cardiac resynchronization": 21.71846385680694, "nationwide retrospective cohort study": 20.853389126933767, "complete reverse cardiac remodeling": 20.533596501668793, "using general linear models": 19.040883785866036, "higher diastolic blood pressure": 19.835370700972963, "body mass index levels": 17.863897858016276, "coronary artery calcium scores": 19.64676632748936, "% confidence interval 0.50": 18.82391160673009, "share many risk factors": 18.11928378611478, "logistic regression analysis established": 21.302121326270232, "hospital readmission reduction program": 21.00687637042384, "day readmission rate following": 19.64676632748936, "readmission rate following hospital": 20.533596501668793, "rate following hospital stay": 19.249992901334256, "indicating possible suboptimal care": 20.533596501668793, "linear hr variability measures": 19.64676632748936, "term fractal scaling exponent": 19.45178899208369, "trials using hr variability": 19.040883785866036, "end stage kidney failure": 18.363844965370397, "adequate blood pressure control": 19.835370700972963, "showed modest clinical benefit": 19.64676632748936, "reveals several key genes": 18.59846183625364, "functional enrichment analysis revealed": 21.156386809679958, "longitudinal analysis using medicare": 20.695707727999235, "analysis using medicare data": 19.249992901334256, "retrospective matched cohort study": 20.366799336547242, "score matched control group": 19.040883785866036, "negative binomial regression models": 20.533596501668793, "contemporary chronic heart failure": 20.366799336547242, "socioeconomic status versus whites": 20.366799336547242, "given similar cardiovascular mortality": 21.00687637042384, "optimal therapy including anticoagulation": 21.444265955177283, "modern rhythm control therapy": 19.45178899208369, "blinded outcome assessment trial": 20.018005568939763, "term ventricular assist device": 19.64676632748936, "stage heart failure fall": 18.363844965370397, "advanced structural heart disease": 20.195037247679423, "requires special therapeutic interventions": 21.582993312716134, "ventricular action potential duration": 20.853389126933767, "type channel isoforms known": 19.040883785866036, "common inpatient medical conditions": 20.533596501668793, "derived composite quality measure": 20.195037247679423, "higher estimated glomerular filtration": 21.00687637042384, "attain maximal spironolactone dose": 20.366799336547242, "achieved study drug dose": 18.363844965370397, "derive less clinical benefit": 19.249992901334256, "free shotgun proteomics approach": 20.018005568939763, "associated signaling pathway changes": 20.695707727999235, "pathway changes using ingenuity": 19.835370700972963, "changes using ingenuity pathway": 19.835370700972963, "using ingenuity pathway analysis": 20.018005568939763, "congestive heart failure phenotypes": 20.533596501668793, "ingenuity pathway analysis noted": 20.018005568939763, "care transfer policy led": 18.363844965370397, "ami without major complications": 19.835370700972963, "costs across volume groups": 18.82391160673009, "physician volume within strata": 19.64676632748936, "symptomatic chronic advanced heart": 20.366799336547242, "infarction heart failure patients": 20.195037247679423, "large idiopathic dilated cardiomyopathy": 21.156386809679958, "idiopathic dilated cardiomyopathy cohort": 21.302121326270232, "including negative coronary angiography": 21.156386809679958, "heart failure treatment eras": 19.249992901334256, "severe left ventricular dilatation": 20.366799336547242, "end point including death": 18.59846183625364, "recent enrollment period represented": 20.695707727999235, "maximal cardiopulmonary exercise test": 20.853389126933767, "cardiopulmonary exercise test investigations": 21.85082700268063, "peak respiratory quotient \u22641.05": 19.835370700972963, "at multivariable logistic analysis": 20.366799336547242, "reduced peak oxygen uptake": 18.82391160673009, "kidney index score value": 18.363844965370397, "secondary study end point": 18.59846183625364, "associations among cardiorespiratory fitness": 21.85082700268063, "measures included body mass": 19.040883785866036, "included body mass index": 18.363844965370397, "maximal treadmill exercise testing": 20.366799336547242, "obese body mass index": 17.596684375279292, "body mass index categories": 18.82391160673009, "overweight body mass index": 18.82391160673009, "body mass index strata": 17.863897858016276, "decreased mitochondrial energy production": 21.444265955177283, "mitochondrial energy production precede": 21.156386809679958, "reduced mitochondrial complex v": 19.835370700972963, "mitochondrial complex v activity": 20.018005568939763, "decreased mitochondrial oxidative metabolism": 21.85082700268063, "guide health service planning": 19.45178899208369, "relevant health service provision": 20.195037247679423, "health service provision related": 20.018005568939763, "raised blood glucose levels": 19.040883785866036, "lower gross national income": 19.040883785866036, "national income per capita": 18.82391160673009, "renal chloride channel gene": 19.040883785866036, "tac cardiac functional deterioration": 20.695707727999235, "health system data partners": 19.040883785866036, "without prior cardiovascular disease": 20.695707727999235, "prospective studies evaluating implementation": 21.980222113472074, "studies evaluating implementation interventions": 22.230620618901686, "left ventricular function assessment": 20.695707727999235, "experiencing distressing implantable cardioverter": 22.470604477709323, "carotid baroreflex activation therapy": 20.853389126933767, "primary safety end point": 18.363844965370397, "primary efficacy end points": 19.040883785866036, "minute hall walk distance": 18.59846183625364, "trend toward fewer days": 18.11928378611478, "using cardiopulmonary exercise testing": 21.00687637042384, "cardiopulmonary exercise testing guide": 21.00687637042384, "exercise testing guide exercise": 19.835370700972963, "testing guide exercise rehabilitation": 20.853389126933767, "exercise patients used \u03b450%w": 19.249992901334256, "patients used \u03b450%w intensity": 19.45178899208369, "reduced long axis function": 18.82391160673009, "other cardiovascular risk factors": 20.195037247679423, "peripheral oedema allows assessment": 20.533596501668793, "regular physical activity controls": 20.366799336547242, "physical activity controls acquired": 20.533596501668793, "acquired cardiovascular risk factors": 20.695707727999235, "exercise prevents cell senescence": 20.195037247679423, "certain malignancies including cancer": 20.853389126933767, "aerobic exercise per week": 18.59846183625364, "recommendations confer health benefits": 21.00687637042384, "cardiac disease including heart": 19.835370700972963, "disease including heart failure": 19.835370700972963, "detect congenital accessory pathways": 20.695707727999235, "week aerobic training period": 19.249992901334256, "integrated dynamic resistance training": 21.00687637042384, "perceived social support score": 19.64676632748936, "higher exercise time associated": 19.835370700972963, "% confidence interval 0.99": 18.82391160673009, "% confidence interval 0.66": 18.82391160673009, "exercise training improves outcomes": 20.533596501668793, "implement exercise training therapy": 20.533596501668793, "recent onset heart failure": 18.82391160673009, "hr<70 versus \u226570 bpm": 17.316494385166266, "elevated left atrial pressure": 19.45178899208369, "atrial pressure improve symptoms": 20.018005568939763, "canadian special access programme": 20.195037247679423, "min walk test distance": 17.863897858016276, "incessant ventricular tachycardia storm": 21.156386809679958, "prospective randomized multicenter trial": 21.302121326270232, "randomized multicenter trial paradigm": 20.853389126933767, "stabilized chronic heart failure": 20.018005568939763, "stable chronic heart failure": 19.249992901334256, "failure among older persons": 19.040883785866036, "urban academic medical center": 19.45178899208369, "indicate worse heart failure": 19.249992901334256, "percent lean body mass": 17.863897858016276, "related serious adverse events": 19.64676632748936, "among obese older patients": 18.82391160673009, "aerobic exercise training increased": 20.533596501668793, "exercise training increased peak": 20.018005568939763, "left ventricular assist system": 19.64676632748936, "adverse events included reoperation": 20.533596501668793, "favorable adverse event profile": 19.835370700972963, "influence medical resource use": 19.64676632748936, "target patient population is": 14.437494676000693, "appropriate risk stratification is": 15.27509950241043, "dilated by another disease": 14.117933705047566, "ventricular ejection fraction was": 15.146277935759567, "aortic valve replacement is": 14.280662839399527, "receptor antagonist therapy is": 14.73507474561702, "patients at high risk": 13.197513281459468, "extracorporeal life support is": 14.73507474561702, "abnormal hr variability have": 14.437494676000693, "magnetic resonance angiography is": 15.146277935759567, "sickle cell disease has": 13.589462839586087, "secondary end point was": 13.589462839586087, "mass index categories were": 14.117933705047566, "total adiponectin at baseline": 9.725894496041844, "term mortality after hospitalization": 10.347853863999617, "significant difference between numbers": 10.50343818521192, "similar among all subgroups": 9.520441892933018, "mortality among these subgroups": 9.917685350486481, "cognitive impairment at hospitalization": 10.578193404839979, "heart disease by angiotensin": 9.624996450667128, "limited mortality at hospital": 9.725894496041844, "restricted without any clear": 9.624996450667128, "opening without any clear": 9.29923091812682, "preserved and reduced ejection": 9.82338316374468, "benefits across all study": 9.29923091812682, "independent association between spironolactone": 11.053389691083952, "kidney injury during spironolactone": 10.266798250834396, "flow velocity over tissue": 9.29923091812682, "severe ischemia after bottleneck": 10.009002784469882, "hr reduction by ivabradine": 9.411955803365045, "prognostic factors at admission": 9.917685350486481, "cardiovascular disease at baseline": 10.183399668273621, "insulin action through activation": 10.097518623839711, "cardiac dysfunction during insulin": 10.183399668273621, "day readmissions as part": 9.181922482685199, "medication changes at follow": 9.624996450667128, "compelling improvement after device": 10.266798250834396, "free probability after catheter": 9.917685350486481, "strain rate at systole": 8.931948929008138, "strain rate at diastole": 9.05964189305739, "sinus rhythm at follow": 8.931948929008138, "cardiovascular events after adjustment": 10.50343818521192, "parasympathetic tone by pyridostigmine": 10.50343818521192, "significant improvement between baseline": 10.651060663135116, "heart rate during exercise": 9.411955803365045, "sarcomeric microstructure at baseline": 10.426694563466883, "membrane oxygenation as bridge": 9.82338316374468, "sham levels by dnx": 8.355835584391686, "ecmo+vad group until day": 9.181922482685199, "urgent readmission after discharge": 10.183399668273621, "influences outcomes after discharge": 10.266798250834396, "surface ecgs at baseline": 9.181922482685199, "target genes by sequence": 9.181922482685199, "cardiac filling during exercise": 9.917685350486481, "patient plasma by use": 8.798342187639646, "subcellular alterations by metoprolol": 10.426694563466883, "cardiac performance by \u03b2": 9.181922482685199, "cardiovascular events as subjects": 10.097518623839711, "telehealth technology has potential": 10.266798250834396, "onset af at risk": 8.01797756645451, "heart failure at rest": 8.798342187639646, "cell disease has life": 8.798342187639646, "test investigations at study": 9.624996450667128, "heart failure after pressure": 9.624996450667128, "care education at discharge": 9.520441892933018, "defibrillator deactivation at implant": 10.426694563466883, "broader discussions about end": 9.725894496041844, "defibrillator shocks at end": 9.520441892933018, "nontraumatic death during sport": 9.917685350486481, "gas analysis at baseline": 9.181922482685199, "echocardiography evaluations at baseline": 10.651060663135116, "gastrointestinal bleeding at month": 10.183399668273621, "association between any predictor": 5.048759311919856, "study other potential predictors": 5.004501392234941, "expression during cardiac hypertrophy": 5.213347281733442, "association between serial measurements": 5.2890967024199895, "monitoring after recent hospital": 5.004501392234941, "genes by western blot": 4.399171093819823, "patients having heart failure": 4.862947248020922, "shock after myocardial infarction": 5.048759311919856, "mortality at hospital discharge": 4.958842675243241, "improve such functional ms": 4.705977901682522, "disappeared and postoperative echocardiography": 5.526694845541976, "flow by continuous wave": 4.529820946528695, "years after valve plasty": 4.590961241342599, "left and right heart": 4.329123596291566, "remodeling after cardiac resynchronization": 5.3957483281790335, "response after cardiac resynchronization": 5.325530331567558, "hospitalization during 57\u00b122 months": 5.133399125417198, "association between spironolactone use": 5.25171909260596, "injury during spironolactone use": 5.004501392234941, "weeks after b treatment": 4.529820946528695, "paralleled by any attenuation": 4.862947248020922, "revision by open surgery": 4.590961241342599, "dysfunction during insulin resistance": 5.213347281733442, "association between treatment variation": 5.2890967024199895, "patients had blood work": 4.529820946528695, "rats after heart failure": 4.590961241342599, "outcomes after cardiac resynchronization": 5.325530331567558, "improvement after device implantation": 5.213347281733442, "controls not expressing human": 4.862947248020922, "probability after catheter ablation": 5.133399125417198, "infarction after coronary artery": 5.004501392234941, "interplay between these transcription": 5.213347281733442, "mri during tidal respiration": 4.812498225333564, "fraction after myocardial infarction": 5.173926931999809, "interval between local myocyte": 4.91169158187234, "mechanism during cardiac stress": 4.958842675243241, "subgroups at high risk": 4.465974464504069, "therapy during exercise rehabilitation": 5.25171909260596, "functions after myocardial infarction": 5.213347281733442, "levels by renal dnx": 4.255500733148387, "continuity further influences outcomes": 5.25171909260596, "blockade at advanced stages": 4.760220946466509, "provide more concrete data": 4.705977901682522, "controls during this same": 4.64961545906341, "therapy by antiarrhythmic drugs": 4.958842675243241, "mistargeting or altered regulation": 5.0916998341368105, "race by treatment interaction": 4.862947248020922, "relationship between physician volume": 5.213347281733442, "devices at final evaluation": 4.760220946466509, "investigations at study enrollment": 5.0916998341368105, "developed and nondeveloped countries": 5.173926931999809, "link between air pollution": 4.705977901682522, "findings through briefing reports": 5.048759311919856, "decisions about implantable cardioverter": 5.325530331567558, "exercise below these recommendations": 5.173926931999809, "association between social support": 5.0916998341368105, "guidance under general anaesthesia": 5.0916998341368105, "% confidence interval": 501.5055046954598, "left ventricular ejection": 474.2607768244678, "chronic heart failure": 422.320425006703, "ventricular ejection fraction": 452.25409406594576, "methods and results": 395.7615681828, "preserved ejection fraction": 428.4198851819858, "congestive heart failure": 385.64074427277836, "heart failure patients": 267.95846787024414, "acute heart failure": 242.56354178945804, "reduced ejection fraction": 265.02808116661436, "systolic heart failure": 214.36677429619533, "type natriuretic peptide": 206.59325586041697, "cardiac resynchronization therapy": 196.90161316487436, "glomerular filtration rate": 169.4152044605708, "ventricular assist device": 167.38615652628278, "body mass index": 140.9931591997578, "acute myocardial infarction": 157.0872912333948, "estimated glomerular filtration": 163.64180828302693, "advanced heart failure": 147.37715732863427, "left ventricular assist": 135.89462839586085, "ventricular assist devices": 127.0614033454281, "right heart failure": 114.89851979500645, "stage heart failure": 102.13201759556128, "early diastolic mitral": 107.18338714809767, "converting enzyme inhibitors": 101.06246273200485, "coronary artery disease": 95.1262398771026, "rhythm control therapy": 93.78546375458545, "systolic blood pressure": 81.53677703751652, "adjusted hazard ratio": 79.18507968875682, "brain natriuretic peptide": 83.69307826314139, "angiotensin receptor blockers": 87.5330504643766, "cardiac magnetic resonance": 84.7076022302854, "induced heart failure": 79.18507968875682, "peak oxygen uptake": 75.20252025952517, "idiopathic dilated cardiomyopathy": 90.8776676145574, "coronary heart disease": 66.98961696756103, "obstructive pulmonary disease": 72.94420872031384, "left ventricular dysfunction": 72.18747338000345, "proportional hazards models": 71.40331419699764, "acute kidney injury": 63.8325109972258, "severe heart failure": 64.9368539443735, "ischemic heart failure": 66.98961696756103, "day readmission rate": 64.9368539443735, "cardiopulmonary exercise testing": 75.06752088352411, "left bundle branch": 50.13501350635012, "bundle branch block": 51.06600879778064, "annular size reduction": 53.59169357404883, "adjusted odds ratio": 51.06600879778064, "left ventricular filling": 55.09153489611119, "angiotensin converting enzyme": 58.35536697625106, "mineralocorticoid receptor antagonists": 63.02062911127152, "criteria cardiac transplant": 57.12265135759811, "quality improvement initiative": 58.94029898246808, "implantable cardioverter defibrillator": 63.02062911127152, "ventricular contractile reserve": 59.50611210291889, "diastolic mitral annular": 55.09153489611119, "mitral annular velocity": 54.35785135834435, "peak oxygen consumption": 54.35785135834435, "extracorporeal membrane oxygenation": 61.600789505006375, "mechanical cardiac support": 56.471734820190264, "sudden cardiac death": 51.9494831554988, "skeletal muscle mass": 51.9494831554988, "defibrillator deactivation discussions": 63.02062911127152, "disease management programs": 57.12265135759811, "adverse event rates": 38.29950659833548, "peripheral vascular disease": 42.84198851819858, "hour cumulative urine": 39.59253984437841, "cumulative urine volume": 40.76838851875826, "coronary artery bypass": 40.193770180536625, "among older patients": 38.9621123666241, "cd34+vegfr2 + cells": 38.29950659833548, "primary end point": 36.863319779986824, "morbidity and mortality": 40.76838851875826, "% confidence intervals": 40.193770180536625, "predictive cutoff value": 40.76838851875826, "materials and methods": 39.59253984437841, "mitral valve plasty": 38.29950659833548, "developed heart failure": 40.76838851875826, "aggressive medical treatment": 43.312484028002075, "successful valve plasty": 40.76838851875826, "mitral valve opening": 38.9621123666241, "mean pressure gradient": 40.193770180536625, "heart failure hospitalization": 43.7665252321883, "assist device implantation": 42.3538011151427, "vascular endothelial growth": 42.84198851819858, "endothelial growth factor": 41.846539131570694, "myocardial infarction heart": 42.84198851819858, "chronic myocardial ischemia": 42.84198851819858, "standard cardiac rehabilitation": 44.629584077189165, "cardiac rehabilitation care": 42.84198851819858, "mean ejection fraction": 40.193770180536625, "optimal combined treatment": 42.3538011151427, "breast cancer patients": 40.193770180536625, "dash diet scores": 36.08089904904529, "standard criteria cardiac": 41.846539131570694, "magnetic resonance imaging": 42.3538011151427, "adverse cv events": 36.863319779986824, "converting enzyme inhibitor": 42.84198851819858, "ventricular diastolic function": 44.20522423685106, "transverse aortic constriction": 44.20522423685106, "pulmonary arterial hypertension": 44.629584077189165, "human heart failure": 38.29950659833548, "diastolic mitral flow": 39.59253984437841, "mitral flow velocity": 38.9621123666241, "low testosterone status": 40.76838851875826, "improves exercise capacity": 42.3538011151427, "heart rate variability": 40.193770180536625, "group included patients": 40.76838851875826, "hospitalized older adults": 41.846539131570694, "end stage heart": 35.24828979993945, "cardiopulmonary exercise test": 43.7665252321883, "study end point": 35.24828979993945, "cardiovascular risk factors": 42.84198851819858, "lv diastolic dysfunction": 27.545767448055596, "implantable cardioverter defibrillators": 31.734580214519937, "right ventricular assist": 27.545767448055596, "preserve renal function": 27.178925679172174, "cystatin c level": 24.05393269936353, "proteins alter chromatin": 27.545767448055596, "alter chromatin structure": 27.89769275438046, "gene expression profile": 27.178925679172174, "receive cardiac resynchronization": 30.292555871519134, "acute coronary syndromes": 27.545767448055596, "among study patients": 25.9747415777494, "subsequent heart failure": 27.545767448055596, "outcomes among patients": 27.178925679172174, "circulating progenitor cells": 28.874989352001386, "improved functional capacity": 28.874989352001386, "recent hospital discharge": 27.89769275438046, "implanted monitoring devices": 28.874989352001386, "medical support provided": 27.545767448055596, "ventricular ejection fractions": 29.47014949123404, "recommended target dose": 27.178925679172174, "natriuretic peptide levels": 28.235867410095132, "predict inhospital mortality": 28.874989352001386, "pediatric heart failure": 27.178925679172174, "systemic vascular resistance": 28.874989352001386, "minute walk test": 24.05393269936353, "induced no production": 26.395026562918936, "hypertensive heart disease": 28.235867410095132, "heart failure risk": 25.06750675317506, "operating characteristic curve": 29.47014949123404, "integrated discrimination improvement": 31.28008369040065, "net reclassification improvement": 30.027008353409645, "requiring biventricular support": 29.753056051459446, "transplantation eligibility status": 30.55019900482086, "functional mitral stenosis": 28.235867410095132, "ischemic mitral regurgitation": 29.17768348812553, "diastolic mitral valve": 26.795846787024416, "mitral valve tethering": 26.795846787024416, "anterior leaflet opening": 27.545767448055596, "posteriorly displaced papillary": 29.753056051459446, "displaced papillary muscles": 28.561325678799054, "left ventricular dilatation": 28.561325678799054, "diastolic volume index": 26.795846787024416, "mitral filling flow": 25.53300439889032, "clear organic lesion": 25.9747415777494, "cause medical hospitalization": 29.17768348812553, "month event rates": 24.575546519991214, "stage renal disease": 25.53300439889032, "cardiovascular event rate": 27.89769275438046, "high sst2 treated": 24.575546519991214, "multiparametric echocardiographic score": 31.734580214519937, "global longitudinal strain": 28.235867410095132, "left atrial area": 24.05393269936353, "newly diagnosed heart": 26.395026562918936, "diagnosed heart failure": 27.178925679172174, "fold increased risk": 25.53300439889032, "ventricular filling pressure": 28.874989352001386, "mitral annulus velocity": 27.178925679172174, "pulmonary capillary wedge": 27.89769275438046, "capillary wedge pressure": 27.545767448055596, "good diagnostic performance": 28.561325678799054, "annular plane systolic": 26.795846787024416, "plane systolic excursion": 27.545767448055596, "pulmonary arterial systolic": 28.561325678799054, "arterial systolic pressure": 28.235867410095132, "left anterior descending": 27.545767448055596, "heart rate reduction": 25.9747415777494, "effective arterial elastance": 28.874989352001386, "ejection fraction \u226435": 26.395026562918936, "fraction \u226435 %": 22.905739545068585, "isolated hr reduction": 26.395026562918936, "aortic valve replacement": 27.545767448055596, "exercise per week": 24.575546519991214, "hand grip strength": 25.06750675317506, "ventricular ejection time": 27.89769275438046, "higher serum levels": 25.53300439889032, "higher furosemide dose": 26.795846787024416, "right atrial myxoma": 25.53300439889032, "% confidence level": 25.06750675317506, "vasopressin receptor antagonist": 29.753056051459446, "embryonic gene programs": 27.178925679172174, "median rate ratio": 24.575546519991214, "adjusted hazard ratios": 26.795846787024416, "extended criteria cardiac": 27.89769275438046, "chronic kidney disease": 26.795846787024416, "magnetic resonance postcontrast": 29.753056051459446, "myocardial extracellular matrix": 29.753056051459446, "magnetic resonance t1": 26.395026562918936, "pulmonary vascular resistance": 29.17768348812553, "heart magnetic resonance": 27.545767448055596, "mild heart failure": 25.06750675317506, "clinical composite response": 28.561325678799054, "underlying myocardial dd": 27.545767448055596, "longitudinal systolic strain": 28.874989352001386, "consecutive case series": 27.178925679172174, "serum resistin levels": 26.395026562918936, "aortic blood flow": 24.575546519991214, "adenine nucleotides contents": 28.874989352001386, "mitochondrial oxidative phosphorylation": 31.734580214519937, "oxidative phosphorylation capacity": 30.55019900482086, "creatine kinase activity": 27.545767448055596, "preoperative renal dysfunction": 29.47014949123404, "artery bypass grafting": 26.795846787024416, "primary isolated cabg": 26.395026562918936, "onset heart failure": 25.53300439889032, "maladaptive cardiac remodelling": 29.753056051459446, "severe pulmonary hypertension": 29.17768348812553, "pulmonary hypertension patients": 29.753056051459446, "unfolded protein response": 27.89769275438046, "channel mrna splice": 25.53300439889032, "mrna splice variants": 25.9747415777494, "acute right heart": 24.575546519991214, "cardiac sympathetic activity": 28.874989352001386, "stable heart failure": 25.9747415777494, "adrenergic receptor haplotype": 29.17768348812553, "dyssynchronous heart failure": 28.874989352001386, "lean body mass": 22.905739545068585, "clinical prediction rule": 27.545767448055596, "multivariate logistic regression": 30.027008353409645, "logistic regression analysis": 28.874989352001386, "worsening renal function": 27.545767448055596, "chinese herbal medicine": 27.178925679172174, "ventricular diastolic end": 27.89769275438046, "diastolic end diameter": 26.795846787024416, "acute care surgery": 25.06750675317506, "refractory cardiogenic shock": 28.874989352001386, "key health outcomes": 25.53300439889032, "shuttle walk test": 24.575546519991214, "functional electrical stimulation": 30.292555871519134, "minute walked distance": 26.795846787024416, "transforming growth factor": 28.235867410095132, "mesenchymal transition markers": 29.47014949123404, "cardiac autonomic balance": 27.89769275438046, "worsening heart failure": 27.178925679172174, "early physician follow": 26.795846787024416, "proportional hazard models": 28.235867410095132, "autonomic nervous system": 27.545767448055596, "angiotensin receptor neprilysin": 29.753056051459446, "receptor neprilysin inhibitor": 29.17768348812553, "inappropriate implantable cardioverter": 31.51031455563576, "patients receiving carvedilol": 29.17768348812553, "% lower rate": 21.581610854323394, "retrospective cohort study": 28.235867410095132, "myosin heavy chain": 25.06750675317506, "peripheral artery disease": 27.89769275438046, "health care system": 25.06750675317506, "major public health": 25.53300439889032, "public health problem": 26.395026562918936, "heart failure samples": 26.395026562918936, "functional enrichment analysis": 29.47014949123404, "early rhythm control": 25.9747415777494, "terminal heart failure": 26.795846787024416, "versus best quintile": 25.9747415777494, "combined end point": 25.06750675317506, "global proteomics changes": 27.89769275438046, "ingenuity pathway analysis": 28.235867410095132, "acute care transfer": 25.53300439889032, "care transfer policy": 25.9747415777494, "without major complications": 28.561325678799054, "across hospital volume": 26.795846787024416, "hospital volume groups": 26.795846787024416, "chronic advanced heart": 26.795846787024416, "infarction heart failure": 27.545767448055596, "primary study end": 24.575546519991214, "kidney index score": 25.06750675317506, "lower total expenditure": 27.178925679172174, "health per capita": 24.575546519991214, "assisted gait therapy": 26.395026562918936, "peak quadriceps force": 26.395026562918936, "adverse events occurred": 27.178925679172174, "versus \u226570 bpm": 22.905739545068585, "right interatrial shunting": 28.235867410095132, "principle cohort study": 26.795846787024416, "min walk test": 22.268969439900527, "aerobic exercise training": 27.89769275438046, "obese older patients": 25.9747415777494, "heart failure disease": 26.395026562918936, "failure disease management": 28.235867410095132, "characteristics and outcomes": 24.06249112666782, "safety and efficacy": 21.277503665741936, "patient population is": 17.596684375279292, "effectiveness and safety": 18.363844965370397, "death or hospitalization": 18.363844965370397, "national efforts dedicated": 14.117933705047566, "improve patient safety": 13.397923393512208, "patient safety remain": 13.197513281459468, "assess national trends": 13.397923393512208, "conditions requiring surgery": 14.437494676000693, "large study sample": 12.53375337658753, "hospital adverse events": 13.589462839586087, "adverse events averted": 13.397923393512208, "measurable overall improvements": 14.876528025729723, "considerable national attention": 14.876528025729723, "national patient safety": 13.589462839586087, "patient safety initiatives": 14.117933705047566, "cachectic heart failure": 13.589462839586087, "increased energy expenditure": 14.437494676000693, "b natriuretic peptides": 13.397923393512208, "fat free mass": 11.134484719950263, "body fat distribution": 13.197513281459468, "dual energy x": 11.134484719950263, "prior myocardial infarction": 14.280662839399527, "stable body weight": 12.53375337658753, "heart failure show": 12.53375337658753, "major underlying mechanism": 14.117933705047566, "clinical diastolic dysfunction": 14.73507474561702, "diastolic dysfunction leading": 14.588841744062766, "guidelines based definition": 14.280662839399527, "dilated left ventricle": 13.397923393512208, "clinical practice guideline": 14.280662839399527, "provide clinical recommendations": 15.013504176704823, "guideline included mortality": 14.437494676000693, "heart failure exacerbation": 14.117933705047566, "venous thromboembolic events": 14.437494676000693, "ischemic cerebrovascular events": 14.876528025729723, "target patient population": 13.94884637719023, "deficient adult patients": 13.772883724027798, "clinical practice guidelines": 14.437494676000693, "practice guidelines grading": 14.280662839399527, "guidelines grading system": 13.94884637719023, "restrictive red blood": 13.197513281459468, "red blood cell": 11.452869772534292, "blood cell transfusion": 13.397923393512208, "cell transfusion strategy": 13.94884637719023, "trigger hemoglobin threshold": 14.437494676000693, "higher hemoglobin levels": 13.772883724027798, "clinical trial registries": 13.94884637719023, "observational studies suggests": 14.73507474561702, "liberal transfusion protocols": 14.588841744062766, "term mortality rates": 12.9873707888747, "less aggressive protocols": 13.94884637719023, "combined relative risk": 13.397923393512208, "risk among trials": 12.287773259995607, "decreased mortality rates": 13.94884637719023, "acute coronary syndrome": 13.589462839586087, "intravenous iron found": 13.397923393512208, "term exercise tolerance": 13.589462839586087, "stimulating agent therapy": 13.94884637719023, "data supporting iron": 12.9873707888747, "supporting iron use": 12.76650219944516, "higher transfusion thresholds": 14.588841744062766, "consistently improve mortality": 14.73507474561702, "improve mortality rates": 13.589462839586087, "remote ischemic conditioning": 14.437494676000693, "heart failure clinical": 13.397923393512208, "failure clinical trials": 13.589462839586087, "enriching patient identification": 15.013504176704823, "modern acute heart": 12.53375337658753, "appropriate risk stratification": 14.876528025729723, "implantable cardiac defibrillator": 15.146277935759567, "many current predictors": 13.589462839586087, "reviewers selected citations": 14.437494676000693, "using multivariable regression": 14.73507474561702, "baseline glomerular filtration": 14.73507474561702, "strong reliable mortality": 13.94884637719023, "reliable mortality predictors": 14.588841744062766, "failure randomized trial": 13.772883724027798, "small studies suggest": 13.197513281459468, "min without bolus": 12.287773259995607, "controlled clinical trial": 13.94884637719023, "1:1 allocation ratio": 12.9873707888747, "pooled placebo group": 12.9873707888747, "decongestion end point": 13.397923393512208, "serum cystatin c": 12.026966349681764, "renal function end": 12.53375337658753, "function end point": 12.53375337658753, "secondary end points": 12.9873707888747, "end points reflective": 13.197513281459468, "conclusion and relevance": 13.772883724027798, "nesiritide enhanced decongestion": 15.013504176704823, "improved renal function": 13.589462839586087, "heart failure guidelines": 13.772883724027798, "many multisite studies": 13.397923393512208, "improving patient outcomes": 14.117933705047566, "specific research questions": 14.280662839399527, "utilizing voluntary testimonies": 14.876528025729723, "extend beyond meeting": 13.197513281459468, "beyond meeting magnet": 13.197513281459468, "cardiac chromatin identifies": 14.437494676000693, "chromatin identifies nucleolin": 14.73507474561702, "failure involves changes": 13.772883724027798, "global gene expression": 13.397923393512208, "coordinate dna accessibility": 14.437494676000693, "accompany heart failure": 13.589462839586087, "present study tests": 12.76650219944516, "conserved developmental chromatin": 15.146277935759567, "developmental chromatin remodeling": 15.27509950241043, "chromatin remodeling events": 14.280662839399527, "used quantitative proteomics": 14.437494676000693, "extracted via detergent": 13.589462839586087, "using strong acid": 12.287773259995607, "exhibited altered expression": 14.437494676000693, "extensive functional characterization": 15.640041845200326, "nearly abolished protein": 13.772883724027798, "abolished protein expression": 14.437494676000693, "gross morphological development": 14.876528025729723, "severe developmental impairment": 14.876528025729723, "abnormal chamber patterning": 14.280662839399527, "bone morphogenetic protein": 14.117933705047566, "decreased rrna transcription": 14.437494676000693, "new chromatin subproteome": 13.94884637719023, "diseased mouse heart": 12.9873707888747, "complementary model system": 14.117933705047566, "genomic reprogramming events": 14.437494676000693, "myocardial ischemic events": 14.117933705047566, "limited data regarding": 13.397923393512208, "data regarding risk": 12.76650219944516, "regarding risk factors": 13.397923393512208, "present study population": 13.772883724027798, "proportional hazards regression": 14.876528025729723, "identify risk factors": 13.197513281459468, "included previous revascularization": 15.400197376251594, "artery bypass surgery": 13.197513281459468, "percutaneous coronary intervention": 15.27509950241043, "increased systolic blood": 13.772883724027798, "branch block pattern": 12.9873707888747, "dependent analysis showed": 13.94884637719023, "contemporary heart failure": 14.117933705047566, "increased increase rate": 13.589462839586087, "interaction term analysis": 13.94884637719023, "patients \u226475 years": 12.53375337658753, "older age group": 11.74942993331315, "cd133 + cells": 11.134484719950263, "increased functional capacity": 14.588841744062766, "patients without diabetes": 13.94884637719023, "noted differential relations": 14.437494676000693, "three readmission metrics": 13.94884637719023, "day readmission rates": 13.197513281459468, "three disease groups": 12.9873707888747, "average hospital rates": 13.397923393512208, "extreme decile according": 13.772883724027798, "correlations among metrics": 14.117933705047566, "hospital longitudinal change": 14.437494676000693, "produce different hospital": 14.117933705047566, "different hospital rankings": 14.280662839399527, "readmission metric choice": 13.94884637719023, "deliver specialised care": 13.772883724027798, "heart failure population": 13.772883724027798, "strategies improve outcomes": 14.280662839399527, "searching relevant articles": 14.280662839399527, "observational cohort studies": 14.437494676000693, "contemporaneous control group": 14.588841744062766, "interventions included home": 14.280662839399527, "included home telemonitoring": 14.437494676000693, "structured telephone support": 14.437494676000693, "delivered via human": 12.76650219944516, "reaching statitistical significance": 15.400197376251594, "% credible interval": 12.76650219944516, "generally improved health": 13.94884637719023, "showed beneficial trends": 13.772883724027798, "recently discharged patients": 14.437494676000693, "induced dilated cardiomyopathy": 14.73507474561702, "right ventricular pacing": 13.772883724027798, "interventricular septum biopsies": 15.013504176704823, "evaluated protein levels": 13.772883724027798, "moderate heart failure": 13.397923393512208, "pump sternal sparing": 12.9873707888747, "sternal sparing approach": 13.772883724027798, "dysfunction requiring pump": 14.117933705047566, "requiring pump replacement": 14.117933705047566, "isolated pump replacement": 13.94884637719023, "angiotensin system blocker": 14.117933705047566, "blocker dose changes": 12.9873707888747, "blocker dose increase": 13.197513281459468, "patients without uptitration": 14.437494676000693, "higher heart rate": 12.287773259995607, "better renal function": 13.197513281459468, "predicts clinical outcome": 13.94884637719023, "explored sex differences": 13.772883724027798, "determine prognostic significance": 15.146277935759567, "compute odds ratios": 12.76650219944516, "higher admission median": 13.589462839586087, "difference among reduced": 13.772883724027798, "difference among preserved": 14.117933705047566, "women vs men": 10.790805427161697, "article presents guidelines": 14.280662839399527, "early medical management": 13.772883724027798, "emergency room practice": 13.589462839586087, "undiagnosed heart disease": 13.94884637719023, "received surgical palliation": 14.437494676000693, "advanced management involving": 14.588841744062766, "involving ventricular assist": 14.437494676000693, "elderly patients hospitalized": 14.588841744062766, "consecutive patients seen": 13.94884637719023, "determined chf visit": 12.9873707888747, "chf visit rates": 11.74942993331315, "performed regression analyses": 14.588841744062766, "heart failure visits": 12.9873707888747, "% relative decrease": 12.76650219944516, "annual ed visits": 12.026966349681764, "better chf treatments": 13.197513281459468, "systolic ventricular function": 14.588841744062766, "significant liver disease": 13.94884637719023, "traditional heart failure": 13.94884637719023, "low systemic vascular": 13.197513281459468, "preserved cardiac index": 13.589462839586087, "case cohort analysis": 12.9873707888747, "mean catheterization findings": 14.588841744062766, "central venous pressure": 13.589462839586087, "index 2.7 \u00b1": 10.41746331438823, "\u00b1 0.7 l": 8.48345707385196, "abnormal liver texture": 13.397923393512208, "liver texture changes": 13.197513281459468, "similar cardiac index": 13.197513281459468, "cardiac index compared": 13.397923393512208, "distinct circulatory derangement": 15.013504176704823, "hemodynamic features similar": 14.437494676000693, "augment cardiac output": 13.397923393512208, "hospitalization or death": 13.772883724027798, "versus without preserved": 13.772883724027798, "final multivariate models": 13.94884637719023, "failure promotes restoration": 14.437494676000693, "density lipoprotein functional": 14.73507474561702, "lipoprotein functional properties": 15.146277935759567, "effects via stimulation": 13.589462839586087, "mediated protective effects": 14.280662839399527, "respective molecular pathways": 14.588841744062766, "significantly improved hdl": 14.117933705047566, "improved hdl function": 13.197513281459468, "mediated dilatation improvement": 14.876528025729723, "mediated vascular effects": 13.94884637719023, "exerts beneficial effects": 13.94884637719023, "first research done": 12.76650219944516, "\u00b1 10.3 years": 10.790805427161697, "\u00b1 11.07 years": 11.134484719950263, "85.9 % sensitivity": 12.53375337658753, "39.1 % specificity": 12.53375337658753, "optimal cutoff level": 12.9873707888747, "novel heart failure": 12.76650219944516, "heart failure mice": 12.53375337658753, "failure mice model": 12.53375337658753, "mouse heart failure": 12.76650219944516, "new therapeutic targets": 13.589462839586087, "simple experimental procedures": 14.73507474561702, "combining salt loading": 13.397923393512208, "showed significant decreases": 14.437494676000693, "infusion mouse model": 12.9873707888747, "predict heart failure": 13.197513281459468, "various cardiovascular diseases": 14.876528025729723, "cardiac troponin t": 12.53375337658753, "antihypertensive medication use": 14.876528025729723, "prevalent coronary heart": 13.772883724027798, "participants developed incident": 14.876528025729723, "simpler laboratory report": 13.94884637719023, "laboratory report model": 13.589462839586087, "clinical characteristics results": 15.013504176704823, "right ventricular support": 13.94884637719023, "chronic decompensated heart": 14.280662839399527, "decompensated heart failure": 14.280662839399527, "hybrid system consisting": 13.772883724027798, "requiring isolated lvad": 13.589462839586087, "required biventricular support": 14.73507474561702, "\u00b1 11.9 days": 10.41746331438823, "however biventricular dysfunction": 15.146277935759567, "assist device use": 12.287773259995607, "using simulation models": 13.589462839586087, "studies per outcome": 12.76650219944516, "made policy recommendations": 14.280662839399527, "meet traditional cost": 13.197513281459468, "using historical data": 13.197513281459468, "canadian data point": 12.76650219944516, "left heart twist": 12.026966349681764, "improves cardiac output": 13.589462839586087, "selected cardiac surgery": 13.772883724027798, "cardiac surgery patients": 13.772883724027798, "used speckle tracking": 13.197513281459468, "speckle tracking echocardiography": 15.146277935759567, "right ventricular pressure": 14.117933705047566, "ventricular pressure overload": 14.588841744062766, "inferior vena cava": 12.53375337658753, "pulmonary artery snared": 13.589462839586087, "ventricular midpapillary level": 14.73507474561702, "varying atrioventricular delay": 14.73507474561702, "regional circumferential strain": 14.876528025729723, "left ventricular base": 13.197513281459468, "mixed linear models": 12.76650219944516, "free wall rs": 10.790805427161697, "open chest model": 12.026966349681764, "varying regional strain": 13.589462839586087, "regional strain contributions": 14.588841744062766, "reflect postsystolic function": 14.588841744062766, "successful mitral valve": 13.589462839586087, "degenerative mitral regurgitation": 15.146277935759567, "mild mitral regurgitation": 13.94884637719023, "significant mitral stenosis": 14.280662839399527, "degenerative mitral valve": 13.94884637719023, "third heart sound": 12.287773259995607, "underwent mitral valve": 13.397923393512208, "underwent triangular resection": 14.73507474561702, "postoperative echocardiography confirmed": 15.976590994702674, "preserved mitral valve": 13.397923393512208, "mitral valve area": 12.287773259995607, "filling flow volume": 12.76650219944516, "\u00d7 velocity time": 11.74942993331315, "velocity time integral": 13.397923393512208, "without major concerns": 13.397923393512208, "limited mitral valve": 12.9873707888747, "coronary angiography revealed": 14.588841744062766, "diastolic mitral leaflet": 13.772883724027798, "mitral leaflet motions": 13.397923393512208, "cardiac murmurs disappeared": 14.280662839399527, "surgical ring implantation": 14.117933705047566, "reports demonstrating development": 15.146277935759567, "following ring annuloplasty": 14.280662839399527, "surgical indications need": 13.94884637719023, "fixed ring size": 11.74942993331315, "requires careful evaluation": 14.280662839399527, "heart failure clinic": 12.9873707888747, "failure clinic outpatients": 14.117933705047566, "most heart failure": 12.53375337658753, "risk stratification models": 14.117933705047566, "available outpatient models": 14.280662839399527, "collected clinical data": 13.589462839586087, "quality improvement database": 14.437494676000693, "reached primary outcome": 13.589462839586087, "arbitrary start date": 12.9873707888747, "model included blood": 12.9873707888747, "included blood urea": 12.76650219944516, "blood urea nitrogen": 12.76650219944516, "concordance c statistics": 13.772883724027798, "demonstrated excellent risk": 14.280662839399527, "excellent risk stratification": 14.588841744062766, "readily available data": 13.397923393512208, "resources within health": 13.589462839586087, "within health systems": 13.197513281459468, "important prognostic factor": 14.280662839399527, "composite end point": 12.76650219944516, "uncontrolled hypertension identify": 15.27509950241043, "hypertension identify patients": 14.73507474561702, "commonly used criterion": 13.589462839586087, "used criterion standard": 13.589462839586087, "using spearman correlations": 14.280662839399527, "category among patients": 13.589462839586087, "high internal consistency": 13.94884637719023, "consistency among patients": 14.117933705047566, "excellent prognostic ability": 14.437494676000693, "interleukin receptor family": 14.280662839399527, "receptor family member": 13.397923393512208, "affect sst2 concentrations": 14.117933705047566, "concentrations identify benefit": 14.876528025729723, "heart failure attributable": 14.117933705047566, "ventricular systolic dysfunction": 15.013504176704823, "post hoc analysis": 12.287773259995607, "baseline sst2 status": 12.9873707888747, "daily equivalent dose": 13.197513281459468, "low sst2 titrated": 12.287773259995607, "lowest cardiovascular event": 14.280662839399527, "lowest cumulative hazard": 13.772883724027798, "highest cardiovascular event": 14.437494676000693, "highest cumulative hazard": 13.94884637719023, "intermediate odds ratios": 13.772883724027798, "therapy exerted dose": 12.9873707888747, "measurement identifies patients": 14.876528025729723, "exerts positive inotropic": 13.94884637719023, "adult mouse ventricular": 13.589462839586087, "mouse ventricular myocytes": 14.117933705047566, "dependently increased sarcomere": 14.876528025729723, "soluble guanylate cyclase": 13.94884637719023, "left ventricular end": 12.9873707888747, "myocardial oxygen consumption": 14.588841744062766, "increasing ejection fraction": 14.437494676000693, "maximal ventricular power": 13.94884637719023, "ventricular power index": 13.589462839586087, "provided venoarterial dilation": 14.73507474561702, "right heart filling": 12.76650219944516, "heart filling pressures": 13.589462839586087, "stroke volume index": 12.76650219944516, "arterial pressure declined": 14.117933705047566, "enhance myocardial function": 14.280662839399527, "involved single parameters": 14.117933705047566, "standard echocardiographic measurements": 15.867290107259969, "underwent baseline echocardiography": 15.400197376251594, "\u226515 % reduction": 11.74942993331315, "lv reverse remodeling": 13.197513281459468, "diastolic dimension index": 13.94884637719023, "right ventricular end": 13.197513281459468, "diastolic area index": 12.9873707888747, "right atrial area": 12.287773259995607, "ventricular fractional area": 14.280662839399527, "fractional area change": 13.397923393512208, "change \u226535 %": 10.790805427161697, "echocardiographic score allowed": 14.876528025729723, "score allowed prediction": 13.772883724027798, "lv assist device": 12.026966349681764, "assist device implantations": 14.280662839399527, "heart failure admissions": 13.772883724027798, "heart failure admission": 13.589462839586087, "initial functional class": 13.772883724027798, "undergo reverse remodeling": 14.117933705047566, "predicts clinical outcomes": 14.117933705047566, "symptomatic systolic heart": 14.117933705047566, "diagnosed systolic heart": 13.772883724027798, "previous spironolactone use": 14.280662839399527, "baseline serum creatinine": 13.94884637719023, "serum creatinine level": 13.397923393512208, "serum potassium level": 13.197513281459468, "incident systolic heart": 13.589462839586087, "growth factor blockade": 13.397923393512208, "adrenergic receptor blocker": 14.280662839399527, "receptor blocker therapy": 13.772883724027798, "improve myocardial perfusion": 14.437494676000693, "induced myocardial infarction": 14.588841744062766, "heart failure rats": 12.53375337658753, "week treatment period": 13.197513281459468, "reduced cardiac diameters": 13.94884637719023, "improved cardiac function": 13.94884637719023, "increased cardiac angiogenesis": 14.73507474561702, "vivo coronary perfusion": 13.589462839586087, "reduced cardiac fibrosis": 13.772883724027798, "untreated failing hearts": 13.772883724027798, "act via activation": 12.53375337658753, "adenoviral vector encoding": 14.117933705047566, "histological analysis revealed": 14.73507474561702, "treated plus ad": 11.74942993331315, "promotes cardiac angiogenesis": 14.588841744062766, "failure via activation": 13.397923393512208, "emergency department volume": 14.280662839399527, "influences patient outcomes": 14.280662839399527, "exhibited higher risk": 13.197513281459468, "exhibited worse outcomes": 13.772883724027798, "repeat ed visits": 12.026966349681764, "oxidase inhibition preserves": 14.437494676000693, "left ventricular systolic": 13.94884637719023, "cardiac volume overload": 13.589462839586087, "decrease mitochondrial respiration": 15.27509950241043, "inhibition improves cardiomyocyte": 15.146277935759567, "improves cardiomyocyte bioenergetics": 15.521780795999426, "acf \u00b1 allopurinol": 12.287773259995607, "lv ejection fraction": 12.9873707888747, "maximal systolic elastance": 14.117933705047566, "isolated cardiomyocytes using": 14.588841744062766, "extracellular flux analyzer": 14.280662839399527, "severe systolic heart": 13.197513281459468, "early transmitral blood": 13.589462839586087, "transmitral blood flow": 13.397923393512208, "blood flow velocity": 12.76650219944516, "diastolic mitral annulus": 13.772883724027798, "decompensated systolic heart": 14.437494676000693, "sided cardiac catheterization": 14.588841744062766, "transmitral flow velocities": 14.280662839399527, "mitral annulus velocities": 13.94884637719023, "negative predictive value": 13.94884637719023, "negative likelihood ratio": 13.94884637719023, "detecting normal filling": 13.772883724027798, "normal filling pressures": 13.772883724027798, "systolic pressure relationship": 14.73507474561702, "ventricular contractile function": 15.013504176704823, "derived pulmonary arterial": 14.117933705047566, "tricuspid annular plane": 13.589462839586087, "better disclosing prognosis": 14.280662839399527, "natriuretic peptide assessment": 14.73507474561702, "downward regression line": 13.772883724027798, "regression line shift": 13.197513281459468, "improves prognostic resolution": 14.73507474561702, "bottleneck stent model": 13.397923393512208, "large animal model": 12.53375337658753, "novel therapeutic approaches": 14.437494676000693, "novel percutaneous one-": 13.589462839586087, "myocardial ischemia using": 13.94884637719023, "proximal circumflex artery": 14.117933705047566, "given antiarrhythmic medication": 14.876528025729723, "prevent sudden death": 12.9873707888747, "fractional flow reserve": 13.589462839586087, "flow reserve measurements": 13.94884637719023, "positron emission tomography": 14.437494676000693, "emission tomography imaging": 14.280662839399527, "showed severe ischemia": 13.397923393512208, "complete coronary occlusion": 14.280662839399527, "significant collateral growth": 14.588841744062766, "competitive collateral growth": 14.588841744062766, "collateral growth patterns": 14.117933705047566, "vessel disease model": 12.9873707888747, "novel bottleneck stent": 13.397923393512208, "novel porcine model": 12.76650219944516, "reversible myocardial ischemia": 14.73507474561702, "new therapeutic approaches": 14.117933705047566, "selective heart rate": 12.9873707888747, "isolated heart rate": 12.76650219944516, "ivabradine reduces afterload": 14.437494676000693, "pressure volume relation": 13.772883724027798, "ivabradine 7.5 mg": 12.287773259995607, "total arterial compliance": 13.94884637719023, "ivabradine improves tac": 13.589462839586087, "preoperative serum albumin": 14.117933705047566, "serum albumin levels": 12.9873707888747, "consecutive patients undergoing": 14.876528025729723, "preoperative clinical characteristics": 15.640041845200326, "normal albumin concentration": 14.437494676000693, "normal albumin levels": 13.197513281459468, "albumin levels compared": 13.589462839586087, "decreasing albumin levels": 13.94884637719023, "aortic valve insufficiency": 14.117933705047566, "onset aortic insufficiency": 14.117933705047566, "mechanical circulatory support": 14.73507474561702, "underwent aortic valve": 13.397923393512208, "aortic valve surgery": 12.9873707888747, "patients underwent lvad": 13.589462839586087, "underwent lvad implantation": 14.280662839399527, "requiring surgical intervention": 14.876528025729723, "after medical therapy": 13.197513281459468, "aortic valve procedures": 13.589462839586087, "bioprosthetic valve replacement": 14.876528025729723, "dacron patch closure": 12.9873707888747, "aortic valve repairs": 12.9873707888747, "patients underwent transcatheter": 15.013504176704823, "transcatheter aortic valve": 14.117933705047566, "aortic valve procedure": 13.397923393512208, "experienced significant improvement": 15.400197376251594, "aortic valve oversewing": 13.589462839586087, "bioprosthetic aortic valve": 14.117933705047566, "restoring functional capacity": 14.588841744062766, "various transcatheter approaches": 15.013504176704823, "less invasive alternatives": 14.117933705047566, "youngest age group": 12.53375337658753, "year mortality rates": 12.9873707888747, "respective age categories": 13.94884637719023, "referent age group": 12.53375337658753, "beyond divergent etiology": 13.94884637719023, "younger patients exhibited": 14.117933705047566, "higher hospitalization rates": 14.437494676000693, "within cardiac rehabilitation": 14.588841744062766, "\u00b1 11.4 years": 10.790805427161697, "functional capacity assessed": 14.437494676000693, "nordic walking led": 12.53375337658753, "higher functional capacity": 14.117933705047566, "reported physical activity": 14.117933705047566, "\u00b1 118.5 minutes": 11.74942993331315, "\u00b1 125.6 minutes": 11.74942993331315, "increased right grip": 12.9873707888747, "right grip strength": 12.76650219944516, "\u00b1 3.5 kg": 9.053765723991788, "\u00b1 3.1 kg": 9.053765723991788, "fewer depressive symptoms": 13.94884637719023, "peak aerobic capacity": 13.197513281459468, "improving functional capacity": 14.588841744062766, "precapillary pulmonary hypertension": 15.400197376251594, "experiencing heart failure": 14.117933705047566, "major right ventricle": 13.197513281459468, "right ventricle overload": 13.772883724027798, "decreased stroke volume": 13.589462839586087, "arterial tonometry study": 13.772883724027798, "carries prognostic value": 13.772883724027798, "radial artery tonometry": 13.589462839586087, "artery tonometry variables": 14.117933705047566, "reconstructed aortic pressure": 14.588841744062766, "aortic pressure curve": 13.197513281459468, "other prognostic factors": 13.772883724027798, "higher oxygen flow": 12.53375337658753, "documented prognostic factors": 14.588841744062766, "atrial myxoma complicated": 13.94884637719023, "cardiac benign tumors": 13.197513281459468, "pulmonary arterial vasculature": 14.73507474561702, "pulmonary arteries treated": 14.117933705047566, "right atrial mass": 12.287773259995607, "atrial mass removal": 12.76650219944516, "right atrium mass": 12.287773259995607, "left pulmonary artery": 13.197513281459468, "right pulmonary artery": 13.397923393512208, "surgical tactics included": 13.94884637719023, "hypothermic circulatory arrest": 14.73507474561702, "advanced chronic organ": 13.397923393512208, "chronic organ failure": 13.197513281459468, "chronic renal failure": 13.197513281459468, "median body mass": 12.026966349681764, "intraclass correlation coefficient": 15.27509950241043, "minimal detectable change": 13.94884637719023, "statistical improvement occurred": 15.013504176704823, "third trial added": 12.287773259995607, "similar values found": 12.9873707888747, "daily clinical practice": 13.589462839586087, "represents true change": 13.397923393512208, "risk among patients": 12.76650219944516, "rheumatoid arthritis starting": 14.588841744062766, "tumor necrosis factor": 13.197513281459468, "treat rheumatoid arthritis": 14.117933705047566, "biological disease modifying": 14.437494676000693, "modifying antirheumatic drug": 14.437494676000693, "propensity score decile": 13.589462839586087, "oral glucocorticoid dosage": 14.117933705047566, "similar baseline covariates": 14.280662839399527, "1\u22645 mg hr": 9.557599635934, "current economic climate": 13.772883724027798, "within acute hospital": 13.197513281459468, "acute hospital facilities": 13.94884637719023, "specific health interventions": 14.588841744062766, "structured exercise programme": 14.588841744062766, "secondary outcome measures": 14.117933705047566, "intervention post study": 13.589462839586087, "overall significant improvements": 15.013504176704823, "demonstrated significant improvements": 15.640041845200326, "showing minor improvement": 13.94884637719023, "participant satisfaction responses": 15.27509950241043, "body composition study": 13.397923393512208, "adverse health outcomes": 13.589462839586087, "per sd decrease": 11.74942993331315, "activated neurohormonal systems": 14.876528025729723, "sympathetic nervous systems": 14.280662839399527, "improved clinical outcomes": 14.117933705047566, "various physiologic processes": 14.588841744062766, "receptor antagonist therapy": 14.280662839399527, "new therapeutic approach": 13.772883724027798, "pathological heart disease": 14.117933705047566, "mutant mice overexpressing": 14.117933705047566, "otherwise healthy heart": 13.589462839586087, "healthy heart muscle": 12.9873707888747, "heart muscle cells": 12.53375337658753, "fetal gene program": 12.53375337658753, "specific antagomir evoked": 13.94884637719023, "spontaneous cardiac dysfunction": 14.876528025729723, "bhlh transcription factor": 13.94884637719023, "postnatal mammalian myocardium": 14.73507474561702, "enzyme inhibitors intolerance": 14.588841744062766, "beta receptor blockers": 13.397923393512208, "negative inotropic effect": 13.94884637719023, "past decades several": 12.9873707888747, "decades several studies": 13.589462839586087, "blockers decrease mortality": 14.280662839399527, "causes heart failure": 12.9873707888747, "insulin receptor substrates": 14.280662839399527, "regulating cellular metabolism": 14.73507474561702, "causes myocardial insulin": 13.94884637719023, "myocardial insulin resistance": 14.588841744062766, "reduced ventricular mass": 13.772883724027798, "developed cardiac apoptosis": 14.280662839399527, "box class o-1": 11.134484719950263, "impaired cardiac metabolic": 14.117933705047566, "cardiac metabolic gene": 13.397923393512208, "metabolic gene expression": 13.94884637719023, "impaired cardiac energy": 13.589462839586087, "cardiac energy metabolism": 13.94884637719023, "energy metabolism gene": 13.397923393512208, "metabolism gene expression": 14.117933705047566, "activated protein kinase": 13.772883724027798, "using neonatal rat": 12.53375337658753, "neonatal rat ventricular": 13.772883724027798, "rat ventricular cardiomyocytes": 14.73507474561702, "chronic insulin exposure": 13.772883724027798, "prevented insulin action": 13.772883724027798, "medications among outpatients": 14.588841744062766, "combined treatment measure": 14.117933705047566, "multivariable hierarchical regression": 15.640041845200326, "hierarchical regression models": 14.73507474561702, "randomly selected practices": 14.280662839399527, "level prescription rates": 13.772883724027798, "adjusted median rate": 12.9873707888747, "receptor blockers therapy": 13.94884637719023, "adjuvant setting improves": 13.94884637719023, "setting improves outcomes": 13.94884637719023, "iii breast cancer": 12.287773259995607, "included descriptive statistics": 14.876528025729723, "among trastuzumab users": 13.589462839586087, "weekly trastuzumab administration": 15.146277935759567, "older breast cancer": 12.76650219944516, "further studies need": 12.9873707888747, "current dietary recommendations": 14.876528025729723, "therefore evaluated associations": 15.013504176704823, "mortality among postmenopausal": 14.73507474561702, "among postmenopausal women": 14.117933705047566, "last participant contact": 13.772883724027798, "calculate hazard ratios": 13.589462839586087, "dash diet score": 11.74942993331315, "diet score components": 13.197513281459468, "whole grain intake": 12.53375337658753, "higher dash diet": 12.026966349681764, "modestly lower mortality": 13.772883724027798, "data provide support": 12.9873707888747, "dietary recommendations developed": 15.146277935759567, "potentially promising biomarker": 14.876528025729723, "term clinical outcomes": 13.397923393512208, "evaluable plasma samples": 13.772883724027798, "significantly affect reclassification": 15.640041845200326, "criteria cardiac transplantation": 15.013504176704823, "undergoing isolated heart": 13.94884637719023, "isolated heart transplant": 13.94884637719023, "cardiac transplant recipients": 14.588841744062766, "identify clinical variables": 14.280662839399527, "clinical variables contributing": 14.876528025729723, "additional risk associated": 14.117933705047566, "underwent heart transplant": 14.117933705047566, "underwent standard criteria": 14.280662839399527, "cardiac transplant survival": 14.280662839399527, "included listing criteria": 13.94884637719023, "heart failure therapy": 13.197513281459468, "heart failure readmission": 13.94884637719023, "failure readmission quality": 14.280662839399527, "readmission quality improvement": 14.876528025729723, "hospital quality improvement": 14.437494676000693, "retrospective chart review": 14.117933705047566, "heart failure discharges": 13.772883724027798, "heart failure nurse": 12.76650219944516, "failure nurse practitioner": 14.117933705047566, "extracellular matrix accumulation": 15.146277935759567, "extracellular matrix using": 14.117933705047566, "resonance t1 mapping": 12.9873707888747, "confirmatory diagnostic tests": 14.588841744062766, "imaging including t1": 12.9873707888747, "including t1 mapping": 12.9873707888747, "invasive hemodynamic assessments": 15.013504176704823, "resonance t1 time": 12.287773259995607, "left ventricular biopsies": 13.94884637719023, "pulmonary arterial coupling": 14.280662839399527, "right ventricular ejection": 14.117933705047566, "present preliminary study": 13.94884637719023, "abnormal cardiac t2": 12.76650219944516, "values determined changes": 13.94884637719023, "remove heart iron": 12.287773259995607, "current guidelines recommend": 14.437494676000693, "recommend cardiac resynchronization": 15.400197376251594, "severe systolic dysfunction": 14.280662839399527, "blinded core laboratory": 13.589462839586087, "end systolic volume": 12.76650219944516, "systolic volume index": 13.197513281459468, "\u00b1 17.6 ml": 9.557599635934, "\u00b1 42.4 g": 9.053765723991788, "reverse remodeling parameters": 14.588841744062766, "produced reverse remodeling": 14.280662839399527, "similar clinical benefit": 13.772883724027798, "clinical benefit compared": 13.94884637719023, "myocardial titin hypophosphorylation": 15.521780795999426, "rat metabolic risk": 12.53375337658753, "metabolic risk model": 12.9873707888747, "important metabolic risk": 13.772883724027798, "metabolic risk factors": 13.397923393512208, "myocardial diastolic dysfunction": 15.013504176704823, "ejection fraction development": 14.588841744062766, "fpassive)-sarcomere length relations": 15.521780795999426, "small muscle strips": 12.76650219944516, "increased lung weight": 13.197513281459468, "left ventricular dd": 12.76650219944516, "high muscle strip": 12.287773259995607, "muscle strip stiffness": 13.397923393512208, "elastic n2bus segment": 13.197513281459468, "rats developed heart": 12.9873707888747, "week time span": 11.452869772534292, "left ventricular mechanics": 14.117933705047566, "predicting cv events": 12.9873707888747, "observational cohort study": 14.117933705047566, "index beat method": 12.287773259995607, "proportional hazards analyses": 14.588841744062766, "systolic mitral annulus": 13.589462839586087, "containing chronic heart": 13.772883724027798, "prior stroke score": 12.53375337658753, "additional prognostic benefit": 14.588841744062766, "echocardiographic systolic parameters": 15.640041845200326, "scale clinical trial": 12.9873707888747, "receiving implantable cardioverter": 15.27509950241043, "refractory congestive heart": 14.280662839399527, "diuretic resistant volume": 13.94884637719023, "resistant volume overload": 13.94884637719023, "provide potential benefit": 13.94884637719023, "clinical status hospitalizations": 15.013504176704823, "transplant ineligible patients": 14.73507474561702, "ineligible patients receiving": 14.588841744062766, "clinical data reviewed": 13.397923393512208, "\u00b1 6.0 %": 8.48345707385196, "right ventricular dysfunction": 14.588841744062766, "average weight loss": 12.76650219944516, "admissions per patient": 13.397923393512208, "reduced average length": 13.397923393512208, "\u00b1 2.3 days": 10.008850163593298, "objective criteriabased institution": 15.400197376251594, "diuretic refractory severe": 14.117933705047566, "demonstrated favorable outcomes": 14.876528025729723, "improved clinical status": 13.772883724027798, "treatable pdrelated complications": 15.146277935759567, "stage congestive heart": 13.397923393512208, "potentially higher risks": 13.772883724027798, "bundle branch morphology": 13.772883724027798, "angiotensin ii receptor": 13.589462839586087, "ii receptor blocker": 12.76650219944516, "receptor blocker use": 12.9873707888747, "observed among dialysis": 13.589462839586087, "among dialysis patients": 13.589462839586087, "\u00b1 9.2 %": 8.48345707385196, "derived absolute improvements": 14.588841744062766, "year event rates": 12.026966349681764, "superior reverse remodeling": 14.280662839399527, "\u00b1 9.5 %": 8.48345707385196, "9.5 % increase": 11.452869772534292, "certain dialysis patients": 13.94884637719023, "demonstrated compelling improvement": 15.400197376251594, "worsened echocardiographic outcomes": 15.400197376251594, "sodium dash diet": 12.026966349681764, "improves diastolic function": 14.280662839399527, "hypertensive heart failure": 14.117933705047566, "dietary sodium restriction": 14.117933705047566, "restricted dietary approaches": 14.588841744062766, "stop hypertension diet": 13.397923393512208, "central blood pressure": 13.397923393512208, "via radial arterial": 12.76650219944516, "radial arterial tonometry": 13.94884637719023, "parametrized diastolic filling": 14.73507474561702, "diastolic filling formalism": 14.280662839399527, "mitral inflow velocity": 13.397923393512208, "previously published techniques": 14.876528025729723, "brachial systolic pressure": 14.117933705047566, "diastolic function improved": 14.280662839399527, "\u00b1 8.1 g": 8.48345707385196, "restricted dash diet": 12.9873707888747, "humanized male mice": 12.76650219944516, "recent clinical studies": 13.589462839586087, "connected elevated resistin": 14.280662839399527, "elevated resistin levels": 13.772883724027798, "humanized mouse model": 13.197513281459468, "model lacking murine": 12.9873707888747, "lacking murine resistin": 13.589462839586087, "stimulated resistin levels": 14.117933705047566, "resistin levels similar": 13.589462839586087, "expressing human resistin": 13.94884637719023, "cardiac mrna levels": 12.76650219944516, "cell adhesion genes": 12.76650219944516, "showed dramatic induction": 13.94884637719023, "also examined resistin": 13.397923393512208, "examined resistin levels": 13.772883724027798, "treated breast cancer": 13.197513281459468, "women undergoing anthracycline": 14.73507474561702, "efficacy and safety": 12.76650219944516, "free success rates": 12.53375337658753, "pharmaceutically assisted success": 15.146277935759567, "assisted success rate": 13.197513281459468, "major complications occurred": 14.437494676000693, "lv systolic indices": 12.76650219944516, "early transmitral flow": 13.397923393512208, "patients maintaining sinus": 14.117933705047566, "maintaining sinus rhythm": 13.772883724027798, "larger randomized control": 13.94884637719023, "randomized control studies": 14.117933705047566, "ameliorates mitochondrial dysfunction": 15.640041845200326, "mitochondrial dysfunction induced": 15.146277935759567, "without doxorubicin treatment": 14.588841744062766, "oxidative stress markers": 13.772883724027798, "mitochondrial oxidative stress": 14.73507474561702, "also preserved phosphocreatine": 14.73507474561702, "restoring mitochondrial oxidative": 15.146277935759567, "cardioprotection via inhibition": 14.876528025729723, "apoptotic signaling pathway": 14.280662839399527, "mitochondrial ultrastructural changes": 15.640041845200326, "solid ehrlich carcinoma": 13.589462839586087, "changes without affecting": 13.94884637719023, "isolated coronary artery": 13.772883724027798, "heart failure \u226490": 12.287773259995607, "failure \u226490 days": 12.026966349681764, "logistic regression models": 14.117933705047566, "developed acute kidney": 13.397923393512208, "enormous clinical burden": 13.772883724027798, "atheromatous coronary disease": 14.588841744062766, "paediatric cardiac transplants": 14.73507474561702, "congenital heart lesions": 13.772883724027798, "poor myocardial function": 13.772883724027798, "poorly contracting ventricles": 14.588841744062766, "paediatric heart failure": 13.772883724027798, "heart failure concern": 13.197513281459468, "versus dilated cardiomyopathy": 14.588841744062766, "new onset heart": 11.74942993331315, "anthracycline treated survivors": 14.876528025729723, "childhood malignant disease": 14.280662839399527, "certain stimuli mediate": 13.589462839586087, "specific signalling pathways": 14.437494676000693, "erk1/2 signalling pathway": 13.94884637719023, "targeting specific effector": 14.280662839399527, "specific effector molecules": 14.280662839399527, "erk1/2 scaffold proteins": 13.772883724027798, "therapeutic strategies capable": 14.73507474561702, "hypertensive cardiomyiopathy based": 15.27509950241043, "inducible myocardial ischemia": 14.588841744062766, "normal coronary arteries": 13.772883724027798, "typical amyloidotic pattern": 14.280662839399527, "important prognostic indicator": 14.73507474561702, "weak grip strength": 12.53375337658753, "unintentional weight loss": 13.94884637719023, "% intermediate frail": 12.9873707888747, "intermediate frail according": 14.437494676000693, "0.1 unit increase": 12.287773259995607, "% increased risk": 12.026966349681764, "measures predicted death": 13.772883724027798, "equally predict mortality": 13.94884637719023, "heart failure trials": 12.9873707888747, "therapeutics including calcium": 14.73507474561702, "recent studies including": 13.772883724027798, "selecting appropriate end": 13.94884637719023, "appropriate end points": 13.397923393512208, "developing heart failure": 13.772883724027798, "clinical care delivery": 13.397923393512208, "produce test results": 12.9873707888747, "community outpatient settings": 14.588841744062766, "designed clinical trials": 13.772883724027798, "take full advantage": 12.76650219944516, "faster turnaround times": 13.589462839586087, "measuring heart failure": 13.589462839586087, "heart failure care": 12.53375337658753, "operationalized hospital quality": 15.013504176704823, "expected future expansion": 13.94884637719023, "inhibition halts heart": 13.397923393512208, "halts heart failure": 12.76650219944516, "involves cardiac hypertrophy": 14.437494676000693, "family bromodomain proteins": 14.280662839399527, "lysine reader proteins": 13.397923393512208, "signal transduction cascade": 14.280662839399527, "neurohormonally induced heart": 14.588841744062766, "induced heart disease": 13.197513281459468, "pathological gene induction": 14.280662839399527, "gene expression profiling": 13.94884637719023, "several pathological changes": 14.437494676000693, "including cardiac hypertrophy": 14.588841744062766, "systemic blood pressure": 13.589462839586087, "detailed transcriptional analysis": 15.146277935759567, "pathological cardiac gene": 13.94884637719023, "cardiac gene expression": 13.589462839586087, "gene expression programme": 13.94884637719023, "further molecular analysis": 14.117933705047566, "molecular analysis revealed": 14.280662839399527, "mediated signal transduction": 14.437494676000693, "activating transcription factor": 14.876528025729723, "transcription factor networks": 14.588841744062766, "including nuclear factor": 13.772883724027798, "activated t cells": 12.287773259995607, "promoting transcriptional pause": 14.876528025729723, "transcriptional pause release": 14.588841744062766, "implicates epigenetic readers": 14.588841744062766, "cardiac gene control": 12.9873707888747, "dependent signal transduction": 14.588841744062766, "abrogate pathological gene": 14.117933705047566, "pathological gene expression": 14.437494676000693, "breathing pulse sequence": 13.772883724027798, "quantify myocardial t1": 13.397923393512208, "myocardial t1 changes": 13.197513281459468, "induce heart failure": 12.9873707888747, "t mri scanner": 11.134484719950263, "chelate contrast agent": 13.397923393512208, "heart failure scans": 12.76650219944516, "heart failure myocardial": 13.772883724027798, "failure myocardial tissue": 13.94884637719023, "left ventricular tissue": 13.589462839586087, "trichrome blue histologic": 13.94884637719023, "blue histologic analysis": 13.772883724027798, "heart failure t1": 12.026966349681764, "contrast agent administration": 14.588841744062766, "myocardial collagen compared": 14.437494676000693, "healthy control animals": 13.589462839586087, "diffuse myocardial changes": 14.117933705047566, "myocardial changes associated": 14.588841744062766, "myocardial delayed enhancement": 14.73507474561702, "delayed enhancement imaging": 14.280662839399527, "significant myocardial fibrosis": 14.876528025729723, "induced pulmonary artery": 13.772883724027798, "pulmonary artery systolic": 13.94884637719023, "artery systolic pressure": 13.772883724027798, "diagnosed pulmonary arterial": 14.437494676000693, "thromboembolic pulmonary hypertension": 15.640041845200326, "right ventricular pump": 13.397923393512208, "ventricular pump function": 13.94884637719023, "targeted pulmonary arterial": 14.280662839399527, "arterial hypertension medication": 15.013504176704823, "including stress echocardiography": 15.146277935759567, "\u00b1 1.8 years": 10.41746331438823, "factors predicting survival": 14.280662839399527, "minute walking distance": 13.589462839586087, "year survival rates": 12.76650219944516, "remained independent prognostic": 14.876528025729723, "independent prognostic markers": 14.73507474561702, "preserved systolic function": 14.280662839399527, "interesting therapeutic concepts": 15.013504176704823, "alone diagnostic devices": 13.772883724027798, "commoner among women": 12.9873707888747, "poses significant challenges": 14.437494676000693, "regulates cardiac sodium": 13.772883724027798, "cardiac sodium current": 13.397923393512208, "systolic human heart": 12.9873707888747, "alternative mrna splicing": 13.94884637719023, "generating variants encoding": 14.437494676000693, "human induced pluripotent": 13.94884637719023, "induced pluripotent stem": 13.772883724027798, "pluripotent stem cell": 13.197513281459468, "protein kinase r": 12.026966349681764, "exogenous variants induced": 14.117933705047566, "receptor potential cation": 13.94884637719023, "potential cation channel": 13.772883724027798, "cation channel m7": 12.287773259995607, "kv4.3 mrna levels": 12.287773259995607, "mrna levels resulting": 13.197513281459468, "multiple cardiac genes": 13.397923393512208, "normal cardiac function": 13.589462839586087, "receives little attention": 13.94884637719023, "requires diagnostic procedures": 14.73507474561702, "chronic pulmonary arterial": 14.117933705047566, "acute pulmonary embolism": 13.772883724027798, "examine clinical circumstances": 14.73507474561702, "clinical circumstances common": 14.588841744062766, "pulmonary embolism represent": 14.437494676000693, "particularly high mortality": 14.280662839399527, "possibly affect outcomes": 13.772883724027798, "data describing trends": 13.397923393512208, "evaluated temporal trends": 13.94884637719023, "characteristics yielded hazard": 14.73507474561702, "yielded hazard ratios": 13.197513281459468, "requires new prevention": 13.589462839586087, "new prevention strategies": 13.94884637719023, "versus selective beta": 13.197513281459468, "various serum factors": 13.197513281459468, "label crossover study": 13.197513281459468, "masked outcome assessments": 14.117933705047566, "secondary outcomes included": 14.280662839399527, "outcomes included markers": 13.94884637719023, "receptor haplotype status": 13.94884637719023, "often contextual factors": 13.772883724027798, "competing priorities impact": 14.280662839399527, "priorities impact prescribing": 14.588841744062766, "performance measurement systems": 14.876528025729723, "health care systems": 12.76650219944516, "primary care clinicians": 13.589462839586087, "identified biomedical reasons": 14.588841744062766, "clinician interviews identified": 14.876528025729723, "reasons per patient": 12.76650219944516, "common contextual reasons": 13.94884637719023, "prevents ventricular dysfunction": 15.013504176704823, "elevated sympathetic activity": 14.588841744062766, "reduced parasympathetic control": 14.876528025729723, "experimental evidence suggests": 14.73507474561702, "acetylcholinesterase inhibitor pyridostigmine": 16.485166585104054, "following myocardial infarction": 14.876528025729723, "cardiac sympathovagal balance": 14.588841744062766, "tachycardic response caused": 14.280662839399527, "bradycardic response caused": 14.280662839399527, "basal heart rate": 12.026966349681764, "reduced sympathetic control": 14.280662839399527, "growth factor protein": 13.197513281459468, "suggesting myocardial angiogenesis": 15.27509950241043, "volume conductance catheter": 14.280662839399527, "conductance catheter system": 14.280662839399527, "higher stroke volume": 12.9873707888747, "coronary artery ligation": 13.772883724027798, "reduced sympathetic tone": 13.772883724027798, "attenuating cardiac remodeling": 14.73507474561702, "prolonged electromechanical delay": 15.146277935759567, "branch block type": 12.287773259995607, "altered ventricular structure": 14.588841744062766, "reduced wall stiffness": 13.397923393512208, "local myocyte depolarization": 14.437494676000693, "myofiber shortening onset": 13.94884637719023, "dyssynchronous failing heart": 14.437494676000693, "induced remodeling aspects": 14.117933705047566, "constructed additional models": 14.588841744062766, "four remodeling aspects": 13.589462839586087, "branch block electrical": 13.589462839586087, "block electrical activation": 14.280662839399527, "electrical activation sequence": 14.73507474561702, "slows myofiber shortening": 13.94884637719023, "myofiber shortening velocity": 14.437494676000693, "activated lateral wall": 13.397923393512208, "myofiber dynamics delay": 13.589462839586087, "thus giving rise": 12.026966349681764, "right ventricular function": 14.117933705047566, "previous studies investigating": 14.73507474561702, "abnormal body composition": 13.94884637719023, "underwent prospective assessment": 15.013504176704823, "circulatory assist device": 13.94884637719023, "lower body mass": 11.74942993331315, "lower fat mass": 11.452869772534292, "fat mass index": 11.452869772534292, "greater antecedent weight": 13.94884637719023, "antecedent weight loss": 13.397923393512208, "body mass ratio": 11.74942993331315, "increased body mass": 12.76650219944516, "lower event rate": 12.026966349681764, "higher fat mass": 11.74942993331315, "free mass index": 11.74942993331315, "additive adverse impact": 13.589462839586087, "diastolic filling time": 13.397923393512208, "controlling heart rate": 13.397923393512208, "demonstrated significant improvement": 15.521780795999426, "\u00b1 1.8 mets": 10.008850163593298, "\u00b1 1.9 mets": 10.008850163593298, "\u00b1 6.1 ml": 9.053765723991788, "\u00b1 3.3 ml": 9.053765723991788, "corrected chronotropic response": 14.876528025729723, "ivabradine increased exercise": 14.588841744062766, "increased exercise capacity": 14.280662839399527, "filling pressure response": 13.94884637719023, "therapeutic treatments targeting": 15.013504176704823, "targeting abnormal exercise": 14.280662839399527, "abnormal exercise hemodynamic": 14.588841744062766, "exercise hemodynamic status": 14.280662839399527, "validated clinical tool": 13.589462839586087, "undergo coronary angiography": 14.437494676000693, "undergone coronary angiography": 14.73507474561702, "% diameter stenosis": 12.76650219944516, "anterior descending artery": 14.117933705047566, "defined prediction rule": 13.589462839586087, "separate cohort recruited": 13.94884637719023, "electrocardiographic q waves": 14.437494676000693, "nondiabetes risk factors": 13.772883724027798, "independent predictor identified": 15.013504176704823, "prospective validation cohort": 14.588841744062766, "simple clinical prediction": 14.117933705047566, "accurately identify patients": 14.437494676000693, "potentially significant cost": 14.437494676000693, "significant cost savings": 13.772883724027798, "japanese heart failure": 13.397923393512208, "optimal diuretic therapy": 13.772883724027798, "serum sodium levels": 12.76650219944516, "newly introduced drug": 13.197513281459468, "relieve congestive symptoms": 14.280662839399527, "adverse neurohormonal activation": 15.013504176704823, "accurate risk stratification": 14.437494676000693, "associated treatment strategies": 14.876528025729723, "human failing hearts": 12.9873707888747, "diminished cyclic adenosine": 14.280662839399527, "cyclic adenosine monophosphate": 14.73507474561702, "augmented cyclic guanosine": 14.117933705047566, "cyclic guanosine monophosphate": 14.73507474561702, "negative cross talk": 12.76650219944516, "fluorescence resonance energy": 14.588841744062766, "resonance energy transfer": 13.94884637719023, "video edge detection": 12.9873707888747, "stimulation via catecholamine": 14.588841744062766, "via catecholamine infusions": 14.280662839399527, "camp hydrolytic activity": 13.772883724027798, "blunted cardiac \u03b2": 12.287773259995607, "via nitric oxide": 12.026966349681764, "nitric oxide donors": 12.76650219944516, "partially restored \u03b2": 12.9873707888747, "healthy cardiomyocytes reduced": 14.73507474561702, "inotropic effect following": 14.117933705047566, "following acute \u03b2": 12.287773259995607, "affecting basal contractility": 14.588841744062766, "induced hypertrophic responses": 14.73507474561702, "important defense mechanism": 14.280662839399527, "antagonizing excessive \u03b2": 13.772883724027798, "activating myocardial pde2": 14.117933705047566, "antiadrenergic therapeutic strategy": 15.400197376251594, "receiving optimal therapy": 13.94884637719023, "major safety measures": 13.197513281459468, "primary composite endpoint": 14.117933705047566, "meeting specific inclusion": 14.117933705047566, "treatment group effects": 13.589462839586087, "linear mixed models": 12.76650219944516, "mixed models according": 13.397923393512208, "control vs. rate": 12.026966349681764, "similar efficacy outcomes": 13.94884637719023, "health care expenditures": 13.772883724027798, "control treatment strategies": 14.437494676000693, "trial resource utilization": 14.117933705047566, "fewer cardiac procedures": 13.772883724027798, "lower costs related": 12.76650219944516, "cardiac arrhythmia devices": 14.117933705047566, "cost per patient": 12.026966349681764, "therapeutic strategy used": 13.94884637719023, "overall financial burden": 13.772883724027798, "skeletal muscle sarcomere": 13.94884637719023, "muscle sarcomere structure": 14.117933705047566, "skm mitochondrial structure": 14.280662839399527, "improved mitochondrial structure": 15.013504176704823, "maximum oxygen consumption": 14.117933705047566, "western blot analysis": 13.197513281459468, "report severe perturbations": 14.280662839399527, "associated protein complex": 14.117933705047566, "reach statistical significance": 14.73507474561702, "initial results warrant": 13.589462839586087, "improving muscle function": 13.94884637719023, "versus biomedical treatment": 14.280662839399527, "showed significant improvement": 14.73507474561702, "most adverse events": 12.76650219944516, "adverse events observed": 13.589462839586087, "without special treatment": 13.94884637719023, "systemic adverse events": 13.589462839586087, "adverse events evaluation": 13.94884637719023, "apparently healthy volunteers": 14.588841744062766, "key biosynthetic enzymes": 13.772883724027798, "lower median activities": 13.589462839586087, "newly diagnosed patients": 13.772883724027798, "cardiopulmonary exercise variables": 15.27509950241043, "widely accepted peak": 12.9873707888747, "accepted peak oxygen": 12.9873707888747, "exercise oscillatory ventilation": 15.013504176704823, "different mechanisms underlie": 14.588841744062766, "different pathophysiological origin": 15.400197376251594, "heart transplant recipients": 14.280662839399527, "orthotopic heart transplantation": 15.013504176704823, "including intravenous inotropes": 14.876528025729723, "inflammatory abdominal problems": 14.876528025729723, "abdominal problems occurred": 14.280662839399527, "consultation and/or operation": 14.588841744062766, "patients undergoing oht": 13.589462839586087, "refractory right heart": 13.397923393512208, "posterior wall infarction": 13.94884637719023, "cardiac catheterization showed": 14.73507474561702, "right coronary artery": 13.197513281459468, "percutaneous coronary revascularization": 15.867290107259969, "hemodynamically stable situation": 15.013504176704823, "intensive care unit": 12.76650219944516, "therapy refractory cardiogenic": 14.73507474561702, "extra corporeal membrane": 13.772883724027798, "corporeal membrane oxygenation": 14.73507474561702, "emergency cardiac catheterization": 15.146277935759567, "extracorporeal life support": 14.280662839399527, "ischemic right heart": 12.9873707888747, "successful reperfusion therapy": 14.73507474561702, "early research focused": 13.397923393512208, "careful clinical evaluation": 14.280662839399527, "invasive haemodynamic assessment": 15.013504176704823, "novel treatment strategies": 14.117933705047566, "linked administrative health": 14.437494676000693, "administrative health data": 14.117933705047566, "controlled feasibility study": 14.437494676000693, "without intramuscular testosterone": 15.27509950241043, "intramuscular testosterone supplementation": 16.187244984537102, "collected preliminary data": 14.117933705047566, "age 67.2 years": 11.452869772534292, "mean \u00b1 sd": 9.557599635934, "\u00b1 sd testosterone": 12.287773259995607, "sd testosterone levels": 13.397923393512208, "\u00b1 2.6 nmol": 10.008850163593298, "incremental shuttle walk": 13.772883724027798, "group showed improvements": 13.94884637719023, "elderly male patients": 13.197513281459468, "peripheral muscles improves": 14.280662839399527, "improves endothelial function": 14.588841744062766, "impaired systolic function": 14.117933705047566, "rated depression scores": 13.589462839586087, "mediated dilatation diameter": 14.437494676000693, "toward lower mitral": 12.76650219944516, "lower mitral e": 11.452869772534292, "also improves exercise": 13.397923393512208, "growth factor beta": 12.53375337658753, "improve cardiac functions": 13.94884637719023, "derived progenitor cells": 13.772883724027798, "cardiac explant c": 12.287773259995607, "descending coronary artery": 14.117933705047566, "coronary artery occlusion": 13.94884637719023, "developed infarcted animals": 14.280662839399527, "left ventricle end": 12.53375337658753, "atrial explants produced": 13.772883724027798, "\u03b2 receptor type": 11.74942993331315, "differentiation toward cardiomyocyte": 15.521780795999426, "kit+ cell phenotype": 12.76650219944516, "optimizing cardiac progenitor": 14.588841744062766, "cardiac progenitor function": 14.280662839399527, "cell expansion protocols": 13.772883724027798, "study breathing control": 13.589462839586087, "following cardiac arrest": 13.772883724027798, "pulseless ventricular fibrillation": 15.27509950241043, "newly implanted cardioverter": 14.437494676000693, "class iii heart": 11.74942993331315, "iii heart failure": 12.287773259995607, "permanent periodic breathing": 14.437494676000693, "final data analysis": 12.76650219944516, "cerebral blood flow": 12.76650219944516, "primary oscillations originating": 15.013504176704823, "central pattern generator": 13.94884637719023, "treating heart failure": 13.397923393512208, "much work remains": 12.287773259995607, "including better tools": 13.397923393512208, "increasing evidence points": 14.117933705047566, "different gastrointestinal regions": 15.27509950241043, "disturbed intestinal barrier": 14.437494676000693, "chronic inflammatory state": 14.117933705047566, "particularly poor prognosis": 14.280662839399527, "heart failure research": 13.397923393512208, "stable coronary artery": 13.397923393512208, "ventricular wall stress": 13.589462839586087, "providing prognostic information": 15.013504176704823, "unfavourable clinical outcome": 14.588841744062766, "unilateral renal denervation": 14.437494676000693, "renal denervation improves": 14.117933705047566, "improves autonomic balance": 14.117933705047566, "increased sympathetic tone": 14.117933705047566, "sympathetic tone resulting": 14.117933705047566, "protective mechanisms remain": 14.437494676000693, "unilateral renal dnx": 12.9873707888747, "present study used": 12.53375337658753, "white rabbits undergoing": 13.772883724027798, "undergoing renal dnx": 12.9873707888747, "four treatment groups": 13.197513281459468, "examined several markers": 13.772883724027798, "several markers indicative": 14.117933705047566, "time domain heart": 12.287773259995607, "domain heart rate": 12.287773259995607, "power spectral analysis": 13.589462839586087, "spectral analysis indicated": 14.280662839399527, "heart rate response": 12.76650219944516, "cardiac sympathetic tone": 13.772883724027798, "cardiac vagal tone": 12.53375337658753, "suggest renal dnx": 12.287773259995607, "renal dnx improves": 12.53375337658753, "chronic systolic heart": 13.397923393512208, "randomized trial involving": 14.117933705047566, "left ventricular dyssynchrony": 14.588841744062766, "patients underwent device": 13.94884637719023, "underwent device implantation": 14.588841744062766, "primary efficacy outcome": 13.772883724027798, "safety monitoring board": 13.589462839586087, "at study closure": 12.026966349681764, "primary outcome occurred": 13.772883724027798, "single center retrospective": 14.280662839399527, "retrospective observational study": 15.146277935759567, "receiving ventricular assist": 14.437494676000693, "assist device support": 13.197513281459468, "patients receiving extracorporeal": 15.146277935759567, "receiving extracorporeal membrane": 15.146277935759567, "membrane oxygenation membrane": 14.588841744062766, "oxygenation membrane support": 14.437494676000693, "renal dysfunction improves": 14.117933705047566, "sensitive outcome change": 13.772883724027798, "outcome change scores": 13.197513281459468, "preliminary descriptive study": 14.588841744062766, "ensure effective practice": 13.94884637719023, "using standardized nursing": 14.117933705047566, "standardized nursing terminologies": 15.27509950241043, "retrospective descriptive research": 15.27509950241043, "descriptive research design": 14.280662839399527, "statistically significant improvement": 15.640041845200326, "study provide insight": 13.197513281459468, "sensitive outcome measures": 14.117933705047566, "prospective experimental research": 15.146277935759567, "regarding effective treatment": 14.588841744062766, "older adults hospitalized": 13.94884637719023, "reciprocal downregulation influences": 15.521780795999426, "influences cardiac hypertrophic": 14.876528025729723, "cardiac hypertrophic response": 14.588841744062766, "cardiac gene therapy": 12.9873707888747, "classic signaling paradigms": 14.280662839399527, "human embryonic kidney": 13.397923393512208, "adrenergic receptor agonist": 14.280662839399527, "show reciprocal regulation": 14.117933705047566, "undergoing chronic \u03b2": 12.9873707888747, "adrenergic receptor stimulation": 14.876528025729723, "postischemic heart failure": 14.117933705047566, "cardiac plasma membrane": 13.589462839586087, "plasma membrane levels": 13.397923393512208, "produces beneficial effects": 14.280662839399527, "deleterious \u03b21ar overstimulation": 15.013504176704823, "discharge among patients": 13.772883724027798, "readmission among patients": 14.117933705047566, "linked administrative databases": 14.876528025729723, "saw unfamiliar physician(s": 14.117933705047566, "month observation period": 13.772883724027798, "altered protein kinase": 13.397923393512208, "adrenergic receptor blockade": 14.437494676000693, "reduces total mortality": 13.589462839586087, "halt disease progression": 13.772883724027798, "dependent protein kinase": 13.772883724027798, "adrenergic receptor activation": 14.73507474561702, "human myocardial tissue": 13.589462839586087, "total myosin binding": 12.9873707888747, "myosin binding protein": 13.397923393512208, "site specific rii\u03b1": 12.53375337658753, "vivo phosphorylation sites": 14.117933705047566, "specific monoclonal antibodies": 14.73507474561702, "monoclonal antibodies showed": 14.437494676000693, "mutant ri\u03b1 proteins": 12.76650219944516, "failing myocardium displays": 14.280662839399527, "displays altered expression": 14.280662839399527, "heart failure prone": 12.76650219944516, "signifies repolarization lability": 15.146277935759567, "nervous system activity": 13.589462839586087, "spontaneous ventricular tachycardia": 15.400197376251594, "structurally normal hearts": 14.117933705047566, "beat qt interval": 12.026966349681764, "rate atrial pacing": 12.53375337658753, "isoprenaline infusion increased": 14.876528025729723, "heart rate variation": 12.9873707888747, "nervous system modulation": 13.94884637719023, "related congestive heart": 13.772883724027798, "haematopoietic cell transplantation": 15.400197376251594, "developing congestive heart": 14.280662839399527, "control study design": 12.9873707888747, "cumulative anthracycline exposure": 15.146277935759567, "stem cell source": 12.026966349681764, "doxorubicin efflux transporter": 14.73507474561702, "chf predictive model": 12.9873707888747, "predictive model performed": 14.117933705047566, "propose fundamental definitions": 14.876528025729723, "right heart circulation": 13.589462839586087, "right heart circulatory": 13.589462839586087, "heart circulatory failure": 13.94884637719023, "foster collaborative research": 14.588841744062766, "collaborative research initiatives": 15.27509950241043, "class angiotensin receptor": 14.117933705047566, "natriuretic peptide system": 14.117933705047566, "atrial natriuretic peptide": 14.117933705047566, "neprilysin inhibitor prodrug": 14.437494676000693, "angiotensin receptor antagonist": 14.876528025729723, "receptor antagonist valsartan": 14.588841744062766, "large outcomes trial": 12.9873707888747, "ejection fraction outcomes": 14.117933705047566, "fraction outcomes trial": 13.589462839586087, "improve clinical symptoms": 13.94884637719023, "term survival rates": 12.76650219944516, "underlying clinical trials": 14.117933705047566, "new pharmacologic targets": 13.94884637719023, "purely hemodynamic disorder": 14.280662839399527, "interconnected molecular pathways": 15.146277935759567, "maladaptive molecular processes": 14.876528025729723, "molecular biomarkers provide": 14.437494676000693, "important therapeutic implications": 15.27509950241043, "guided clinical trials": 13.397923393512208, "potential therapeutic implications": 15.27509950241043, "strict statistical standards": 14.437494676000693, "guided clinical trial": 13.197513281459468, "clinical trial design": 13.197513281459468, "fastest growing subclass": 13.772883724027798, "small noncoding rnas": 12.9873707888747, "heart failure development": 13.94884637719023, "provide brief insight": 13.197513281459468, "novel therapeutic targets": 13.94884637719023, "aldosterone system inhibitors": 14.588841744062766, "carries significant morbidity": 14.588841744062766, "direct renin inhibitors": 13.589462839586087, "neutral endopeptidase inhibitors": 15.013504176704823, "skeletal muscle abnormalities": 14.588841744062766, "peripheral muscle pump": 13.397923393512208, "promoting cardiac filling": 13.94884637719023, "acquired heart failure": 13.397923393512208, "reduced skeletal muscle": 13.589462839586087, "mass and/or metabolic": 13.197513281459468, "design and patients": 12.76650219944516, "underwent cardiopulmonary exercise": 15.27509950241043, "lean mass quantification": 13.772883724027798, "magnetic resonance spectroscopy": 14.876528025729723, "australian reference data": 13.94884637719023, "single tertiary referral": 13.772883724027798, "tertiary referral centre": 13.772883724027798, "appendicular lean mass": 13.397923393512208, "lean mass index": 11.74942993331315, "matched reference values": 13.772883724027798, "low skeletal muscle": 12.76650219944516, "muscle mass t": 11.134484719950263, "young normal reference": 13.397923393512208, "normal reference mean": 13.197513281459468, "sarcopenic range muscle": 13.589462839586087, "clinically significant wasting": 14.73507474561702, "muscle aerobic capacity": 13.589462839586087, "postexercise phosphocreatine resynthesis": 15.976590994702674, "adults versus controls": 13.397923393512208, "performed confirmatory factor": 14.588841744062766, "confirmatory factor analysis": 14.437494676000693, "used exploratory factor": 13.589462839586087, "exploratory factor analysis": 14.280662839399527, "separate scale dimensions": 13.94884637719023, "individual scales showed": 13.772883724027798, "excellent fit indices": 13.197513281459468, "contrasting groups validity": 14.280662839399527, "type natriuretic peptides": 13.94884637719023, "common consensus regarding": 14.117933705047566, "-80 \u00b0 c": 8.48345707385196, "mass spectrometric analysis": 14.280662839399527, "customized homogeneous sandwich": 14.876528025729723, "sandwich alphalisa \u00ae": 12.9873707888747, "alphalisa \u00ae immunoassays": 13.772883724027798, "terminally processed forms": 14.117933705047566, "low apparent concentration": 14.117933705047566, "terminally truncated fragments": 14.73507474561702, "targeting nonterminal epitopes": 14.73507474561702, "central glycosylated region": 14.280662839399527, "left ventricular hypertrophy": 14.437494676000693, "relative wall thickness": 13.589462839586087, "data among groups": 12.287773259995607, "lower systolic blood": 12.9873707888747, "less renal impairment": 13.197513281459468, "elevated cardiac filling": 13.772883724027798, "cardiac filling pressures": 13.94884637719023, "equivalent adverse outcomes": 14.280662839399527, "carvedilol and metoprolol": 13.94884637719023, "\u00b1 1.1 years": 10.41746331438823, "significantly decreased risk": 14.437494676000693, "inappropriate therapy compared": 14.73507474561702, "inappropriate shock therapy": 14.280662839399527, "inappropriate therapy caused": 14.437494676000693, "nationwide retrospective cohort": 14.876528025729723, "general population comprised": 14.437494676000693, "proportional hazard analyses": 14.437494676000693, "commonly used bisphosphonates": 14.588841744062766, "observed across refill": 13.397923393512208, "across refill compliance": 13.772883724027798, "refill compliance strata": 13.772883724027798, "increasing refill compliance": 14.437494676000693, "matched control subjects": 13.772883724027798, "weeks infarcted rats": 12.9873707888747, "weeks mi animals": 12.026966349681764, "posterior wall thickness": 13.772883724027798, "dopamine without affecting": 14.117933705047566, "increased mrna level": 12.9873707888747, "reverse cardiac remodeling": 14.117933705047566, "incident cardiovascular events": 14.73507474561702, "independent risk factor": 13.589462839586087, "shown inconsistent results": 14.117933705047566, "subclinical atherosclerosis using": 15.146277935759567, "general linear models": 13.197513281459468, "8,009 reference subjects": 13.772883724027798, "higher diastolic blood": 13.397923393512208, "diastolic blood pressure": 13.772883724027798, "mass index levels": 12.287773259995607, "adjusted carotid intima": 13.589462839586087, "coronary artery calcium": 13.589462839586087, "artery calcium scores": 13.197513281459468, "predominantly mild disease": 14.117933705047566, "subjects without psoriasis": 14.117933705047566, "share many risk": 11.74942993331315, "many risk factors": 12.287773259995607, "hospital readmission reduction": 14.73507474561702, "readmission reduction program": 14.588841744062766, "rate following hospital": 13.589462839586087, "following hospital stay": 13.589462839586087, "possible suboptimal care": 13.772883724027798, "significant economic considerations": 15.400197376251594, "center pilot project": 12.9873707888747, "cardiac specialty hospital": 14.117933705047566, "ensure adequate self": 12.9873707888747, "percent relative reduction": 14.117933705047566, "net economic savings": 12.9873707888747, "urbanized midwestern state": 14.117933705047566, "abnormal hr variability": 13.589462839586087, "reflecting rapid r": 12.53375337658753, "r interval oscillations": 13.589462839586087, "linear hr variability": 13.197513281459468, "hr variability measures": 13.589462839586087, "term fractal scaling": 12.9873707888747, "fractal scaling exponent": 13.772883724027798, "better prognostic information": 14.588841744062766, "fatal arrhythmia events": 13.589462839586087, "future randomized trials": 13.772883724027798, "trials using hr": 11.74942993331315, "using hr variability": 12.9873707888747, "defined inclusion criteria": 14.117933705047566, "routine clinical tool": 13.197513281459468, "renal artery stenosis": 13.197513281459468, "peripheral arterial disease": 14.280662839399527, "pathophysiologic mechanism stems": 15.013504176704823, "renal underperfusion resulting": 14.73507474561702, "end stage kidney": 12.026966349681764, "stage kidney failure": 12.9873707888747, "computed tomographic angiography": 15.013504176704823, "magnetic resonance angiography": 14.73507474561702, "adequate blood pressure": 13.589462839586087, "blood pressure control": 13.397923393512208, "preventive measures form": 13.772883724027798, "based percutaneous revascularization": 15.521780795999426, "modest clinical benefit": 13.589462839586087, "small retrospective studies": 14.280662839399527, "randomized clinical trials": 14.117933705047566, "clinical trials failed": 13.397923393512208, "concrete data regarding": 13.589462839586087, "determining individualized assessment": 15.640041845200326, "several key genes": 12.287773259995607, "key genes related": 12.287773259995607, "differentially expressed genes": 14.73507474561702, "programmed cell death": 13.197513281459468, "longitudinal analysis using": 14.280662839399527, "analysis using medicare": 13.589462839586087, "using medicare data": 12.76650219944516, "healthcare utilization effects": 14.73507474561702, "combined care management": 13.772883724027798, "retrospective matched cohort": 14.437494676000693, "matched cohort study": 12.9873707888747, "demonstration participating clinics": 15.400197376251594, "score matched control": 13.197513281459468, "matched control group": 13.197513281459468, "driven telehealth system": 13.772883724027798, "year study period": 12.287773259995607, "negative binomial regression": 14.437494676000693, "binomial regression models": 14.117933705047566, "% lower risk": 10.790805427161697, "quarterly inpatient admissions": 14.73507474561702, "driven telehealth technology": 14.437494676000693, "improve health outcomes": 13.589462839586087, "contemporary chronic heart": 14.117933705047566, "exercise training response": 14.117933705047566, "without exercise training": 13.94884637719023, "identified black patients": 13.94884637719023, "less ischemic etiology": 13.397923393512208, "lower socioeconomic status": 14.117933705047566, "status versus whites": 12.9873707888747, "minute walk distance": 12.9873707888747, "after multivariable adjustment": 14.73507474561702, "similar cardiovascular mortality": 15.013504176704823, "modifiable risk factors": 13.589462839586087, "lower exercise performance": 14.117933705047566, "optimal therapy including": 13.94884637719023, "therapy including anticoagulation": 15.146277935759567, "major cardiovascular complications": 15.27509950241043, "prevent adverse outcomes": 13.772883724027798, "adverse outcomes related": 13.772883724027798, "preserve atrial structure": 13.94884637719023, "maintain sinus rhythm": 13.197513281459468, "delayed rhythm control": 13.397923393512208, "otherwise effective rate": 13.772883724027798, "effective rate control": 13.397923393512208, "new antiarrhythmic drugs": 13.772883724027798, "modern rhythm control": 13.197513281459468, "reduce cardiovascular complications": 15.400197376251594, "recent onset af": 11.74942993331315, "mandated usual care": 12.76650219944516, "blinded outcome assessment": 14.117933705047566, "outcome assessment trial": 13.772883724027798, "composite primary outcome": 13.94884637719023, "underlying heart disease": 13.772883724027798, "care plus rhythm": 12.026966349681764, "operated electrocardiographic device": 15.521780795999426, "key secondary outcomes": 13.397923393512208, "secondary outcomes include": 14.117933705047566, "include cognitive function": 14.117933705047566, "prevent cardiovascular complications": 15.521780795999426, "cardiovascular complications associated": 15.867290107259969, "term ventricular assist": 13.589462839586087, "health care providers": 13.197513281459468, "significant gastrointestinal bleeding": 15.640041845200326, "called end stage": 12.026966349681764, "advanced structural heart": 13.94884637719023, "structural heart disease": 13.772883724027798, "minimal physical exertion": 13.94884637719023, "maximal medical treatment": 13.94884637719023, "medical treatment according": 14.280662839399527, "year mortality rate": 12.76650219944516, "special therapeutic interventions": 15.146277935759567, "correct reversible causes": 13.94884637719023, "poor patient compliance": 13.589462839586087, "describe current strategies": 14.280662839399527, "ca2 + currents": 11.452869772534292, "influx via l": 10.790805427161697, "ventricular action potentials": 14.588841744062766, "monomeric g proteins": 12.9873707888747, "regulates ventricular action": 14.437494676000693, "ventricular action potential": 14.437494676000693, "action potential duration": 13.94884637719023, "inhibit cardiac l": 12.287773259995607, "type channel activity": 13.197513281459468, "occurring rad variant": 13.197513281459468, "type channel isoforms": 13.197513281459468, "type channel inhibition": 13.589462839586087, "ethically complex situations": 14.437494676000693, "religious beliefs preclude": 14.117933705047566, "involving young adults": 13.397923393512208, "sickle cell disease": 12.76650219944516, "urgently recommend blood": 13.772883724027798, "recommend blood transfusions": 14.437494676000693, "composite quality measures": 14.117933705047566, "inpatient medical conditions": 14.437494676000693, "select better hospitals": 13.589462839586087, "individual quality measures": 14.280662839399527, "inferior hospitals based": 13.772883724027798, "derived composite quality": 13.94884637719023, "composite quality measure": 13.94884637719023, "composite measure predicts": 14.117933705047566, "future hospital mortality": 13.94884637719023, "older patients treated": 13.397923393512208, "acute care hospital": 12.76650219944516, "existing quality indicators": 14.280662839399527, "race influences efficacy": 13.772883724027798, "functional class iv": 12.76650219944516, "myocardial infarction compared": 14.73507474561702, "attain maximal spironolactone": 14.588841744062766, "maximal spironolactone dose": 14.280662839399527, "achieved study drug": 12.76650219944516, "study drug dose": 11.74942993331315, "less clinical benefit": 13.197513281459468, "free shotgun proteomics": 13.589462839586087, "shotgun proteomics approach": 14.280662839399527, "tac)-induced heart failure": 14.117933705047566, "associated signaling pathway": 14.437494676000693, "signaling pathway changes": 13.94884637719023, "changes using ingenuity": 13.589462839586087, "using ingenuity pathway": 13.589462839586087, "heart failure phenotypes": 13.772883724027798, "mitochondrial damage induced": 14.437494676000693, "mitochondrial proteome changes": 14.73507474561702, "nonmitochondrial protein changes": 15.013504176704823, "included significant amelioration": 15.146277935759567, "actin cytoskeleton pathways": 14.280662839399527, "induced proteomic alterations": 14.588841744062766, "perturbed mitochondrial function": 15.013504176704823, "potential clinical application": 14.73507474561702, "targeted peptide drugs": 13.397923393512208, "treatment heart failure": 13.589462839586087, "stay increase rehospitalization": 14.876528025729723, "skilled nursing facilities": 14.117933705047566, "1.56 percentage points": 13.397923393512208, "0.81 percentage points": 13.397923393512208, "urinary tract infection": 13.589462839586087, "patients undergoing procedures": 14.73507474561702, "medically managed diseases": 14.117933705047566, "acute care hospitals": 12.9873707888747, "costs across volume": 12.76650219944516, "across volume groups": 12.9873707888747, "examined physician volume": 13.94884637719023, "volume within strata": 12.9873707888747, "higher readmission rates": 13.772883724027798, "among noncardiologist physicians": 15.013504176704823, "major clinical trials": 13.197513281459468, "clinical trials designed": 13.772883724027798, "analyze clinical outcomes": 13.94884637719023, "clinical outcomes using": 13.589462839586087, "myocardial infarction patients": 14.73507474561702, "aldosterone antagonist eplerenone": 15.146277935759567, "aldosterone antagonist therapy": 14.73507474561702, "improving survival rates": 13.772883724027798, "contemporary therapeutic options": 15.013504176704823, "thus examined changes": 13.197513281459468, "dilated cardiomyopathy cohort": 14.588841744062766, "negative coronary angiography": 14.588841744062766, "heart failure treatment": 13.589462839586087, "failure treatment eras": 13.397923393512208, "patients receiving angiotensin": 14.73507474561702, "angiotensin receptors blockers": 14.73507474561702, "final evaluation increased": 14.117933705047566, "trend toward enrollment": 13.589462839586087, "point including death": 13.197513281459468, "recent enrollment period": 13.772883724027798, "powerful independent predictor": 14.73507474561702, "% risk reduction": 12.026966349681764, "reflecting marked decreases": 14.280662839399527, "controlled randomized trials": 14.437494676000693, "indeterminable anaerobic threshold": 15.27509950241043, "maximal cardiopulmonary exercise": 15.013504176704823, "stable clinical conditions": 14.117933705047566, "exercise test investigations": 14.437494676000693, "peak respiratory quotient": 13.94884637719023, "respiratory quotient \u22641.05": 14.117933705047566, "urgent cardiac transplant": 13.94884637719023, "secondary end point": 12.76650219944516, "multivariable logistic analysis": 14.876528025729723, "reduced peak oxygen": 12.76650219944516, "higher metabolic exercise": 13.94884637719023, "index score value": 12.287773259995607, "at multivariable analysis": 13.94884637719023, "ventilatory efficiency slope": 14.437494676000693, "secondary study end": 12.76650219944516, "independent prognostic role": 14.280662839399527, "heart failure mortality": 13.589462839586087, "among cardiorespiratory fitness": 14.876528025729723, "versus unfit men": 12.026966349681764, "cardiovascular disease underwent": 15.013504176704823, "measures included body": 13.397923393512208, "included body mass": 12.53375337658753, "maximal treadmill exercise": 14.117933705047566, "treadmill exercise testing": 14.117933705047566, "obese body mass": 11.74942993331315, "mass index categories": 13.197513281459468, "overweight body mass": 12.9873707888747, "mass index strata": 12.287773259995607, "risk factors present": 12.9873707888747, "decreased mitochondrial energy": 14.73507474561702, "mitochondrial energy production": 14.876528025729723, "energy production precede": 13.94884637719023, "energy metabolism precede": 13.94884637719023, "cardiac hypertrophy secondary": 14.588841744062766, "abdominal aortic constriction": 14.588841744062766, "energy substrate metabolism": 14.280662839399527, "demonstrated diastolic dysfunction": 15.27509950241043, "% ejection fraction": 12.76650219944516, "marked cardiac insulin": 13.397923393512208, "plasma membrane translocation": 14.588841744062766, "myocardial glycolysis rates": 14.280662839399527, "reduced mitochondrial complex": 14.588841744062766, "mitochondrial complex v": 13.589462839586087, "complex v activity": 12.53375337658753, "decreased mitochondrial oxidative": 15.146277935759567, "mitochondrial oxidative metabolism": 15.27509950241043, "early metabolic changes": 13.589462839586087, "guide health service": 12.9873707888747, "health service planning": 13.589462839586087, "relevant health service": 13.589462839586087, "health service provision": 13.772883724027798, "reduced gross income": 12.9873707888747, "including lower risk": 12.9873707888747, "raised blood glucose": 12.9873707888747, "blood glucose levels": 12.9873707888747, "gross national income": 13.197513281459468, "income per capita": 12.287773259995607, "renal chloride channel": 13.397923393512208, "chloride channel gene": 13.197513281459468, "reported greater risk": 13.197513281459468, "ambient air pollution": 13.197513281459468, "recognised risk factor": 13.397923393512208, "new systematic review": 13.197513281459468, "common disorder associated": 14.117933705047566, "aggravate cardiovascular health": 14.876528025729723, "exacerbates heart failure": 13.94884637719023, "cytoskeletal actin dynamics": 14.280662839399527, "produced cardiac dysfunction": 14.437494676000693, "mildly increased heart": 13.397923393512208, "increased heart mass": 12.9873707888747, "eliminated cardiac hypertrophy": 14.73507474561702, "cardiac functional deterioration": 15.013504176704823, "mechanical support devices": 14.117933705047566, "collaboration among cardiologists": 15.146277935759567, "medical staff responsible": 13.94884637719023, "regarding appropriate referrals": 14.876528025729723, "present consensus report": 13.772883724027798, "information regarding conditions": 15.013504176704823, "recent postmarketing trials": 14.280662839399527, "hospitalized heart failure": 14.117933705047566, "user cohort study": 12.287773259995607, "health system data": 12.53375337658753, "system data partners": 12.9873707888747, "acting insulin products": 13.589462839586087, "principal discharge diagnosis": 14.588841744062766, "disease risk score": 12.53375337658753, "saxagliptin versus sitagliptin": 14.73507474561702, "saxagliptin versus pioglitazone": 14.876528025729723, "saxagliptin versus insulin": 14.117933705047566, "stratified hazard ratios": 13.772883724027798, "sitagliptin versus pioglitazone": 14.876528025729723, "sitagliptin versus insulin": 14.117933705047566, "1:1 propensity score": 12.9873707888747, "prior cardiovascular disease": 14.437494676000693, "large cohort study": 12.53375337658753, "selected antihyperglycemic agents": 15.146277935759567, "improving physician adherence": 14.588841744062766, "systematic review protocol": 14.117933705047566, "identify implementation strategies": 15.27509950241043, "improve physician adherence": 14.280662839399527, "include prospective studies": 14.280662839399527, "prospective studies evaluating": 14.73507474561702, "studies evaluating implementation": 15.146277935759567, "evaluating implementation interventions": 15.867290107259969, "common underlying characteristics": 15.146277935759567, "recommended pharmacological treatment": 15.640041845200326, "left ventricular function": 13.94884637719023, "ventricular function assessment": 14.876528025729723, "include clinical outcomes": 13.94884637719023, "determine patient awareness": 14.280662839399527, "analyze interview data": 13.397923393512208, "setting and participants": 13.772883724027798, "felt implantable cardioverter": 14.588841744062766, "previously established preferences": 15.27509950241043, "within broader discussions": 14.117933705047566, "life treatment preferences": 14.117933705047566, "defibrillator deactivation preferences": 15.75515727781788, "distressing implantable cardioverter": 15.521780795999426, "carotid baroreflex activation": 14.588841744062766, "baroreflex activation therapy": 14.588841744062766, "decreased parasympathetic activity": 15.27509950241043, "parasympathetic activity contribute": 15.400197376251594, "centrally mediated reduction": 14.437494676000693, "increased parasympathetic activity": 15.27509950241043, "chronic stable guideline": 13.772883724027798, "directed medical therapy": 13.772883724027798, "receive ongoing gdmt": 12.9873707888747, "gdmt plus bat": 11.134484719950263, "primary safety end": 12.53375337658753, "safety end point": 12.026966349681764, "primary efficacy end": 12.9873707888747, "efficacy end points": 12.76650219944516, "hall walk distance": 12.53375337658753, "control group patients": 13.397923393512208, "\u00b1 3.1 points": 10.790805427161697, "functional class ranking": 13.772883724027798, "significantly reduced n": 13.589462839586087, "toward fewer days": 12.287773259995607, "fewer days hospitalized": 13.589462839586087, "improves functional status": 14.117933705047566, "heart failure hospitalizations": 14.73507474561702, "using cardiopulmonary exercise": 14.73507474561702, "exercise testing guide": 13.397923393512208, "testing guide exercise": 13.397923393512208, "guide exercise rehabilitation": 14.588841744062766, "standard clinical practice": 14.117933705047566, "prescribe exercise rehabilitation": 15.146277935759567, "limited maximal cpet": 12.9873707888747, "control without exercise": 13.772883724027798, "patients used \u03b450%w": 12.76650219944516, "used \u03b450%w intensity": 12.9873707888747, "two groups patients": 12.76650219944516, "guiding exercise rehabilitation": 14.876528025729723, "newer imaging techniques": 13.772883724027798, "reduced long axis": 12.287773259995607, "long axis function": 12.53375337658753, "other cardiovascular risk": 13.94884637719023, "single diagnostic test": 13.397923393512208, "thorough medical history": 13.772883724027798, "standing blood pressure": 13.589462839586087, "jugular venous pressure": 13.589462839586087, "peripheral oedema allows": 13.772883724027798, "oedema allows assessment": 13.772883724027798, "heart failure nurses": 12.9873707888747, "local cardiology services": 13.94884637719023, "regular physical activity": 13.94884637719023, "physical activity controls": 14.117933705047566, "acquired cardiovascular risk": 14.437494676000693, "recent evidence suggests": 13.772883724027798, "exercise prevents cell": 13.397923393512208, "prevents cell senescence": 13.772883724027798, "developing certain malignancies": 14.876528025729723, "certain malignancies including": 14.73507474561702, "malignancies including cancer": 14.588841744062766, "even lower volumes": 12.53375337658753, "recommendations confer health": 14.588841744062766, "confer health benefits": 13.397923393512208, "established cardiac disease": 14.280662839399527, "cardiac disease including": 13.94884637719023, "disease including heart": 13.589462839586087, "including heart failure": 13.589462839586087, "rare with.estimates ranging": 14.280662839399527, "aged recreational athletes": 14.117933705047566, "sudden cardiac deaths": 13.197513281459468, "cardiac deaths occur": 12.9873707888747, "detect congenital accessory": 14.280662839399527, "congenital accessory pathways": 14.588841744062766, "limited value given": 12.76650219944516, "small pilot study": 12.287773259995607, "week aerobic training": 13.197513281459468, "aerobic training period": 13.589462839586087, "trainings per week": 12.53375337658753, "integrated dynamic resistance": 14.588841744062766, "dynamic resistance training": 14.280662839399527, "patients underwent testing": 14.117933705047566, "combined training resulted": 14.117933705047566, "peak work rate": 11.452869772534292, "resistance training intervention": 15.013504176704823, "augmented feedback resulted": 14.280662839399527, "assess social support": 13.197513281459468, "perceived social support": 13.772883724027798, "social support score": 12.9873707888747, "indicated higher levels": 13.589462839586087, "higher btes indicated": 13.197513281459468, "higher exercise time": 12.9873707888747, "usual care group": 12.026966349681764, "poor social support": 12.76650219944516, "lower exercise time": 12.76650219944516, "training improves outcomes": 14.117933705047566, "facilitate individualized approaches": 15.521780795999426, "implement exercise training": 14.280662839399527, "exercise training therapy": 13.94884637719023, "recent onset heart": 12.53375337658753, "standardized exercise protocol": 14.73507474561702, "respiratory gas analysis": 13.772883724027798, "recommended target doses": 13.772883724027798, "resting hr<70 bpm": 12.287773259995607, "hr<70 versus \u226570": 12.026966349681764, "similar dose uptitration": 13.772883724027798, "significantly larger hr": 13.589462839586087, "larger hr reduction": 12.76650219944516, "lower resting hr": 12.026966349681764, "aggressive dose uptitration": 14.280662839399527, "little hr reduction": 12.76650219944516, "left atrial pressure": 12.9873707888747, "atrial pressure improve": 13.589462839586087, "pressure improve symptoms": 13.94884637719023, "canadian special access": 13.589462839586087, "special access programme": 13.772883724027798, "transoesophageal echocardiographic guidance": 16.288847892605204, "procedural adverse events": 13.94884637719023, "walk test distance": 12.53375337658753, "right atrial pressure": 13.197513281459468, "pulmonary arterial pressure": 14.280662839399527, "ventricular tachycardia storm": 14.588841744062766, "right interatrial shunt": 13.589462839586087, "interatrial shunt demonstrates": 14.73507474561702, "demonstrates initial safety": 14.280662839399527, "scale randomised studies": 13.772883724027798, "receptor neprilysin inhibitors": 14.73507474561702, "neprilysin blocks renin": 13.589462839586087, "supports natural vasodilatory": 14.588841744062766, "prospective randomized multicenter": 15.27509950241043, "randomized multicenter trial": 14.437494676000693, "multicenter trial paradigm": 14.117933705047566, "stabilized chronic heart": 13.772883724027798, "specified subgroup analyses": 14.280662839399527, "typical adverse event": 13.197513281459468, "long time become": 12.026966349681764, "stable chronic heart": 12.9873707888747, "systolic dysfunction treatment": 14.73507474561702, "among older persons": 12.76650219944516, "factorial trial conducted": 13.94884637719023, "academic medical center": 13.589462839586087, "initially screened participants": 14.876528025729723, "older obese participants": 13.772883724027798, "higher scores indicate": 13.397923393512208, "indicate worse heart": 12.9873707888747, "worse heart failure": 12.76650219944516, "by main effects": 11.74942993331315, "main effects analysis": 13.197513281459468, "kg body mass": 10.790805427161697, "statistically significant change": 15.013504176704823, "percent lean body": 12.287773259995607, "intermuscular fat ratio": 13.589462839586087, "serious adverse events": 13.397923393512208, "conclusions and relevance": 13.94884637719023, "training increased peak": 13.589462839586087, "ventricular assist system": 13.94884637719023, "centrifugal flow pump": 13.197513281459468, "magnetically levitated rotor": 14.437494676000693, "support)-derived performance goal": 15.146277935759567, "optimal medical management": 14.117933705047566, "% received transplants": 13.397923393512208, "% performance goal": 12.53375337658753, "significantly reduced mortality": 14.876528025729723, "reduced mortality risk": 13.397923393512208, "key adverse events": 12.53375337658753, "adverse events included": 13.589462839586087, "events included reoperation": 14.280662839399527, "month survival rates": 12.9873707888747, "favorable adverse event": 13.589462839586087, "adverse event profile": 13.197513281459468, "influence medical resource": 14.117933705047566, "medical resource use": 12.9873707888747, "based simulation tool": 13.197513281459468, "cohort study designs": 12.9873707888747, "virtual cohorts used": 12.9873707888747, "replicating resource use": 13.772883724027798, "debilitating chronic disease": 14.437494676000693, "enhancing medical management": 14.437494676000693, "ultimately reduce morbidity": 14.280662839399527, "anemia and iron": 7.832953288875434, "male sex were": 7.422989813300176, "development and disease": 9.05964189305739, "failure or death": 8.01797756645451, "mortality as patients": 8.798342187639646, "review and network": 8.355835584391686, "provided during office": 8.931948929008138, "mortality and readmissions": 9.411955803365045, "relationship between sex": 9.181922482685199, "prescribed therapy were": 9.05964189305739, "loading and uninephrectomy": 9.411955803365045, "use and outcomes": 8.01797756645451, "develops after ring": 8.511001466296774, "reduction by surgery": 8.658247192583133, "old man had": 6.944975542925487, "incidence and predictors": 9.181922482685199, "function and remodeling": 9.05964189305739, "ischemia and heart": 8.355835584391686, "assessed by echocardiography": 9.624996450667128, "tonometric indices were": 9.05964189305739, "chronic disease such": 8.658247192583133, "frailty and risk": 8.01797756645451, "association between frailty": 9.520441892933018, "blockers and \u03b2": 7.635246515022862, "rates and risk": 7.635246515022862, "performed at baseline": 8.798342187639646, "failure and arrhythmias": 9.05964189305739, "morphology and duration": 9.05964189305739, "duration and extent": 8.511001466296774, "inhibitor or angiotensin": 9.181922482685199, "occurred during follow": 8.931948929008138, "cardiac remodelling is": 8.931948929008138, "biological phenotype had": 9.181922482685199, "baseline and heart": 8.355835584391686, "diagnostic features such": 9.181922482685199, "mortality and morbidity": 9.05964189305739, "cardiac washout was": 8.511001466296774, "contextual factors such": 9.05964189305739, "inclusion and exclusion": 9.05964189305739, "limited data are": 8.01797756645451, "important comorbidities such": 9.624996450667128, "recent data is": 7.635246515022862, "physician continuity further": 9.624996450667128, "month after discharge": 8.798342187639646, "symptoms and signs": 8.355835584391686, "matched and sex": 7.832953288875434, "reversed by metoprolol": 8.931948929008138, "internal diameter were": 8.931948929008138, "management and telehealth": 9.29923091812682, "patient population has": 8.931948929008138, "major complications had": 9.05964189305739, "fit men had": 6.944975542925487, "prevention and treatment": 9.181922482685199, "cardiac pathophysiology is": 9.411955803365045, "patient care is": 7.832953288875434, "clinical outcomes such": 8.931948929008138, "primary symptoms are": 8.658247192583133, "risk factors such": 8.191848839997071, "active individuals are": 8.931948929008138, "recreational athletes more": 9.411955803365045, "support and barriers": 8.658247192583133, "use and quality": 7.832953288875434, "neurohormones and adipokines": 4.812498225333564, "chf and individuals": 4.255500733148387, "follow up body": 3.817623257511431, "adiponectin at baseline": 4.529820946528695, "nps or adiponectin": 4.177917792195843, "adiponectin during follow": 4.64961545906341, "signs and symptoms": 4.177917792195843, "developed this guideline": 4.590961241342599, "includes all clinicians": 4.529820946528695, "evidence and recommendations": 4.812498225333564, "benefits and harms": 4.177917792195843, "tolerance and quality": 4.399171093819823, "confounded by indication": 4.590961241342599, "failure and iron": 4.008988783227255, "warrants further study": 4.465974464504069, "anemia and heart": 4.008988783227255, "fraction and patients": 4.399171093819823, "identification and enrollment": 4.862947248020922, "review and meta": 3.916476644437717, "predictor and mortality": 4.529820946528695, "shocks during follow": 4.329123596291566, "within each strategy": 4.329123596291566, "treatment or placebo": 4.329123596291566, "dopamine or nesiritide": 4.465974464504069, "issues and strategies": 4.399171093819823, "individuals and organizations": 4.862947248020922, "testimonies and conversations": 4.862947248020922, "structure by changing": 4.399171093819823, "growth and plasticity": 4.399171093819823, "abundance during disease": 4.590961241342599, "hypertrophy and failure": 4.529820946528695, "looping and myocyte": 4.255500733148387, "underlying these defects": 4.590961241342599, "shared between development": 4.705977901682522, "factors and outcomes": 4.329123596291566, "mortality after hospitalization": 4.958842675243241, "years after hospitalization": 4.760220946466509, "capacity and outcomes": 4.399171093819823, "cfus and diabetes": 4.095924419998536, "requires further examination": 4.812498225333564, "change and correlation": 4.465974464504069, "correlation between performance": 4.958842675243241, "deciles and level": 4.095924419998536, "conditions and metrics": 4.465974464504069, "rankings and impact": 4.255500733148387, "care and management": 4.255500733148387, "supplemented by hand": 4.329123596291566, "extracted and validity": 4.465974464504069, "blot and dna": 3.5969351423872324, "difference between numbers": 4.705977901682522, "failure or driveline": 4.329123596291566, "used this technique": 4.255500733148387, "loss and transfusion": 4.329123596291566, "deaths or strokes": 4.095924419998536, "blocker and beta": 4.008988783227255, "blockers at guideline": 4.399171093819823, "failure and associations": 4.590961241342599, "levels between reduced": 4.465974464504069, "fraction and sex": 4.008988783227255, "among all subgroups": 4.255500733148387, "among these subgroups": 4.399171093819823, "based or emergency": 4.177917792195843, "disease and symptoms": 4.329123596291566, "impairment at hospitalization": 4.862947248020922, "mortality or readmission": 4.590961241342599, "patients as having": 4.177917792195843, "patients having heart": 4.399171093819823, "gender and adherence": 4.329123596291566, "malondialdehyde and hdl": 4.529820946528695, "assessed by flow": 4.008988783227255, "profiled by shotgun": 4.255500733148387, "correlation between changes": 4.760220946466509, "production and flow": 4.255500733148387, "years after admission": 4.399171093819823, "disease by angiotensin": 4.465974464504069, "infusion and uninephrectomy": 4.760220946466509, "infusion and salt": 4.095924419998536, "shortening and increases": 4.590961241342599, "age and race": 3.5969351423872324, "women and men": 3.711494906650088, "survival after left": 4.255500733148387, "lvad and patients": 4.095924419998536, "mortality at hospital": 4.399171093819823, "effects and cost": 4.008988783227255, "complications after implantation": 5.004501392234941, "status and device": 4.095924419998536, "conclude that evidence": 4.465974464504069, "selected and program": 4.329123596291566, "infrastructure and budget": 4.64961545906341, "vasodilators and diuretics": 4.705977901682522, "surgery by echocardiography": 4.760220946466509, "confirmed no findings": 4.399171093819823, "resection and edge": 4.177917792195843, "at this time": 3.5969351423872324, "closure and opening": 4.255500733148387, "years after valve": 4.095924419998536, "at this point": 3.711494906650088, "curves and log": 3.817623257511431, "equation and patients": 4.399171093819823, "constructed and predictors": 4.705977901682522, "differences between patients": 4.812498225333564, "bb at enrollment": 4.008988783227255, "regimen and sst2": 4.008988783227255, "across all study": 4.008988783227255, "limited by chemical": 4.255500733148387, "instability and cogeneration": 4.812498225333564, "assessed by end": 3.916476644437717, "identified all adults": 4.399171093819823, "association between spironolactone": 5.0916998341368105, "use and death": 3.711494906650088, "injury during spironolactone": 4.812498225333564, "perfusion by enhancing": 4.465974464504069, "weeks after b": 3.711494906650088, "vary by emergency": 4.095924419998536, "human and rat": 3.711494906650088, "regurgitation and aortocaval": 4.812498225333564, "function and efficiency": 4.529820946528695, "symptoms and hospitalizations": 4.862947248020922, "velocity over tissue": 4.329123596291566, "catheterization and transthoracic": 5.048759311919856, "function and prognosis": 4.465974464504069, "measurements and positron": 4.64961545906341, "ischemia after bottleneck": 4.64961545906341, "wk after stenting": 4.095924419998536, "placebo or ivabradine": 4.399171093819823, "calculated at baseline": 4.465974464504069, "measured by arm": 3.916476644437717, "reduction by ivabradine": 4.529820946528695, "characteristics and laboratory": 4.91169158187234, "hypoalbuminemia before surgery": 4.91169158187234, "levels by correcting": 4.329123596291566, "insufficiency after left": 4.590961241342599, "accompanied by heart": 4.329123596291566, "capacity and symptoms": 4.399171093819823, "failure and sepsis": 4.177917792195843, "oversewing or leaflet": 4.399171093819823, "etiology and comorbidities": 4.705977901682522, "presentation and outcomes": 4.64961545906341, "obtained at admission": 4.399171093819823, "factors at admission": 4.329123596291566, "dose and oxygen": 3.916476644437717, "dobutamine or norepinephrine": 4.812498225333564, "admission and follow": 4.329123596291566, "sample and subgroups": 4.329123596291566, "showed no benefit": 4.095924419998536, "receiving these agents": 4.465974464504069, "stratified by propensity": 4.590961241342599, "capacity and quality": 4.329123596291566, "satisfaction and sustainability": 4.958842675243241, "risk after adjusting": 4.329123596291566, "disease at baseline": 4.255500733148387, "antagonists and inhibitors": 4.705977901682522, "driving these gene": 4.177917792195843, "human and mouse": 3.916476644437717, "dysfunction and induction": 4.64961545906341, "epidemiology and treatment": 4.705977901682522, "blockers and mineralocorticoid": 4.91169158187234, "metabolism and survival": 4.529820946528695, "mice and liver": 3.817623257511431, "expression and activation": 4.64961545906341, "action through activation": 4.64961545906341, "dysfunction during insulin": 4.705977901682522, "resistance and type": 4.255500733148387, "association between treatment": 4.862947248020922, "variation and practice": 4.465974464504069, "scores and mortality": 4.329123596291566, "outcomes after adjustment": 4.64961545906341, "risk as assessed": 4.008988783227255, "assessed by changes": 4.255500733148387, "pool by matching": 4.008988783227255, "donors and recipients": 4.399171093819823, "age or comorbidity": 4.177917792195843, "readmissions and follow": 4.529820946528695, "visits as part": 3.817623257511431, "readmissions as part": 4.329123596291566, "known about patient": 4.255500733148387, "events at follow": 4.008988783227255, "cardiologist or heart": 4.399171093819823, "patients had blood": 4.177917792195843, "testing and medication": 4.465974464504069, "changes at follow": 4.095924419998536, "relationship between pathobiology": 5.048759311919856, "pathophysiology and prognosis": 4.862947248020922, "quantified by tissuefaxs": 4.590961241342599, "treatment and risk": 4.177917792195843, "prolongation and ejection": 4.64961545906341, "deposition and titin": 4.329123596291566, "rats after heart": 4.008988783227255, "assessed at euthanization": 4.64961545906341, "measured by index": 4.095924419998536, "stroke and hospitalisation": 4.705977901682522, "mortality or heart": 4.177917792195843, "needs further investigation": 4.760220946466509, "hospitalizations and length": 4.760220946466509, "usefulness and consequences": 4.760220946466509, "blocker and angiotensin": 4.529820946528695, "improvement after device": 4.590961241342599, "stiffness and function": 4.465974464504069, "development and severity": 4.590961241342599, "resistin but transgenic": 4.529820946528695, "basal and inflammation": 4.465974464504069, "controls not expressing": 4.529820946528695, "link between inflammation": 4.64961545906341, "probability after catheter": 4.705977901682522, "ablation and factors": 4.329123596291566, "strain and strain": 4.095924419998536, "echocardiography at baseline": 4.812498225333564, "months after ablation": 4.399171093819823, "rate at systole": 3.916476644437717, "rate at diastole": 4.008988783227255, "rhythm at follow": 4.008988783227255, "procedures and pharmaceuticals": 4.91169158187234, "h after receiving": 4.095924419998536, "sacrificed and hearts": 4.399171093819823, "induced by doxorubicin": 4.465974464504069, "contents by restoring": 4.399171093819823, "capacity and creatine": 4.399171093819823, "rats as indicated": 4.095924419998536, "indicated by improvement": 4.590961241342599, "events after adjustment": 4.529820946528695, "comprise those children": 4.529820946528695, "diagnosis and management": 4.590961241342599, "workload during stress": 4.465974464504069, "method has strengths": 4.329123596291566, "strengths and limitations": 4.64961545906341, "sex and ejection": 4.008988783227255, "characterized by disappointments": 5.004501392234941, "agents and antagonists": 4.465974464504069, "points and sites": 4.008988783227255, "patients at risk": 4.008988783227255, "embolism or diabetes": 4.329123596291566, "like other biomarkers": 4.399171093819823, "throughput and disposition": 4.705977901682522, "mortality and readmission": 4.64961545906341, "fibrosis and inflammation": 4.64961545906341, "achieved through knockdown": 4.705977901682522, "presence or absence": 4.255500733148387, "toxicity or effects": 4.255500733148387, "increase by means": 4.095924419998536, "age and sex": 3.4724877714627436, "increase during exercise": 4.590961241342599, "symptoms and mortality": 4.465974464504069, "procedures and management": 4.64961545906341, "structure and function": 4.465974464504069, "activity and hemostasis": 4.529820946528695, "serve as markers": 4.008988783227255, "carvedilol or metoprolol": 4.590961241342599, "activity as measured": 4.329123596291566, "patients not receiving": 4.465974464504069, "nonprescribing as chart": 4.529820946528695, "preferences and nonadherence": 4.812498225333564, "receive these medications": 4.64961545906341, "tone by pyridostigmine": 4.465974464504069, "improved by acetylcholinesterase": 5.004501392234941, "methylatropine and propranolol": 4.91169158187234, "caused by methylatropine": 4.590961241342599, "caused by propranolol": 4.399171093819823, "diameter and collagen": 4.399171093819823, "assessed by means": 4.095924419998536, "geometry and fiber": 4.177917792195843, "depolarization and myofiber": 4.760220946466509, "defined as death": 4.008988783227255, "time by controlling": 4.255500733148387, "undertaken at rest": 4.177917792195843, "improvement between baseline": 4.812498225333564, "rate during exercise": 4.329123596291566, "prognostic and treatment": 4.590961241342599, "savings and risk": 4.008988783227255, "failure and outcomes": 4.329123596291566, "options and challenges": 4.465974464504069, "older have heart": 4.008988783227255, "failure and delivery": 4.329123596291566, "radioenzymatic- and fluorescence": 5.004501392234941, "expression and activity": 4.529820946528695, "fold and camp": 3.711494906650088, "enhanced by stimulation": 4.529820946528695, "levels and l": 3.5969351423872324, "discontinuation or hospitalization": 5.0916998341368105, "hyperkalemia or discontinuation": 4.958842675243241, "hrqol and training": 4.177917792195843, "hrqol as measured": 4.095924419998536, "modulated by baseline": 4.399171093819823, "rhythm and rate": 3.916476644437717, "utilization and unit": 4.329123596291566, "supplemented by disease": 4.529820946528695, "failure and type": 4.008988783227255, "immunohistochemistry and electron": 5.048759311919856, "microstructure at baseline": 4.705977901682522, "serum and leukocytes": 4.329123596291566, "underlie these exercise": 4.529820946528695, "consultations and procedures": 4.812498225333564, "consultations and operations": 4.812498225333564, "oxygenation as bridge": 4.399171093819823, "incidence and mortality": 4.529820946528695, "support this contention": 4.529820946528695, "year after discharge": 4.329123596291566, "therapy during exercise": 4.529820946528695, "testosterone or placebo": 4.529820946528695, "exercise and injections": 4.529820946528695, "program or placebo": 4.177917792195843, "warrants further investigation": 4.91169158187234, "number and phenotype": 4.329123596291566, "phenotype and function": 4.465974464504069, "function and cell": 4.095924419998536, "period or amplitude": 4.255500733148387, "anticoagulants or antiplatelet": 4.91169158187234, "agents or anticoagulants": 4.590961241342599, "stratification and clarity": 4.705977901682522, "imbalance as seen": 4.095924419998536, "sensitivity and time": 4.329123596291566, "levels by dnx": 3.711494906650088, "metoprolol or atropine": 4.465974464504069, "data and safety": 3.916476644437717, "device and extracorporeal": 4.64961545906341, "followed by vad": 3.916476644437717, "group until day": 3.916476644437717, "continued until day": 4.255500733148387, "response and progression": 4.590961241342599, "desensitization and downregulation": 5.0916998341368105, "overexpressing both \u03b21ar": 4.590961241342599, "occur after stimulation": 4.529820946528695, "triggered by isoproterenol": 4.705977901682522, "demonstrate that restoration": 4.812498225333564, "readmission after discharge": 4.760220946466509, "death and readmission": 4.399171093819823, "continuity further influences": 4.862947248020922, "outcomes after discharge": 4.590961241342599, "discharge and physician": 4.529820946528695, "phosphorylation and ser23/24": 4.812498225333564, "demonstrated no change": 4.465974464504069, "mutant as compared": 4.177917792195843, "ecgs at baseline": 4.008988783227255, "pacing and esmolol": 4.177917792195843, "group during fixed": 4.177917792195843, "development and defects": 4.529820946528695, "system by preventing": 4.329123596291566, "peptide and b": 3.711494906650088, "diagnosis and initiation": 4.590961241342599, "measurement and modification": 4.812498225333564, "pathogenesis and progression": 4.812498225333564, "genes by sequence": 4.095924419998536, "remodeling and heart": 4.329123596291566, "abnormalities and exercise": 4.705977901682522, "filling during exercise": 4.529820946528695, "spectroscopy as did": 4.255500733148387, "practice and research": 4.399171093819823, "plasma by use": 3.711494906650088, "delivered as antitachycardia": 4.812498225333564, "bisphosphonates and raloxifene": 4.91169158187234, "etidronate- and raloxifene": 4.705977901682522, "alendronate and etidronate": 4.705977901682522, "age- and gender": 3.916476644437717, "alterations by metoprolol": 4.64961545906341, "norepinephrine and dopamine": 4.760220946466509, "performance by \u03b2": 4.008988783227255, "atherosclerosis and incident": 4.812498225333564, "association between psoriasis": 4.862947248020922, "pressure and body": 4.095924419998536, "events as subjects": 4.177917792195843, "prevalence and characteristics": 4.91169158187234, "patients had brain": 4.177917792195843, "highlighting these patients": 4.760220946466509, "hypertension and end": 4.329123596291566, "angioplasty and stenting": 4.590961241342599, "evaluation and management": 4.64961545906341, "assessment and treatment": 4.590961241342599, "diagnosis and treatment": 4.529820946528695, "mortality and healthcare": 4.590961241342599, "intervention and survival": 4.64961545906341, "survival and utilization": 4.590961241342599, "groups after matching": 4.399171093819823, "use or number": 3.711494906650088, "disease and mortality": 4.399171093819823, "technology has potential": 4.590961241342599, "association between race": 4.590961241342599, "race and outcomes": 4.095924419998536, "significantly more hypertension": 4.958842675243241, "hypertension and diabetes": 4.64961545906341, "interaction between race": 4.590961241342599, "rationale and design": 4.329123596291566, "anticoagulation and rate": 4.590961241342599, "offset by side": 3.817623257511431, "af at risk": 3.3362833878644325, "function and quality": 4.329123596291566, "manage this population": 4.465974464504069, "incidence and prevalence": 4.590961241342599, "death and hospitalisation": 4.64961545906341, "failure at rest": 3.916476644437717, "decisions about life": 4.329123596291566, "disease has life": 4.008988783227255, "repeated this analysis": 4.465974464504069, "measures at explaining": 4.465974464504069, "caused by mineralocorticoid": 4.760220946466509, "vary by race": 3.5969351423872324, "hyperkalemia and outcomes": 4.64961545906341, "rate and heart": 3.817623257511431, "race by treatment": 4.095924419998536, "differ by race": 3.817623257511431, "proteomics and pathway": 4.465974464504069, "relationship between length": 4.760220946466509, "stay and rehospitalization": 4.705977901682522, "volume and physician": 4.329123596291566, "relationship between physician": 4.91169158187234, "volume and mortality": 4.329123596291566, "mortality and hospitalizations": 4.91169158187234, "dilatation and dysfunction": 4.705977901682522, "p<001 and hr": 3.5969351423872324, "investigations at study": 4.529820946528695, "quantified as duration": 4.465974464504069, "failure after pressure": 4.465974464504069, "glycolysis and glucose": 4.465974464504069, "link between air": 4.008988783227255, "pollution and heart": 4.255500733148387, "physicians and professionals": 4.812498225333564, "hospitalisation and death": 4.64961545906341, "abnormalities and hypertrophy": 4.862947248020922, "dilatation and hypertrophy": 4.705977901682522, "indicated by guidelines": 4.529820946528695, "communication and collaboration": 4.958842675243241, "country has physicians": 4.465974464504069, "connection between certified": 4.812498225333564, "phase and healthcare": 4.329123596291566, "saxagliptin and sitagliptin": 4.760220946466509, "insurance and health": 4.329123596291566, "saxagliptin or sitagliptin": 4.705977901682522, "methods and analysis": 4.329123596291566, "education at discharge": 4.465974464504069, "readmissions and mortality": 4.705977901682522, "discussion and dissemination": 4.812498225333564, "findings through briefing": 4.64961545906341, "publications and presentations": 4.91169158187234, "occur between physicians": 4.590961241342599, "physicians and heart": 4.329123596291566, "preferences and timing": 4.465974464504069, "wished further review": 4.399171093819823, "preferences and decisions": 4.64961545906341, "deactivation at implant": 4.529820946528695, "discussions about end": 4.399171093819823, "using this process": 4.177917792195843, "shocks at end": 3.711494906650088, "symptoms and disease": 4.329123596291566, "patients as control": 4.255500733148387, "min after rehabilitation": 4.590961241342599, "classified as heart": 4.255500733148387, "rate and rhythm": 3.916476644437717, "pressure and auscultation": 4.64961545906341, "hypertension and hyperlipidaemia": 5.004501392234941, "depression and dementia": 4.529820946528695, "death during sport": 4.177917792195843, "pathways and ion": 4.008988783227255, "strength by measuring": 4.399171093819823, "aerobic and resistance": 4.465974464504069, "strength and quality": 4.329123596291566, "need further validation": 4.529820946528695, "indicated more barriers": 4.529820946528695, "association between increasing": 4.91169158187234, "given that exercise": 4.255500733148387, "reduction and exercise": 4.465974464504069, "analysis at baseline": 4.329123596291566, "decreased at follow": 4.255500733148387, "achieve this target": 4.255500733148387, "safety and proof": 4.008988783227255, "evaluations at baseline": 4.529820946528695, "baseline and months": 4.255500733148387, "thrombosis or migration": 4.529820946528695, "bleeding at month": 4.095924419998536, "receptors and neprilysin": 4.590961241342599, "excluded by inclusion": 4.399171093819823, "life as measured": 4.008988783227255, "hemocompatibility by incorporating": 5.0916998341368105, "performance and safety": 4.465974464504069, "costs and survival": 4.177917792195843, "functioning and use": 4.255500733148387, "researchers and providers": 4.64961545906341, "managing this disease": 4.399171093819823, "heart failure": 3696.6489270234874, "ejection fraction": 933.8707677596661, "left ventricular": 673.5101155821789, "hazard ratio": 338.11190338439985, "% confidence": 316.53029253007645, "confidence interval": 340.44005865187097, "myocardial infarction": 307.9419765673876, "ventricular ejection": 303.03865174040965, "chronic heart": 237.53567402560563, "preserved ejection": 250.67506753175059, "congestive heart": 224.50337186072628, "heart rate": 160.14160261749277, "natriuretic peptide": 204.26403519112256, "exercise training": 188.41252331993263, "this study": 146.79646906603503, "heart disease": 163.30577589260386, "ventricular assist": 183.82838285661708, "% ci": 89.56745202815173, "failure patients": 168.3775288955447, "implantable cardioverter": 192.82037213638918, "atrial fibrillation": 170.22002932593549, "reduced ejection": 160.3595513290902, "right ventricular": 155.64512795994435, "acute heart": 131.95453531558425, "functional capacity": 153.19802639334193, "p =": 55.49711932698344, "body mass": 108.31946254058535, "renal function": 122.1639442403658, "risk factors": 115.10192455639144, "assist device": 118.76783701280281, "type natriuretic": 128.28764106327216, "systolic heart": 122.1639442403658, "resynchronization therapy": 139.4884637719023, "blood pressure": 114.52869772534294, "primary outcome": 117.49429933313151, "mass index": 100.08850163593297, "renal dysfunction": 114.685883759959, "end point": 89.20426326871734, "coronary artery": 109.66134604425608, "control group": 103.92185738620246, "cause mortality": 101.82839275538063, "cardiac resynchronization": 120.89000193564867, "among patients": 99.25820469529721, "increased risk": 99.25820469529721, "terminal pro": 93.52031370206804, "right heart": 90.28468205803134, "adverse events": 91.62295818027434, "cardiovascular events": 105.58010625167574, "glomerular filtration": 105.58010625167574, "filtration rate": 93.9954394665052, "independently associated": 110.18306979222238, "consecutive patients": 103.8989663109976, "exercise capacity": 98.30218607996486, "acute myocardial": 88.19775323099961, "clinical trials": 86.16248617762977, "estimated glomerular": 95.24071911841446, "dilated cardiomyopathy": 98.25143821908952, "advanced heart": 83.98771166525148, "% versus": 66.39428197593978, "diastolic mitral": 88.19775323099961, "mitral valve": 79.13257313251911, "systolic hf": 76.39473097218035, "functional class": 88.19775323099961, "hazard ratios": 81.65288794630193, "body composition": 80.1797756645451, "preserved left": 76.35246515022862, "diastolic dysfunction": 87.98342187639646, "left ventricle": 76.35246515022862, "% vs.": 47.00994494168267, "gene expression": 78.32953288875433, "odds ratio": 66.72566775728865, "cardiac function": 80.1797756645451, "functional ms": 74.22989813300175, "diabetes mellitus": 81.91848839997071, "adrenergic receptor": 85.11001466296774, "patients undergoing": 85.11001466296774, "converting enzyme": 81.91848839997071, "magnetic resonance": 83.55835584391686, "peak oxygen": 69.44975542925488, "term mortality": 68.71721863520575, "assist devices": 68.71721863520575, "risk stratification": 76.59901319667097, "usual care": 60.05310098155979, "cardiovascular death": 77.9242247332482, "reverse remodeling": 75.20252025952517, "% \u00b1": 29.380827878991234, "angiotensin receptor": 77.9242247332482, "artery disease": 68.71721863520575, "cohort study": 64.74483256297019, "cardiopulmonary exercise": 82.63730234416678, "clinical practice": 65.53479071997657, "systematic review": 65.53479071997657, "cardiac hypertrophy": 68.08801173037419, "older patients": 61.0819721201829, "day readmission": 62.66362631100347, "% vs": 32.56998255569154, "ventricular dysfunction": 72.47713514445913, "stage heart": 55.5598043434039, "medical treatment": 65.53479071997657, "systolic dysfunction": 69.26597754066506, "adjusted hazard": 62.66362631100347, "patients treated": 64.14382053163608, "early diastolic": 62.66362631100347, "pulmonary arterial": 66.84668467513349, "arterial coupling": 65.53479071997657, "aortic valve": 57.55096227819572, "pulmonary hypertension": 71.4555914320651, "patients receiving": 66.84668467513349, "receptor blockers": 65.53479071997657, "rhythm control": 61.0819721201829, "control therapy": 62.66362631100347, "defibrillator deactivation": 75.29564642692036, "patients hospitalized": 61.58839531347752, "clinical outcomes": 57.3429418799795, "proportional hazards": 60.60773034808193, "mean age": 42.250906711961676, "blocker therapy": 54.83067302212804, "year survival": 51.96092869310123, "valve plasty": 50.35709199342126, "diastolic function": 58.490849090741804, "e /": 22.85175501699318, "older adults": 50.35709199342126, "enzyme inhibitors": 57.3429418799795, "day follow": 46.70796743010205, "induced heart": 51.96092869310123, "biological phenotype": 60.60773034808193, "skeletal muscle": 54.83067302212804, "suggest that": 46.76015685103402, "event rates": 41.66985325755292, "assessed by": 41.66985325755292, "emergency department": 51.9494831554988, "association between": 51.06600879778064, "dose dopamine": 44.537938879801054, "systolic blood": 45.81147909013717, "walk test": 38.230398543736, "endothelial function": 51.9494831554988, "mitral regurgitation": 51.9494831554988, "diastolic volume": 48.10786539872706, "min per": 33.93382829540784, "diastolic pressure": 50.13501350635012, "oxygen consumption": 50.13501350635012, "median follow": 44.537938879801054, "systolic pressure": 49.15109303998243, "myocardial ischemia": 51.06600879778064, "albumin levels": 45.81147909013717, "study sought": 43.16322170864679, "cardiovascular mortality": 55.09153489611119, "brain natriuretic": 49.15109303998243, "interquartile range": 51.06600879778064, "outcome measures": 48.10786539872706, "insulin resistance": 50.13501350635012, "breast cancer": 44.537938879801054, "dash diet": 38.230398543736, "cardiac transplant": 50.13501350635012, "cardiac magnetic": 48.10786539872706, "cv events": 38.230398543736, "sinus rhythm": 43.16322170864679, "deficit index": 44.537938879801054, "chronic hf": 40.03540065437319, "exercise testing": 48.10786539872706, "sympathetic tone": 48.10786539872706, "oxygen uptake": 44.537938879801054, "peak early": 40.03540065437319, "prediction rule": 46.9977197332526, "biomedical treatment": 51.9494831554988, "acute care": 40.03540065437319, "exercise rehabilitation": 54.35785135834435, "inappropriate therapy": 52.79005312583787, "hr variability": 45.81147909013717, "gastrointestinal bleeding": 55.79538550876092, "idiopathic dilated": 50.13501350635012, "defined as": 36.69911726650876, "showed that": 38.19736548609018, "adverse event": 37.11494906650088, "natriuretic peptides": 43.291235962915664, "filling pressures": 40.959244199985356, "cardiac death": 37.11494906650088, "patient population": 41.77917792195843, "coronary heart": 38.17623257511431, "clinical trial": 38.17623257511431, "health outcomes": 39.164766444377165, "mortality rates": 39.164766444377165, "chronic obstructive": 42.55500733148387, "obstructive pulmonary": 43.99171093819823, "pulmonary disease": 40.959244199985356, "dose nesiritide": 39.164766444377165, "present study": 37.11494906650088, "left bundle": 34.72487771462744, "bundle branch": 37.11494906650088, "branch block": 35.969351423872325, "analysis showed": 39.164766444377165, "independent predictor": 43.99171093819823, "hospital discharge": 41.77917792195843, "determine whether": 40.959244199985356, "beneficial effect": 40.959244199985356, "significantly younger": 43.99171093819823, "ci ]": 20.35623909730721, "medical management": 41.77917792195843, "cardiovascular disease": 44.65974464504069, "significantly improved": 44.65974464504069, "acute hf": 30.179219079972626, "salt loading": 35.969351423872325, "clinical characteristics": 45.90961241342599, "patients requiring": 41.77917792195843, "all patients": 35.969351423872325, "degenerative mr": 39.164766444377165, "quality improvement": 42.55500733148387, "hazards models": 38.17623257511431, "dose bb": 28.2781902461732, "protein kinase": 38.17623257511431, "failing hearts": 38.17623257511431, "regression analysis": 42.55500733148387, "device implantation": 42.55500733148387, "right atrial": 35.969351423872325, "receptor antagonists": 43.291235962915664, "acute kidney": 35.969351423872325, "kidney injury": 37.11494906650088, "recommended medications": 45.29820946528695, "growth factor": 37.11494906650088, "analysis revealed": 40.959244199985356, "higher risk": 34.72487771462744, "severe heart": 35.969351423872325, "ventricular contractile": 45.29820946528695, "ischemic heart": 38.17623257511431, "hr reduction": 35.969351423872325, "significant improvement": 45.29820946528695, "nordic walking": 38.17623257511431, "pulmonary embolism": 41.77917792195843, "transcription factor": 43.291235962915664, "diet scores": 34.72487771462744, "term outcomes": 37.11494906650088, "significantly associated": 45.90961241342599, "criteria cardiac": 40.08988783227255, "baseline characteristics": 45.90961241342599, "readmission rate": 40.08988783227255, "per patient": 34.72487771462744, "dialysis patients": 40.959244199985356, "ventricular diastolic": 43.99171093819823, "resistin levels": 39.164766444377165, "catheter ablation": 40.959244199985356, "major complications": 42.55500733148387, "treatment strategies": 43.291235962915664, "sympathetic activity": 43.291235962915664, "health care": 34.72487771462744, "contextual reasons": 41.77917792195843, "severe cad": 33.362833878644324, "high risk": 31.85866545311334, "this review": 34.72487771462744, "membrane oxygenation": 43.291235962915664, "familiar physician": 41.77917792195843, "sudden cardiac": 38.17623257511431, "disease management": 41.77917792195843, "end stage": 31.85866545311334, "recent onset": 35.969351423872325, "physician volume": 40.08988783227255, "social support": 38.17623257511431, "relationship between": 38.9621123666241, "found that": 30.026550490779893, "cardiac cachexia": 32.07191026581804, "body weight": 27.77990217170195, "adult patients": 30.54098606009145, "% increase": 26.69026710291546, "strongly associated": 34.044005865187096, "randomized trial": 32.07191026581804, "end points": 26.69026710291546, "significant effect": 33.423342337566744, "vs placebo": 26.69026710291546, "multivariate analysis": 35.193368750558584, "severely reduced": 32.07191026581804, "among older": 27.77990217170195, "reduced mortality": 32.767395359988285, "statistically significant": 37.19692367250728, "measured by": 27.77990217170195, "significant difference": 35.72779571603255, "ambulatory patients": 34.044005865187096, "spironolactone use": 33.423342337566744, "inhospital mortality": 34.63298877033253, "retrospective cohort": 34.63298877033253, "ed visits": 25.48693236249067, "hypothesized that": 32.767395359988285, "vascular resistance": 34.044005865187096, "cardiac index": 29.691959253200704, "cardiac output": 30.54098606009145, "adverse outcomes": 32.07191026581804, "patients had": 28.77548113909786, "protective effects": 33.423342337566744, "mediated dilatation": 34.044005865187096, "these results": 29.691959253200704, "beneficial effects": 33.423342337566744, "term survival": 29.691959253200704, "% sensitivity": 29.691959253200704, "study aimed": 27.77990217170195, "lung weight": 27.77990217170195, "mean follow": 27.77990217170195, "biventricular support": 35.193368750558584, "medical therapy": 31.331813155501735, "pulmonary artery": 32.07191026581804, "rs synchrony": 28.77548113909786, "mitral stenosis": 31.331813155501735, "ring annuloplasty": 32.767395359988285, "annular size": 28.77548113909786, "size reduction": 30.54098606009145, "volume index": 28.77548113909786, "systolic volume": 31.331813155501735, "significant ms": 30.54098606009145, "coronary angiography": 34.63298877033253, "cause hospitalization": 35.193368750558584, "patients developed": 33.423342337566744, "health status": 29.691959253200704, "low sst2": 24.1433752639781, "cardiovascular event": 34.63298877033253, "high sst2": 25.48693236249067, "similar results": 31.331813155501735, "systolic elastance": 33.423342337566744, "stroke volume": 29.691959253200704, "echocardiographic score": 36.23856757222956, "newly diagnosed": 31.331813155501735, "findings suggest": 32.07191026581804, "volume eds": 26.69026710291546, "less likely": 27.77990217170195, "adjusted odds": 29.691959253200704, "contractile function": 34.63298877033253, "ventricular filling": 34.044005865187096, "blood flow": 26.69026710291546, "flow velocity": 29.691959253200704, "bottleneck stent": 32.07191026581804, "arterial elastance": 33.423342337566744, "treated patients": 32.07191026581804, "significantly reduced": 35.193368750558584, "revealed that": 29.691959253200704, "month survival": 30.54098606009145, "patients underwent": 33.423342337566744, "young adults": 28.77548113909786, "year mortality": 30.54098606009145, "cardiac rehabilitation": 35.72779571603255, "randomized controlled": 35.193368750558584, "randomly assigned": 32.767395359988285, "grip strength": 29.691959253200704, "regression models": 32.767395359988285, "receptor antagonist": 34.044005865187096, "cardiac dysfunction": 34.044005865187096, "angiotensin converting": 35.72779571603255, "mineralocorticoid receptor": 37.64782321346018, "beta blockers": 29.691959253200704, "followed up": 27.77990217170195, "trend toward": 28.77548113909786, "after adjustment": 32.07191026581804, "improvement initiative": 35.72779571603255, "extracellular matrix": 34.63298877033253, "obese zsf1": 26.69026710291546, "cardioverter defibrillator": 37.64782321346018, "weight loss": 27.77990217170195, "dependent patients": 33.423342337566744, "human resistin": 30.54098606009145, "increased significantly": 36.23856757222956, "results suggest": 31.331813155501735, "mitochondrial oxidative": 36.23856757222956, "medical records": 31.331813155501735, "aortic constriction": 34.044005865187096, "human hf": 24.1433752639781, "contrast agent": 30.54098606009145, "contractile reserve": 34.044005865187096, "survival rates": 30.54098606009145, "systolic function": 32.767395359988285, "acute rv": 24.1433752639781, "onset hf": 24.1433752639781, "cardiac remodeling": 33.423342337566744, "remodeling aspects": 33.423342337566744, "dyssynchronous hf": 32.767395359988285, "myofiber shortening": 34.044005865187096, "mitral annular": 30.54098606009145, "annular velocity": 32.07191026581804, "exercise time": 29.691959253200704, "extracorporeal membrane": 36.23856757222956, "male patients": 29.691959253200704, "therapeutic implications": 36.727689930740794, "autonomic balance": 32.767395359988285, "renal dnx": 25.48693236249067, "mechanical cardiac": 33.423342337566744, "cardiac support": 31.331813155501735, "ecmo+vad group": 30.54098606009145, "physician continuity": 34.63298877033253, "muscle mass": 27.77990217170195, "shock therapy": 29.691959253200704, "high bnp": 24.1433752639781, "care management": 31.331813155501735, "black race": 26.69026710291546, "type channel": 28.77548113909786, "volume physicians": 32.767395359988285, "aldosterone antagonist": 35.72779571603255, "air pollution": 29.691959253200704, "saxagliptin versus": 33.423342337566744, "deactivation discussions": 36.727689930740794, "exercise group": 30.54098606009145, "management programs": 34.044005865187096, "resource use": 28.77548113909786, "suggests that": 25.980464346550615, "caused by": 22.301065817179335, "accompanied by": 26.723362802580017, "patient safety": 22.905739545068585, "patients admitted": 24.575546519991214, "fat mass": 18.107531447983575, "ray absorptiometry": 25.06750675317506, "general population": 25.06750675317506, "iron deficiency": 23.4988598666263, "exercise tolerance": 25.06750675317506, "thromboembolic events": 26.395026562918936, "hospitalized patients": 26.395026562918936, "stimulating agents": 25.06750675317506, "observational studies": 26.395026562918936, "strength evidence": 24.575546519991214, "relative risk": 22.268969439900527, "acute coronary": 22.905739545068585, "clinical studies": 24.05393269936353, "factors associated": 25.06750675317506, "peripheral vascular": 25.53300439889032, "vascular disease": 24.05393269936353, "ischemic cardiomyopathy": 27.178925679172174, "independent predictors": 26.795846787024416, "diuretic therapy": 24.05393269936353, "placebo group": 22.268969439900527, "hour cumulative": 23.4988598666263, "cumulative urine": 24.05393269936353, "urine volume": 21.581610854323394, "cystatin c": 20.017700327186596, "chromatin structure": 25.53300439889032, "outcomes associated": 25.53300439889032, "study patients": 22.905739545068585, "artery bypass": 22.268969439900527, "data suggest": 21.581610854323394, "older age": 19.115199271868, "age group": 19.115199271868, "progenitor cells": 24.05393269936353, "prognostic factor": 24.575546519991214, "cardiovascular diseases": 27.178925679172174, "+ cells": 16.96691414770392, "patients without": 24.05393269936353, "increased peak": 22.905739545068585, "cause readmission": 24.575546519991214, "readmission rates": 24.575546519991214, "improve outcomes": 24.05393269936353, "office hours": 21.581610854323394, "study assessed": 22.905739545068585, "related quality": 23.4988598666263, "induced by": 20.017700327186596, "treating patients": 24.575546519991214, "ejection fractions": 25.06750675317506, "recommended target": 25.06750675317506, "blocker dose": 21.581610854323394, "primary end": 20.83492662877646, "multivariate models": 25.53300439889032, "odds ratios": 20.83492662877646, "% female": 18.107531447983575, "median bnp": 20.017700327186596, "difference among": 24.05393269936353, "clinical variables": 25.06750675317506, "this article": 21.581610854323394, "cognitive impairment": 25.9747415777494, "confidence intervals": 25.9747415777494, "ventricular function": 25.9747415777494, "major cause": 20.83492662877646, "identify patients": 24.575546519991214, "minute walk": 20.83492662877646, "functional status": 24.575546519991214, "no production": 22.268969439900527, "hdl function": 21.581610854323394, "predictive cutoff": 24.575546519991214, "cutoff value": 21.581610854323394, "% specificity": 22.268969439900527, "hypertensive heart": 25.06750675317506, "new therapeutic": 23.4988598666263, "fractional shortening": 26.395026562918936, "oxidative stress": 24.05393269936353, "significantly impaired": 26.795846787024416, "laboratory report": 24.575546519991214, "cardiogenic shock": 24.575546519991214, "heart transplantation": 26.395026562918936, "acute right": 20.83492662877646, "old man": 16.96691414770392, "years later": 20.83492662877646, "developed heart": 23.4988598666263, "severe hypertension": 25.53300439889032, "aggressive medical": 25.06750675317506, "develop even": 21.581610854323394, "successful valve": 24.05393269936353, "another disease": 23.4988598666263, "valve opening": 22.268969439900527, "mean pressure": 22.268969439900527, "pressure gradient": 24.575546519991214, "without major": 22.268969439900527, "mild mr": 16.96691414770392, "clinic outpatients": 25.06750675317506, "renal disease": 22.268969439900527, "hazard models": 22.268969439900527, "median age": 20.017700327186596, "significant interaction": 27.178925679172174, "ventricular systolic": 25.9747415777494, "event rate": 20.017700327186596, "failure hospitalization": 27.178925679172174, "myocardial function": 25.53300439889032, "left atrial": 20.83492662877646, "atrial area": 20.83492662877646, "during follow": 22.268969439900527, "randomized trials": 24.575546519991214, "vascular endothelial": 25.9747415777494, "endothelial growth": 25.06750675317506, "infarction heart": 24.05393269936353, "receptor blocker": 24.05393269936353, "increased cardiac": 24.575546519991214, "cardiac angiogenesis": 25.9747415777494, "signaling pathway": 24.575546519991214, "cases exhibited": 23.4988598666263, "volume overload": 23.4988598666263, "wall stress": 20.83492662877646, "filling pressure": 24.05393269936353, "severe systolic": 23.4988598666263, "mitral annulus": 22.905739545068585, "/ e": 9.793609292997077, "cardiac catheterization": 27.178925679172174, "diagnostic performance": 26.795846787024416, "chronic myocardial": 25.06750675317506, "left anterior": 22.268969439900527, "anterior descending": 25.53300439889032, "collateral growth": 24.575546519991214, "sudden death": 21.581610854323394, "at baseline": 20.83492662877646, "preoperative hypoalbuminemia": 28.874989352001386, "improved survival": 24.575546519991214, "poor prognosis": 22.905739545068585, "lvad ai": 16.96691414770392, "well defined": 21.581610854323394, "severe ai": 19.115199271868, "valve replacement": 24.575546519991214, "controlled trial": 24.05393269936353, "standard cardiac": 24.05393269936353, "rehabilitation care": 25.53300439889032, "mean ejection": 22.268969439900527, "per week": 18.107531447983575, "physical activity": 24.575546519991214, "right ventricle": 23.4988598666263, "day mortality": 22.268969439900527, "followed by": 20.83492662877646, "right atrium": 21.581610854323394, "retest reliability": 25.06750675317506, "standard error": 22.905739545068585, "total sample": 21.581610854323394, "mean difference": 23.4988598666263, "significant improvements": 27.545767448055596, "secondary outcomes": 25.06750675317506, "gene programs": 22.268969439900527, "transcription factors": 26.395026562918936, "demonstrated that": 24.575546519991214, "energy metabolism": 24.575546519991214, "optimal combined": 24.05393269936353, "combined treatment": 25.06750675317506, "cancer patients": 23.4988598666263, "patients at": 20.83492662877646, "years old": 19.115199271868, "diet score": 20.017700327186596, "lower mortality": 23.4988598666263, "heart transplant": 24.05393269936353, "standard criteria": 24.575546519991214, "chart review": 21.581610854323394, "t1 mapping": 20.017700327186596, "resonance imaging": 24.575546519991214, "first hf": 18.107531447983575, "clinical benefit": 24.05393269936353, "myocardial dd": 22.268969439900527, "myocardial collagen": 25.53300439889032, "adverse cv": 20.017700327186596, "clinical status": 23.4988598666263, "enzyme inhibitor": 24.05393269936353, "matched controls": 24.05393269936353, "echocardiographic measures": 28.235867410095132, "\u00b1 0.4": 14.1029834825048, "induced cardiotoxicity": 26.795846787024416, "mrna levels": 20.83492662877646, "remained elevated": 24.575546519991214, "strain rate": 20.83492662877646, "mitochondrial dysfunction": 27.89769275438046, "ultrastructural changes": 27.178925679172174, "logistic regression": 25.53300439889032, "leading cause": 22.268969439900527, "recent years": 21.581610854323394, "recent studies": 22.905739545068585, "risk patients": 22.268969439900527, "signal transduction": 25.53300439889032, "transverse aortic": 24.575546519991214, "cardiac gene": 21.581610854323394, "clinically significant": 26.795846787024416, "arterial hypertension": 26.395026562918936, "significantly lower": 25.53300439889032, "peak o2": 16.96691414770392, "per kilogram": 21.581610854323394, "common cause": 21.581610854323394, "human heart": 20.83492662877646, "channel mrna": 21.581610854323394, "important role": 22.905739545068585, "high mortality": 22.905739545068585, "cardiac sympathetic": 25.53300439889032, "receptor haplotype": 25.06750675317506, "patient preferences": 25.53300439889032, "lean mass": 19.115199271868, "mitral flow": 20.83492662877646, "unclear etiology": 24.05393269936353, "acute \u03b2": 16.96691414770392, "risk factor": 20.83492662877646, "antiarrhythmic drugs": 25.9747415777494, "sarcomeric microstructure": 27.89769275438046, "pilot study": 20.83492662877646, "adjunctive treatment": 25.9747415777494, "treatment alone": 23.4988598666263, "effective rate": 22.905739545068585, "exercise intolerance": 25.9747415777494, "exercise variables": 25.06750675317506, "low testosterone": 24.05393269936353, "testosterone status": 25.53300439889032, "improves exercise": 24.575546519991214, "group compared": 22.905739545068585, "rate variability": 24.05393269936353, "group included": 22.905739545068585, "included patients": 24.575546519991214, "study period": 21.581610854323394, "hospitalized older": 25.06750675317506, "nursing care": 21.581610854323394, "proportional hazard": 25.53300439889032, "first month": 20.83492662877646, "adjusted hr": 20.83492662877646, "ventricular tachycardia": 27.178925679172174, "adrenoceptor blockade": 26.395026562918936, "receptor neprilysin": 25.53300439889032, "neprilysin inhibitor": 25.9747415777494, "\u03b2 coefficient": 22.268969439900527, "primary endpoint": 24.05393269936353, "% lower": 16.96691414770392, "partially reversed": 25.06750675317506, "elevated levels": 23.4988598666263, "cardiac patients": 24.05393269936353, "public health": 22.268969439900527, "service beneficiaries": 26.395026562918936, "lower risk": 20.017700327186596, "exercise performance": 25.9747415777494, "rate control": 21.581610854323394, "cardiovascular complications": 28.874989352001386, "global proteomics": 24.575546519991214, "pathway analysis": 24.05393269936353, "day rehospitalization": 26.395026562918936, "volume groups": 22.268969439900527, "hospital volume": 23.4988598666263, "therapeutic options": 25.53300439889032, "exercise test": 22.268969439900527, "study end": 19.115199271868, "cardiovascular risk": 25.53300439889032, "unfit men": 19.115199271868, "cardiac insulin": 23.4988598666263, "weeks post": 20.017700327186596, "per capita": 20.017700327186596, "cardiovascular health": 26.395026562918936, "sitagliptin versus": 25.06750675317506, "implementation strategies": 27.89769275438046, "physician adherence": 25.53300439889032, "life score": 20.017700327186596, "aerobic exercise": 24.05393269936353, "resting hr": 20.017700327186596, "right interatrial": 24.575546519991214, "magnetically levitated": 26.795846787024416, "years after": 17.36243885731372, "patients having": 19.582383222188582, "reversed by": 17.36243885731372, "rate at": 14.1390951230866, "national trends": 15.665906577750867, "study used": 13.34513355145773, "results show": 14.38774056954893, "adipose tissue": 15.270493030045724, "prospective study": 16.383697679994143, "free mass": 12.743466181245335, "energy x": 12.07168763198905, "total adiponectin": 16.383697679994143, "correlated inversely": 17.316494385166266, "developed countries": 17.022002932593548, "lv diastolic": 14.38774056954893, "this guideline": 15.270493030045724, "identified using": 16.03595513290902, "acp recommends": 15.270493030045724, "hemoglobin levels": 16.383697679994143, "quality evidence": 16.03595513290902, "moderate anemia": 15.665906577750867, "blood transfusions": 16.711671168783372, "study design": 14.38774056954893, "risk among": 13.34513355145773, "decreased mortality": 17.022002932593548, "intravenous iron": 16.03595513290902, "alleviate symptoms": 16.711671168783372, "cardioverter defibrillators": 19.040883785866036, "cardiac transplantation": 18.11928378611478, "low left": 12.07168763198905, "outpatient settings": 17.022002932593548, "important component": 17.022002932593548, "implantable cardiac": 17.022002932593548, "mortality using": 15.665906577750867, "studies evaluating": 16.711671168783372, "male sex": 12.07168763198905, "this meta": 12.743466181245335, "enhance decongestion": 17.316494385166266, "preserve renal": 15.270493030045724, "main outcomes": 14.845979626600352, "c level": 11.31127609846928, "secondary end": 14.845979626600352, "patient outcomes": 16.03595513290902, "associated proteins": 17.022002932593548, "proteins alter": 15.270493030045724, "alter chromatin": 15.665906577750867, "expression profile": 16.711671168783372, "altered expression": 16.711671168783372, "protein expression": 16.711671168783372, "mouse heart": 13.889951085850974, "ischemic events": 15.665906577750867, "receive cardiac": 15.665906577750867, "limited data": 14.38774056954893, "data regarding": 15.270493030045724, "study population": 16.03595513290902, "population comprised": 17.316494385166266, "coronary syndromes": 16.711671168783372, "among study": 13.889951085850974, "dependent analysis": 16.711671168783372, "subsequent heart": 16.03595513290902, "d recipients": 14.38774056954893, "percutaneous coronary": 17.596684375279292, "outcomes among": 15.270493030045724, "differential effect": 17.022002932593548, "\u226550 %": 9.401988988336534, "patients enrolled": 16.383697679994143, "risk associated": 15.665906577750867, "p value": 11.31127609846928, "circulating progenitor": 17.863897858016276, "ambulatory hf": 14.845979626600352, "hospital admissions": 17.022002932593548, "cd34+vegfr2 +": 14.845979626600352, "without diabetes": 16.03595513290902, "higher eo": 12.743466181245335, "improved functional": 17.022002932593548, "metric choice": 14.845979626600352, "readmission metrics": 17.022002932593548, "remote monitoring": 16.383697679994143, "recent hospital": 15.665906577750867, "network meta": 14.38774056954893, "recently discharged": 17.022002932593548, "electronic databases": 17.316494385166266, "observational cohort": 17.316494385166266, "implanted monitoring": 17.316494385166266, "monitoring devices": 16.711671168783372, "medical support": 15.665906577750867, "support provided": 16.03595513290902, "inclusion criteria": 16.711671168783372, "% cri": 9.401988988336534, "protein levels": 15.270493030045724, "western blot": 14.38774056954893, "dna fragmentation": 16.383697679994143, "remained unchanged": 16.711671168783372, "widely used": 13.889951085850974, "pump replacement": 16.03595513290902, "redo sternotomy": 15.665906577750867, "angiotensin system": 16.711671168783372, "target dose": 13.889951085850974, "blocker uptitrations": 17.316494385166266, "hospital admission": 16.711671168783372, "significant reductions": 17.863897858016276, "composite end": 14.845979626600352, "remained significant": 17.316494385166266, "blocker uptitration": 17.022002932593548, "younger patients": 16.03595513290902, "predicts clinical": 16.383697679994143, "clinical outcome": 16.03595513290902, "peptide levels": 15.270493030045724, "higher mortality": 16.03595513290902, "predict inhospital": 16.711671168783372, "mortality among": 15.665906577750867, "pediatric heart": 15.665906577750867, "patients presenting": 17.022002932593548, "patients as": 13.889951085850974, "regression analyses": 17.022002932593548, "relative decrease": 16.383697679994143, "correlation coefficient": 18.11928378611478, "intubation rates": 16.03595513290902, "rates declined": 15.270493030045724, "adult population": 16.03595513290902, "liver disease": 14.845979626600352, "systemic vascular": 16.383697679994143, "underwent catheterization": 18.59846183625364, "randomly selected": 16.383697679994143, "venous pressure": 15.665906577750867, "using data": 13.34513355145773, "distance covered": 16.03595513290902, "density lipoprotein": 17.022002932593548, "nitric oxide": 14.38774056954893, "molecular pathways": 16.711671168783372, "healthy individuals": 17.022002932593548, "vascular effects": 16.03595513290902, "year follow": 13.889951085850974, "patients died": 14.845979626600352, "area under": 13.34513355145773, "therapeutic targets": 17.022002932593548, "experimental procedures": 18.11928378611478, "male mice": 12.743466181245335, "significant differences": 18.11928378611478, "mice showed": 13.889951085850974, "showed significant": 16.711671168783372, "severe lv": 12.743466181245335, "mouse model": 13.889951085850974, "failure risk": 14.38774056954893, "significant value": 16.383697679994143, "evaluated whether": 16.383697679994143, "risk prediction": 15.665906577750867, "includes age": 14.38774056954893, "receiver operating": 16.711671168783372, "operating characteristic": 18.363844965370397, "characteristic curve": 17.316494385166266, "integrated discrimination": 18.59846183625364, "discrimination improvement": 18.82391160673009, "net reclassification": 17.316494385166266, "reclassification improvement": 19.249992901334256, "participants developed": 17.863897858016276, "adding ctnt": 13.889951085850974, "failure after": 14.845979626600352, "poor outcomes": 14.845979626600352, "requiring biventricular": 18.11928378611478, "requiring isolated": 16.711671168783372, "favorable outcome": 16.383697679994143, "ineligible patients": 17.022002932593548, "destination therapy": 17.022002932593548, "highly effective": 16.03595513290902, "transplantation eligibility": 19.040883785866036, "eligibility status": 16.711671168783372, "porcine model": 14.845979626600352, "improves cardiac": 16.03595513290902, "linear models": 14.845979626600352, "during rvpo": 13.889951085850974, "free wall": 12.743466181245335, "functional mitral": 16.383697679994143, "frequently develops": 17.022002932593548, "ischemic mitral": 15.665906577750867, "reduction by": 14.38774056954893, "valve tethering": 15.665906577750867, "anterior leaflet": 16.03595513290902, "leaflet opening": 15.665906577750867, "opening due": 13.889951085850974, "posteriorly displaced": 17.596684375279292, "displaced papillary": 17.022002932593548, "papillary muscles": 16.383697679994143, "ventricular dilatation": 17.863897858016276, "degenerative mitral": 17.022002932593548, "edge anastomosis": 16.03595513290902, "mitral filling": 15.270493030045724, "filling flow": 14.38774056954893, "clear organic": 14.845979626600352, "organic lesion": 15.270493030045724, "also confirmed": 15.270493030045724, "surgical indications": 17.316494385166266, "case report": 13.889951085850974, "clinical data": 14.845979626600352, "month risk": 13.34513355145773, "cause medical": 14.845979626600352, "medical hospitalization": 18.11928378611478, "risk group": 13.34513355145773, "month event": 13.889951085850974, "stage renal": 13.889951085850974, "important prognostic": 17.316494385166266, "egfr group": 13.34513355145773, "uncontrolled hypertension": 18.59846183625364, "reduced ef": 13.34513355145773, "commonly used": 14.845979626600352, "year event": 13.34513355145773, "internal consistency": 17.316494385166266, "sst2 concentrations": 17.022002932593548, "remains unclear": 15.665906577750867, "mg daily": 12.07168763198905, "cumulative hazard": 16.383697679994143, "sst2 treated": 14.38774056954893, "pure hno": 12.07168763198905, "reduced left": 14.38774056954893, "ventricular end": 15.665906577750867, "arterial pressure": 16.383697679994143, "these data": 13.34513355145773, "data show": 12.743466181245335, "potential usefulness": 17.316494385166266, "echocardiographic predictors": 19.249992901334256, "multiparametric echocardiographic": 20.195037247679423, "global longitudinal": 17.022002932593548, "longitudinal strain": 17.022002932593548, "% reduction": 13.889951085850974, "diastolic dimension": 17.022002932593548, "cause death": 13.889951085850974, "reduce morbidity": 16.03595513290902, "diagnosed heart": 15.665906577750867, "excluded patients": 16.383697679994143, "serum potassium": 15.665906577750867, "severe hyperkalemia": 17.022002932593548, "eligible patients": 16.383697679994143, "fold increased": 15.270493030045724, "reduced compared": 16.03595513290902, "cardiac failure": 15.665906577750867, "myocardial perfusion": 17.316494385166266, "failing heart": 14.845979626600352, "revealed reduced": 16.03595513290902, "reduced cardiac": 15.665906577750867, "b treatment": 13.889951085850974, "coronary perfusion": 16.711671168783372, "test whether": 14.38774056954893, "via activation": 15.270493030045724, "failure via": 13.889951085850974, "twofold increase": 16.03595513290902, "isolated cardiomyocytes": 18.11928378611478, "improve symptoms": 16.03595513290902, "stable severe": 14.845979626600352, "early transmitral": 16.383697679994143, "annulus velocity": 16.03595513290902, "pulmonary capillary": 17.022002932593548, "capillary wedge": 15.665906577750867, "wedge pressure": 15.270493030045724, "stable hf": 12.743466181245335, "transmitral flow": 16.03595513290902, "p values": 12.07168763198905, "predictive value": 16.03595513290902, "showed good": 13.889951085850974, "good diagnostic": 15.665906577750867, "annular plane": 14.845979626600352, "plane systolic": 15.270493030045724, "systolic excursion": 16.711671168783372, "arterial systolic": 16.383697679994143, "force relationship": 16.711671168783372, "regression line": 15.665906577750867, "patients exhibited": 16.711671168783372, "similar distribution": 17.316494385166266, "study shows": 13.889951085850974, "step forward": 14.38774056954893, "novel therapeutic": 16.383697679994143, "therapeutic approaches": 17.863897858016276, "vessel model": 14.38774056954893, "proximal left": 14.845979626600352, "proximal lad": 14.38774056954893, "rate reduction": 15.270493030045724, "isolated heart": 15.270493030045724, "effective arterial": 16.711671168783372, "fraction \u226435": 14.38774056954893, "\u226435 %": 9.401988988336534, "ivabradine group": 16.03595513290902, "isolated hr": 13.889951085850974, "prognostic indicator": 17.316494385166266, "postoperative survival": 17.863897858016276, "normal albumin": 15.270493030045724, "postoperative normalization": 19.040883785866036, "survival compared": 16.383697679994143, "lvad implantation": 16.383697679994143, "circulatory support": 17.022002932593548, "surgical intervention": 17.596684375279292, "patient died": 14.38774056954893, "few studies": 13.889951085850974, "youngest patients": 16.383697679994143, "vs. oldest": 13.34513355145773, "radiological signs": 16.711671168783372, "multivariable adjustment": 18.363844965370397, "hospitalization rates": 17.596684375279292, "less common": 13.889951085850974, "exercise per": 14.38774056954893, "kg vs": 9.401988988336534, "\u00b1 3.1": 9.401988988336534, "depressive symptoms": 17.022002932593548, "aerobic capacity": 16.03595513290902, "hand grip": 12.743466181245335, "ejection time": 14.845979626600352, "arterial tonometry": 16.711671168783372, "prognostic value": 16.03595513290902, "precapillary ph": 15.665906577750867, "clinical deterioration": 17.863897858016276, "unfavorable outcome": 17.022002932593548, "prognostic factors": 16.711671168783372, "higher serum": 14.38774056954893, "serum levels": 14.38774056954893, "higher furosemide": 16.383697679994143, "furosemide dose": 15.665906577750867, "oxygen flow": 13.889951085850974, "atrial myxoma": 14.845979626600352, "day test": 12.07168763198905, "advanced chronic": 16.03595513290902, "% men": 9.401988988336534, "advanced copd": 14.845979626600352, "absolute value": 15.270493030045724, "confidence level": 16.03595513290902, "rheumatoid arthritis": 17.316494385166266, "severe hf": 12.743466181245335, "used data": 12.743466181245335, "study cohort": 14.38774056954893, "these groups": 14.38774056954893, "propensity score": 16.03595513290902, "new users": 12.743466181245335, "mg hr": 9.401988988336534, "chronic disease": 15.665906577750867, "methods study": 14.845979626600352, "secondary outcome": 16.383697679994143, "demonstrated significant": 18.363844965370397, "groups based": 14.38774056954893, "improved clinical": 16.383697679994143, "vasopressin receptor": 17.316494385166266, "antagonist therapy": 16.711671168783372, "embryonic gene": 15.270493030045724, "inotropic effect": 16.03595513290902, "long time": 12.743466181245335, "decrease mortality": 16.711671168783372, "molecular mechanism": 17.022002932593548, "specific irs1": 14.845979626600352, "impaired cardiac": 16.03595513290902, "ventricular cardiomyocytes": 18.82391160673009, "dysfunction during": 16.711671168783372, "level variation": 15.665906577750867, "median rate": 13.889951085850974, "rate ratio": 13.34513355145773, "blockers therapy": 16.03595513290902, "improves outcomes": 16.383697679994143, "among trastuzumab": 16.383697679994143, "% compared": 13.34513355145773, "nontrastuzumab users": 17.316494385166266, "large cohort": 14.38774056954893, "dietary recommendations": 18.11928378611478, "across quartiles": 16.03595513290902, "plasma samples": 15.270493030045724, "modestly associated": 17.022002932593548, "extended criteria": 16.383697679994143, "transplant recipients": 17.596684375279292, "chronic kidney": 15.270493030045724, "kidney disease": 15.270493030045724, "hospital quality": 16.03595513290902, "average age": 13.889951085850974, "cause readmissions": 16.711671168783372, "resonance postcontrast": 17.863897858016276, "myocardial extracellular": 18.363844965370397, "major role": 13.34513355145773, "resonance t1": 14.38774056954893, "observational study": 17.022002932593548, "invasive hemodynamic": 17.316494385166266, "pulmonary vascular": 16.711671168783372, "cardiac events": 15.270493030045724, "greater risk": 14.38774056954893, "heart magnetic": 15.270493030045724, "chelation choices": 16.383697679994143, "patient compliance": 16.711671168783372, "mild heart": 13.34513355145773, "current guidelines": 16.711671168783372, "less severe": 13.889951085850974, "% subgroup": 13.34513355145773, "clinical composite": 16.711671168783372, "composite response": 16.711671168783372, "titin hypophosphorylation": 18.59846183625364, "hypophosphorylation importantly": 19.835370700972963, "metabolic risk": 15.270493030045724, "collagen deposition": 17.022002932593548, "titin modification": 16.711671168783372, "lean zsf1": 12.743466181245335, "underlying myocardial": 17.596684375279292, "global left": 13.889951085850974, "ventricular longitudinal": 18.363844965370397, "longitudinal systolic": 17.596684375279292, "systolic strain": 15.665906577750867, "persistent af": 14.845979626600352, "fatal stroke": 14.38774056954893, "predicting adverse": 16.711671168783372, "interaction between": 17.022002932593548, "significant reduction": 17.596684375279292, "continuous relationship": 18.11928378611478, "reduced hospitalizations": 18.363844965370397, "peritoneal dialysis": 17.022002932593548, "consecutive case": 16.03595513290902, "case series": 13.889951085850974, "potential benefit": 16.383697679994143, "significant decrease": 17.316494385166266, "control analysis": 16.03595513290902, "patients demonstrated": 17.596684375279292, "cause hospitalizations": 17.863897858016276, "animal models": 14.845979626600352, "hypertensive hfpef": 16.711671168783372, "cardiovascular function": 18.11928378611478, "diastolic filling": 16.383697679994143, "elevated resistin": 16.383697679994143, "explored whether": 16.03595513290902, "serum resistin": 15.270493030045724, "showed increased": 16.03595513290902, "month follow": 14.38774056954893, "complications occurred": 17.863897858016276, "several cancers": 15.665906577750867, "aortic blood": 14.38774056954893, "adenine nucleotides": 17.022002932593548, "nucleotides contents": 17.316494385166266, "oxidative phosphorylation": 18.59846183625364, "phosphorylation capacity": 18.363844965370397, "creatine kinase": 15.665906577750867, "kinase activity": 15.665906577750867, "preoperative renal": 16.711671168783372, "bypass grafting": 15.665906577750867, "primary isolated": 16.03595513290902, "isolated cabg": 14.845979626600352, "significantly increased": 18.11928378611478, "coronary disease": 16.03595513290902, "onset heart": 13.889951085850974, "maladaptive remodelling": 18.11928378611478, "maladaptive cardiac": 17.022002932593548, "cardiac remodelling": 17.022002932593548, "erk1/2 signalling": 16.383697679994143, "% male": 10.435236970702096, "recent trials": 14.845979626600352, "current status": 15.270493030045724, "clinical care": 14.845979626600352, "care delivery": 14.845979626600352, "care systems": 14.38774056954893, "day risk": 12.07168763198905, "show that": 12.743466181245335, "bromodomain proteins": 17.316494385166266, "pathological changes": 17.316494385166266, "pathological gene": 16.383697679994143, "activating transcription": 18.363844965370397, "nuclear factor": 15.270493030045724, "tidal respiration": 16.383697679994143, "myocardial t1": 14.845979626600352, "mapping values": 15.270493030045724, "myocardial tissue": 16.383697679994143, "control animals": 15.665906577750867, "healthy control": 15.665906577750867, "prognostic relevance": 17.316494385166266, "severe pulmonary": 16.03595513290902, "\u00b1 1.8": 9.401988988336534, "multivariate analyses": 17.596684375279292, "low pasp": 12.07168763198905, "significantly different": 18.11928378611478, "independent prognostic": 17.863897858016276, "hypertension patients": 17.596684375279292, "fluid overload": 15.270493030045724, "cardiovascular hospitalization": 19.64676632748936, "unfolded protein": 16.03595513290902, "protein response": 16.03595513290902, "mrna splicing": 14.845979626600352, "cardiac na+": 13.889951085850974, "tested whether": 15.270493030045724, "stem cell": 12.743466181245335, "na+ channel": 13.889951085850974, "mrna splice": 13.889951085850974, "splice variants": 15.665906577750867, "diagnostic procedures": 17.596684375279292, "management strategies": 17.596684375279292, "assess whether": 15.270493030045724, "differential response": 17.596684375279292, "stable heart": 14.38774056954893, "outcomes included": 16.383697679994143, "carvedilol resulted": 17.022002932593548, "lower von": 12.743466181245335, "contextual factors": 16.711671168783372, "biomedical reasons": 16.711671168783372, "parasympathetic tone": 17.316494385166266, "evidence suggests": 16.383697679994143, "sympathovagal balance": 17.596684375279292, "response caused": 15.665906577750867, "vagal tone": 13.34513355145773, "reduced sympathetic": 17.022002932593548, "cardiac vagal": 14.845979626600352, "electromechanical delay": 18.11928378611478, "dyssynchronous heart": 17.316494385166266, "electrical activation": 17.596684375279292, "abnormal ca(2": 14.845979626600352, "advanced hf": 13.889951085850974, "lower fat": 12.743466181245335, "lean body": 12.743466181245335, "channel inhibition": 16.711671168783372, "hemodynamic status": 16.711671168783372, "clinical tool": 14.845979626600352, "clinical prediction": 17.022002932593548, "derivation cohort": 16.383697679994143, "multivariate logistic": 17.596684375279292, "diuretic use": 14.38774056954893, "current knowledge": 16.383697679994143, "diseased cardiomyocytes": 18.11928378611478, "cross talk": 13.34513355145773, "poorly understood": 16.383697679994143, "chronic \u03b2": 12.743466181245335, "therapeutic strategy": 17.316494385166266, "worsening renal": 15.665906577750867, "optimal therapy": 15.665906577750867, "exclusion criteria": 16.711671168783372, "treatment group": 15.665906577750867, "control strategies": 16.711671168783372, "rich cocoa": 13.34513355145773, "detrimental alterations": 18.11928378611478, "mitochondrial structure": 18.11928378611478, "chinese herbal": 15.270493030045724, "herbal medicine": 15.665906577750867, "diastolic end": 14.845979626600352, "end diameter": 14.38774056954893, "analysis indicated": 16.711671168783372, "week follow": 13.889951085850974, "metabolic enzymes": 16.383697679994143, "healthy volunteers": 16.711671168783372, "biosynthetic enzymes": 17.316494385166266, "therapeutic interventions": 18.59846183625364, "review provides": 15.665906577750867, "pathophysiological origin": 18.59846183625364, "care surgery": 14.38774056954893, "abdominal problems": 16.711671168783372, "cardiac arrest": 15.270493030045724, "posterior wall": 15.270493030045724, "refractory cardiogenic": 17.863897858016276, "heart team": 13.34513355145773, "effective treatment": 17.022002932593548, "complicating ami": 16.03595513290902, "linked administrative": 17.596684375279292, "fatality rate": 14.845979626600352, "concurrent hf": 14.845979626600352, "day survivors": 14.845979626600352, "testosterone supplementation": 19.249992901334256, "key health": 13.34513355145773, "shuttle walk": 14.38774056954893, "muscular strength": 16.383697679994143, "inflammatory markers": 17.316494385166266, "functional electrical": 17.596684375279292, "electrical stimulation": 17.863897858016276, "emotional status": 16.03595513290902, "minute walked": 14.845979626600352, "walked distance": 15.665906577750867, "transforming growth": 17.022002932593548, "derived c": 12.743466181245335, "cardiac explant": 15.665906577750867, "improve cardiac": 15.665906577750867, "mesenchymal transition": 17.863897858016276, "transition markers": 16.711671168783372, "clinical application": 17.316494385166266, "periodic breathing": 16.711671168783372, "defibrillator device": 17.316494385166266, "antiplatelet agents": 17.022002932593548, "prognostic information": 17.863897858016276, "unilateral renal": 16.03595513290902, "renal denervation": 16.383697679994143, "increased sympathetic": 17.596684375279292, "cardiac autonomic": 16.383697679994143, "sham levels": 13.889951085850974, "narrow qrs": 13.34513355145773, "primary efficacy": 16.03595513290902, "worsening heart": 15.665906577750867, "sensitive outcome": 16.383697679994143, "outcome ratings": 15.665906577750867, "provide insight": 15.665906577750867, "phosphate receptor": 16.711671168783372, "coupled receptors": 16.383697679994143, "coupled receptor": 16.03595513290902, "plasma membrane": 15.665906577750867, "urgent readmission": 16.711671168783372, "early physician": 15.665906577750867, "physician follow": 16.03595513290902, "lower rates": 13.889951085850974, "index admission": 15.665906577750867, "better outcomes": 15.665906577750867, "subunit expression": 16.711671168783372, "disease progression": 17.022002932593548, "significantly decreased": 18.11928378611478, "autonomic nervous": 16.383697679994143, "nervous system": 15.270493030045724, "spontaneous vt": 15.270493030045724, "atrial pacing": 14.845979626600352, "higher baseline": 15.665906577750867, "cell transplantation": 17.316494385166266, "performed better": 16.03595513290902, "outcomes trial": 15.270493030045724, "pharmacological treatment": 18.59846183625364, "new targets": 13.889951085850974, "clinical symptoms": 16.383697679994143, "guided clinical": 15.665906577750867, "aldosterone system": 16.711671168783372, "cardiac filling": 15.665906577750867, "factor analysis": 15.665906577750867, "antibodies targeting": 17.316494385166266, "nonterminal epitopes": 17.316494385166266, "these findings": 15.270493030045724, "wall thickness": 15.270493030045724, "inappropriate implantable": 18.59846183625364, "defibrillator therapy": 17.596684375279292, "therapy due": 13.889951085850974, "therapy compared": 16.03595513290902, "inappropriate atp": 16.383697679994143, "receiving carvedilol": 17.316494385166266, "carvedilol compared": 17.022002932593548, "lower rate": 13.34513355145773, "refill compliance": 16.383697679994143, "matched control": 15.665906577750867, "failure due": 13.889951085850974, "myosin heavy": 14.38774056954893, "heavy chain": 13.889951085850974, "reference subjects": 16.711671168783372, "psoriasis patients": 16.711671168783372, "brachial index": 15.270493030045724, "peripheral artery": 16.383697679994143, "index \u2264": 11.31127609846928, "intensive transitions": 17.596684375279292, "care program": 14.38774056954893, "care system": 13.889951085850974, "abnormal hr": 13.889951085850974, "various measures": 16.03595513290902, "artery stenosis": 15.665906577750867, "common form": 13.889951085850974, "progressive disease": 17.022002932593548, "major public": 14.38774056954893, "health problem": 15.270493030045724, "differentially expressed": 18.363844965370397, "failure samples": 15.665906577750867, "functional enrichment": 17.596684375279292, "enrichment analysis": 17.022002932593548, "analysis using": 15.270493030045724, "driven telehealth": 16.383697679994143, "inpatient admissions": 17.316494385166266, "hospital days": 14.845979626600352, "without exercise": 16.03595513290902, "walk distance": 14.845979626600352, "increased mortality": 17.022002932593548, "lower exercise": 15.270493030045724, "early treatment": 15.665906577750867, "applied early": 14.845979626600352, "early rhythm": 14.38774056954893, "cardiac nurses": 15.270493030045724, "article describes": 16.383697679994143, "life expectancy": 15.665906577750867, "terminal heart": 15.270493030045724, "ventricular action": 16.711671168783372, "sustaining treatment": 17.316494385166266, "composite quality": 16.383697679994143, "quality measures": 16.03595513290902, "help patients": 14.845979626600352, "future high": 13.889951085850974, "low performers": 15.270493030045724, "adjusted mortality": 16.711671168783372, "versus best": 13.889951085850974, "best quintile": 14.845979626600352, "vs. hospital": 14.38774056954893, "race influences": 15.665906577750867, "aa participants": 15.665906577750867, "combined end": 14.38774056954893, "signaling pathways": 16.711671168783372, "proteomics changes": 16.711671168783372, "ingenuity pathway": 16.383697679994143, "significantly changed": 17.596684375279292, "actin cytoskeleton": 16.711671168783372, "mitochondrial function": 17.863897858016276, "global attenuation": 16.711671168783372, "targeted peptide": 16.03595513290902, "care transfer": 14.845979626600352, "transfer policy": 15.665906577750867, "percentage points": 16.383697679994143, "kidney infection": 16.03595513290902, "patients cared": 15.270493030045724, "across hospital": 15.665906577750867, "chronic advanced": 16.03595513290902, "anaerobic threshold": 17.022002932593548, "primary study": 14.845979626600352, "at multivariable": 16.03595513290902, "metabolic exercise": 16.711671168783372, "kidney index": 14.38774056954893, "index score": 13.889951085850974, "following variables": 17.022002932593548, "cardiorespiratory fitness": 18.59846183625364, "lower hf": 12.07168763198905, "mortality risk": 15.270493030045724, "decreased mitochondrial": 18.11928378611478, "% decrease": 13.34513355145773, "health service": 15.270493030045724, "lower total": 13.889951085850974, "total expenditure": 16.383697679994143, "health per": 13.34513355145773, "rheumatic fever": 15.665906577750867, "cardiac injury": 15.270493030045724, "terminal phase": 15.270493030045724, "antihyperglycemic agents": 18.363844965370397, "versus pioglitazone": 17.022002932593548, "versus insulin": 15.270493030045724, "parasympathetic activity": 18.363844965370397, "ongoing gdmt": 14.38774056954893, "major adverse": 14.845979626600352, "adverse neurological": 17.316494385166266, "physical examination": 17.316494385166266, "young athletes": 15.270493030045724, "atherosclerotic cad": 17.022002932593548, "assisted gait": 14.845979626600352, "gait therapy": 14.38774056954893, "resistance training": 17.022002932593548, "inflammatory biomarkers": 18.11928378611478, "peak quadriceps": 15.665906577750867, "quadriceps force": 16.03595513290902, "events occurred": 15.665906577750867, "higher psss": 13.889951085850974, "lower btes": 13.34513355145773, "resting hr<70": 14.845979626600352, "versus \u226570": 13.34513355145773, "\u226570 bpm": 11.31127609846928, "dose uptitration": 16.03595513290902, "kg increase": 13.889951085850974, "interatrial shunting": 17.316494385166266, "principle cohort": 16.03595513290902, "atrial pressure": 15.665906577750867, "mean score": 13.34513355145773, "min walk": 12.07168763198905, "caloric restriction": 17.022002932593548, "obese older": 13.889951085850974, "stable hfpef": 14.38774056954893, "diet group": 13.34513355145773, "performance goal": 16.03595513290902, "failure disease": 15.665906577750867, "talk between": 10.790805427161697, "follow up": 9.557599635934, "known about": 10.41746331438823, "mortality at": 10.790805427161697, "supplemented by": 11.74942993331315, "months after": 10.790805427161697, "characterized by": 12.026966349681764, "recognized as": 11.134484719950263, "wk after": 9.053765723991788, "dilated by": 10.008850163593298, "echocardiography at": 12.76650219944516, "% had": 7.0514917412524, "levels by": 9.557599635934, "found between": 11.134484719950263, "outcomes after": 11.452869772534292, "days after": 10.008850163593298, "suggesting that": 11.74942993331315, "common conditions": 8.191848839997071, "national efforts": 8.01797756645451, "efforts dedicated": 8.191848839997071, "improve patient": 7.832953288875434, "safety remain": 7.422989813300176, "remain largely": 7.635246515022862, "largely unclear": 7.832953288875434, "assess national": 7.832953288875434, "conditions requiring": 8.658247192583133, "requiring surgery": 8.191848839997071, "analysis included": 8.191848839997071, "large study": 6.944975542925487, "study sample": 7.193870284774465, "patients across": 7.832953288875434, "significant decline": 8.511001466296774, "estimated 81,000": 8.01797756645451, "hospital adverse": 8.01797756645451, "events averted": 7.635246515022862, "measurable overall": 8.355835584391686, "overall improvements": 8.658247192583133, "surgical conditions": 8.511001466296774, "some events": 6.944975542925487, "pressure ulcers": 7.832953288875434, "surgical patients": 8.191848839997071, "actually increased": 8.355835584391686, "increased despite": 8.191848839997071, "considerable national": 8.798342187639646, "national attention": 8.355835584391686, "study suggests": 7.635246515022862, "national patient": 8.01797756645451, "safety initiatives": 8.355835584391686, "real progress": 7.422989813300176, "created across": 7.635246515022862, "board improvements": 8.355835584391686, "cachectic heart": 7.832953288875434, "increased energy": 8.01797756645451, "energy expenditure": 8.355835584391686, "expenditure caused": 8.355835584391686, "b natriuretic": 7.422989813300176, "progressive loss": 8.01797756645451, "fat free": 6.035843815994525, "takes place": 6.944975542925487, "body fat": 6.035843815994525, "fat distribution": 8.01797756645451, "dual energy": 6.944975542925487, "diabetic patients": 8.191848839997071, "cachectic chf": 7.422989813300176, "prior myocardial": 8.01797756645451, "neurohormonal stimulation": 9.29923091812682, "endothelial dysfunction": 9.05964189305739, "midregional proanp": 8.355835584391686, "inverse correlation": 8.511001466296774, "groups even": 6.944975542925487, "increased by": 7.193870284774465, "decreased by": 7.193870284774465, "cc patients": 6.944975542925487, "latter correlated": 8.191848839997071, "baseline nt": 6.944975542925487, "no correlation": 7.635246515022862, "plasma nps": 6.672566775728865, "stable body": 6.944975542925487, "clinical doppler": 8.01797756645451, "failure show": 7.193870284774465, "show preserved": 7.635246515022862, "steadily increasing": 8.511001466296774, "major underlying": 8.01797756645451, "underlying mechanism": 8.658247192583133, "even mild": 6.3717330906226675, "mild clinical": 7.422989813300176, "clinical diastolic": 8.355835584391686, "pronounced increases": 8.658247192583133, "dysfunction leading": 8.511001466296774, "critical importance": 8.511001466296774, "guidelines based": 8.01797756645451, "based definition": 8.01797756645451, "dilated left": 7.193870284774465, "impaired lv": 6.944975542925487, "diastolic stiffness": 8.511001466296774, "elevated lv": 6.944975542925487, "assessed non": 7.193870284774465, "invasively using": 8.01797756645451, "practice guideline": 8.355835584391686, "provide clinical": 8.01797756645451, "clinical recommendations": 9.181922482685199, "published literature": 8.658247192583133, "english language": 8.01797756645451, "additional studies": 8.355835584391686, "outcomes evaluated": 8.355835584391686, "guideline included": 8.355835584391686, "included mortality": 8.355835584391686, "failure exacerbation": 8.658247192583133, "including hypertension": 8.931948929008138, "venous thromboembolic": 8.798342187639646, "ischemic cerebrovascular": 9.181922482685199, "cerebrovascular events": 8.931948929008138, "target audience": 7.832953288875434, "guideline includes": 8.355835584391686, "target patient": 7.635246515022862, "population is": 7.422989813300176, "deficient adult": 7.832953288875434, "guideline grades": 8.01797756645451, "recommendations using": 8.798342187639646, "practice guidelines": 8.511001466296774, "guidelines grading": 8.355835584391686, "grading system": 7.635246515022862, "recommends using": 8.01797756645451, "restrictive red": 7.832953288875434, "red blood": 6.3717330906226675, "blood cell": 6.672566775728865, "cell transfusion": 8.01797756645451, "transfusion strategy": 8.658247192583133, "trigger hemoglobin": 8.355835584391686, "hemoglobin threshold": 8.658247192583133, "higher hemoglobin": 8.191848839997071, "weak recommendation": 8.511001466296774, "strong recommendation": 8.798342187639646, "anemia treatment": 8.01797756645451, "trial registries": 8.01797756645451, "reference lists": 7.832953288875434, "technical advisors": 8.355835584391686, "study selection": 7.832953288875434, "language trials": 7.832953288875434, "population characteristics": 9.411955803365045, "studies suggests": 8.01797756645451, "liberal transfusion": 8.511001466296774, "transfusion protocols": 8.798342187639646, "improve short": 7.422989813300176, "rates compared": 7.635246515022862, "less aggressive": 7.832953288875434, "aggressive protocols": 8.658247192583133, "combined relative": 8.191848839997071, "among trials": 7.193870284774465, "rates occurred": 7.635246515022862, "small trial": 6.944975542925487, "coronary syndrome": 8.191848839997071, "iron found": 6.672566775728865, "found improved": 7.635246515022862, "improved short": 7.635246515022862, "term exercise": 7.422989813300176, "stimulating agent": 8.191848839997071, "agent therapy": 7.422989813300176, "therapy found": 7.422989813300176, "consistent benefits": 8.511001466296774, "venous thromboembolism": 8.931948929008138, "few trials": 6.672566775728865, "examined transfusions": 8.798342187639646, "potentially confounded": 8.931948929008138, "data supporting": 7.832953288875434, "supporting iron": 7.832953288875434, "iron use": 6.035843815994525, "use come": 6.035843815994525, "come mainly": 6.944975542925487, "large trial": 6.944975542925487, "term effects": 7.193870284774465, "higher transfusion": 8.355835584391686, "transfusion thresholds": 8.931948929008138, "consistently improve": 8.658247192583133, "improve mortality": 8.191848839997071, "large trials": 7.193870284774465, "also warrants": 7.422989813300176, "warrants further": 8.01797756645451, "benefit patients": 8.01797756645451, "serious harms": 7.422989813300176, "remote ischemic": 7.832953288875434, "ischemic conditioning": 8.798342187639646, "nonischemic cardiomyopathies": 9.624996450667128, "inroads made": 7.193870284774465, "pharmacological armamentarium": 9.725894496041844, "eventual resort": 7.832953288875434, "both patients": 7.422989813300176, "hospital frequently": 8.511001466296774, "keep physicians": 7.832953288875434, "physicians busy": 7.832953288875434, "also prompting": 7.635246515022862, "better ways": 6.944975542925487, "worldwide epidemic": 8.355835584391686, "medical resources": 8.191848839997071, "financial costs": 7.832953288875434, "failure clinical": 8.01797756645451, "enriching patient": 8.191848839997071, "patient identification": 8.931948929008138, "authors suggest": 7.832953288875434, "patient categorization": 8.931948929008138, "modern acute": 7.193870284774465, "highly heterogeneous": 8.658247192583133, "appropriate risk": 8.01797756645451, "conducting studies": 8.355835584391686, "cardiac defibrillator": 8.798342187639646, "many current": 7.193870284774465, "current predictors": 8.355835584391686, "identify factors": 8.01797756645451, "reviewers selected": 8.355835584391686, "selected citations": 8.355835584391686, "included ambulatory": 8.511001466296774, "ambulatory icd": 7.635246515022862, "using multivariable": 8.511001466296774, "multivariable regression": 9.181922482685199, "analyzed mortality": 8.355835584391686, "using random": 7.193870284774465, "effects models": 7.635246515022862, "studies reviewed": 8.01797756645451, "patients proved": 7.832953288875434, "proved eligible": 7.832953288875434, "high confidence": 7.832953288875434, "year increase": 7.422989813300176, "baseline glomerular": 8.511001466296774, "min decrease": 7.193870284774465, "inappropriate icd": 8.191848839997071, "congestive hf": 7.422989813300176, "analysis identified": 8.511001466296774, "identified strong": 8.191848839997071, "strong reliable": 7.832953288875434, "reliable mortality": 8.355835584391686, "mortality predictors": 8.658247192583133, "strong predictors": 8.191848839997071, "further research": 8.01797756645451, "potential predictors": 8.658247192583133, "particularly biomarkers": 9.05964189305739, "failure randomized": 8.355835584391686, "small studies": 7.422989813300176, "studies suggest": 7.832953288875434, "neither strategy": 8.01797756645451, "rigorously tested": 8.191848839997071, "independent hypotheses": 8.931948929008138, "min without": 6.944975542925487, "without bolus": 7.422989813300176, "controlled clinical": 8.511001466296774, "randomized within": 8.191848839997071, "enrollment occurred": 8.511001466296774, "allocation ratio": 8.01797756645451, "nesiritide strategy": 8.511001466296774, "active treatment": 8.01797756645451, "independently compared": 8.931948929008138, "pooled placebo": 7.635246515022862, "points included": 7.832953288875434, "decongestion end": 8.01797756645451, "serum cystatin": 7.635246515022862, "function end": 7.193870284774465, "points reflective": 8.191848839997071, "nesiritide enhanced": 8.511001466296774, "enhanced decongestion": 8.798342187639646, "improved renal": 7.635246515022862, "multihospital study": 8.511001466296774, "promote adoption": 8.01797756645451, "failure guidelines": 8.355835584391686, "nurse leaders": 7.422989813300176, "many multisite": 7.635246515022862, "multisite studies": 8.191848839997071, "practice settings": 8.191848839997071, "settings focus": 7.635246515022862, "improving processes": 8.511001466296774, "adopting evidence": 8.191848839997071, "based practices": 7.832953288875434, "improving patient": 8.191848839997071, "specific research": 8.191848839997071, "research questions": 8.355835584391686, "implementation issues": 8.798342187639646, "profoundly transformed": 8.931948929008138, "utilizing voluntary": 8.511001466296774, "voluntary testimonies": 8.798342187639646, "participating nurses": 8.658247192583133, "multisite study": 7.832953288875434, "study extend": 7.193870284774465, "extend beyond": 7.422989813300176, "beyond meeting": 7.635246515022862, "meeting magnet": 7.635246515022862, "research requirements": 8.798342187639646, "systems proteomics": 8.355835584391686, "cardiac chromatin": 8.191848839997071, "chromatin identifies": 8.658247192583133, "identifies nucleolin": 8.658247192583133, "cellular plasticity": 8.511001466296774, "hypertrophy antecedent": 8.931948929008138, "failure involves": 8.01797756645451, "involves changes": 8.01797756645451, "global gene": 6.944975542925487, "preceding mechanisms": 8.658247192583133, "coordinate dna": 7.635246515022862, "dna accessibility": 8.191848839997071, "genomic scale": 7.422989813300176, "thereby altering": 8.01797756645451, "global changes": 7.635246515022862, "chromatin subproteomes": 8.931948929008138, "accompany heart": 7.832953288875434, "study tests": 6.944975542925487, "fundamental hypothesis": 8.931948929008138, "cardiac growth": 7.635246515022862, "disease recapitulates": 8.798342187639646, "recapitulates conserved": 9.05964189305739, "conserved developmental": 9.05964189305739, "developmental chromatin": 9.05964189305739, "chromatin remodeling": 8.658247192583133, "remodeling events": 8.191848839997071, "used quantitative": 8.191848839997071, "quantitative proteomics": 9.05964189305739, "identify chromatin": 8.355835584391686, "proteins extracted": 8.355835584391686, "extracted via": 7.422989813300176, "via detergent": 7.422989813300176, "quantify changes": 8.01797756645451, "study identified": 8.01797756645451, "modest conservation": 8.511001466296774, "revealed using": 7.635246515022862, "using strong": 7.193870284774465, "strong acid": 6.944975542925487, "exhibited altered": 8.191848839997071, "conducted extensive": 8.511001466296774, "extensive functional": 8.658247192583133, "functional characterization": 9.520441892933018, "based knockdown": 7.832953288875434, "nucleolin nearly": 8.01797756645451, "nearly abolished": 8.01797756645451, "abolished protein": 8.191848839997071, "little impact": 7.422989813300176, "gross morphological": 8.511001466296774, "morphological development": 9.29923091812682, "fish lacking": 7.193870284774465, "displayed severe": 8.01797756645451, "severe developmental": 8.658247192583133, "developmental impairment": 9.181922482685199, "abnormal chamber": 8.01797756645451, "chamber patterning": 8.355835584391686, "functional deficits": 8.511001466296774, "cardiac looping": 7.832953288875434, "myocyte differentiation": 9.05964189305739, "mechanisms underlying": 8.798342187639646, "defects involve": 7.832953288875434, "involve perturbed": 8.191848839997071, "perturbed bone": 7.635246515022862, "bone morphogenetic": 8.355835584391686, "morphogenetic protein": 8.798342187639646, "decreased rrna": 7.635246515022862, "rrna transcription": 8.355835584391686, "heterochromatic chromatin": 9.29923091812682, "study reports": 7.422989813300176, "quantitative analysis": 8.798342187639646, "new chromatin": 7.422989813300176, "chromatin subproteome": 8.798342187639646, "diseased mouse": 7.635246515022862, "validation studies": 8.355835584391686, "complementary model": 8.511001466296774, "model system": 7.193870284774465, "zebrafish examine": 8.191848839997071, "orchestrate genomic": 8.511001466296774, "genomic reprogramming": 8.798342187639646, "reprogramming events": 8.658247192583133, "events shared": 7.422989813300176, "myocardial ischemic": 8.511001466296774, "regarding risk": 7.635246515022862, "comprised 1,045": 7.832953288875434, "used multivariate": 8.191848839997071, "hazards regression": 8.355835584391686, "regression modeling": 8.511001466296774, "identify risk": 7.422989813300176, "comprising hospitalization": 9.411955803365045, "coronary interventions": 8.931948929008138, "patients included": 8.191848839997071, "included previous": 8.191848839997071, "previous revascularization": 9.411955803365045, "bypass surgery": 7.635246515022862, "coronary intervention": 8.798342187639646, "increased systolic": 8.355835584391686, "block pattern": 7.422989813300176, "baseline electrocardiogram": 9.411955803365045, "reduced risk": 7.193870284774465, "risk compared": 7.422989813300176, "ies among": 6.3717330906226675, "dependent effect": 8.01797756645451, "contemporary heart": 8.355835584391686, "improved outcomes": 8.191848839997071, "mortality after": 7.832953288875434, "acute decompensated": 8.511001466296774, "decompensated hf": 8.01797756645451, "world setting": 7.422989813300176, "categorized as": 7.635246515022862, "severe reductions": 8.191848839997071, "similar risk": 7.193870284774465, "mortality as": 7.193870284774465, "moderate reduction": 8.355835584391686, "conferred increased": 8.511001466296774, "increased increase": 8.355835584391686, "increase rate": 7.422989813300176, "rate compared": 7.422989813300176, "interaction term": 8.01797756645451, "term analysis": 7.422989813300176, "patients \u226475": 7.193870284774465, "\u226475 years": 6.3717330906226675, "preserved versus": 8.01797756645451, "experience similar": 8.355835584391686, "similar long": 7.193870284774465, "moderate reductions": 8.511001466296774, "significantly attenuated": 9.181922482685199, "longitudinal study": 8.355835584391686, "endothelial repair": 8.355835584391686, "serial measurements": 8.511001466296774, "consecutive consenting": 8.931948929008138, "consenting ambulatory": 8.798342187639646, "measured as": 6.944975542925487, "outgrowth colony": 8.01797756645451, "forming units": 7.422989813300176, "cd133 +": 5.65563804923464, "recorded mortality": 8.355835584391686, "increased functional": 8.658247192583133, "cell decrease": 7.422989813300176, "interaction effect": 8.355835584391686, "noted differential": 8.355835584391686, "differential relations": 8.931948929008138, "lower cd34+vegfr2": 8.191848839997071, "nondiabetic patients": 8.658247192583133, "lower eo": 6.035843815994525, "differences requires": 8.658247192583133, "common applications": 8.511001466296774, "differential impact": 8.511001466296774, "hospital performance": 8.658247192583133, "rates using": 6.944975542925487, "using three": 6.944975542925487, "disease groups": 7.635246515022862, "absolute change": 7.832953288875434, "correlation between": 8.511001466296774, "hospitals remaining": 8.511001466296774, "extreme deciles": 7.832953288875434, "longitudinal performance": 9.181922482685199, "principal findings": 8.355835584391686, "average hospital": 8.01797756645451, "hospital rates": 7.635246515022862, "generally higher": 8.01797756645451, "rates calculated": 8.01797756645451, "calculated using": 8.01797756645451, "moderately correlated": 8.798342187639646, "extreme decile": 7.635246515022862, "decile according": 8.01797756645451, "metric remained": 7.832953288875434, "different metric": 8.01797756645451, "correlations among": 8.355835584391686, "among metrics": 7.422989813300176, "measuring hospital": 8.355835584391686, "hospital longitudinal": 8.798342187639646, "longitudinal change": 8.511001466296774, "different approaches": 8.658247192583133, "computing readmissions": 8.931948929008138, "produce different": 8.191848839997071, "different hospital": 8.355835584391686, "hospital rankings": 8.191848839997071, "impact pay": 6.672566775728865, "careful consideration": 8.798342187639646, "readmission metric": 8.355835584391686, "recent discharge": 8.01797756645451, "deliver specialised": 8.511001466296774, "specialised care": 8.01797756645451, "growing needs": 7.422989813300176, "failure population": 8.355835584391686, "strategies improve": 8.355835584391686, "unplanned admission": 8.511001466296774, "admission due": 7.422989813300176, "searching relevant": 8.355835584391686, "relevant articles": 8.191848839997071, "all randomised": 7.635246515022862, "controlled trials": 8.191848839997071, "cohort studies": 7.635246515022862, "contemporaneous control": 9.05964189305739, "rm interventions": 8.01797756645451, "interventions included": 8.931948929008138, "included home": 7.422989813300176, "home telemonitoring": 8.511001466296774, "including implanted": 8.511001466296774, "provided during": 7.832953288875434, "structured telephone": 8.658247192583133, "telephone support": 8.191848839997071, "programmes delivered": 8.658247192583133, "delivered via": 7.422989813300176, "via human": 6.3717330906226675, "human contact": 7.422989813300176, "machine interface": 8.191848839997071, "assessed independently": 8.931948929008138, "studies evaluated": 8.191848839997071, "studies assessed": 8.01797756645451, "no trial": 6.035843815994525, "devices met": 6.944975542925487, "reaching statitistical": 8.931948929008138, "statitistical significance": 9.411955803365045, "% credible": 6.672566775728865, "credible interval": 8.191848839997071, "provided better": 7.832953288875434, "usual support": 7.422989813300176, "group rendered": 7.635246515022862, "comparisons statistically": 9.29923091812682, "also observed": 7.422989813300176, "cause hospitalisations": 8.931948929008138, "care packages": 7.422989813300176, "packages generally": 8.355835584391686, "generally improved": 8.355835584391686, "improved health": 7.832953288875434, "hours showed": 7.193870284774465, "showed beneficial": 8.191848839997071, "beneficial trends": 8.191848839997071, "discharged patients": 8.511001466296774, "care is": 5.65563804923464, "less good": 6.3717330906226675, "canine model": 7.193870284774465, "failure induced": 7.832953288875434, "induced dilated": 7.832953288875434, "fully understood": 8.01797756645451, "weeks rapid": 6.944975542925487, "rapid right": 6.944975542925487, "ventricular pacing": 8.355835584391686, "gene expressions": 8.01797756645451, "interventricular septum": 9.05964189305739, "septum biopsies": 7.832953288875434, "taken weekly": 7.193870284774465, "beagle dogs": 6.944975542925487, "evaluated protein": 8.191848839997071, "genes by": 6.035843815994525, "autopsy samples": 7.832953288875434, "pacing period": 7.422989813300176, "expression transiently": 8.931948929008138, "transiently decreased": 8.798342187639646, "moderate heart": 7.635246515022862, "significantly altered": 8.798342187639646, "expression increased": 8.658247192583133, "no band": 5.65563804923464, "paced myocardium": 8.01797756645451, "difference between": 8.355835584391686, "apoptotic cells": 7.832953288875434, "positive cells": 7.635246515022862, "paced groups": 7.193870284774465, "pump sternal": 7.193870284774465, "sternal sparing": 7.832953288875434, "sparing approach": 8.01797756645451, "pump dysfunction": 8.01797756645451, "dysfunction requiring": 8.798342187639646, "requiring pump": 7.635246515022862, "when dysfunction": 8.01797756645451, "pump failure": 7.193870284774465, "driveline injury": 8.01797756645451, "isolated pump": 7.422989813300176, "safe pump": 6.3717330906226675, "exchange technique": 8.355835584391686, "cardiopulmonary bypass": 8.931948929008138, "exchange malfunctioning": 9.05964189305739, "extubated within": 8.01797756645451, "blood loss": 6.672566775728865, "transfusion requirements": 9.181922482685199, "periprocedural deaths": 8.798342187639646, "system blocker": 7.635246515022862, "reduced versus": 7.635246515022862, "dose reduce": 6.944975542925487, "remain uncertain": 8.01797756645451, "study assesses": 7.635246515022862, "dose changes": 7.193870284774465, "followed during": 7.832953288875434, "dose increase": 7.422989813300176, "\u226510 %": 4.700994494168267, "without uptitration": 8.511001466296774, "received uptitration": 8.658247192583133, "higher heart": 7.193870284774465, "better renal": 7.193870284774465, "received spironolactone": 9.05964189305739, "hr 0.51": 5.65563804923464, "after correction": 8.01797756645451, "association remained": 8.658247192583133, "ci 0.39": 5.65563804923464, "no benefit": 6.672566775728865, "neurohumoral blockers": 8.798342187639646, "frequently performed": 8.658247192583133, "low co": 5.217618485351048, "morbidity burden": 8.01797756645451, "uptitration independently": 9.29923091812682, "independently predicts": 8.931948929008138, "inhospital outcomes": 8.511001466296774, "known differences": 8.191848839997071, "plasma b": 6.035843815994525, "explored sex": 7.193870284774465, "sex differences": 7.832953288875434, "determine prognostic": 8.658247192583133, "prognostic significance": 9.05964189305739, "included hospitals": 8.355835584391686, "admitted 99,930": 7.832953288875434, "compute odds": 7.193870284774465, "hospital clustering": 8.511001466296774, "women compared": 7.635246515022862, "men had": 5.65563804923464, "higher admission": 8.01797756645451, "admission median": 8.01797756645451, "greatest difference": 8.511001466296774, "smallest difference": 8.511001466296774, "women vs": 6.035843815994525, "vs men": 5.217618485351048, "ef reduced": 6.672566775728865, "reduced 1,259": 7.422989813300176, "heterogeneity =": 7.832953288875434, "= .47": 4.700994494168267, "large registry": 7.635246515022862, "important cause": 7.832953288875434, "article presents": 8.01797756645451, "presents guidelines": 8.511001466296774, "early medical": 7.422989813300176, "assist practitioners": 8.658247192583133, "emergency room": 7.635246515022862, "room practice": 7.422989813300176, "encounter children": 8.355835584391686, "undiagnosed heart": 8.191848839997071, "possible hf": 6.944975542925487, "already received": 8.01797756645451, "received surgical": 8.191848839997071, "surgical palliation": 8.511001466296774, "developed using": 7.832953288875434, "practical recommendations": 9.29923091812682, "clinical setting": 8.01797756645451, "online material": 7.832953288875434, "this work": 6.3717330906226675, "include recommendations": 9.05964189305739, "advanced management": 8.511001466296774, "management involving": 8.658247192583133, "involving ventricular": 8.798342187639646, "device therapies": 8.01797756645451, "authors evaluated": 8.191848839997071, "nurse assessment": 8.01797756645451, "elderly patients": 8.01797756645451, "authors analyzed": 8.01797756645451, "month mortality": 7.832953288875434, "failure declined": 8.01797756645451, "many advances": 7.422989813300176, "made recently": 7.422989813300176, "fewer chf": 6.3717330906226675, "patients seen": 7.422989813300176, "suburban hospitals": 8.355835584391686, "classified patients": 8.511001466296774, "determined chf": 7.635246515022862, "chf visit": 6.3717330906226675, "visit rates": 6.944975542925487, "total ed": 6.035843815994525, "patients intubated": 8.355835584391686, "performed regression": 8.658247192583133, "% were": 5.217618485351048, "failure visits": 7.635246515022862, "visits declined": 7.832953288875434, "% relative": 6.672566775728865, "coefficient r(2": 7.832953288875434, "annual ed": 6.3717330906226675, "these decreases": 7.832953288875434, "better chf": 6.672566775728865, "chf treatments": 7.635246515022862, "hemodynamic phenotype": 8.798342187639646, "occur even": 6.672566775728865, "normal systolic": 7.832953288875434, "systolic ventricular": 8.658247192583133, "significant liver": 8.191848839997071, "hemodynamically distinct": 9.181922482685199, "traditional heart": 8.191848839997071, "low systemic": 7.193870284774465, "preserved cardiac": 8.191848839997071, "symptomatic adult": 8.191848839997071, "study group": 6.944975542925487, "predominantly asymptomatic": 9.411955803365045, "asymptomatic pediatric": 8.931948929008138, "pediatric fontan": 8.01797756645451, "case cohort": 6.944975542925487, "cohort analysis": 7.832953288875434, "clinical comparisons": 8.658247192583133, "made between": 7.193870284774465, "mean catheterization": 8.658247192583133, "catheterization findings": 9.181922482685199, "central venous": 7.635246515022862, "index 1,680": 6.944975542925487, "index 2.7": 6.3717330906226675, "\u00b1 0.8": 4.700994494168267, "\u00b1 0.7": 4.700994494168267, "by imaging": 6.672566775728865, "cohort demonstrated": 8.511001466296774, "greater incidence": 8.191848839997071, "abnormal liver": 7.635246515022862, "liver texture": 7.422989813300176, "texture changes": 7.832953288875434, "lower svr": 6.3717330906226675, "similar cardiac": 7.832953288875434, "index compared": 7.635246515022862, "pediatric cohort": 8.01797756645451, "distinct circulatory": 8.658247192583133, "circulatory derangement": 9.05964189305739, "hemodynamic features": 8.658247192583133, "features similar": 8.01797756645451, "portal hypertension": 8.511001466296774, "limited ability": 7.832953288875434, "augment cardiac": 7.832953288875434, "related hospitalization": 9.05964189305739, "versus without": 7.635246515022862, "cardiovascular morbidity": 9.181922482685199, "careful management": 8.355835584391686, "recently hospitalized": 8.798342187639646, "management counseling": 8.798342187639646, "final multivariate": 8.355835584391686, "male gender": 6.944975542925487, "% adherence": 6.944975542925487, "prescribed medications": 8.931948929008138, "prescribed therapy": 8.355835584391686, "predicting death": 8.01797756645451, "failure promotes": 8.01797756645451, "promotes restoration": 8.658247192583133, "lipoprotein functional": 8.931948929008138, "functional properties": 8.798342187639646, "exerts endothelial": 8.355835584391686, "effects via": 6.944975542925487, "via stimulation": 7.832953288875434, "endothelial cell": 8.01797756645451, "this function": 7.422989813300176, "mediated protective": 8.511001466296774, "respective molecular": 8.658247192583133, "healthy controls": 8.01797756645451, "bound malondialdehyde": 8.798342187639646, "hdl particles": 7.422989813300176, "lower stimulation": 8.191848839997071, "phosphorylation at": 8.355835584391686, "higher phosphorylation": 8.931948929008138, "elevated activation": 8.511001466296774, "higher amount": 7.422989813300176, "malondialdehyde bound": 8.798342187639646, "improved hdl": 7.193870284774465, "dilatation improvement": 8.931948929008138, "results demonstrate": 8.511001466296774, "demonstrate that": 8.01797756645451, "mediated vascular": 8.191848839997071, "exerts beneficial": 8.191848839997071, "main objective": 7.635246515022862, "plasma n": 6.035843815994525, "successfully predict": 8.658247192583133, "best knowledge": 7.635246515022862, "first research": 7.635246515022862, "research done": 7.422989813300176, "plasma obtained": 7.832953288875434, "\u00b1 10.3": 5.217618485351048, "years vs": 6.035843815994525, "\u00b1 11.07": 5.65563804923464, "optimal nt": 6.672566775728865, "cutoff point": 7.193870284774465, "elevated nt": 6.944975542925487, "optimal cutoff": 7.635246515022862, "cutoff level": 7.193870284774465, "high sensitivity": 8.01797756645451, "additional prospective": 8.931948929008138, "multicenter studies": 8.511001466296774, "novel heart": 6.944975542925487, "failure mice": 7.193870284774465, "mice model": 6.672566775728865, "model using": 6.944975542925487, "using simple": 7.193870284774465, "simple experimental": 8.511001466296774, "stable phenotypes": 8.191848839997071, "novel mouse": 6.944975542925487, "combining salt": 7.635246515022862, "old c57bl/6": 6.944975542925487, "significantly elevated": 8.931948929008138, "significant decreases": 8.798342187639646, "high incidence": 7.635246515022862, "this phenotype": 7.635246515022862, "early deaths": 7.193870284774465, "small gtpase": 7.193870284774465, "rac1 activity": 7.422989813300176, "infusion mouse": 7.635246515022862, "mice developed": 7.635246515022862, "useful mouse": 7.193870284774465, "biomarker approach": 8.355835584391686, "predict heart": 7.422989813300176, "atherosclerosis risk": 8.658247192583133, "communities study": 8.191848839997071, "various cardiovascular": 8.931948929008138, "largest increases": 8.191848839997071, "coming decades": 7.635246515022862, "cardiac troponin": 8.01797756645451, "troponin t": 6.672566775728865, "sensitivity assay": 8.191848839997071, "biomarkers strongly": 8.511001466296774, "using sex": 6.3717330906226675, "specific models": 7.832953288875434, "added ctnt": 6.672566775728865, "antihypertensive medication": 9.520441892933018, "medication use": 7.635246515022862, "former smoking": 7.635246515022862, "prevalent coronary": 8.355835584391686, "participants without": 8.658247192583133, "without prevalent": 8.191848839997071, "prevalent hf": 7.193870284774465, "model fit": 6.3717330906226675, "developed incident": 8.355835584391686, "model significantly": 8.511001466296774, "statistical parameters": 8.931948929008138, "aucs increased": 7.635246515022862, "continuous nris": 7.832953288875434, "simpler laboratory": 8.355835584391686, "report model": 7.193870284774465, "simple sex": 6.672566775728865, "specific model": 7.635246515022862, "good model": 6.672566775728865, "characteristics results": 9.05964189305739, "excellent hf": 7.193870284774465, "prediction model": 8.01797756645451, "survival after": 7.635246515022862, "without temporary": 8.191848839997071, "temporary right": 7.832953288875434, "ventricular support": 8.511001466296774, "historically results": 8.658247192583133, "requiring temporary": 8.511001466296774, "temporary rv": 7.193870284774465, "heterogeneous group": 8.511001466296774, "patients consisting": 8.511001466296774, "chronic decompensated": 8.798342187639646, "decompensated heart": 8.511001466296774, "hybrid system": 7.422989813300176, "system consisting": 8.191848839997071, "isolated lvad": 7.422989813300176, "temporary centrimag": 8.511001466296774, "preoperative demographics": 9.29923091812682, "operative outcomes": 8.355835584391686, "patients required": 8.191848839997071, "required biventricular": 8.931948929008138, "mean duration": 7.422989813300176, "\u00b1 11.9": 5.217618485351048, "successfully explanted": 8.931948929008138, "significantly greater": 8.798342187639646, "required isolated": 8.191848839997071, "support using": 7.422989813300176, "limited mortality": 8.191848839997071, "however biventricular": 8.798342187639646, "biventricular dysfunction": 9.29923091812682, "isolated heartmate": 8.355835584391686, "device use": 6.672566775728865, "recommendations based": 8.798342187639646, "chronic end": 6.944975542925487, "clinical effects": 8.01797756645451, "systematically searched": 9.05964189305739, "scientific literature": 8.798342187639646, "economic evaluations": 8.658247192583133, "using simulation": 8.01797756645451, "simulation models": 8.191848839997071, "studies per": 6.944975542925487, "per outcome": 6.944975542925487, "made policy": 6.944975542925487, "policy recommendations": 8.931948929008138, "across transplantation": 8.931948929008138, "survival reaching": 8.191848839997071, "currently meet": 7.635246515022862, "meet traditional": 8.01797756645451, "traditional cost": 8.01797756645451, "effectiveness limits": 8.658247192583133, "models using": 7.193870284774465, "using historical": 8.01797756645451, "historical data": 7.832953288875434, "standard practice": 8.191848839997071, "limited number": 7.635246515022862, "many regions": 7.193870284774465, "implantation strategies": 9.05964189305739, "strategies tend": 7.832953288875434, "mutually exclusive": 8.355835584391686, "carefully selected": 8.355835584391686, "program infrastructure": 8.931948929008138, "evidence gaps": 7.422989813300176, "economic models": 7.832953288875434, "canadian data": 7.422989813300176, "data point": 6.672566775728865, "systematic monitoring": 8.798342187639646, "biventricular pacing": 8.658247192583133, "left heart": 6.672566775728865, "heart twist": 6.944975542925487, "selected cardiac": 8.01797756645451, "cardiac surgery": 7.832953288875434, "surgery patients": 8.01797756645451, "response remains": 8.01797756645451, "remains variable": 8.01797756645451, "better understanding": 8.658247192583133, "used speckle": 7.193870284774465, "speckle tracking": 8.01797756645451, "tracking echocardiography": 9.29923091812682, "analyze bivp": 7.193870284774465, "ventricular pressure": 8.658247192583133, "pressure overload": 8.191848839997071, "inferior vena": 7.422989813300176, "vena cava": 6.3717330906226675, "control model": 7.422989813300176, "heart block": 6.944975542925487, "artery snared": 7.422989813300176, "ventricular midpapillary": 9.181922482685199, "midpapillary level": 8.355835584391686, "varying atrioventricular": 9.181922482685199, "atrioventricular delay": 8.931948929008138, "interventricular delay": 8.931948929008138, "regional circumferential": 9.181922482685199, "circumferential strain": 8.931948929008138, "radial strain": 7.422989813300176, "ventricular base": 8.01797756645451, "bivp setting": 7.193870284774465, "basal rotations": 7.832953288875434, "mixed linear": 7.193870284774465, "apical rotation": 7.832953288875434, "wall rs": 5.65563804923464, "septal wall": 6.944975542925487, "open chest": 6.672566775728865, "chest model": 6.944975542925487, "noninvasive surrogates": 8.931948929008138, "varying regional": 8.01797756645451, "regional strain": 7.832953288875434, "strain contributions": 8.658247192583133, "primary mechanism": 8.191848839997071, "remaining indices": 8.191848839997071, "reflect postsystolic": 8.658247192583133, "postsystolic function": 8.798342187639646, "stenosis reversed": 8.191848839997071, "stenosis frequently": 8.511001466296774, "develops after": 7.635246515022862, "successful mitral": 8.191848839997071, "mild mitral": 6.944975542925487, "significant mitral": 8.355835584391686, "potentially improve": 8.511001466296774, "severe mr": 6.3717330906226675, "grade 4/6": 6.3717330906226675, "holosystolic murmur": 8.511001466296774, "third heart": 6.944975542925487, "heart sound": 6.944975542925487, "underwent mitral": 8.01797756645451, "chordal ruptures": 8.01797756645451, "underwent triangular": 8.658247192583133, "triangular resection": 8.658247192583133, "postoperative echocardiography": 9.82338316374468, "echocardiography confirmed": 9.411955803365045, "normal sized": 7.193870284774465, "sized lv": 6.035843815994525, "normal lv": 6.3717330906226675, "preserved mitral": 8.01797756645451, "valve area": 6.672566775728865, "continuity equation": 8.511001466296774, "lv end": 5.217618485351048, "flow volume": 6.944975542925487, "\u00d7 velocity": 6.672566775728865, "velocity time": 7.422989813300176, "time integral": 7.422989813300176, "continuous wave": 7.832953288875434, "utilized even": 7.422989813300176, "successfully performed": 8.931948929008138, "performed without": 8.191848839997071, "major concerns": 7.635246515022862, "this time": 6.3717330906226675, "diastolic murmurs": 8.191848839997071, "demonstrated moderately": 9.05964189305739, "moderately dilated": 8.355835584391686, "dilated lv": 6.672566775728865, "limited mitral": 7.635246515022862, "angiography revealed": 8.658247192583133, "significant lesions": 8.511001466296774, "major branches": 7.635246515022862, "diagnosed as": 7.193870284774465, "hypertensive lv": 7.832953288875434, "mitral leaflet": 7.635246515022862, "leaflet motions": 7.832953288875434, "restricted without": 8.355835584391686, "as significant": 7.635246515022862, "surgical indication": 8.511001466296774, "highly dynamic": 7.635246515022862, "potentially respond": 8.511001466296774, "cardiac murmurs": 7.832953288875434, "murmurs disappeared": 8.511001466296774, "repeated echocardiography": 9.29923091812682, "months later": 7.193870284774465, "later demonstrated": 8.355835584391686, "direct observation": 8.355835584391686, "surgery also": 7.193870284774465, "possible reasons": 8.01797756645451, "modest reduction": 8.01797756645451, "surgical ring": 7.422989813300176, "ring implantation": 8.191848839997071, "mild restriction": 8.01797756645451, "leaflet motion": 7.635246515022862, "leaflet resection": 8.191848839997071, "symptoms disappeared": 8.658247192583133, "patient developed": 8.191848839997071, "moderate lv": 6.944975542925487, "valve demonstrated": 8.355835584391686, "demonstrated restricted": 9.05964189305739, "restricted closure": 8.355835584391686, "opening without": 7.832953288875434, "diastolic tethering": 8.511001466296774, "functional etiology": 8.511001466296774, "reports demonstrating": 8.798342187639646, "demonstrating development": 9.29923091812682, "following ring": 7.635246515022862, "ischemic mr": 6.944975542925487, "this patient": 7.193870284774465, "patient showed": 7.635246515022862, "potentially vary": 8.01797756645451, "vary considerably": 8.191848839997071, "second hf": 6.3717330906226675, "considered indicative": 8.798342187639646, "after aggressive": 8.01797756645451, "symptom disappeared": 8.511001466296774, "insignificant ms": 8.01797756645451, "considered as": 7.422989813300176, "indications need": 8.01797756645451, "carefully evaluated": 8.511001466296774, "leaflet configurations": 8.931948929008138, "serial evaluation": 8.191848839997071, "evaluation strongly": 8.511001466296774, "strongly suggested": 8.355835584391686, "therefore dynamic": 8.191848839997071, "annular ms": 6.672566775728865, "fixed ring": 6.672566775728865, "ring size": 6.3717330906226675, "this case": 6.3717330906226675, "report demonstrates": 8.511001466296774, "thus requires": 7.422989813300176, "requires careful": 8.01797756645451, "careful evaluation": 8.355835584391686, "failure clinic": 7.635246515022862, "most heart": 6.672566775728865, "stratification models": 8.798342187639646, "inpatient use": 7.422989813300176, "available outpatient": 8.658247192583133, "outpatient models": 8.191848839997071, "models use": 6.672566775728865, "complex set": 6.944975542925487, "routinely collected": 8.511001466296774, "collected clinical": 8.355835584391686, "improvement database": 8.658247192583133, "multivariable cox": 8.191848839997071, "reached primary": 7.832953288875434, "externally validated": 8.658247192583133, "recently calculated": 8.511001466296774, "arbitrary start": 7.832953288875434, "start date": 6.672566775728865, "model included": 7.635246515022862, "included blood": 7.635246515022862, "blood urea": 6.672566775728865, "urea nitrogen": 7.422989813300176, "diabetes status": 7.832953288875434, "hospitalization within": 8.931948929008138, "concordance c": 7.422989813300176, "c statistics": 7.193870284774465, "rank testing": 7.193870284774465, "testing demonstrated": 8.658247192583133, "demonstrated excellent": 8.931948929008138, "excellent risk": 7.635246515022862, "cohorts 8%/12%/12": 8.191848839997071, "cohorts 57%/58%/79": 8.355835584391686, "uses readily": 7.193870284774465, "readily available": 8.191848839997071, "available data": 7.635246515022862, "potentially help": 8.01797756645451, "help allocate": 7.422989813300176, "allocate specialized": 8.658247192583133, "resources within": 8.01797756645451, "within health": 7.422989813300176, "health systems": 7.635246515022862, "dysfunction progresses": 8.931948929008138, "examined incidence": 8.355835584391686, "onset esrd": 6.672566775728865, "estimated by": 7.193870284774465, "patients grouped": 8.01797756645451, "group iii": 6.3717330906226675, "group iv": 6.035843815994525, "median left": 6.944975542925487, "median egfr": 6.944975542925487, "mainly observed": 7.832953288875434, "low egfr": 6.035843815994525, "hypertension identify": 8.798342187639646, "comparable performance": 8.931948929008138, "growing epidemic": 8.01797756645451, "valid measure": 7.422989813300176, "validated measure": 8.191848839997071, "prospective hf": 7.635246515022862, "dichotomized patients": 8.798342187639646, "used criterion": 7.635246515022862, "criterion standard": 8.355835584391686, "total symptom": 7.422989813300176, "evaluated using": 7.832953288875434, "using spearman": 7.635246515022862, "spearman correlations": 8.798342187639646, "interaction terms": 8.191848839997071, "predictive validity": 8.511001466296774, "made using": 6.672566775728865, "internal reliability": 8.658247192583133, "summary scores": 7.635246515022862, "free rates": 6.672566775728865, "category among": 7.635246515022862, "log rank": 6.035843815994525, "domains demonstrated": 8.658247192583133, "demonstrated high": 8.191848839997071, "high internal": 7.422989813300176, "consistency among": 8.191848839997071, "overall summary": 7.832953288875434, "reliable measure": 8.01797756645451, "offers excellent": 8.01797756645451, "excellent prognostic": 8.658247192583133, "prognostic ability": 8.355835584391686, "future studies": 7.635246515022862, "clinical change": 7.832953288875434, "soluble concentrations": 8.931948929008138, "interleukin receptor": 8.658247192583133, "receptor family": 7.832953288875434, "family member": 7.422989813300176, "predict prognosis": 8.191848839997071, "recently found": 7.635246515022862, "found changing": 7.635246515022862, "changing doses": 7.635246515022862, "affect sst2": 6.944975542925487, "concentrations identify": 9.05964189305739, "identify benefit": 8.01797756645451, "failure attributable": 8.658247192583133, "post hoc": 6.035843815994525, "hoc analysis": 7.193870284774465, "taking bb": 6.3717330906226675, "medication regimen": 8.355835584391686, "sst2 values": 6.944975542925487, "baseline sst2": 7.422989813300176, "sst2 status": 6.944975542925487, "low \u226435": 5.65563804923464, "versus high": 6.944975542925487, "final achieved": 7.635246515022862, "versus low": 6.672566775728865, "daily equivalent": 8.01797756645451, "equivalent dose": 7.832953288875434, "metoprolol succinate": 8.658247192583133, "sst2 titrated": 7.422989813300176, "bb had": 5.217618485351048, "lowest cardiovascular": 8.798342187639646, "lowest cumulative": 8.191848839997071, "intermediate outcomes": 8.798342187639646, "highest cardiovascular": 8.931948929008138, "highest cumulative": 8.355835584391686, "intermediate odds": 8.191848839997071, "therapy exerted": 7.832953288875434, "exerted dose": 7.193870284774465, "related benefits": 8.01797756645451, "benefits across": 7.832953288875434, "study participants": 8.355835584391686, "sst2 measurement": 8.01797756645451, "measurement identifies": 8.931948929008138, "identifies patients": 8.511001466296774, "particularly benefit": 8.658247192583133, "higher bb": 6.3717330906226675, "novel approach": 7.635246515022862, "acute treatment": 7.832953288875434, "exerts positive": 7.832953288875434, "positive inotropic": 8.355835584391686, "vasodilator effects": 8.511001466296774, "camp independent": 8.01797756645451, "clinical usefulness": 8.511001466296774, "limited by": 6.672566775728865, "chemical instability": 8.658247192583133, "isolated myoctyes": 8.191848839997071, "intact hearts": 7.422989813300176, "experimental models": 8.511001466296774, "converts solely": 7.832953288875434, "inactive cxl-1051": 8.191848839997071, "adult mouse": 6.944975542925487, "mouse ventricular": 8.191848839997071, "ventricular myocytes": 8.658247192583133, "dose dependently": 8.01797756645451, "dependently increased": 8.798342187639646, "increased sarcomere": 8.511001466296774, "sarcomere shortening": 8.658247192583133, "% rise": 5.217618485351048, "higher doses": 7.193870284774465, "neither inhibition": 8.355835584391686, "soluble guanylate": 8.191848839997071, "guanylate cyclase": 8.191848839997071, "cyclase altered": 7.832953288875434, "contractile response": 8.658247192583133, "unlike isoproterenol": 8.658247192583133, "equally effective": 8.191848839997071, "anesthetized dogs": 8.191848839997071, "coronary microembolization": 9.411955803365045, "myocardial oxygen": 8.191848839997071, "increasing ejection": 8.511001466296774, "maximal ventricular": 8.511001466296774, "ventricular power": 8.191848839997071, "power index": 6.944975542925487, "conscious dogs": 7.635246515022862, "increased contractility": 9.05964189305739, "contractility assessed": 8.931948929008138, "provided venoarterial": 8.798342187639646, "venoarterial dilation": 8.798342187639646, "minimally altered": 8.191848839997071, "heart filling": 7.422989813300176, "increasing cardiac": 8.355835584391686, "pressure declined": 8.191848839997071, "declined modestly": 8.191848839997071, "functional efficacy": 8.511001466296774, "novel pure": 6.672566775728865, "enhance myocardial": 8.355835584391686, "present first": 7.422989813300176, "man evidence": 7.193870284774465, "remodeling after": 8.01797756645451, "subsequent events": 8.191848839997071, "largely involved": 8.01797756645451, "involved single": 7.832953288875434, "single parameters": 8.191848839997071, "combining parameters": 8.658247192583133, "standard echocardiographic": 9.411955803365045, "echocardiographic measurements": 9.82338316374468, "underwent baseline": 8.355835584391686, "baseline echocardiography": 9.29923091812682, "underwent follow": 8.01797756645451, "57\u00b122 months": 7.193870284774465, "lv reverse": 6.672566775728865, "dimension index": 7.832953288875434, "diastolic area": 7.635246515022862, "area index": 6.672566775728865, "ventricular fractional": 8.931948929008138, "fractional area": 7.832953288875434, "area change": 6.944975542925487, "change \u226535": 6.672566775728865, "\u226535 %": 4.700994494168267, "score allowed": 7.422989813300176, "allowed prediction": 8.355835584391686, "heart transplantations": 8.931948929008138, "lv assist": 6.3717330906226675, "device implantations": 8.658247192583133, "failure admissions": 8.355835584391686, "failure admission": 8.191848839997071, "ischemic cause": 7.635246515022862, "initial functional": 8.355835584391686, "selecting patients": 8.355835584391686, "patients likely": 7.832953288875434, "undergo reverse": 7.832953288875434, "symptomatic systolic": 8.658247192583133, "diagnosed systolic": 8.355835584391686, "previous spironolactone": 9.05964189305739, "baseline serum": 7.635246515022862, "serum creatinine": 8.01797756645451, "creatinine level": 8.01797756645451, "potassium level": 7.832953288875434, "varying covariates": 8.355835584391686, "independent association": 9.05964189305739, "initiated spironolactone": 9.181922482685199, "ratio 0.91": 6.672566775728865, "interval 0.77": 7.422989813300176, "ratio 0.93": 6.672566775728865, "interval 0.60": 7.422989813300176, "crude rates": 6.944975542925487, "diverse community": 8.191848839997071, "based cohort": 7.193870284774465, "incident systolic": 8.191848839997071, "factor blockade": 7.832953288875434, "blockade prevents": 8.191848839997071, "impaired angiogenesis": 8.798342187639646, "heart contributes": 8.191848839997071, "compensatory hypertrophy": 9.181922482685199, "also shown": 6.672566775728865, "improve myocardial": 8.355835584391686, "enhancing neoangiogenesis": 9.29923091812682, "surgically induced": 8.355835584391686, "induced myocardial": 8.355835584391686, "failure rats": 7.193870284774465, "week treatment": 7.635246515022862, "treatment period": 8.01797756645451, "echocardiography revealed": 9.29923091812682, "cardiac diameters": 8.191848839997071, "improved cardiac": 8.01797756645451, "treated compared": 8.01797756645451, "treated rats": 7.193870284774465, "vivo coronary": 7.422989813300176, "cardiac fibrosis": 8.01797756645451, "weeks after": 6.944975542925487, "cardiac vegf": 7.193870284774465, "no synthase": 6.944975542925487, "synthase activation": 8.511001466296774, "comparing b": 6.944975542925487, "untreated failing": 8.191848839997071, "proangiogenic effects": 8.798342187639646, "b act": 4.700994494168267, "act via": 5.65563804923464, "intravenously injected": 8.931948929008138, "adenoviral vector": 8.191848839997071, "vector encoding": 7.832953288875434, "control adenovirus": 8.355835584391686, "histological analysis": 8.798342187639646, "reduced capillary": 8.191848839997071, "rats compared": 7.422989813300176, "c rats": 5.217618485351048, "inhibition counteracted": 9.05964189305739, "positive effects": 8.01797756645451, "promotes cardiac": 8.01797756645451, "induced enhancement": 8.511001466296774, "favorable effects": 8.191848839997071, "do outcomes": 6.944975542925487, "failure vary": 7.193870284774465, "vary by": 5.65563804923464, "department volume": 8.191848839997071, "common emergency": 8.01797756645451, "volume influences": 8.191848839997071, "influences patient": 8.355835584391686, "adults presenting": 8.191848839997071, "responsible diagnosis": 8.798342187639646, "cases seen": 6.672566775728865, "less comorbidities": 8.355835584391686, "aor ]": 4.700994494168267, "exhibited higher": 8.01797756645451, "day death": 6.3717330906226675, "discharge patients": 8.355835584391686, "failure home": 7.193870284774465, "exhibited worse": 7.832953288875434, "worse outcomes": 7.635246515022862, "driven largely": 7.635246515022862, "repeat ed": 6.3717330906226675, "improve management": 8.355835584391686, "volume sites": 7.193870284774465, "oxidase inhibition": 8.355835584391686, "inhibition preserves": 8.658247192583133, "preserves left": 7.635246515022862, "cardiac volume": 7.635246515022862, "rat left": 6.035843815994525, "aortocaval fistula": 8.355835584391686, "decrease mitochondrial": 8.931948929008138, "mitochondrial respiration": 9.29923091812682, "inhibition improves": 8.511001466296774, "improves cardiomyocyte": 8.931948929008138, "cardiomyocyte bioenergetics": 9.520441892933018, "chronic acf": 6.944975542925487, "acf \u00b1": 4.700994494168267, "\u00b1 allopurinol": 7.422989813300176, "wk demonstrated": 7.832953288875434, "groups versus": 7.422989813300176, "sham group": 6.672566775728865, "lv ejection": 6.944975542925487, "circumferential shortening": 9.411955803365045, "maximal systolic": 8.01797756645451, "contractile efficiency": 8.931948929008138, "significantly depressed": 9.05964189305739, "allopurinol rats": 8.01797756645451, "maximum o2": 6.672566775728865, "consumption rate": 8.01797756645451, "rate measured": 7.422989813300176, "cardiomyocytes using": 8.658247192583133, "extracellular flux": 8.355835584391686, "flux analyzer": 7.422989813300176, "allopurinol improves": 8.658247192583133, "efficiency possibly": 8.511001466296774, "myofilament ca(2": 8.01797756645451, "diastolic properties": 8.658247192583133, "assessing left": 7.635246515022862, "transmitral blood": 8.191848839997071, "found unreliable": 8.01797756645451, "estimating pulmonary": 8.658247192583133, "decompensated systolic": 8.931948929008138, "underwent right": 7.832953288875434, "sided cardiac": 7.422989813300176, "transthoracic echocardiography": 9.82338316374468, "flow velocities": 7.832953288875434, "annulus velocities": 8.355835584391686, "/ e'mean": 6.035843815994525, "ci 0.70": 5.65563804923464, "negative predictive": 8.511001466296774, "negative likelihood": 8.511001466296774, "likelihood ratio": 8.01797756645451, "e'lateral showed": 8.01797756645451, "e'septal showed": 7.832953288875434, "detecting normal": 8.01797756645451, "normal filling": 7.635246515022862, "pressure relationship": 8.798342187639646, "derived pulmonary": 8.191848839997071, "tricuspid annular": 8.191848839997071, "basic relevance": 7.832953288875434, "clinical follow": 7.832953288875434, "carrying two-": 7.422989813300176, "threefold increase": 8.355835584391686, "cardiac risk": 7.193870284774465, "longitudinal rv": 7.832953288875434, "fiber shortening": 8.01797756645451, "force generated": 7.832953288875434, "vivo rv": 5.65563804923464, "ratio better": 7.193870284774465, "better disclosing": 8.191848839997071, "disclosing prognosis": 8.658247192583133, "underwent echo": 7.635246515022862, "peptide assessment": 8.355835584391686, "relationship showed": 8.511001466296774, "downward regression": 8.511001466296774, "line shift": 6.672566775728865, "frequently presenting": 8.798342187639646, "higher pasp": 6.944975542925487, "lower tapse": 6.944975542925487, "distribution along": 8.355835584391686, "separate cox": 7.193870284774465, "individual measures": 8.511001466296774, "ratio form": 6.672566775728865, "variables retained": 8.355835584391686, "multivariate regression": 9.05964189305739, "shows that": 6.672566775728865, "shifted downward": 8.01797756645451, "ratio improves": 7.635246515022862, "improves prognostic": 8.511001466296774, "prognostic resolution": 8.798342187639646, "possible index": 7.635246515022862, "efficient rv": 7.193870284774465, "function evaluation": 8.511001466296774, "stent model": 6.944975542925487, "large animal": 7.193870284774465, "animal model": 7.193870284774465, "novel percutaneous": 8.355835584391686, "percutaneous one-": 8.191848839997071, "ischemia using": 7.635246515022862, "stent coated": 7.193870284774465, "polytetrafluoroethylene tube": 9.624996450667128, "tube formed": 6.944975542925487, "bottleneck shape": 8.01797756645451, "proximal circumflex": 8.511001466296774, "circumflex artery": 8.191848839997071, "proximal lcx": 7.193870284774465, "mid lad": 5.65563804923464, "wk later": 6.035843815994525, "infarct size": 7.193870284774465, "given antiarrhythmic": 8.658247192583133, "antiarrhythmic medication": 9.29923091812682, "prevent sudden": 7.635246515022862, "occlusion time": 7.635246515022862, "modulated by": 7.193870284774465, "antiplatelet medication": 9.05964189305739, "fractional flow": 7.832953288875434, "flow reserve": 7.193870284774465, "reserve measurements": 8.658247192583133, "positron emission": 8.191848839997071, "emission tomography": 8.511001466296774, "tomography imaging": 8.355835584391686, "imaging showed": 7.635246515022862, "showed severe": 7.422989813300176, "severe ischemia": 7.832953288875434, "bottleneck stenting": 8.511001466296774, "stenting covering": 8.191848839997071, "complete coronary": 8.191848839997071, "coronary occlusion": 8.355835584391686, "significant collateral": 8.931948929008138, "occurred already": 8.01797756645451, "first wk": 6.035843815994525, "stent occlusion": 7.832953288875434, "competitive collateral": 8.931948929008138, "growth patterns": 7.832953288875434, "% infarcted": 6.944975542925487, "infarcted left": 7.635246515022862, "vessel disease": 7.635246515022862, "disease model": 7.422989813300176, "novel bottleneck": 8.01797756645451, "novel porcine": 7.422989813300176, "reversible myocardial": 8.798342187639646, "open stent": 6.672566775728865, "occluded stent": 7.635246515022862, "selective heart": 7.832953288875434, "ivabradine unloads": 8.355835584391686, "ivabradine reduces": 8.355835584391686, "reduces afterload": 8.191848839997071, "represents resistive": 8.658247192583133, "pulsatile afterload": 8.511001466296774, "heart derived": 7.422989813300176, "pressure volume": 7.832953288875434, "volume relation": 7.832953288875434, "hr modulates": 7.193870284774465, "afterload burden": 8.01797756645451, "ivabradine 7.5": 7.635246515022862, "echocardiographic substudy": 9.411955803365045, "total arterial": 7.635246515022862, "arterial compliance": 8.511001466296774, "arm cuff": 6.035843815994525, "differ significantly": 8.658247192583133, "marked reduction": 8.01797756645451, "improved tac": 7.193870284774465, "contractility remained": 8.931948929008138, "markedly improved": 8.191848839997071, "higher sv": 6.3717330906226675, "ivabradine improves": 8.511001466296774, "improves tac": 7.193870284774465, "thus reducing": 7.422989813300176, "improved ventricular": 8.658247192583133, "preoperative serum": 8.355835584391686, "serum albumin": 7.422989813300176, "postoperative mortality": 9.05964189305739, "undergoing left": 7.832953288875434, "preoperative clinical": 8.798342187639646, "laboratory variables": 8.658247192583133, "variables associated": 8.658247192583133, "albumin concentration": 8.798342187639646, "levels compared": 7.832953288875434, "preoperative albumin": 8.658247192583133, "ratio 0.521": 6.944975542925487, "interval 0.290": 7.635246515022862, "levels during": 7.422989813300176, "subgroup analysis": 8.191848839997071, "showed improved": 7.832953288875434, "remained hypoalbuminemia": 9.181922482685199, "decreasing albumin": 8.355835584391686, "albumin level": 7.422989813300176, "correcting nutrition": 8.658247192583133, "hepatic function": 8.01797756645451, "effective way": 7.422989813300176, "improve prognosis": 8.191848839997071, "patients evaluated": 8.355835584391686, "surgical correction": 8.511001466296774, "valve insufficiency": 8.511001466296774, "onset aortic": 7.193870284774465, "aortic insufficiency": 8.658247192583133, "instituting mechanical": 8.931948929008138, "mechanical circulatory": 8.931948929008138, "continuous flow": 7.832953288875434, "pulsatile devices": 8.191848839997071, "treatment algorithms": 8.658247192583133, "de novo": 5.65563804923464, "present report": 7.635246515022862, "underwent aortic": 8.01797756645451, "valve surgery": 7.422989813300176, "onset post": 6.672566775728865, "underwent lvad": 7.635246515022862, "cf devices": 6.672566775728865, "onset severe": 7.193870284774465, "requiring surgical": 8.355835584391686, "developed new": 7.422989813300176, "after medical": 7.422989813300176, "valve procedures": 8.01797756645451, "bioprosthetic valve": 8.511001466296774, "dacron patch": 7.193870284774465, "patch closure": 7.422989813300176, "valve repairs": 7.422989813300176, "underwent transcatheter": 9.05964189305739, "transcatheter aortic": 8.658247192583133, "valve procedure": 7.832953288875434, "requiring revision": 8.355835584391686, "open surgery": 7.193870284774465, "experienced significant": 9.05964189305739, "died postoperatively": 8.658247192583133, "postoperatively secondary": 9.29923091812682, "multiorgan failure": 8.355835584391686, "surgical treatment": 8.355835584391686, "valve oversewing": 8.01797756645451, "leaflet repair": 7.635246515022862, "bioprosthetic aortic": 8.658247192583133, "restoring functional": 8.658247192583133, "develop symptomatic": 8.511001466296774, "performed safely": 8.01797756645451, "good results": 7.193870284774465, "various transcatheter": 8.798342187639646, "transcatheter approaches": 9.181922482685199, "difficult problems": 8.355835584391686, "also available": 7.635246515022862, "offer less": 6.672566775728865, "less invasive": 7.422989813300176, "invasive alternatives": 8.798342187639646, "conventional surgery": 8.658247192583133, "age groups": 6.672566775728865, "index \u226535": 6.3717330906226675, "black ethnicity": 7.832953288875434, "salt intake": 6.944975542925487, "dietary measures": 8.01797756645451, "youngest age": 7.193870284774465, "rates across": 7.193870284774465, "respective age": 7.635246515022862, "age categories": 7.635246515022862, "referent age": 7.193870284774465, "youngest group": 7.635246515022862, "group even": 6.672566775728865, "beyond divergent": 8.01797756645451, "divergent etiology": 8.355835584391686, "exhibited striking": 8.355835584391686, "striking differences": 8.658247192583133, "outcomes compared": 8.191848839997071, "older counterparts": 8.355835584391686, "nonfatal outcomes": 8.191848839997071, "better survival": 7.832953288875434, "higher hospitalization": 8.931948929008138, "growing population": 8.355835584391686, "population within": 8.191848839997071, "within cardiac": 7.635246515022862, "\u00b1 11.4": 5.217618485351048, "groups performed": 8.01797756645451, "measured after": 7.635246515022862, "capacity assessed": 8.191848839997071, "standard care": 7.422989813300176, "walking led": 6.944975542925487, "higher functional": 8.191848839997071, "\u00b1 59.4": 5.217618485351048, "\u00b1 71.3": 5.217618485351048, "greater self": 7.193870284774465, "reported physical": 8.191848839997071, "\u00b1 118.5": 5.65563804923464, "minutes vs": 6.672566775728865, "\u00b1 125.6": 5.65563804923464, "increased right": 7.832953288875434, "right grip": 6.672566775728865, "\u00b1 3.5": 4.700994494168267, "fewer depressive": 8.01797756645451, "\u00b1 2.4": 4.700994494168267, "peak aerobic": 7.193870284774465, "waist circumference": 8.511001466296774, "improving functional": 8.658247192583133, "important outcomes": 8.355835584391686, "this exercise": 7.422989813300176, "exercise modality": 8.191848839997071, "promising alternative": 8.798342187639646, "failure complicating": 8.658247192583133, "complicating precapillary": 9.29923091812682, "precapillary pulmonary": 8.931948929008138, "noninvasive tools": 8.191848839997071, "experiencing heart": 8.355835584391686, "major right": 6.944975542925487, "ventricle overload": 8.355835584391686, "overload leads": 7.635246515022862, "decreased stroke": 8.01797756645451, "shortens left": 7.422989813300176, "tonometry study": 7.832953288875434, "study tested": 7.193870284774465, "carries prognostic": 8.355835584391686, "radial artery": 7.422989813300176, "artery tonometry": 8.01797756645451, "tonometry variables": 8.511001466296774, "prospectively obtained": 8.931948929008138, "reconstructed aortic": 8.658247192583133, "aortic pressure": 7.832953288875434, "pressure curve": 7.635246515022862, "overall icu": 6.944975542925487, "median stay": 6.944975542925487, "at admission": 7.193870284774465, "tonometric indices": 8.355835584391686, "identifying death": 8.191848839997071, "other prognostic": 8.01797756645451, "lower natremia": 7.635246515022862, "higher oxygen": 7.422989813300176, "second evaluation": 8.191848839997071, "norepinephrine requirement": 9.411955803365045, "poor outcome": 7.193870284774465, "previously documented": 8.798342187639646, "documented prognostic": 8.798342187639646, "myxoma complicated": 8.355835584391686, "common type": 6.944975542925487, "cardiac benign": 7.635246515022862, "benign tumors": 7.422989813300176, "left atrium": 6.944975542925487, "rarely embolize": 7.832953288875434, "arterial vasculature": 8.658247192583133, "massive embolism": 8.01797756645451, "pulmonary arteries": 8.355835584391686, "arteries treated": 8.01797756645451, "treated surgically": 8.355835584391686, "atrial mass": 6.944975542925487, "mass removal": 7.193870284774465, "pulmonary embolectomy": 8.798342187639646, "atrium mass": 6.944975542925487, "mass presented": 7.635246515022862, "tricuspid valve": 7.832953288875434, "valve causing": 7.422989813300176, "stenotic physiology": 8.511001466296774, "left pulmonary": 7.635246515022862, "completed occluded": 8.355835584391686, "right pulmonary": 7.832953288875434, "partially obstructed": 8.658247192583133, "surgical tactics": 8.01797756645451, "tactics included": 8.01797756645451, "brief hypothermic": 8.191848839997071, "hypothermic circulatory": 9.05964189305739, "circulatory arrest": 8.355835584391686, "uneventful recovery": 8.511001466296774, "go test": 5.65563804923464, "chronic organ": 7.422989813300176, "organ failure": 7.422989813300176, "chronic renal": 7.422989813300176, "renal failure": 7.422989813300176, "home environment": 8.01797756645451, "median body": 6.944975542925487, "intraclass correlation": 8.931948929008138, "kappa coefficient": 8.191848839997071, "relative minimal": 8.01797756645451, "minimal detectable": 8.355835584391686, "detectable change": 8.191848839997071, "good agreement": 7.635246515022862, "values ranging": 7.635246515022862, "kappa coefficients": 8.355835584391686, "statistical improvement": 9.05964189305739, "improvement occurred": 8.658247192583133, "second trial": 7.193870284774465, "large limits": 7.193870284774465, "third trial": 6.944975542925487, "trial added": 6.944975542925487, "added little": 7.193870284774465, "measurement value": 8.191848839997071, "relative value": 7.635246515022862, "similar values": 7.635246515022862, "values found": 7.193870284774465, "daily clinical": 7.635246515022862, "represents true": 7.832953288875434, "true change": 6.944975542925487, "repeated measures": 8.191848839997071, "arthritis starting": 8.355835584391686, "tumor necrosis": 7.635246515022862, "necrosis factor": 7.832953288875434, "several trials": 7.635246515022862, "antagonists showed": 8.355835584391686, "possibly worsening": 8.355835584391686, "known severe": 7.193870284774465, "recurrent hf": 7.193870284774465, "treat rheumatoid": 8.01797756645451, "different us": 7.193870284774465, "healthcare programmes": 8.798342187639646, "receiving methotrexate": 8.931948929008138, "biological disease": 8.355835584391686, "disease modifying": 8.191848839997071, "modifying antirheumatic": 9.05964189305739, "antirheumatic drug": 8.355835584391686, "models stratified": 8.191848839997071, "score decile": 7.193870284774465, "oral glucocorticoid": 8.511001466296774, "glucocorticoid dosage": 8.798342187639646, "loop diuretics": 7.635246515022862, "similar baseline": 8.01797756645451, "baseline covariates": 8.511001466296774, "antagonists compared": 8.658247192583133, "elevated prior": 7.635246515022862, "ci 0.45": 5.65563804923464, "oral glucocorticoids": 8.658247192583133, "related gradient": 8.01797756645451, "hr 1.30": 5.65563804923464, "hr 1.54": 5.65563804923464, "admissions compared": 8.511001466296774, "using exercise": 7.635246515022862, "improve quality": 7.832953288875434, "current economic": 8.01797756645451, "economic climate": 8.01797756645451, "climate within": 7.635246515022862, "change interventions": 8.658247192583133, "exercise programmes": 8.511001466296774, "limited within": 7.635246515022862, "within acute": 7.193870284774465, "acute hospital": 7.635246515022862, "hospital facilities": 8.511001466296774, "deliver cost": 7.193870284774465, "specific health": 7.832953288875434, "health interventions": 8.658247192583133, "measurable benefits": 8.511001466296774, "structured exercise": 8.511001466296774, "exercise programme": 8.355835584391686, "primary outcomes": 8.01797756645451, "measures related": 8.01797756645451, "patient satisfaction": 8.658247192583133, "intervention post": 8.191848839997071, "post study": 6.672566775728865, "overall significant": 8.511001466296774, "participants demonstrated": 9.29923091812682, "others showing": 7.635246515022862, "showing minor": 7.422989813300176, "minor improvement": 8.191848839997071, "anecdotal evidence": 8.355835584391686, "perceived benefit": 8.191848839997071, "participant satisfaction": 9.181922482685199, "satisfaction responses": 8.931948929008138, "based programmes": 8.01797756645451, "composition study": 8.191848839997071, "adverse health": 7.635246515022862, "participants aged": 8.191848839997071, "frail participants": 8.355835584391686, "ci 1.08": 5.65563804923464, "severe frailty": 7.635246515022862, "ci 1.02": 5.65563804923464, "linearly associated": 8.511001466296774, "per sd": 5.217618485351048, "sd decrease": 6.944975542925487, "competing risk": 7.635246515022862, "across age": 6.672566775728865, "improved discrimination": 9.05964189305739, "ci 0.018": 6.035843815994525, "appropriately reclassified": 9.411955803365045, "reclassified 13.4": 8.191848839997071, "improvement 0.073": 8.191848839997071, "ci 0.021": 6.035843815994525, "abnormalities contribute": 9.181922482685199, "successful approaches": 8.798342187639646, "based largely": 7.422989813300176, "therapeutic interruption": 9.181922482685199, "activated neurohormonal": 9.05964189305739, "neurohormonal systems": 8.798342187639646, "sympathetic nervous": 8.511001466296774, "nervous systems": 7.832953288875434, "excessive secretion": 8.511001466296774, "arginine vasopressin": 8.658247192583133, "deleterious effects": 8.511001466296774, "various physiologic": 8.511001466296774, "physiologic processes": 8.798342187639646, "potentially beneficial": 8.931948929008138, "beneficial new": 7.635246515022862, "therapeutic approach": 8.658247192583133, "mir-25 cooperate": 8.01797756645451, "aberrant reactivation": 8.798342187639646, "intricately linked": 8.355835584391686, "pathological heart": 8.355835584391686, "factors driving": 7.832953288875434, "programs remain": 7.832953288875434, "remain ill": 6.672566775728865, "increased calcineurin": 8.798342187639646, "decreased mir-25": 8.01797756645451, "expression integrate": 8.658247192583133, "basic helix": 6.944975542925487, "factor dhand": 7.193870284774465, "also known": 6.672566775728865, "diseased human": 7.635246515022862, "mouse myocardium": 8.01797756645451, "mutant mice": 6.944975542925487, "mice overexpressing": 8.511001466296774, "otherwise healthy": 8.191848839997071, "healthy heart": 7.422989813300176, "heart muscle": 7.193870284774465, "muscle cells": 7.193870284774465, "cells developed": 7.832953288875434, "pathological hypertrophy": 9.181922482685199, "conditional gene": 8.01797756645451, "mice demonstrated": 8.191848839997071, "marked resistance": 8.191848839997071, "induced hypertrophy": 8.511001466296774, "fetal gene": 6.672566775728865, "gene program": 7.193870284774465, "vivo inhibition": 7.832953288875434, "specific antagomir": 8.355835584391686, "antagomir evoked": 8.01797756645451, "evoked spontaneous": 8.355835584391686, "spontaneous cardiac": 8.511001466296774, "murine myocardium": 8.191848839997071, "dependent manner": 8.01797756645451, "results reveal": 7.635246515022862, "signalling cascades": 8.511001466296774, "cascades integrate": 8.355835584391686, "bhlh transcription": 8.355835584391686, "postnatal mammalian": 8.511001466296774, "mammalian myocardium": 8.658247192583133, "hormonal system": 7.832953288875434, "inhibitors intolerance": 8.931948929008138, "beta receptor": 7.422989813300176, "negative inotropic": 8.355835584391686, "past decades": 7.193870284774465, "decades several": 7.832953288875434, "several studies": 7.832953288875434, "blockers decrease": 8.191848839997071, "reducing mortality": 8.355835584391686, "myocardial loss": 7.832953288875434, "causes heart": 7.193870284774465, "links diabetes": 7.635246515022862, "failure remains": 7.832953288875434, "insulin receptor": 8.01797756645451, "receptor substrates": 8.511001466296774, "major insulin": 7.422989813300176, "signaling components": 8.658247192583133, "components regulating": 8.798342187639646, "regulating cellular": 8.511001466296774, "cellular metabolism": 8.511001466296774, "examine whether": 7.832953288875434, "hyperinsulinemia causes": 9.05964189305739, "causes myocardial": 8.191848839997071, "myocardial insulin": 8.355835584391686, "cellular dysfunction": 8.658247192583133, "dysfunction via": 7.832953288875434, "generated heart": 7.832953288875434, "gene double": 6.944975542925487, "reduced ventricular": 8.511001466296774, "ventricular mass": 8.01797756645451, "developed cardiac": 8.191848839997071, "cardiac apoptosis": 8.191848839997071, "showed diminished": 8.191848839997071, "box class": 6.3717330906226675, "class o-1": 6.3717330906226675, "o-1 signaling": 7.422989813300176, "cardiac metabolic": 8.191848839997071, "metabolic gene": 7.635246515022862, "decreased cardiac": 8.191848839997071, "cardiac irs1": 7.193870284774465, "exhibited features": 8.355835584391686, "cardiac energy": 7.635246515022862, "metabolism gene": 7.832953288875434, "p38\u03b1 mitogen": 7.193870284774465, "activated protein": 8.191848839997071, "using neonatal": 7.635246515022862, "neonatal rat": 7.193870284774465, "rat ventricular": 7.832953288875434, "chronic insulin": 7.832953288875434, "insulin exposure": 8.01797756645451, "exposure reduced": 8.01797756645451, "prevented insulin": 8.191848839997071, "insulin action": 7.635246515022862, "fundamental mechanism": 8.798342187639646, "medications among": 8.191848839997071, "among outpatients": 8.191848839997071, "examine practice": 8.01797756645451, "recommended treatment": 8.798342187639646, "treatment variation": 8.511001466296774, "practice site": 7.422989813300176, "patient factors": 7.832953288875434, "cardiology practices": 8.658247192583133, "practices participating": 9.05964189305739, "practice rates": 7.635246515022862, "treatment measure": 8.191848839997071, "documented contraindications": 9.624996450667128, "multivariable hierarchical": 9.411955803365045, "hierarchical regression": 9.05964189305739, "insurance status": 8.01797756645451, "given comorbidities": 8.511001466296774, "selected practices": 8.355835584391686, "unadjusted practice": 8.511001466296774, "level prescription": 8.355835584391686, "prescription rates": 8.355835584391686, "rates ranged": 7.193870284774465, "adjusted median": 7.832953288875434, "fraction exists": 7.832953288875434, "outpatient setting": 8.355835584391686, "addressing practice": 8.511001466296774, "level differences": 8.191848839997071, "improving quality": 8.191848839997071, "related cardiotoxicity": 8.931948929008138, "cardiotoxicity among": 8.658247192583133, "adjuvant setting": 8.01797756645451, "setting improves": 8.01797756645451, "cardiotoxicity manifested": 9.29923091812682, "related chf": 6.944975542925487, "chf among": 6.3717330906226675, "full medicare": 7.422989813300176, "trastuzumab use": 7.832953288875434, "analyses included": 8.191848839997071, "included descriptive": 8.658247192583133, "descriptive statistics": 8.931948929008138, "received trastuzumab": 8.658247192583133, "entire cohort": 7.422989813300176, "trastuzumab users": 8.191848839997071, "weekly trastuzumab": 8.355835584391686, "trastuzumab administration": 9.411955803365045, "older breast": 7.193870284774465, "cardiac comorbidities": 8.798342187639646, "further studies": 7.832953288875434, "studies need": 7.193870284774465, "administration plays": 8.658247192583133, "current dietary": 7.832953288875434, "largely based": 7.422989813300176, "hf populations": 7.635246515022862, "dietary patterns": 8.01797756645451, "therefore evaluated": 8.511001466296774, "evaluated associations": 8.931948929008138, "among postmenopausal": 8.658247192583133, "postmenopausal women": 8.658247192583133, "last participant": 8.01797756645451, "participant contact": 8.511001466296774, "frequency questionnaires": 9.181922482685199, "models adjusted": 7.832953288875434, "health behaviors": 8.01797756645451, "calculate hazard": 8.01797756645451, "hospitalization died": 8.658247192583133, "p trend=0.08": 7.193870284774465, "p trend=0.01": 7.193870284774465, "score components": 8.01797756645451, "whole grain": 6.944975542925487, "grain intake": 7.193870284774465, "inversely associated": 8.658247192583133, "higher dash": 6.944975542925487, "modestly lower": 7.635246515022862, "nonsignificant trend": 8.658247192583133, "inverse association": 8.511001466296774, "data provide": 7.193870284774465, "provide support": 7.832953288875434, "recommendations developed": 9.29923091812682, "cardiovascular conditions": 9.29923091812682, "general populations": 8.511001466296774, "cardioprotective signaling": 9.411955803365045, "potentially promising": 8.798342187639646, "promising biomarker": 8.511001466296774, "term clinical": 7.422989813300176, "randomized study": 8.01797756645451, "evaluable plasma": 8.01797756645451, "relationship among": 8.355835584391686, "median baseline": 7.832953288875434, "univariable analysis": 8.658247192583133, "log2 ng": 5.65563804923464, "multivariable models": 8.658247192583133, "add significantly": 8.191848839997071, "c statistic": 6.944975542925487, "treated cohort": 7.635246515022862, "significantly affect": 8.658247192583133, "affect reclassification": 9.05964189305739, "year experience": 7.832953288875434, "programs expand": 7.832953288875434, "transplant pool": 7.832953288875434, "matching donors": 7.832953288875434, "recipients typically": 8.658247192583133, "typically excluded": 8.355835584391686, "transplant process": 8.355835584391686, "data examining": 7.635246515022862, "examining long": 7.635246515022862, "undergoing isolated": 8.511001466296774, "prospectively classified": 9.181922482685199, "classified as": 7.422989813300176, "prespecified criteria": 8.798342187639646, "compared between": 8.01797756645451, "identify clinical": 8.191848839997071, "variables contributing": 8.931948929008138, "additional risk": 7.832953288875434, "underwent heart": 7.832953288875434, "underwent standard": 8.355835584391686, "years versus": 7.193870284774465, "higher frequency": 8.01797756645451, "median estimated": 8.01797756645451, "transplant survival": 8.511001466296774, "multivariate model": 8.355835584391686, "included listing": 8.01797756645451, "listing criteria": 8.01797756645451, "significant predictor": 8.798342187639646, "transplant mortality": 8.658247192583133, "acceptable alternative": 8.931948929008138, "failure therapy": 7.832953288875434, "select patients": 7.832953288875434, "important determinants": 8.931948929008138, "transplant morbidity": 8.658247192583133, "failure readmission": 8.511001466296774, "readmission quality": 8.511001466296774, "study objectives": 8.01797756645451, "day readmissions": 8.01797756645451, "characterize events": 8.511001466296774, "events at": 6.3717330906226675, "some data": 6.3717330906226675, "outpatient assessments": 8.931948929008138, "failure within": 7.635246515022862, "prevent readmissions": 8.658247192583133, "patient needs": 7.422989813300176, "retrospective chart": 8.511001466296774, "failure discharges": 8.355835584391686, "year before": 6.944975542925487, "year after": 6.672566775728865, "included mandatory": 8.355835584391686, "readmissions decreased": 8.931948929008138, "visits increased": 8.01797756645451, "day visits": 6.672566775728865, "visits occurred": 7.832953288875434, "failure nurse": 7.422989813300176, "nurse practitioner": 8.355835584391686, "blood work": 6.672566775728865, "work drawn": 6.672566775728865, "medication dose": 7.832953288875434, "dose changed": 7.193870284774465, "medication lists": 8.01797756645451, "failure decreased": 8.191848839997071, "diagnostic testing": 8.355835584391686, "medication changes": 8.355835584391686, "underlying pathophysiology": 9.411955803365045, "incompletely understood": 9.05964189305739, "matrix accumulation": 8.511001466296774, "estimate myocardial": 8.511001466296774, "matrix using": 7.193870284774465, "using cardiac": 7.422989813300176, "confirmatory diagnostic": 9.05964189305739, "diagnostic tests": 8.01797756645451, "imaging including": 8.191848839997071, "including t1": 7.193870284774465, "hemodynamic assessments": 9.05964189305739, "performed at": 7.193870284774465, "longitudinal outcome": 8.658247192583133, "monitoring phase": 8.01797756645451, "cardiac event": 7.422989813300176, "t1 time": 5.65563804923464, "ventricular biopsies": 8.658247192583133, "tissuefaxs technology": 8.798342187639646, "technology correlated": 8.798342187639646, "time also": 6.3717330906226675, "also correlated": 7.832953288875434, "present preliminary": 8.511001466296774, "preliminary study": 8.191848839997071, "possible biomarker": 8.355835584391686, "thalassaemia major": 8.355835584391686, "institution cohort": 8.355835584391686, "abnormal cardiac": 8.01797756645451, "cardiac t2": 6.672566775728865, "values determined": 8.191848839997071, "determined changes": 8.355835584391686, "highly predictive": 8.191848839997071, "chelation regimens": 8.355835584391686, "regimens known": 7.635246515022862, "remove heart": 7.193870284774465, "heart iron": 6.672566775728865, "iron efficiently": 8.01797756645451, "remarkable role": 7.832953288875434, "clinical response": 8.191848839997071, "guidelines recommend": 8.658247192583133, "recommend cardiac": 8.191848839997071, "\u226430 %": 4.700994494168267, "blinded core": 7.193870284774465, "core laboratory": 7.832953288875434, "end systolic": 7.193870284774465, "\u00b1 21.1": 5.217618485351048, "\u00b1 17.6": 5.217618485351048, "\u00b1 50.5": 5.217618485351048, "\u00b1 42.4": 5.217618485351048, "significantly prolonged": 9.05964189305739, "remodeling parameters": 8.798342187639646, "important covariates": 8.658247192583133, "improved time": 7.422989813300176, "among subjects": 7.635246515022862, "mild hf": 5.65563804923464, "produced reverse": 8.01797756645451, "similar clinical": 8.01797756645451, "benefit compared": 8.01797756645451, "myocardial titin": 8.01797756645451, "importantly contributes": 9.05964189305739, "rat metabolic": 7.422989813300176, "risk model": 6.672566775728865, "important metabolic": 8.511001466296774, "frequent comorbidities": 8.931948929008138, "myocardial diastolic": 8.658247192583133, "relative importance": 8.511001466296774, "diabetic zsf1": 7.422989813300176, "fraction development": 8.658247192583133, "fat diet": 6.035843815994525, "repeat metabolic": 8.01797756645451, "echocardiographic evaluations": 9.725894496041844, "hemodynamically assessed": 9.181922482685199, "collagen cross": 7.635246515022862, "titin isoforms": 7.635246515022862, "also determined": 7.832953288875434, "resting tension": 7.832953288875434, "fpassive)-sarcomere length": 9.411955803365045, "length relations": 8.01797756645451, "small muscle": 7.193870284774465, "muscle strips": 7.422989813300176, "unanchors titin": 7.832953288875434, "allows contributions": 8.658247192583133, "increased lung": 7.635246515022862, "ventricular dd": 7.635246515022862, "high muscle": 6.944975542925487, "muscle strip": 7.193870284774465, "strip stiffness": 7.832953288875434, "latter occurred": 7.832953288875434, "occurred specifically": 8.798342187639646, "elastic n2bus": 7.422989813300176, "n2bus segment": 7.422989813300176, "rats developed": 7.635246515022862, "week time": 6.3717330906226675, "time span": 6.3717330906226675, "importantly contributed": 9.05964189305739, "major predictor": 7.832953288875434, "sensitive measure": 8.191848839997071, "ventricular mechanics": 8.798342187639646, "adverse cardiovascular": 8.931948929008138, "predicting cv": 7.422989813300176, "university hospital": 8.511001466296774, "patients referred": 8.191848839997071, "echocardiographic examination": 9.725894496041844, "index beat": 6.672566775728865, "beat method": 6.944975542925487, "hazards analyses": 8.01797756645451, "average follow": 7.635246515022862, "showed worsening": 8.01797756645451, "direct comparison": 8.191848839997071, "outperformed left": 8.191848839997071, "systolic mitral": 7.832953288875434, "p \u2264": 3.264536430999026, "\u2264 0.043": 5.65563804923464, "model containing": 8.01797756645451, "containing chronic": 8.355835584391686, "age \u2265": 4.700994494168267, "prior stroke": 7.193870284774465, "stroke score": 7.193870284774465, "additional benefit": 8.355835584391686, "major parameter": 7.832953288875434, "additional prognostic": 8.798342187639646, "prognostic benefit": 8.355835584391686, "conventional clinical": 8.798342187639646, "echocardiographic systolic": 9.411955803365045, "systolic parameters": 8.511001466296774, "usually assessed": 8.01797756645451, "assessed separately": 8.511001466296774, "simple ecg": 6.672566775728865, "systematically assessed": 9.05964189305739, "scale clinical": 7.635246515022862, "previous pacemaker": 8.355835584391686, "all baseline": 7.193870284774465, "baseline ecgs": 7.422989813300176, "experienced electrocardiographers": 10.097518623839711, "receiving implantable": 8.798342187639646, "individual component": 8.658247192583133, "broader qrs": 6.944975542925487, "greater benefit": 7.832953288875434, "delayed benefit": 7.832953288875434, "refractory congestive": 8.798342187639646, "term management": 7.832953288875434, "diuretic resistant": 8.355835584391686, "resistant volume": 8.01797756645451, "provide potential": 8.191848839997071, "adverse consequences": 8.658247192583133, "status hospitalizations": 9.05964189305739, "severe end": 6.672566775728865, "transplant ineligible": 8.798342187639646, "volume management": 8.191848839997071, "data reviewed": 7.422989813300176, "reviewed pre-": 7.422989813300176, "pd initiation": 7.422989813300176, "\u00b1 6.0": 4.700994494168267, "severe right": 7.193870284774465, "average weight": 7.635246515022862, "diuretic response": 8.191848839997071, "peripheral edema": 8.01797756645451, "\u00b1 2.5": 4.700994494168267, "admissions per": 7.635246515022862, "reduced average": 7.832953288875434, "average length": 7.635246515022862, "\u00b1 36.7": 5.217618485351048, "\u00b1 2.3": 4.700994494168267, "objective criteriabased": 9.05964189305739, "criteriabased institution": 9.29923091812682, "diuretic refractory": 8.511001466296774, "refractory severe": 8.191848839997071, "well tolerated": 7.635246515022862, "demonstrated favorable": 8.931948929008138, "favorable outcomes": 8.355835584391686, "included improved": 8.191848839997071, "easily treatable": 8.01797756645451, "treatable pdrelated": 8.511001466296774, "pdrelated complications": 9.05964189305739, "viable option": 7.422989813300176, "stage congestive": 8.01797756645451, "often deferred": 7.635246515022862, "perceived lack": 7.635246515022862, "potentially higher": 8.355835584391686, "higher risks": 7.193870284774465, "therefore studied": 8.191848839997071, "descriptive assessment": 8.931948929008138, "analysis matching": 8.191848839997071, "branch morphology": 8.191848839997071, "cardiomyopathy origin": 8.798342187639646, "angiotensin ii": 7.635246515022862, "blocker use": 6.944975542925487, "month echocardiograms": 8.798342187639646, "term complications": 8.355835584391686, "observed among": 7.635246515022862, "among dialysis": 7.635246515022862, "heterogenous improvement": 9.181922482685199, "+3.1 \u00b1": 5.217618485351048, "\u00b1 9.2": 4.700994494168267, "patients derived": 8.01797756645451, "derived absolute": 8.01797756645451, "absolute improvements": 8.798342187639646, "controls demonstrated": 8.798342187639646, "demonstrated superior": 8.798342187639646, "superior reverse": 8.01797756645451, "+9.2 \u00b1": 5.217618485351048, "\u00b1 9.5": 4.700994494168267, "serious complications": 8.798342187639646, "certain dialysis": 8.01797756645451, "demonstrated compelling": 9.05964189305739, "compelling improvement": 8.931948929008138, "worsened echocardiographic": 9.411955803365045, "echocardiographic outcomes": 9.411955803365045, "sodium dash": 6.944975542925487, "diet improves": 7.422989813300176, "improves diastolic": 8.355835584391686, "involves failure": 8.01797756645451, "cardiovascular reserve": 8.931948929008138, "multiple domains": 8.01797756645451, "dietary sodium": 7.635246515022862, "sodium restriction": 8.355835584391686, "restriction improves": 8.658247192583133, "improves ventricular": 8.658247192583133, "vascular stiffness": 8.355835584391686, "restricted dietary": 8.355835584391686, "dietary approaches": 8.355835584391686, "stop hypertension": 8.191848839997071, "hypertension diet": 8.191848839997071, "improve left": 7.193870284774465, "treated hypertension": 8.658247192583133, "target sodium": 7.422989813300176, "mmol/2100 kcal": 7.635246515022862, "measured baseline": 8.191848839997071, "central blood": 7.422989813300176, "via radial": 6.672566775728865, "radial arterial": 7.832953288875434, "invasively validated": 8.658247192583133, "quantified via": 7.635246515022862, "parametrized diastolic": 8.931948929008138, "filling formalism": 8.191848839997071, "yields relaxation": 8.191848839997071, "mitral inflow": 7.422989813300176, "inflow velocity": 7.832953288875434, "ratio ees": 6.3717330906226675, "determined using": 8.01797756645451, "using previously": 8.01797756645451, "previously published": 8.658247192583133, "published techniques": 8.658247192583133, "pairs signed": 7.193870284774465, "rank tests": 6.672566775728865, "post comparisons": 8.01797756645451, "reduced clinic": 7.635246515022862, "hour brachial": 7.422989813300176, "brachial systolic": 8.191848839997071, "central end": 6.944975542925487, "pressure trended": 8.01797756645451, "trended lower": 7.422989813300176, "function improved": 8.191848839997071, "\u00b1 8.1": 4.700994494168267, "coupling improved": 8.191848839997071, "restricted dash": 7.832953288875434, "favorable changes": 8.191848839997071, "humanized male": 7.635246515022862, "women treated": 7.422989813300176, "circulating mediator": 8.658247192583133, "resistance mainly": 8.191848839997071, "mainly expressed": 8.01797756645451, "human monocytes": 7.832953288875434, "inflammatory stimuli": 8.658247192583133, "recent clinical": 7.832953288875434, "connected elevated": 8.355835584391686, "humanized mouse": 7.832953288875434, "model lacking": 7.422989813300176, "lacking murine": 7.635246515022862, "murine resistin": 7.832953288875434, "human retn": 6.672566775728865, "exhibits basal": 7.635246515022862, "stimulated resistin": 8.511001466296774, "levels similar": 7.635246515022862, "resistin underlies": 8.355835584391686, "underlies acute": 7.832953288875434, "acute anthracycline": 8.511001466296774, "kg ip": 4.700994494168267, "fold induction": 7.635246515022862, "littermate controls": 8.511001466296774, "expressing human": 8.01797756645451, "cardiac mrna": 7.193870284774465, "cell adhesion": 7.422989813300176, "adhesion genes": 7.635246515022862, "genes compared": 7.635246515022862, "mice treated": 7.193870284774465, "showed dramatic": 7.832953288875434, "dramatic induction": 8.355835584391686, "also examined": 7.422989813300176, "examined resistin": 8.191848839997071, "treated breast": 7.635246515022862, "without cardiotoxicity": 8.931948929008138, "women undergoing": 8.01797756645451, "undergoing anthracycline": 9.181922482685199, "containing chemotherapy": 9.05964189305739, "chemotherapy increased": 8.931948929008138, "subsequent cardiotoxicity": 9.29923091812682, "resistin correlated": 8.511001466296774, "direct effects": 7.635246515022862, "implicate resistin": 8.355835584391686, "link between": 7.193870284774465, "precipitating factor": 8.658247192583133, "free probability": 8.01797756645451, "factors relating": 8.01797756645451, "procedure drug": 7.635246515022862, "free success": 7.193870284774465, "success rates": 7.422989813300176, "multiple procedures": 8.511001466296774, "pharmaceutically assisted": 9.29923091812682, "assisted success": 8.01797756645451, "success rate": 7.193870284774465, "occurred during": 7.832953288875434, "analyses revealed": 8.191848839997071, "standing persistent": 8.511001466296774, "lv systolic": 6.944975542925487, "systolic indices": 8.01797756645451, "diastolic indices": 8.191848839997071, "patients maintaining": 8.658247192583133, "maintaining sinus": 8.191848839997071, "safely treated": 7.635246515022862, "repeat procedures": 8.191848839997071, "current study": 7.422989813300176, "arm analysis": 7.193870284774465, "larger randomized": 8.191848839997071, "randomized control": 8.355835584391686, "control studies": 7.832953288875434, "ameliorates mitochondrial": 9.29923091812682, "possible mechanism": 8.355835584391686, "known cardiotoxicity": 8.658247192583133, "effective anti": 7.635246515022862, "neoplastic agent": 8.01797756645451, "cardioprotective effect": 9.05964189305739, "hemodynamic alterations": 9.05964189305739, "dysfunction induced": 8.511001466296774, "cumulative administration": 9.29923091812682, "cumulative dose": 7.832953288875434, "given orally": 7.193870284774465, "without doxorubicin": 8.511001466296774, "doxorubicin treatment": 8.798342187639646, "last dose": 6.3717330906226675, "rapidly excised": 7.832953288875434, "cytochrome c": 7.193870284774465, "stress markers": 7.635246515022862, "measured together": 8.191848839997071, "stress induced": 7.635246515022862, "doxorubicin cardiotoxicity": 9.411955803365045, "also preserved": 7.635246515022862, "preserved phosphocreatine": 9.29923091812682, "restoring mitochondrial": 9.05964189305739, "significant cardioprotection": 9.624996450667128, "cardioprotection via": 8.658247192583133, "via inhibition": 7.635246515022862, "apoptotic signaling": 8.511001466296774, "mitochondrial ultrastructural": 9.725894496041844, "cytotoxic effect": 8.01797756645451, "solid ehrlich": 7.422989813300176, "ehrlich carcinoma": 8.191848839997071, "indicated by": 7.193870284774465, "hemodynamic perturbations": 9.29923091812682, "changes without": 7.832953288875434, "antitumor activity": 8.355835584391686, "isolated coronary": 8.191848839997071, "early risk": 6.672566775728865, "swedish web": 6.944975542925487, "based care": 6.672566775728865, "disease evaluated": 8.191848839997071, "evaluated according": 8.511001466296774, "underwent primary": 8.191848839997071, "failure \u226490": 6.944975542925487, "\u226490 days": 6.035843815994525, "developed acute": 7.832953288875434, "injury postoperatively": 8.931948929008138, "became nonsignificant": 8.798342187639646, "statistical model": 8.191848839997071, "ratio 1.76": 6.672566775728865, "interval 1.38": 7.422989813300176, "postoperative months": 8.658247192583133, "enormous clinical": 8.191848839997071, "clinical burden": 7.832953288875434, "adult medicine": 7.635246515022862, "atheromatous coronary": 8.798342187639646, "important disease": 8.191848839997071, "paediatric cardiac": 8.355835584391686, "cardiac transplants": 8.511001466296774, "cardiac symptoms": 8.01797756645451, "congenital lesions": 8.355835584391686, "septal defects": 7.635246515022862, "congenital heart": 8.01797756645451, "heart lesions": 7.422989813300176, "small subgroup": 7.635246515022862, "diastolic failure": 8.191848839997071, "cardiomyopathic restriction": 9.520441892933018, "remaining patients": 8.355835584391686, "principally related": 8.511001466296774, "poor myocardial": 7.832953288875434, "largely comprise": 8.01797756645451, "dilated poorly": 7.635246515022862, "poorly contracting": 8.355835584391686, "contracting ventricles": 8.931948929008138, "specific aetiologies": 8.658247192583133, "particular topics": 8.191848839997071, "paediatric heart": 8.01797756645451, "failure concern": 7.832953288875434, "versus dilated": 7.635246515022862, "appropriate investigations": 9.411955803365045, "new onset": 6.3717330906226675, "cellular responses": 8.355835584391686, "increasing population": 8.798342187639646, "anthracycline treated": 8.798342187639646, "treated survivors": 8.191848839997071, "childhood malignant": 8.511001466296774, "malignant disease": 8.191848839997071, "key role": 6.035843815994525, "molecular scaffolds": 8.511001466296774, "heart pathology": 7.832953288875434, "detect mechanical": 8.191848839997071, "humoral stimuli": 7.832953288875434, "new conditions": 7.635246515022862, "increased workload": 8.355835584391686, "certain stimuli": 7.832953288875434, "stimuli mediate": 7.832953288875434, "beneficial adaptation": 8.798342187639646, "stress conditions": 8.191848839997071, "others result": 7.422989813300176, "ultimately leading": 8.355835584391686, "specific signalling": 8.511001466296774, "signalling pathways": 8.511001466296774, "pathways activating": 8.511001466296774, "transduction pathways": 8.798342187639646, "pathways involved": 8.191848839997071, "opposing responses": 8.355835584391686, "responses engage": 8.01797756645451, "signalling proteins": 8.511001466296774, "notable example": 7.832953288875434, "signalling pathway": 8.355835584391686, "signalling requires": 8.511001466296774, "signalosome complex": 8.511001466296774, "scaffold protein": 8.01797756645451, "protein drives": 7.635246515022862, "linear pathway": 7.635246515022862, "sequential phosphorylation": 9.411955803365045, "ultimately targeting": 8.658247192583133, "targeting specific": 8.355835584391686, "specific effector": 8.191848839997071, "effector molecules": 8.355835584391686, "different raf": 7.422989813300176, "erk1/2 scaffold": 7.832953288875434, "scaffold proteins": 8.191848839997071, "promising field": 7.832953288875434, "therapeutic strategies": 8.931948929008138, "strategies capable": 8.355835584391686, "selectively potentiating": 9.181922482685199, "adaptive response": 8.191848839997071, "cardiac amyloidosis": 8.511001466296774, "atypical case": 7.422989813300176, "described report": 8.01797756645451, "report deals": 7.193870284774465, "hypertensive cardiomyiopathy": 9.624996450667128, "cardiomyiopathy based": 8.798342187639646, "inducible myocardial": 8.658247192583133, "normal coronary": 7.832953288875434, "coronary arteries": 8.191848839997071, "typical amyloidotic": 8.511001466296774, "amyloidotic pattern": 8.511001466296774, "final diagnosis": 7.832953288875434, "multiple myeloma": 8.01797756645451, "osteomedullary biopsy": 8.798342187639646, "measuring frailty": 8.191848839997071, "community perspective": 8.798342187639646, "each method": 6.944975542925487, "frailty according": 8.191848839997071, "weak grip": 6.3717330906226675, "physical exhaustion": 8.511001466296774, "low activity": 7.193870284774465, "unintentional weight": 8.658247192583133, "intermediate frailty": 8.658247192583133, "deficits present": 8.01797756645451, "% intermediate": 7.635246515022862, "intermediate frail": 8.355835584391686, "frail according": 7.832953288875434, "index ranged": 7.193870284774465, "patients categorized": 8.658247192583133, "death compared": 7.635246515022862, "unit increase": 7.422989813300176, "% increased": 6.944975542925487, "both measures": 7.422989813300176, "measures predicted": 8.355835584391686, "predicted death": 7.832953288875434, "death equally": 7.422989813300176, "phenotype equally": 8.191848839997071, "equally predict": 7.832953288875434, "predict mortality": 8.191848839997071, "routinely assessed": 8.355835584391686, "assessed clinically": 8.511001466296774, "feasible alternative": 8.658247192583133, "ascertain frailty": 8.191848839997071, "failure trials": 7.635246515022862, "last decade": 6.944975542925487, "large phase": 6.944975542925487, "pharmacologic studies": 8.798342187639646, "therapeutics including": 8.931948929008138, "including calcium": 8.191848839997071, "sensitizing agents": 8.355835584391686, "pharmacologic management": 9.181922482685199, "changed little": 7.635246515022862, "rates remain": 7.193870284774465, "remain higher": 7.422989813300176, "neutral results": 7.832953288875434, "many acute": 6.672566775728865, "studies including": 8.191848839997071, "appropriate timing": 8.355835584391686, "patient enrollment": 8.355835584391686, "selecting appropriate": 8.798342187639646, "appropriate end": 7.832953288875434, "describe lessons": 8.01797756645451, "lessons learned": 7.832953288875434, "outline strategies": 8.355835584391686, "future trials": 7.422989813300176, "ambulatory setting": 8.355835584391686, "future perspectives": 8.511001466296774, "important tool": 7.635246515022862, "acute dyspnea": 7.422989813300176, "international guidelines": 9.181922482685199, "subsequent meta": 7.832953288875434, "routine np": 6.672566775728865, "used also": 6.3717330906226675, "guide treatment": 7.832953288875434, "assess risk": 6.944975542925487, "developing heart": 8.01797756645451, "receiving chemotherapy": 8.931948929008138, "measurement together": 8.658247192583133, "potential contribution": 8.931948929008138, "several poc": 6.944975542925487, "produce test": 7.193870284774465, "test results": 7.193870284774465, "results within": 7.635246515022862, "appear sufficiently": 8.511001466296774, "sufficiently sensitive": 8.931948929008138, "used routinely": 7.635246515022862, "diagnostic evaluations": 8.931948929008138, "community outpatient": 8.658247192583133, "time frame": 6.672566775728865, "patient consultation": 8.658247192583133, "appropriately designed": 8.931948929008138, "designed clinical": 8.191848839997071, "potential benefits": 8.355835584391686, "also important": 7.635246515022862, "take full": 6.3717330906226675, "full advantage": 7.635246515022862, "faster turnaround": 8.191848839997071, "turnaround times": 8.01797756645451, "times provided": 7.635246515022862, "measuring heart": 7.832953288875434, "failure care": 7.193870284774465, "operationalized hospital": 9.181922482685199, "care outcomes": 7.422989813300176, "publicly reported": 8.191848839997071, "standardized mortality": 8.931948929008138, "associated penalties": 8.658247192583133, "expected rates": 7.635246515022862, "motivate hospitals": 8.355835584391686, "provide patients": 8.01797756645451, "expected future": 7.832953288875434, "future expansion": 8.01797756645451, "inhibition halts": 8.01797756645451, "halts heart": 6.944975542925487, "modern society": 7.635246515022862, "pathological remodelling": 9.181922482685199, "involves cardiac": 8.01797756645451, "robust predictor": 8.01797756645451, "subsequent hf": 7.422989813300176, "molecular level": 7.832953288875434, "chromatin hyperacetylation": 9.411955803365045, "family bromodomain": 8.355835584391686, "lysine reader": 7.422989813300176, "reader proteins": 7.832953288875434, "promising targets": 8.191848839997071, "neuronal stressors": 8.355835584391686, "these activate": 7.635246515022862, "transduction cascade": 8.658247192583133, "defined set": 6.944975542925487, "cardiomyocytes occur": 8.658247192583133, "epigenetic changes": 8.355835584391686, "histone acetyltransferases": 9.411955803365045, "histone deacetylases": 8.658247192583133, "cardiac development": 8.511001466296774, "group utilized": 7.635246515022862, "recently developed": 8.355835584391686, "developed first": 7.832953288875434, "class inhibitor": 7.832953288875434, "displaces bets": 7.635246515022862, "downstream signalling": 8.798342187639646, "vitro model": 6.944975542925487, "neurohormonally induced": 9.05964189305739, "authors showed": 7.635246515022862, "nanomolar doses": 7.832953288875434, "significantly blocked": 8.798342187639646, "blocked phenylephrine": 8.798342187639646, "mediated hypertrophy": 8.658247192583133, "gene induction": 7.635246515022862, "containing protein": 8.355835584391686, "highly expressed": 8.01797756645451, "cardiac tissues": 7.832953288875434, "expression profiling": 8.658247192583133, "cultured cardiomyocytes": 9.05964189305739, "drug abrogated": 7.635246515022862, "substantial subset": 8.355835584391686, "induced genes": 7.422989813300176, "vivo experiments": 8.01797756645451, "mice via": 6.035843815994525, "via phenylephrine": 8.191848839997071, "haemodynamic stress": 8.511001466296774, "surgical method": 7.832953288875434, "several pathological": 8.658247192583133, "including cardiac": 8.191848839997071, "systemic blood": 7.635246515022862, "detailed transcriptional": 9.181922482685199, "transcriptional analysis": 9.181922482685199, "cardiac tissue": 7.635246515022862, "vehicle revealed": 8.01797756645451, "inhibition suppresses": 8.798342187639646, "pathological cardiac": 8.658247192583133, "expression programme": 8.658247192583133, "also found": 6.672566775728865, "further molecular": 8.191848839997071, "molecular analysis": 8.355835584391686, "bets play": 6.3717330906226675, "crucial role": 7.193870284774465, "mediated signal": 7.832953288875434, "factor networks": 7.832953288875434, "including nuclear": 8.191848839997071, "activated t": 6.944975542925487, "t cells": 5.65563804923464, "promoting transcriptional": 9.29923091812682, "transcriptional pause": 8.798342187639646, "pause release": 7.422989813300176, "pathological stress": 8.511001466296774, "study implicates": 8.01797756645451, "implicates epigenetic": 8.798342187639646, "epigenetic readers": 8.355835584391686, "cardiac biology": 7.832953288875434, "gene control": 7.193870284774465, "control via": 6.944975542925487, "dependent signal": 8.01797756645451, "potentially abrogate": 8.658247192583133, "abrogate pathological": 8.798342187639646, "mapping mri": 6.944975542925487, "breathing pulse": 7.832953288875434, "pulse sequence": 7.635246515022862, "quantify myocardial": 8.511001466296774, "t1 changes": 6.672566775728865, "swine model": 6.944975542925487, "ventricularly paced": 8.511001466296774, "induce heart": 7.193870284774465, "scanned twice": 7.422989813300176, "t mri": 4.700994494168267, "mri scanner": 6.944975542925487, "mapping sequence": 8.01797756645451, "chelate contrast": 8.01797756645451, "failure scans": 7.422989813300176, "failure myocardial": 8.355835584391686, "similar left": 7.193870284774465, "ventricular tissue": 8.355835584391686, "animals using": 7.422989813300176, "using trichrome": 7.832953288875434, "trichrome blue": 7.635246515022862, "blue histologic": 7.832953288875434, "histologic analysis": 8.511001466296774, "failure t1": 6.672566775728865, "agent administration": 8.658247192583133, "failure also": 7.193870284774465, "difference histologically": 9.29923091812682, "collagen compared": 8.191848839997071, "mapping technique": 8.191848839997071, "quantify diffuse": 8.01797756645451, "diffuse myocardial": 8.355835584391686, "myocardial changes": 8.355835584391686, "changes associated": 8.355835584391686, "failure without": 7.832953288875434, "without breath": 7.635246515022862, "changes appear": 7.635246515022862, "traditional myocardial": 8.931948929008138, "myocardial delayed": 8.355835584391686, "delayed enhancement": 8.511001466296774, "enhancement imaging": 8.511001466296774, "useful technique": 8.01797756645451, "detecting early": 7.832953288875434, "significant myocardial": 8.931948929008138, "myocardial fibrosis": 8.511001466296774, "new approach": 7.193870284774465, "assess exercise": 7.832953288875434, "induced pulmonary": 8.191848839997071, "artery systolic": 7.832953288875434, "possible measure": 8.01797756645451, "invasively diagnosed": 8.658247192583133, "diagnosed pulmonary": 8.511001466296774, "inoperable chronic": 8.355835584391686, "chronic thromboembolic": 8.931948929008138, "thromboembolic pulmonary": 9.181922482685199, "impaired right": 7.635246515022862, "ventricular pump": 8.01797756645451, "pump function": 7.422989813300176, "stable targeted": 7.832953288875434, "targeted pulmonary": 8.355835584391686, "hypertension medication": 9.05964189305739, "medication underwent": 8.658247192583133, "broad panel": 6.944975542925487, "noninvasive assessments": 9.05964189305739, "including stress": 8.01797756645451, "stress echocardiography": 9.05964189305739, "groups according": 8.01797756645451, "factors predicting": 8.355835584391686, "predicting survival": 8.511001466296774, "median exercise": 7.832953288875434, "high pasp": 6.3717330906226675, "resting hemodynamics": 8.658247192583133, "minute walking": 7.635246515022862, "walking distance": 8.01797756645451, "model analysis": 7.635246515022862, "analysis adjusted": 8.191848839997071, "kilogram remained": 8.191848839997071, "remained independent": 8.658247192583133, "prognostic markers": 8.355835584391686, "high clinical": 7.422989813300176, "indicate right": 7.635246515022862, "useful tool": 6.944975542925487, "prognostic assessment": 8.798342187639646, "contemporary use": 8.01797756645451, "improves symptoms": 8.191848839997071, "most data": 6.3717330906226675, "preserved systolic": 8.355835584391686, "interesting therapeutic": 9.05964189305739, "therapeutic concepts": 8.658247192583133, "therapeutic functions": 8.798342187639646, "diagnostic features": 8.511001466296774, "early detection": 7.832953288875434, "alone diagnostic": 8.01797756645451, "diagnostic devices": 8.355835584391686, "disease complex": 7.832953288875434, "challenging therapeutics": 9.181922482685199, "significant portion": 8.511001466296774, "care budget": 6.944975542925487, "commoner among": 7.635246515022862, "among women": 6.944975542925487, "underlying hypertension": 9.05964189305739, "significant progress": 8.658247192583133, "lifesaving drugs": 8.01797756645451, "still poses": 6.944975542925487, "poses significant": 8.191848839997071, "significant challenges": 8.931948929008138, "response regulates": 8.355835584391686, "regulates cardiac": 8.191848839997071, "cardiac sodium": 7.635246515022862, "sodium current": 7.635246515022862, "systolic human": 7.635246515022862, "increases alternative": 8.798342187639646, "alternative mrna": 8.01797756645451, "type v": 5.217618485351048, "gated cardiac": 7.422989813300176, "channel \u03b1": 6.3717330906226675, "generating variants": 8.511001466296774, "variants encoding": 8.191848839997071, "encoding truncated": 8.355835584391686, "nonfunctional channels": 8.931948929008138, "endoplasmic reticulum": 8.798342187639646, "channels activate": 8.191848839997071, "electric remodeling": 8.511001466296774, "human ventricular": 8.191848839997071, "tissue samples": 7.635246515022862, "human induced": 7.422989813300176, "induced pluripotent": 8.511001466296774, "pluripotent stem": 8.01797756645451, "derived cardiomyocytes": 8.931948929008138, "known activators": 8.01797756645451, "abnormal scn5a": 7.635246515022862, "kinase r": 6.035843815994525, "like er": 5.65563804923464, "exogenous variants": 8.355835584391686, "variants induced": 8.01797756645451, "concomitant downregulation": 9.411955803365045, "perk activation": 7.832953288875434, "activation destabilized": 9.05964189305739, "transient receptor": 8.355835584391686, "receptor potential": 8.355835584391686, "potential cation": 8.01797756645451, "cation channel": 7.635246515022862, "channel m7": 6.672566775728865, "perk inhibition": 7.832953288875434, "inhibition prevented": 8.658247192583133, "kv4.3 mrna": 6.672566775728865, "levels resulting": 8.01797756645451, "entirely specific": 8.191848839997071, "multiple cardiac": 8.01797756645451, "cardiac genes": 7.422989813300176, "normal cardiac": 7.635246515022862, "receives little": 7.832953288875434, "little attention": 8.01797756645451, "medical literature": 8.355835584391686, "etiologic causes": 8.01797756645451, "failure often": 7.422989813300176, "often differ": 7.193870284774465, "failure frequently": 8.355835584391686, "frequently requires": 8.511001466296774, "requires diagnostic": 8.511001466296774, "routinely used": 7.635246515022862, "intrinsic left": 7.635246515022862, "pathophysiologic mechanisms": 9.520441892933018, "mechanisms behind": 8.191848839997071, "distinct populations": 8.658247192583133, "chronic pulmonary": 8.191848839997071, "acute pulmonary": 7.832953288875434, "chronic pah": 6.944975542925487, "examine clinical": 8.01797756645451, "clinical circumstances": 8.931948929008138, "circumstances common": 8.658247192583133, "provoke acute": 7.422989813300176, "pharmacologic therapies": 9.05964189305739, "failure management": 8.355835584391686, "embolism represent": 8.355835584391686, "particularly high": 8.191848839997071, "specific diagnostic": 8.511001466296774, "contemporary trends": 8.511001466296774, "community study": 7.832953288875434, "major changes": 7.422989813300176, "recently occurred": 8.191848839997071, "possibly affect": 7.832953288875434, "affect outcomes": 7.832953288875434, "outcomes such": 7.422989813300176, "data describing": 7.832953288875434, "describing trends": 8.191848839997071, "evaluated temporal": 8.355835584391686, "temporal trends": 7.832953288875434, "all residents": 7.422989813300176, "classified according": 8.658247192583133, "patient presentation": 8.658247192583133, "including fewer": 7.832953288875434, "fewer st": 6.035843815994525, "elevation mis": 7.422989813300176, "lower killip": 7.193870284774465, "comorbid conditions": 8.511001466296774, "first week": 6.672566775728865, "adjusted risk": 7.422989813300176, "risk declined": 7.422989813300176, "further adjustment": 8.355835584391686, "characteristics yielded": 9.05964189305739, "yielded hazard": 7.635246515022862, "case mix": 6.035843815994525, "requires new": 7.193870284774465, "new prevention": 7.635246515022862, "prevention strategies": 8.798342187639646, "differential effects": 8.658247192583133, "versus selective": 8.01797756645451, "selective beta": 7.635246515022862, "nonselective \u03b2": 7.635246515022862, "selective \u03b2": 6.944975542925487, "blocker metoprolol": 8.355835584391686, "assessed whether": 8.01797756645451, "response correlates": 8.511001466296774, "various serum": 7.422989813300176, "serum factors": 7.422989813300176, "label crossover": 7.832953288875434, "crossover study": 7.832953288875434, "masked outcome": 7.635246515022862, "outcome assessments": 8.511001466296774, "equipotent dosages": 8.355835584391686, "wk periods": 6.672566775728865, "myocardial washout": 8.355835584391686, "included markers": 8.01797756645451, "cardiac washout": 7.832953288875434, "metoprolol treatment": 8.658247192583133, "greater reduction": 8.191848839997071, "factor concentrations": 8.798342187639646, "haplotype status": 8.01797756645451, "prescribing guideline": 8.798342187639646, "often contextual": 8.01797756645451, "factors such": 7.193870284774465, "competing priorities": 8.658247192583133, "priorities impact": 8.191848839997071, "impact prescribing": 8.355835584391686, "performance measurement": 9.05964189305739, "measurement systems": 8.511001466296774, "veterans aged": 7.422989813300176, "clinic notes": 7.193870284774465, "primary care": 7.193870284774465, "care clinicians": 7.832953288875434, "clinicians caring": 8.191848839997071, "these reasons": 7.422989813300176, "classified using": 8.01797756645451, "published taxonomy": 8.355835584391686, "receiving guideline": 8.511001466296774, "recommended drugs": 8.191848839997071, "review identified": 8.191848839997071, "identified biomedical": 8.798342187639646, "clinician interviews": 8.658247192583133, "interviews identified": 8.798342187639646, "identified twice": 8.01797756645451, "many reasons": 7.193870284774465, "mean 1.6": 6.035843815994525, "reasons per": 6.944975542925487, "common contextual": 8.191848839997071, "clinician belief": 8.01797756645451, "prescribing angiotensin": 9.05964189305739, "poorly documented": 8.191848839997071, "facilitate documentation": 9.181922482685199, "providing guideline": 8.511001466296774, "recommended care": 8.01797756645451, "pyridostigmine prevents": 9.05964189305739, "prevents ventricular": 8.658247192583133, "elevated sympathetic": 8.658247192583133, "reduced parasympathetic": 9.05964189305739, "parasympathetic control": 9.05964189305739, "experimental evidence": 8.798342187639646, "parasympathetic function": 9.181922482685199, "therapeutic alternative": 9.05964189305739, "parasympathetic neurotransmission": 10.097518623839711, "acetylcholinesterase inhibition": 9.917685350486481, "acetylcholinesterase inhibitor": 9.82338316374468, "inhibitor pyridostigmine": 9.181922482685199, "following myocardial": 8.658247192583133, "adult male": 6.672566775728865, "pyridostigmine administration": 9.725894496041844, "per os": 5.217618485351048, "cardiac sympathovagal": 8.798342187639646, "tachycardic response": 8.658247192583133, "bradycardic response": 8.658247192583133, "conscious hf": 7.193870284774465, "pyridostigmine reduced": 8.931948929008138, "basal heart": 6.944975542925487, "increased vagal": 7.832953288875434, "sympathetic control": 8.511001466296774, "myocyte diameter": 8.01797756645451, "collagen density": 8.01797756645451, "surviving left": 7.635246515022862, "also increased": 7.635246515022862, "increased vascular": 8.355835584391686, "factor protein": 7.635246515022862, "suggesting myocardial": 8.798342187639646, "myocardial angiogenesis": 9.05964189305739, "volume conductance": 8.355835584391686, "conductance catheter": 8.658247192583133, "catheter system": 7.832953288875434, "rats treated": 7.193870284774465, "pyridostigmine exhibited": 9.181922482685199, "higher stroke": 7.422989813300176, "term administration": 8.511001466296774, "pyridostigmine started": 8.931948929008138, "started right": 7.422989813300176, "artery ligation": 7.832953288875434, "ligation augmented": 8.355835584391686, "augmented cardiac": 8.191848839997071, "attenuating cardiac": 8.511001466296774, "mechanistic insight": 8.511001466296774, "prolonged electromechanical": 9.520441892933018, "computational study": 8.511001466296774, "block type": 6.672566775728865, "aspects associated": 8.355835584391686, "electromechanical behavior": 9.411955803365045, "altered ventricular": 8.511001466296774, "ventricular structure": 8.798342187639646, "sheet orientation": 8.191848839997071, "slowed conduction": 8.191848839997071, "reduced wall": 7.193870284774465, "wall stiffness": 7.635246515022862, "time interval": 7.422989813300176, "local myocyte": 7.422989813300176, "myocyte depolarization": 8.931948929008138, "shortening onset": 8.01797756645451, "major hf": 6.035843815994525, "dyssynchronous failing": 8.931948929008138, "heart remain": 7.193870284774465, "remain unknown": 7.635246515022862, "combined contributions": 8.931948929008138, "induced remodeling": 8.355835584391686, "used mri": 6.035843815994525, "based models": 7.193870284774465, "dyssynchronous nonfailing": 9.29923091812682, "canine electromechanics": 9.05964189305739, "constructed additional": 8.931948929008138, "additional models": 8.191848839997071, "varying combinations": 8.658247192583133, "block electrical": 8.01797756645451, "activation sequence": 8.511001466296774, "simulation results": 8.355835584391686, "results revealed": 8.01797756645451, "primary culprit": 7.832953288875434, "remodeling contributing": 9.05964189305739, "contributing insignificantly": 9.624996450667128, "slows myofiber": 7.635246515022862, "shortening velocity": 8.511001466296774, "activated septum": 8.01797756645451, "stretch rate": 7.193870284774465, "activated lateral": 8.191848839997071, "lateral wall": 7.193870284774465, "these changes": 7.422989813300176, "myofiber dynamics": 8.191848839997071, "dynamics delay": 7.635246515022862, "thus giving": 6.944975542925487, "giving rise": 6.944975542925487, "prolonged emd": 7.422989813300176, "relationships between": 8.798342187639646, "previous studies": 8.01797756645451, "studies investigating": 8.798342187639646, "related cachexia": 8.01797756645451, "abnormal body": 7.422989813300176, "worsened prognosis": 8.355835584391686, "underwent prospective": 8.798342187639646, "prospective assessment": 8.931948929008138, "skinfold thickness": 8.355835584391686, "comprehensive echocardiography": 9.82338316374468, "blood testing": 7.422989813300176, "circulatory assist": 8.355835584391686, "lower body": 6.672566775728865, "display cachexia": 8.01797756645451, "dysfunction correlated": 8.931948929008138, "greater antecedent": 8.355835584391686, "antecedent weight": 8.191848839997071, "mass ratio": 6.672566775728865, "increased body": 7.635246515022862, "lower event": 6.944975542925487, "hr per": 5.217618485351048, "higher fat": 6.672566775728865, "cachexia often": 7.635246515022862, "often coexist": 7.422989813300176, "additive adverse": 8.01797756645451, "adverse impact": 7.635246515022862, "mechanistically interrelated": 9.624996450667128, "adverse outcome": 7.832953288875434, "fat loss": 6.035843815994525, "enhanced catabolism": 8.511001466296774, "typically exertional": 8.658247192583133, "filling time": 7.193870284774465, "controlling heart": 8.191848839997071, "mg twice": 6.035843815994525, "twice daily": 6.944975542925487, "blind trial": 6.944975542925487, "echocardiographic assessment": 9.624996450667128, "group demonstrated": 8.355835584391686, "mets vs.": 6.035843815994525, "\u00b1 1.9": 4.700994494168267, "\u00b1 6.1": 4.700994494168267, "kg vs.": 5.217618485351048, "\u00b1 3.3": 4.700994494168267, "simultaneous reduction": 8.931948929008138, "induced increase": 8.01797756645451, "\u00b1 2.7": 4.700994494168267, "work load": 6.3717330906226675, "corrected chronotropic": 8.931948929008138, "chronotropic response": 8.798342187639646, "time at": 5.65563804923464, "slower increase": 7.832953288875434, "treated group": 7.422989813300176, "exertional increase": 8.511001466296774, "independent correlates": 8.931948929008138, "independently correlated": 9.181922482685199, "term treatment": 7.635246515022862, "ivabradine increased": 8.658247192583133, "increased exercise": 8.355835584391686, "improved left": 7.422989813300176, "pressure response": 8.191848839997071, "therapeutic treatments": 8.931948929008138, "treatments targeting": 8.658247192583133, "targeting abnormal": 8.355835584391686, "abnormal exercise": 8.191848839997071, "exercise hemodynamic": 8.658247192583133, "prove useful": 7.193870284774465, "simple validated": 8.01797756645451, "validated clinical": 8.355835584391686, "treatment implications": 8.931948929008138, "undergo coronary": 8.01797756645451, "undergone coronary": 8.355835584391686, "primary diagnosis": 8.191848839997071, "using multivariate": 8.355835584391686, "% diameter": 6.672566775728865, "diameter stenosis": 8.191848839997071, "left main": 6.3717330906226675, "descending artery": 8.191848839997071, "defined prediction": 8.355835584391686, "prospectively validated": 9.05964189305739, "separate cohort": 7.832953288875434, "cohort recruited": 8.01797756645451, "included diabetes": 8.191848839997071, "ratio 5.1": 6.3717330906226675, "electrocardiographic q": 8.931948929008138, "q waves": 5.65563804923464, "ratio 3.8": 6.3717330906226675, "nondiabetes risk": 8.01797756645451, "tobacco use": 6.944975542925487, "ratio 4.8": 6.3717330906226675, "predictor identified": 8.658247192583133, "prospective validation": 8.931948929008138, "validation cohort": 8.191848839997071, "simple clinical": 7.832953288875434, "accurately identify": 8.511001466296774, "substantial proportion": 8.931948929008138, "potentially significant": 9.05964189305739, "significant cost": 8.01797756645451, "cost savings": 7.193870284774465, "risk avoidance": 7.635246515022862, "unique indication": 8.191848839997071, "japanese heart": 7.635246515022862, "vasopressin type": 8.01797756645451, "severe hyponatremia": 8.511001466296774, "optimal diuretic": 8.01797756645451, "serum sodium": 7.193870284774465, "sodium levels": 7.422989813300176, "newly introduced": 8.01797756645451, "introduced drug": 7.832953288875434, "frequently administered": 9.05964189305739, "relieve congestive": 8.355835584391686, "congestive symptoms": 8.511001466296774, "widespread use": 7.635246515022862, "prospective data": 8.01797756645451, "related morbidity": 8.191848839997071, "diuretic efficacy": 8.191848839997071, "adverse neurohormonal": 8.798342187639646, "neurohormonal activation": 9.181922482685199, "risk patient": 7.193870284774465, "treatment options": 8.191848839997071, "estimated 5.1": 7.422989813300176, "heart failure.(1": 8.01797756645451, "therapies ranging": 8.191848839997071, "physical therapy": 8.01797756645451, "implantable defibrillators": 9.411955803365045, "possibly transplantation": 9.181922482685199, "accurate risk": 7.422989813300176, "therapies appropriate": 8.798342187639646, "disease severity": 8.01797756645451, "becoming increasingly": 8.798342187639646, "increasingly important": 8.931948929008138, "associated treatment": 8.658247192583133, "brief review": 7.193870284774465, "human failing": 7.422989813300176, "blunts beta": 6.944975542925487, "adrenergic responses": 8.658247192583133, "study investigated": 8.355835584391686, "investigated whether": 8.658247192583133, "myocardial phosphodiesterase-2": 9.82338316374468, "mediated effects": 8.01797756645451, "diminished cyclic": 8.191848839997071, "cyclic adenosine": 8.01797756645451, "adenosine monophosphate": 9.05964189305739, "augmented cyclic": 8.01797756645451, "cyclic guanosine": 8.01797756645451, "guanosine monophosphate": 9.05964189305739, "unique property": 7.832953288875434, "thus leading": 7.193870284774465, "remarkable increase": 8.511001466296774, "camp hydrolysis": 7.832953288875434, "hydrolysis mediating": 8.658247192583133, "negative cross": 7.635246515022862, "camp signaling": 7.635246515022862, "fluorescence resonance": 8.931948929008138, "resonance energy": 8.01797756645451, "energy transfer": 7.832953288875434, "based assays": 7.193870284774465, "video edge": 6.672566775728865, "edge detection": 7.635246515022862, "epifluorescence microscopy": 9.411955803365045, "current measurements": 8.658247192583133, "myocardial tissues": 8.355835584391686, "experimental hf": 7.832953288875434, "fold higher": 6.944975542925487, "advanced human": 7.635246515022862, "stimulation via": 7.832953288875434, "via catecholamine": 8.191848839997071, "catecholamine infusions": 9.05964189305739, "rats enhanced": 7.422989813300176, "camp hydrolytic": 7.832953288875434, "hydrolytic activity": 8.511001466296774, "blunted cardiac": 7.832953288875434, "cardiac \u03b2": 6.3717330906226675, "higher pde2": 6.944975542925487, "cgmp synthesis": 7.635246515022862, "synthesis via": 7.422989813300176, "via nitric": 6.672566775728865, "oxide donors": 7.193870284774465, "specific pde2": 7.422989813300176, "inhibition partially": 8.658247192583133, "partially restored": 8.355835584391686, "restored \u03b2": 6.672566775728865, "healthy cardiomyocytes": 8.931948929008138, "cardiomyocytes reduced": 8.931948929008138, "camp levels": 6.944975542925487, "current amplitude": 8.191848839997071, "effect following": 8.01797756645451, "following acute": 7.832953288875434, "affecting basal": 7.832953288875434, "basal contractility": 8.511001466296774, "overexpressing cardiomyocytes": 9.725894496041844, "cardiomyocytes showed": 8.798342187639646, "showed marked": 7.422989813300176, "marked protection": 8.191848839997071, "induced hypertrophic": 8.658247192583133, "hypertrophic responses": 8.931948929008138, "important defense": 8.191848839997071, "defense mechanism": 8.191848839997071, "cardiac stress": 7.635246515022862, "antagonizing excessive": 8.931948929008138, "excessive \u03b2": 6.944975542925487, "activating myocardial": 8.798342187639646, "myocardial pde2": 7.832953288875434, "novel intracellular": 8.511001466296774, "intracellular antiadrenergic": 9.624996450667128, "antiadrenergic therapeutic": 9.411955803365045, "study subgroups": 7.832953288875434, "mild patients": 7.422989813300176, "enrolled patients": 8.191848839997071, "receiving optimal": 8.191848839997071, "cardiovascular reason": 8.798342187639646, "reason within": 7.422989813300176, "inducing hyperkalemia": 8.798342187639646, "specified analysis": 8.355835584391686, "patients \u2265": 6.672566775728865, "major safety": 7.193870284774465, "safety measures": 7.832953288875434, "hyperkalemia leading": 8.658247192583133, "drug discontinuation": 8.658247192583133, "risk subgroups": 7.635246515022862, "study medication": 8.01797756645451, "medication due": 7.635246515022862, "primary composite": 8.191848839997071, "composite endpoint": 8.355835584391686, "meeting specific": 8.01797756645451, "specific inclusion": 8.355835584391686, "carefully monitored": 8.511001466296774, "developing hyperkalemia": 9.05964189305739, "when treated": 7.193870284774465, "prevalence ranging": 8.355835584391686, "significant gaps": 8.01797756645451, "induced changes": 7.832953288875434, "measured using": 7.635246515022862, "group effects": 7.422989813300176, "estimated using": 7.832953288875434, "using linear": 7.193870284774465, "linear mixed": 7.193870284774465, "mixed models": 7.193870284774465, "models according": 8.01797756645451, "treat principle": 7.832953288875434, "baseline kccq": 7.422989813300176, "significantly correlated": 9.181922482685199, "baseline hrqol.": 7.832953288875434, "subscales relative": 8.355835584391686, "action cohort": 7.422989813300176, "baseline hrqol": 7.635246515022862, "cost analysis": 7.422989813300176, "control vs.": 6.944975542925487, "vs. rate": 6.035843815994525, "similar efficacy": 8.01797756645451, "efficacy outcomes": 8.191848839997071, "economic impact": 7.832953288875434, "care expenditures": 8.191848839997071, "control treatment": 8.191848839997071, "payer perspective": 8.191848839997071, "perspective using": 8.191848839997071, "minimization approach": 8.798342187639646, "trial resource": 7.635246515022862, "resource utilization": 8.658247192583133, "unit costs": 6.672566775728865, "databases supplemented": 8.931948929008138, "specific costs": 7.635246515022862, "n =": 3.264536430999026, "related costs": 7.422989813300176, "costs accounted": 7.832953288875434, "total expenditures": 8.355835584391686, "control patients": 8.01797756645451, "fewer cardiac": 7.422989813300176, "cardiac procedures": 8.355835584391686, "fewer cardioversions": 8.658247192583133, "lower costs": 6.944975542925487, "costs related": 7.422989813300176, "offset by": 6.3717330906226675, "higher expenditures": 8.511001466296774, "expenditures due": 8.01797756645451, "noncardiovascular diagnoses": 9.520441892933018, "cardiac arrhythmia": 8.355835584391686, "arrhythmia devices": 8.355835584391686, "noncardiovascular drugs": 9.05964189305739, "total cost": 6.672566775728865, "cost per": 6.035843815994525, "strategy used": 7.422989813300176, "failure appears": 7.832953288875434, "little influence": 8.01797756645451, "overall financial": 8.191848839997071, "financial burden": 8.01797756645451, "remains substantial": 8.511001466296774, "muscle sarcomere": 8.01797756645451, "sarcomere structure": 8.511001466296774, "restorative effects": 8.511001466296774, "demonstrated recently": 8.798342187639646, "improves skm": 7.193870284774465, "skm mitochondrial": 8.191848839997071, "improved mitochondrial": 8.931948929008138, "treadmill testing": 8.191848839997071, "maximum oxygen": 7.635246515022862, "skm biopsies": 7.193870284774465, "blot analysis": 7.422989813300176, "electron microscopy": 8.511001466296774, "report severe": 7.422989813300176, "severe perturbations": 8.658247192583133, "associated protein": 8.355835584391686, "protein complex": 7.832953288875434, "induced recovery": 8.01797756645451, "ordinated fashion": 8.191848839997071, "skm growth": 6.672566775728865, "differentiation consistent": 9.411955803365045, "myofibre regeneration": 8.798342187639646, "~24 %": 4.700994494168267, "reach statistical": 8.191848839997071, "statistical significance": 9.181922482685199, "initial results": 7.832953288875434, "results warrant": 7.832953288875434, "rigorous investigation": 8.931948929008138, "pure epicatechin": 8.01797756645451, "novel means": 6.944975542925487, "improving muscle": 8.01797756645451, "muscle function": 7.832953288875434, "versus biomedical": 8.191848839997071, "major databases": 7.832953288875434, "overall effects": 7.832953288875434, "most adverse": 7.193870284774465, "events observed": 7.832953288875434, "resolved without": 8.01797756645451, "without special": 7.832953288875434, "special treatment": 8.191848839997071, "term follow": 6.944975542925487, "systemic adverse": 8.01797756645451, "events evaluation": 8.191848839997071, "ethnic groups": 7.422989813300176, "still required": 7.635246515022862, "aimed at": 6.035843815994525, "activating factor": 8.191848839997071, "matched apparently": 8.355835584391686, "apparently healthy": 8.355835584391686, "key biosynthetic": 8.01797756645451, "paf acetyltransferase": 8.798342187639646, "acetyltransferase [": 8.511001466296774, "glycerol cholinephosphotransferase": 10.183399668273621, "catabolic isoenzymes": 8.658247192583133, "associated phospholipase": 9.181922482685199, "lower median": 7.193870284774465, "median activities": 8.191848839997071, "higher activities": 8.191848839997071, "at follow": 6.3717330906226675, "levels marginally": 8.191848839997071, "marginally increased": 8.658247192583133, "remained downregulated": 8.931948929008138, "elevated compared": 8.191848839997071, "diagnosed patients": 8.355835584391686, "drug treatment": 7.635246515022862, "affected profile": 8.01797756645451, "exercise parameters": 8.511001466296774, "hallmark feature": 8.01797756645451, "prognostically important": 9.181922482685199, "widely accepted": 7.832953288875434, "accepted peak": 7.422989813300176, "exercise oscillatory": 8.658247192583133, "oscillatory ventilation": 9.05964189305739, "partial pressure": 8.01797756645451, "gain attention": 7.635246515022862, "also discussed": 7.635246515022862, "different mechanisms": 8.658247192583133, "mechanisms underlie": 8.511001466296774, "important contribution": 8.931948929008138, "peripheral abnormalities": 9.181922482685199, "different pathophysiological": 9.624996450667128, "multivariate assessment": 9.05964189305739, "aforementioned parameters": 9.29923091812682, "prognostic purposes": 8.511001466296774, "orthotopic heart": 8.01797756645451, "optimal treatment": 8.191848839997071, "institutional experience": 9.181922482685199, "procedures within": 8.191848839997071, "recipients bridged": 8.355835584391686, "including intravenous": 8.798342187639646, "intravenous inotropes": 8.798342187639646, "require consultation": 8.658247192583133, "inflammatory abdominal": 8.931948929008138, "problems occurred": 8.191848839997071, "per cent": 6.035843815994525, "deaths occurring": 8.01797756645451, "occurring within": 8.01797756645451, "largest series": 7.635246515022862, "undergoing oht": 7.635246515022862, "oht bridged": 6.944975542925487, "similar incidence": 8.191848839997071, "refractory right": 8.01797756645451, "cardiopulmonary resuscitation": 9.725894496041844, "wall infarction": 7.832953288875434, "cardiac centre": 7.635246515022862, "catheterization showed": 8.931948929008138, "thrombotic obstruction": 8.931948929008138, "right coronary": 7.635246515022862, "after percutaneous": 8.355835584391686, "coronary revascularization": 9.411955803365045, "hemodynamically stable": 8.931948929008138, "stable situation": 8.01797756645451, "intensive care": 7.635246515022862, "care unit": 6.3717330906226675, "patient became": 7.635246515022862, "hemodynamically unstable": 9.181922482685199, "therapy refractory": 8.355835584391686, "decided within": 7.635246515022862, "extra corporeal": 7.832953288875434, "corporeal membrane": 8.355835584391686, "extracorporeal support": 8.931948929008138, "emergency cardiac": 8.191848839997071, "intermediate care": 8.191848839997071, "extracorporeal life": 8.511001466296774, "life support": 7.193870284774465, "feasible und": 7.193870284774465, "und effective": 7.422989813300176, "bridging therapy": 8.01797756645451, "acute ischemic": 7.635246515022862, "ischemic right": 7.635246515022862, "successful reperfusion": 8.931948929008138, "reperfusion therapy": 8.511001466296774, "values observed": 7.832953288875434, "early research": 7.635246515022862, "research focused": 8.01797756645451, "multiple non": 7.193870284774465, "diastolic abnormalities": 9.05964189305739, "function also": 7.422989813300176, "also contribute": 7.832953288875434, "frequently challenging": 8.931948929008138, "relies upon": 6.944975542925487, "careful clinical": 8.01797756645451, "clinical evaluation": 8.511001466296774, "invasive haemodynamic": 8.798342187639646, "haemodynamic assessment": 9.05964189305739, "principal mechanisms": 8.658247192583133, "diagnostic approaches": 8.798342187639646, "novel treatment": 7.832953288875434, "hold promise": 7.193870284774465, "mortality outcomes": 8.355835584391686, "based study": 6.944975542925487, "first acute": 6.944975542925487, "beneficial impact": 8.191848839997071, "deaths attributable": 8.511001466296774, "western australian": 8.355835584391686, "administrative health": 8.798342187639646, "health data": 6.944975542925487, "temporal incidence": 8.355835584391686, "death associated": 8.01797756645451, "day case": 6.035843815994525, "declined marginally": 8.511001466296774, "without concurrent": 8.355835584391686, "rate declined": 7.422989813300176, "index ami": 6.3717330906226675, "encouraging declines": 8.658247192583133, "common problem": 7.635246515022862, "increased attention": 8.511001466296774, "needed given": 7.193870284774465, "term prognosis": 7.635246515022862, "blind randomized": 8.01797756645451, "controlled feasibility": 8.931948929008138, "feasibility study": 8.191848839997071, "week program": 7.193870284774465, "without intramuscular": 8.798342187639646, "intramuscular testosterone": 9.411955803365045, "collected preliminary": 8.798342187639646, "preliminary data": 8.01797756645451, "age 67.2": 6.035843815994525, "mean \u00b1": 5.217618485351048, "\u00b1 sd": 4.071247819461442, "sd testosterone": 7.832953288875434, "testosterone levels": 8.511001466296774, "\u00b1 2.6": 4.700994494168267, "randomly allocated": 8.355835584391686, "placebo groups": 7.635246515022862, "intervention compliance": 9.05964189305739, "incremental shuttle": 8.511001466296774, "% compliance": 7.193870284774465, "similar improvements": 8.658247192583133, "testosterone group": 8.355835584391686, "group showed": 7.193870284774465, "showed improvements": 8.511001466296774, "leg strength": 7.193870284774465, "several medical": 7.832953288875434, "form quality": 7.193870284774465, "life domains": 7.193870284774465, "mostly unchanged": 8.01797756645451, "first time": 6.672566775728865, "positively impact": 8.191848839997071, "elderly male": 7.193870284774465, "peripheral muscles": 8.355835584391686, "muscles improves": 8.01797756645451, "improves endothelial": 8.658247192583133, "emotional stress": 8.01797756645451, "impaired systolic": 8.191848839997071, "training protocol": 8.191848839997071, "rated depression": 8.01797756645451, "depression scores": 8.191848839997071, "dilatation diameter": 8.511001466296774, "peptide also": 7.193870284774465, "also declined": 7.422989813300176, "tendency toward": 7.832953288875434, "toward lower": 7.193870284774465, "lower mitral": 7.193870284774465, "mitral e": 6.035843815994525, "wave ratio": 6.672566775728865, "also improves": 7.422989813300176, "effective evidence": 8.355835584391686, "based therapies": 7.832953288875434, "factor beta": 6.944975542925487, "dependent yield": 7.832953288875434, "functional decline": 8.355835584391686, "atrial explant": 7.635246515022862, "kit+ cells": 6.672566775728865, "cells isolated": 7.635246515022862, "derived cells": 7.422989813300176, "cells modestly": 7.635246515022862, "modestly improve": 8.01797756645451, "cardiac functions": 8.191848839997071, "full potential": 7.635246515022862, "potential candidates": 8.658247192583133, "cell therapy": 7.193870284774465, "therapy suffer": 7.635246515022862, "disease affects": 7.832953288875434, "derived progenitor": 8.355835584391686, "explant c": 6.3717330906226675, "kit+ progenitors": 8.01797756645451, "elucidate mechanisms": 8.658247192583133, "descending coronary": 8.511001466296774, "artery occlusion": 8.01797756645451, "operated animals": 8.01797756645451, "developed infarcted": 8.511001466296774, "infarcted animals": 8.191848839997071, "ventricle end": 7.422989813300176, "pressure \u2265": 6.672566775728865, "scar size": 6.3717330906226675, "size \u2265": 5.217618485351048, "atrial explants": 7.832953288875434, "explants produced": 8.191848839997071, "produced less": 7.422989813300176, "less c": 5.217618485351048, "sham explants": 7.422989813300176, "cells exhibited": 7.832953288875434, "exhibited upregulated": 8.798342187639646, "upregulated transforming": 9.181922482685199, "increased level": 7.832953288875434, "diminished expression": 8.798342187639646, "pluripotency markers": 8.658247192583133, "markers compared": 8.01797756645451, "\u03b2 signaling": 6.944975542925487, "\u03b2 receptor": 6.672566775728865, "receptor type": 7.422989813300176, "using small": 6.944975542925487, "molecule inhibitors": 8.511001466296774, "inhibitors improved": 8.511001466296774, "cell yield": 6.672566775728865, "attenuated epithelial": 8.798342187639646, "pluripotency marker": 8.511001466296774, "improved efficiency": 8.511001466296774, "cell differentiation": 8.658247192583133, "differentiation toward": 8.931948929008138, "toward cardiomyocyte": 8.658247192583133, "like cells": 6.672566775728865, "taken together": 7.635246515022862, "\u03b2 inhibition": 7.193870284774465, "inhibition positively": 8.798342187639646, "positively modulates": 8.658247192583133, "cell phenotype": 7.635246515022862, "optimizing cardiac": 8.355835584391686, "cardiac progenitor": 8.355835584391686, "progenitor function": 8.511001466296774, "cell expansion": 7.635246515022862, "expansion protocols": 8.511001466296774, "heart beat": 6.672566775728865, "originally designed": 8.511001466296774, "study breathing": 7.832953288875434, "breathing control": 8.191848839997071, "following cardiac": 8.191848839997071, "taking advantage": 8.01797756645451, "pulseless ventricular": 8.798342187639646, "ventricular fibrillation": 9.181922482685199, "newly implanted": 7.832953288875434, "implanted cardioverter": 8.931948929008138, "patient aged": 7.193870284774465, "class iii": 6.3717330906226675, "originally part": 7.832953288875434, "study displayed": 7.832953288875434, "displayed permanent": 8.511001466296774, "permanent periodic": 8.355835584391686, "final data": 6.672566775728865, "data analysis": 7.422989813300176, "incidentally produced": 8.798342187639646, "ascending phase": 7.832953288875434, "pb cycle": 6.035843815994525, "recovery period": 7.832953288875434, "low bp": 5.217618485351048, "pb characteristics": 8.355835584391686, "this occurred": 7.422989813300176, "occurred despite": 8.01797756645451, "profound change": 7.832953288875434, "cerebral blood": 7.635246515022862, "carotid bodies": 7.635246515022862, "primary oscillations": 8.658247192583133, "oscillations originating": 9.181922482685199, "central pattern": 7.832953288875434, "pattern generator": 8.191848839997071, "antiplatelet drugs": 8.355835584391686, "treating heart": 7.635246515022862, "new options": 6.944975542925487, "much work": 6.3717330906226675, "work remains": 7.193870284774465, "establish efficacy": 8.355835584391686, "additional progress": 8.511001466296774, "including better": 8.01797756645451, "better tools": 7.193870284774465, "clarity regarding": 8.191848839997071, "vascular diseases": 8.191848839997071, "increasingly recognized": 9.05964189305739, "multisystem disease": 8.511001466296774, "important comorbidities": 9.05964189305739, "autonomic dysbalance": 8.658247192583133, "recent findings": 7.832953288875434, "increasing evidence": 8.511001466296774, "evidence points": 7.832953288875434, "intestinal morphology": 8.798342187639646, "absorption function": 8.511001466296774, "functional abnormalities": 9.181922482685199, "different gastrointestinal": 9.411955803365045, "gastrointestinal regions": 9.181922482685199, "intestinal dysfunction": 8.931948929008138, "disturbed intestinal": 8.658247192583133, "intestinal barrier": 8.355835584391686, "chronic inflammatory": 8.658247192583133, "inflammatory state": 8.355835584391686, "anabolic imbalance": 8.355835584391686, "terminal stage": 7.635246515022862, "particularly poor": 8.191848839997071, "review highlights": 8.191848839997071, "nutritional abnormalities": 9.29923091812682, "including fat": 7.422989813300176, "nutritional strategies": 8.931948929008138, "potentially anti": 8.01797756645451, "inflammatory effects": 8.658247192583133, "dietary interventions": 8.798342187639646, "crucial target": 7.635246515022862, "failure research": 8.01797756645451, "diagnostic role": 7.832953288875434, "stable coronary": 7.832953288875434, "terminal fragment": 8.191848839997071, "ventricular wall": 8.01797756645451, "reliable diagnostic": 8.511001466296774, "prognostic biomarkers": 8.798342187639646, "diagnostic roles": 8.01797756645451, "great number": 7.193870284774465, "stable cad": 6.672566775728865, "limited amount": 7.635246515022862, "recent data": 6.944975542925487, "data is": 5.65563804923464, "thus providing": 7.635246515022862, "providing prognostic": 8.658247192583133, "unfavourable clinical": 8.798342187639646, "denervation improves": 8.658247192583133, "improves autonomic": 8.355835584391686, "conscious rabbits": 8.191848839997071, "tone resulting": 7.635246515022862, "autonomic imbalance": 8.511001466296774, "symptomatic improvement": 9.05964189305739, "protective mechanisms": 8.798342187639646, "mechanisms remain": 8.191848839997071, "remain unclear": 7.635246515022862, "used conscious": 7.635246515022862, "chronically instrumented": 9.181922482685199, "white rabbits": 7.422989813300176, "rabbits undergoing": 8.355835584391686, "undergoing renal": 8.01797756645451, "dnx prior": 6.3717330906226675, "treatment groups": 8.01797756645451, "nonpace dnx": 6.944975542925487, "pace non": 6.035843815994525, "examined several": 8.01797756645451, "several markers": 7.832953288875434, "markers indicative": 8.355835584391686, "time domain": 6.944975542925487, "domain heart": 7.193870284774465, "power spectral": 7.635246515022862, "spectral analysis": 8.191848839997071, "rate response": 7.422989813300176, "intravenous bolus": 8.191848839997071, "intravenous metoprolol": 8.931948929008138, "rabbits compared": 8.01797756645451, "intravenous atropine": 8.658247192583133, "also prevented": 7.635246515022862, "circulating plasma": 8.355835584391686, "suggest renal": 7.422989813300176, "dnx improves": 7.193870284774465, "reduces morbidity": 8.191848839997071, "chronic systolic": 8.01797756645451, "wide qrs": 6.035843815994525, "mechanical dyssynchrony": 9.05964189305739, "dyssynchrony also": 8.191848839997071, "also occurs": 6.944975542925487, "trial involving": 7.832953288875434, "echocardiographic evidence": 9.411955803365045, "ventricular dyssynchrony": 9.181922482685199, "underwent device": 8.01797756645451, "capability turned": 8.191848839997071, "efficacy outcome": 8.01797756645451, "first hospitalization": 8.798342187639646, "safety monitoring": 8.191848839997071, "monitoring board": 8.01797756645451, "at study": 6.035843815994525, "study closure": 7.422989813300176, "undergone randomization": 9.05964189305739, "outcome occurred": 8.01797756645451, "increase mortality": 8.355835584391686, "comparative effects": 8.511001466296774, "single center": 7.422989813300176, "center retrospective": 8.658247192583133, "retrospective observational": 9.520441892933018, "failure supported": 8.191848839997071, "pediatric mechanical": 8.658247192583133, "receiving ventricular": 8.798342187639646, "device support": 7.635246515022862, "receiving extracorporeal": 9.181922482685199, "oxygenation membrane": 8.658247192583133, "membrane support": 8.01797756645451, "vad support": 6.944975542925487, "steady improvement": 8.355835584391686, "egfr continued": 7.635246515022862, "steady decline": 7.635246515022862, "much higher": 6.944975542925487, "dysfunction improves": 8.658247192583133, "improves early": 7.635246515022862, "outcome change": 7.635246515022862, "change scores": 7.422989813300176, "preliminary descriptive": 9.05964189305739, "descriptive study": 8.191848839997071, "social mandate": 7.635246515022862, "ensure effective": 8.01797756645451, "effective practice": 8.355835584391686, "practice within": 7.832953288875434, "using standardized": 8.355835584391686, "standardized nursing": 8.658247192583133, "nursing terminologies": 8.798342187639646, "terminologies makes": 8.511001466296774, "measure aspects": 7.832953288875434, "ratings exists": 7.635246515022862, "retrospective descriptive": 9.29923091812682, "descriptive research": 8.658247192583133, "research design": 7.832953288875434, "inpatient records": 8.191848839997071, "patients discharged": 8.511001466296774, "year period": 6.944975542925487, "outcomes demonstrated": 8.798342187639646, "demonstrated statistically": 9.411955803365045, "study provide": 7.422989813300176, "possible contribution": 8.798342187639646, "incorporating nursing": 8.798342187639646, "future prospective": 8.355835584391686, "prospective experimental": 9.181922482685199, "experimental research": 8.798342187639646, "science regarding": 8.191848839997071, "regarding effective": 8.511001466296774, "adults hospitalized": 8.511001466296774, "reciprocal downregulation": 9.29923091812682, "downregulation influences": 9.29923091812682, "influences cardiac": 8.355835584391686, "cardiac hypertrophic": 8.658247192583133, "hypertrophic response": 8.798342187639646, "protective role": 7.832953288875434, "gene therapy": 7.193870284774465, "receptors expressed": 8.511001466296774, "opposing actions": 8.01797756645451, "adenylyl cyclase": 8.01797756645451, "differential g": 7.635246515022862, "protein coupling": 8.01797756645451, "triggers desensitization": 9.181922482685199, "downregulation processes": 9.181922482685199, "classic signaling": 8.191848839997071, "signaling paradigms": 8.511001466296774, "paradigms suggest": 8.191848839997071, "simultaneous activation": 9.05964189305739, "simply result": 7.422989813300176, "opposing action": 7.832953288875434, "camp production": 7.832953288875434, "direct interaction": 8.355835584391686, "regulatory involvement": 8.931948929008138, "human embryonic": 7.832953288875434, "embryonic kidney": 8.01797756645451, "cells overexpressing": 8.658247192583133, "\u03b21ar downregulation": 8.511001466296774, "receptor agonist": 8.01797756645451, "this cross": 6.672566775728865, "distinct g": 6.672566775728865, "receptors appears": 8.191848839997071, "physiological significance": 9.411955803365045, "show reciprocal": 7.832953288875434, "reciprocal regulation": 8.798342187639646, "mouse hearts": 7.193870284774465, "hearts undergoing": 8.191848839997071, "undergoing chronic": 8.355835584391686, "receptor stimulation": 8.658247192583133, "rat model": 6.3717330906226675, "postischemic heart": 8.355835584391686, "cardiac plasma": 7.635246515022862, "membrane levels": 7.832953288875434, "produces beneficial": 8.511001466296774, "deleterious \u03b21ar": 8.01797756645451, "\u03b21ar overstimulation": 8.658247192583133, "discharge among": 7.832953288875434, "readmission among": 8.191848839997071, "influences outcomes": 8.511001466296774, "administrative databases": 9.181922482685199, "adults aged": 6.944975542925487, "discharged alive": 8.01797756645451, "time diagnosis": 7.635246515022862, "dependent covariates": 8.658247192583133, "physician within": 8.01797756645451, "month after": 6.944975542925487, "least twice": 6.944975542925487, "identified patients": 8.511001466296774, "saw unfamiliar": 7.635246515022862, "unfamiliar physician(s": 8.931948929008138, "unplanned readmission": 8.798342187639646, "month observation": 8.191848839997071, "observation period": 8.355835584391686, "unfamiliar physician": 8.658247192583133, "hr 0.90": 5.65563804923464, "early follow": 7.193870284774465, "month period": 7.193870284774465, "unfamiliar physicians": 8.798342187639646, "hr 0.91": 5.65563804923464, "explore whether": 7.832953288875434, "altered protein": 7.832953288875434, "translational state": 8.511001466296774, "receptor blockade": 8.191848839997071, "blockade reduces": 8.01797756645451, "reduces total": 7.422989813300176, "total mortality": 7.832953288875434, "halt disease": 7.193870284774465, "dependent protein": 8.191848839997071, "signaling downstream": 8.658247192583133, "receptor activation": 8.511001466296774, "unique post": 6.944975542925487, "translational states": 8.658247192583133, "human myocardial": 8.01797756645451, "total myosin": 7.193870284774465, "myosin binding": 7.635246515022862, "binding protein": 7.832953288875434, "c phosphorylation": 8.191848839997071, "ser23/24 troponin": 8.191848839997071, "phosphorylation significantly": 9.725894496041844, "subunits demonstrated": 8.798342187639646, "type ii": 5.65563804923464, "site specific": 7.422989813300176, "specific rii\u03b1": 7.422989813300176, "regulatory subunit": 8.355835584391686, "ri\u03b1 demonstrated": 8.01797756645451, "vivo phosphorylation": 8.658247192583133, "phosphorylation sites": 8.798342187639646, "western blots": 7.422989813300176, "specific monoclonal": 8.511001466296774, "monoclonal antibodies": 8.798342187639646, "antibodies showed": 8.191848839997071, "camp binding": 7.193870284774465, "wild type": 6.3717330906226675, "mutant ri\u03b1": 6.672566775728865, "ri\u03b1 proteins": 7.193870284774465, "proteins demonstrated": 8.798342187639646, "demonstrated reduced": 8.658247192583133, "double mutant": 7.422989813300176, "failing myocardium": 8.355835584391686, "myocardium displays": 8.511001466296774, "displays altered": 8.01797756645451, "translational modification": 9.411955803365045, "impact downstream": 8.191848839997071, "downstream signaling": 8.658247192583133, "autonomic modulation": 8.658247192583133, "repolarization instability": 9.411955803365045, "failure prone": 7.422989813300176, "qt variability": 7.635246515022862, "signifies repolarization": 9.181922482685199, "repolarization lability": 9.05964189305739, "risk predictor": 7.635246515022862, "system activity": 7.832953288875434, "spontaneous ventricular": 9.05964189305739, "tachycardia [": 7.422989813300176, "without spontaneous": 8.511001466296774, "structurally normal": 8.511001466296774, "normal hearts": 7.422989813300176, "beat qt": 5.65563804923464, "qt interval": 6.944975542925487, "min records": 6.944975542925487, "surface ecgs": 7.193870284774465, "atropine infusion": 8.191848839997071, "rr intervals": 7.193870284774465, "sdrr ratio": 6.672566775728865, "groups compared": 7.832953288875434, "rate atrial": 6.944975542925487, "isoprenaline infusion": 8.798342187639646, "infusion increased": 8.355835584391686, "group relative": 7.635246515022862, "larger fluctuations": 8.511001466296774, "this appears": 7.193870284774465, "genuine effect": 7.635246515022862, "rate variation": 7.635246515022862, "acute autonomic": 7.832953288875434, "system modulation": 8.191848839997071, "genetic susceptibility": 8.931948929008138, "related congestive": 8.355835584391686, "haematopoietic cell": 8.511001466296774, "developing congestive": 8.798342187639646, "primarily due": 7.422989813300176, "hct exposure": 7.193870284774465, "candidate genes": 7.832953288875434, "genes involved": 7.635246515022862, "anthracycline metabolism": 9.181922482685199, "iron homeostasis": 8.01797756645451, "oxidant defence": 7.832953288875434, "myocardial remodelling": 8.931948929008138, "nested case": 6.944975542925487, "control study": 7.422989813300176, "this cohort": 6.944975542925487, "cohort formed": 7.422989813300176, "sampling frame": 7.635246515022862, "selecting controls": 8.355835584391686, "cumulative anthracycline": 9.181922482685199, "anthracycline exposure": 8.931948929008138, "cell source": 6.944975542925487, "germline dna": 7.193870284774465, "chest radiation": 7.832953288875434, "genes coding": 7.193870284774465, "oxidase subunit": 7.832953288875434, "doxorubicin efflux": 8.355835584391686, "efflux transporter": 8.355835584391686, "chf predictive": 7.635246515022862, "predictive model": 8.01797756645451, "model performed": 7.832953288875434, "models alone": 7.193870284774465, "common language": 7.832953288875434, "common syndrome": 7.832953288875434, "first propose": 7.422989813300176, "propose fundamental": 8.511001466296774, "fundamental definitions": 9.05964189305739, "distinctive components": 8.931948929008138, "heart circulation": 8.191848839997071, "provide consensus": 8.191848839997071, "universal definition": 8.658247192583133, "these definitions": 8.191848839997071, "uniform nomenclature": 8.658247192583133, "heart circulatory": 8.191848839997071, "circulatory failure": 8.511001466296774, "foster collaborative": 8.658247192583133, "collaborative research": 8.931948929008138, "research initiatives": 8.658247192583133, "conjoint education": 8.355835584391686, "disease unique": 7.635246515022862, "class angiotensin": 8.191848839997071, "inhibitors augment": 8.355835584391686, "peptide system": 7.635246515022862, "atrial natriuretic": 8.355835584391686, "inhibitor composed": 8.355835584391686, "inhibitor prodrug": 8.191848839997071, "antagonist valsartan": 8.658247192583133, "proven effective": 8.01797756645451, "shown promise": 7.422989813300176, "pilot trial": 6.944975542925487, "large outcomes": 7.635246515022862, "fraction outcomes": 8.191848839997071, "current treatment": 8.191848839997071, "rapid onset": 6.944975542925487, "threatening situation": 8.798342187639646, "treatment aims": 7.635246515022862, "improve clinical": 8.01797756645451, "increase long": 7.422989813300176, "few treatments": 7.635246515022862, "review summarizes": 8.191848839997071, "pharmacologic treatment": 9.05964189305739, "underlying clinical": 8.511001466296774, "new pharmacologic": 8.191848839997071, "pharmacologic targets": 8.798342187639646, "purely hemodynamic": 8.355835584391686, "hemodynamic disorder": 8.658247192583133, "interconnected molecular": 9.181922482685199, "research investigations": 9.05964189305739, "maladaptive molecular": 8.798342187639646, "molecular processes": 8.511001466296774, "accumulating evidence": 8.798342187639646, "evidence shows": 7.635246515022862, "molecular biomarkers": 8.658247192583133, "biomarkers provide": 8.355835584391686, "important therapeutic": 8.798342187639646, "research studies": 8.01797756645451, "potential therapeutic": 8.798342187639646, "promising biomarkers": 8.658247192583133, "uniquely capture": 8.01797756645451, "molecular dysfunction": 8.798342187639646, "strict statistical": 8.355835584391686, "statistical standards": 8.798342187639646, "biomarker studies": 8.191848839997071, "trial design": 7.193870284774465, "therapeutic potential": 8.798342187639646, "based strategy": 7.635246515022862, "western society": 7.832953288875434, "fastest growing": 7.832953288875434, "growing subclass": 8.01797756645451, "increasing body": 7.832953288875434, "evidence indicates": 8.355835584391686, "small noncoding": 7.832953288875434, "noncoding rnas": 7.635246515022862, "regulate expression": 8.511001466296774, "target genes": 7.193870284774465, "specific binding": 8.01797756645451, "untranslated region": 8.511001466296774, "translational repression": 9.181922482685199, "many mirnas": 6.944975542925487, "diverse aspects": 7.832953288875434, "failure development": 8.511001466296774, "cardiac pathogenesis": 8.658247192583133, "provide brief": 7.422989813300176, "brief insight": 7.422989813300176, "system inhibitors": 8.191848839997071, "common condition": 8.01797756645451, "carries significant": 8.511001466296774, "significant morbidity": 8.798342187639646, "good evidence": 7.422989813300176, "effective target": 8.01797756645451, "using angiotensin": 8.191848839997071, "aldosterone blockade": 8.658247192583133, "less clear": 6.672566775728865, "review aims": 6.944975542925487, "look first": 6.672566775728865, "newer drugs": 6.944975542925487, "direct renin": 7.193870284774465, "renin inhibitors": 8.01797756645451, "neutral endopeptidase": 8.798342187639646, "endopeptidase inhibitors": 9.181922482685199, "vasopeptidase inhibitors": 9.181922482685199, "muscle abnormalities": 8.658247192583133, "peripheral muscle": 8.191848839997071, "muscle pump": 6.944975542925487, "promoting cardiac": 8.191848839997071, "subpulmonary ventricle": 8.931948929008138, "wasting syndrome": 8.01797756645451, "syndrome exists": 7.832953288875434, "acquired heart": 7.635246515022862, "investigate whether": 8.511001466296774, "circulation exhibit": 8.511001466296774, "exhibit reduced": 7.832953288875434, "reduced skeletal": 8.01797756645451, "metabolic abnormalities": 9.05964189305739, "underwent cardiopulmonary": 9.29923091812682, "mass quantification": 8.511001466296774, "dual x": 5.217618485351048, "calf muscle": 6.944975542925487, "resonance spectroscopy": 8.931948929008138, "healthy age": 6.944975542925487, "australian reference": 8.658247192583133, "reference data": 7.635246515022862, "single tertiary": 7.832953288875434, "tertiary referral": 8.191848839997071, "referral centre": 7.832953288875434, "predicted values": 8.01797756645451, "mass assessed": 7.422989813300176, "relative appendicular": 8.798342187639646, "appendicular lean": 8.191848839997071, "matched reference": 8.191848839997071, "reference values": 8.01797756645451, "score -1.46\u00b10.22": 8.01797756645451, "low skeletal": 7.193870284774465, "mass correlated": 7.832953288875434, "poorer vo2": 6.672566775728865, "mass t": 5.217618485351048, "young normal": 7.193870284774465, "normal reference": 8.01797756645451, "reference mean": 7.635246515022862, "sarcopenic range": 8.01797756645451, "range muscle": 7.193870284774465, "muscle wasting": 7.635246515022862, "less marked": 6.944975542925487, "significant wasting": 8.511001466296774, "muscle aerobic": 7.635246515022862, "rate constant": 7.422989813300176, "postexercise phosphocreatine": 9.624996450667128, "phosphocreatine resynthesis": 9.520441892933018, "adults versus": 7.422989813300176, "versus controls": 7.832953288875434, "psychometric profile": 8.658247192583133, "still questioned": 8.01797756645451, "performed confirmatory": 8.931948929008138, "confirmatory factor": 8.511001466296774, "original construct": 8.355835584391686, "v.6.2 scales": 7.193870284774465, "limited success": 7.832953288875434, "used exploratory": 8.01797756645451, "exploratory factor": 8.355835584391686, "separate scale": 7.635246515022862, "scale dimensions": 8.01797756645451, "separate sub": 7.193870284774465, "construct validity": 8.355835584391686, "individual scales": 8.191848839997071, "scales showed": 7.422989813300176, "showed excellent": 8.01797756645451, "excellent fit": 7.422989813300176, "fit indices": 6.944975542925487, "confidence scale": 8.01797756645451, "contrasting groups": 8.355835584391686, "groups validity": 7.832953288875434, "this evidence": 7.422989813300176, "evidence provides": 8.191848839997071, "new understanding": 8.191848839997071, "circulating fragments": 8.798342187639646, "nonstandardized n": 8.191848839997071, "common consensus": 8.01797756645451, "consensus regarding": 8.511001466296774, "circulating forms": 8.191848839997071, "current assays": 7.635246515022862, "various forms": 7.422989813300176, "\u00b0 c": 3.264536430999026, "patient plasma": 7.635246515022862, "immunoprecipitation followed": 9.624996450667128, "mass spectrometric": 8.355835584391686, "spectrometric analysis": 8.931948929008138, "customized homogeneous": 8.931948929008138, "homogeneous sandwich": 8.658247192583133, "sandwich alphalisa": 8.355835584391686, "\u00ae immunoassays": 7.635246515022862, "spectrometry identified": 9.05964189305739, "several n-": 6.672566775728865, "terminally processed": 8.658247192583133, "processed forms": 7.832953288875434, "physiological proteolysis": 9.29923091812682, "immunoassays demonstrated": 9.29923091812682, "extreme n": 6.3717330906226675, "termini measured": 8.01797756645451, "low apparent": 7.193870284774465, "apparent concentration": 8.931948929008138, "apparent circulating": 8.658247192583133, "circulating nt": 7.635246515022862, "targeting nonglycosylated": 9.29923091812682, "plasma collected": 8.01797756645451, "immunoreactive nt": 8.191848839997071, "multiple n-": 6.944975542925487, "terminally truncated": 8.658247192583133, "truncated fragments": 8.511001466296774, "full length": 6.944975542925487, "terminal regions": 8.01797756645451, "findings support": 8.01797756645451, "next generation": 7.832953288875434, "assay targeting": 7.832953288875434, "targeting nonterminal": 8.798342187639646, "central glycosylated": 8.658247192583133, "glycosylated region": 8.511001466296774, "versus concentric": 8.191848839997071, "concentric left": 7.832953288875434, "ventricular hypertrophy": 9.05964189305739, "concentric remodeling": 8.798342187639646, "concentric hypertrophy": 8.931948929008138, "common forms": 7.193870284774465, "eccentric hypertrophy": 8.798342187639646, "also occur": 6.672566775728865, "well described": 7.635246515022862, "prospectively studied": 8.798342187639646, "normal geometry": 7.832953288875434, "relative wall": 7.422989813300176, "compared clinical": 8.191848839997071, "outcome data": 7.193870284774465, "data among": 6.672566775728865, "among groups": 7.193870284774465, "lower systolic": 7.635246515022862, "less renal": 6.672566775728865, "renal impairment": 8.01797756645451, "similar rates": 7.422989813300176, "contractility compared": 8.931948929008138, "lower lvef": 6.672566775728865, "-1.1 %": 5.217618485351048, "also associated": 7.832953288875434, "compliance compared": 8.511001466296774, "similarly elevated": 8.355835584391686, "elevated cardiac": 8.01797756645451, "equivalent adverse": 8.355835584391686, "distinct subset": 7.832953288875434, "pathophysiologically similar": 9.624996450667128, "using time": 6.672566775728865, "dependent cox": 7.422989813300176, "compared patients": 8.191848839997071, "different types": 7.832953288875434, "antitachycardia pacing": 8.931948929008138, "secondary endpoints": 8.511001466296774, "atrial tachyarrhythmias": 9.05964189305739, "also evaluated": 7.635246515022862, "therapy occurred": 8.01797756645451, "\u00b1 1.1": 4.700994494168267, "decreased risk": 7.635246515022862, "inappropriate shock": 8.511001466296774, "therapy caused": 7.635246515022862, "also reduced": 7.193870284774465, "general use": 6.944975542925487, "receiving metoprolol": 8.658247192583133, "nationwide retrospective": 9.181922482685199, "matched subjects": 8.01797756645451, "hazard analyses": 7.832953288875434, "absolute risk": 7.422989813300176, "exposed group": 7.422989813300176, "crude rr": 6.035843815994525, "rr 1.71": 5.65563804923464, "ci 1.34": 5.65563804923464, "by comparison": 7.422989813300176, "different mechanism": 8.511001466296774, "hr 1.07": 5.65563804923464, "ci 0.76": 5.65563804923464, "used bisphosphonates": 8.658247192583133, "analysed separately": 8.511001466296774, "significant trends": 8.355835584391686, "observed across": 7.832953288875434, "across refill": 7.422989813300176, "compliance strata": 8.191848839997071, "failure increased": 8.191848839997071, "increasing refill": 8.191848839997071, "failure compared": 8.01797756645451, "control subjects": 8.01797756645451, "alendronate showed": 8.355835584391686, "dependent reduction": 8.511001466296774, "subcellular alterations": 9.05964189305739, "alterations by": 7.635246515022862, "weeks infarcted": 7.832953288875434, "infarcted rats": 7.635246515022862, "without metoprolol": 8.355835584391686, "depressed left": 7.635246515022862, "negative rates": 7.635246515022862, "pressure development": 8.658247192583133, "weeks mi": 6.035843815994525, "mi animals": 6.672566775728865, "induced decreases": 8.191848839997071, "internal diameter": 8.191848839997071, "fully reversible": 8.01797756645451, "metoprolol partially": 8.658247192583133, "plasma norepinephrine": 8.798342187639646, "dopamine without": 8.01797756645451, "sarcoplasmic reticular": 8.931948929008138, "protein content": 7.832953288875434, "infarcted hearts": 8.01797756645451, "partially reversible": 8.658247192583133, "depressed myofibrillar": 8.931948929008138, "myofibrillar ca(2+)-stimulated": 9.82338316374468, "increased mrna": 7.635246515022862, "mrna level": 6.672566775728865, "partial improvement": 8.511001466296774, "cardiac performance": 8.511001466296774, "advanced stages": 7.832953288875434, "partial reversal": 8.01797756645451, "complete reverse": 8.01797756645451, "reverse cardiac": 7.832953288875434, "partial reduction": 8.191848839997071, "plasma catecholamines": 8.798342187639646, "incident cardiovascular": 9.05964189305739, "independent risk": 8.01797756645451, "available studies": 8.191848839997071, "shown inconsistent": 8.355835584391686, "inconsistent results": 8.658247192583133, "embedded within": 7.832953288875434, "cardiovascular outcomes": 9.05964189305739, "adjusted means": 7.635246515022862, "subclinical atherosclerosis": 9.520441892933018, "atherosclerosis using": 8.798342187639646, "using general": 7.422989813300176, "general linear": 7.635246515022862, "dependent variable": 8.355835584391686, "% systemic": 6.672566775728865, "uv treatment": 7.193870284774465, "higher diastolic": 8.01797756645451, "diastolic blood": 7.832953288875434, "index levels": 7.193870284774465, "adjusted carotid": 8.01797756645451, "carotid intima": 7.635246515022862, "media thickness": 7.832953288875434, "adjusted ankle": 7.635246515022862, "wave velocity": 7.422989813300176, "artery calcium": 7.635246515022862, "calcium scores": 7.635246515022862, "ratio 0.73": 6.672566775728865, "interval 0.50": 7.422989813300176, "analyzed separately": 8.511001466296774, "predominantly mild": 8.355835584391686, "mild disease": 7.193870284774465, "develop atherosclerosis": 9.05964189305739, "subjects without": 8.01797756645451, "without psoriasis": 8.191848839997071, "share many": 6.672566775728865, "many risk": 6.3717330906226675, "fully examined": 7.635246515022862, "defined by": 6.672566775728865, "levels \u2265": 6.035843815994525, "low bnp": 5.65563804923464, "transmitral e": 7.422989813300176, "analysis established": 8.658247192583133, "highest quartile": 8.01797756645451, "pad suggests": 7.193870284774465, "routine bnp": 6.944975542925487, "hospital readmission": 8.658247192583133, "readmission reduction": 8.798342187639646, "reduction program": 8.191848839997071, "rate following": 7.635246515022862, "following hospital": 8.355835584391686, "hospital stay": 7.422989813300176, "percent nationally": 8.355835584391686, "indicating possible": 8.511001466296774, "possible suboptimal": 8.511001466296774, "suboptimal care": 7.832953288875434, "significant economic": 8.658247192583133, "economic considerations": 9.05964189305739, "center pilot": 7.193870284774465, "pilot project": 7.422989813300176, "cardiac specialty": 8.191848839997071, "specialty hospital": 8.355835584391686, "predominantly rural": 8.511001466296774, "rural south": 6.944975542925487, "ensure adequate": 7.832953288875434, "adequate self": 7.422989813300176, "management training": 8.511001466296774, "patient follow": 7.635246515022862, "percent relative": 8.01797756645451, "relative reduction": 8.355835584391686, "patients participating": 8.931948929008138, "pilot program": 7.422989813300176, "this represented": 8.01797756645451, "net economic": 7.193870284774465, "economic savings": 8.01797756645451, "even accounting": 7.832953288875434, "added cost": 6.672566775728865, "program decreases": 8.191848839997071, "urbanized midwestern": 8.658247192583133, "midwestern state": 8.01797756645451, "state like": 6.672566775728865, "extensively studied": 8.511001466296774, "patients surviving": 8.355835584391686, "mortality within": 8.01797756645451, "hr dynamics": 6.944975542925487, "linear measures": 7.832953288875434, "prognostic power": 8.01797756645451, "reflecting rapid": 8.01797756645451, "rapid r": 5.65563804923464, "r interval": 6.672566775728865, "interval oscillations": 8.798342187639646, "almost identical": 8.01797756645451, "linear hr": 6.3717330906226675, "variability measures": 8.658247192583133, "term fractal": 7.193870284774465, "fractal scaling": 7.832953288875434, "scaling exponent": 8.01797756645451, "provided somewhat": 8.191848839997071, "somewhat better": 7.832953288875434, "better prognostic": 8.191848839997071, "variability predicts": 8.658247192583133, "arrhythmia substrate": 8.658247192583133, "early measurement": 8.191848839997071, "repeated later": 7.635246515022862, "fatal arrhythmia": 8.01797756645451, "arrhythmia events": 8.191848839997071, "future randomized": 8.191848839997071, "trials using": 7.193870284774465, "using hr": 6.035843815994525, "defined inclusion": 8.191848839997071, "show whether": 7.193870284774465, "routine measurement": 8.511001466296774, "routine clinical": 8.01797756645451, "renal artery": 7.193870284774465, "peripheral arterial": 8.511001466296774, "arterial disease": 8.01797756645451, "predominantly unilateral": 9.181922482685199, "pathophysiologic mechanism": 9.411955803365045, "mechanism stems": 7.832953288875434, "renal underperfusion": 8.658247192583133, "underperfusion resulting": 9.181922482685199, "renin- angiotensin": 8.355835584391686, "aldosterone pathway": 8.511001466296774, "clinically present": 8.355835584391686, "resistant hypertension": 8.931948929008138, "stage kidney": 7.193870284774465, "kidney failure": 7.635246515022862, "screening patients": 8.355835584391686, "computed tomographic": 8.658247192583133, "tomographic angiography": 9.05964189305739, "resonance angiography": 8.798342187639646, "adequate blood": 7.635246515022862, "pressure control": 8.01797756645451, "directed lipid": 7.635246515022862, "lowering therapy": 8.01797756645451, "smoking cessation": 8.191848839997071, "preventive measures": 8.511001466296774, "measures form": 7.422989813300176, "based percutaneous": 8.355835584391686, "percutaneous revascularization": 9.82338316374468, "stenting showed": 7.832953288875434, "showed modest": 7.422989813300176, "modest clinical": 7.832953288875434, "small retrospective": 8.511001466296774, "retrospective studies": 8.798342187639646, "randomized clinical": 8.511001466296774, "trials failed": 7.422989813300176, "beneficial results": 8.355835584391686, "current ongoing": 7.832953288875434, "ongoing cardiovascular": 8.931948929008138, "concrete data": 7.422989813300176, "surgical revascularization": 9.411955803365045, "based revascularization": 9.05964189305739, "determining individualized": 9.411955803365045, "individualized assessment": 9.29923091812682, "treatment plans": 7.832953288875434, "bioinformatic analysis": 8.931948929008138, "microarray data": 7.832953288875434, "data reveals": 7.193870284774465, "reveals several": 7.832953288875434, "several key": 6.944975542925487, "key genes": 6.3717330906226675, "genes related": 7.422989813300176, "problem worldwide": 8.191848839997071, "still unclear": 7.422989813300176, "study aims": 6.672566775728865, "discover differentially": 9.05964189305739, "expressed genes": 7.832953288875434, "normal samples": 7.635246515022862, "ischemic samples": 8.01797756645451, "data processing": 7.832953288875434, "differential analysis": 8.798342187639646, "also performed": 7.635246515022862, "globally observe": 8.01797756645451, "overlapping part": 8.01797756645451, "programmed cell": 7.832953288875434, "cell death": 6.672566775728865, "common degs": 6.944975542925487, "develop treatments": 8.355835584391686, "longitudinal analysis": 8.798342187639646, "using medicare": 7.635246515022862, "medicare data": 7.422989813300176, "evaluate mortality": 8.355835584391686, "healthcare utilization": 8.931948929008138, "utilization effects": 8.511001466296774, "combined care": 7.422989813300176, "targeting individuals": 8.798342187639646, "retrospective matched": 8.798342187639646, "matched cohort": 7.635246515022862, "demonstration participating": 9.520441892933018, "participating clinics": 8.798342187639646, "score matched": 7.422989813300176, "telehealth system": 8.191848839997071, "year study": 6.672566775728865, "negative binomial": 8.191848839997071, "binomial regression": 8.511001466296774, "health characteristics": 8.931948929008138, "statistically different": 9.05964189305739, "participants offered": 8.658247192583133, "quarterly inpatient": 8.511001466296774, "% greater": 6.3717330906226675, "time period": 6.944975542925487, "no relationship": 7.832953288875434, "fewer admissions": 8.01797756645451, "management coupled": 8.355835584391686, "telehealth technology": 8.798342187639646, "improve health": 7.635246515022862, "contemporary chronic": 8.658247192583133, "training response": 8.191848839997071, "well established": 8.01797756645451, "explore interactions": 8.658247192583133, "examined characteristics": 9.181922482685199, "race using": 6.672566775728865, "using adjusted": 7.635246515022862, "identified black": 8.01797756645451, "black patients": 7.635246515022862, "less ischemic": 7.422989813300176, "ischemic etiology": 8.191848839997071, "lower socioeconomic": 8.511001466296774, "socioeconomic status": 8.658247192583133, "status versus": 7.422989813300176, "versus whites": 7.422989813300176, "lower peak": 6.672566775728865, "after multivariable": 8.511001466296774, "hazard associated": 8.191848839997071, "largely caused": 7.635246515022862, "given similar": 7.422989813300176, "similar cardiovascular": 8.931948929008138, "increased prevalence": 8.658247192583133, "modifiable risk": 7.832953288875434, "improving outcomes": 8.355835584391686, "therapy including": 8.191848839997071, "including anticoagulation": 9.29923091812682, "major cardiovascular": 8.658247192583133, "prevent adverse": 7.832953288875434, "outcomes related": 8.01797756645451, "moderately effective": 8.658247192583133, "published trials": 8.01797756645451, "side effects": 7.193870284774465, "repeated interventions": 8.931948929008138, "therapy applied": 7.832953288875434, "first diagnosis": 7.832953288875434, "preserve atrial": 7.832953288875434, "atrial structure": 8.01797756645451, "maintain sinus": 7.635246515022862, "current practice": 8.01797756645451, "delayed rhythm": 7.635246515022862, "symptoms persist": 8.01797756645451, "otherwise effective": 8.511001466296774, "new antiarrhythmic": 8.355835584391686, "potential effectiveness": 9.05964189305739, "modern rhythm": 7.422989813300176, "reduce cardiovascular": 8.798342187639646, "randomize approximately": 9.05964189305739, "onset af": 6.035843815994525, "mandated usual": 7.635246515022862, "blinded outcome": 7.832953288875434, "outcome assessment": 8.355835584391686, "assessment trial": 8.01797756645451, "composite primary": 8.191848839997071, "nights spent": 7.193870284774465, "coprimary outcome": 8.191848839997071, "underlying heart": 8.01797756645451, "initial approach": 8.01797756645451, "operated electrocardiographic": 9.725894496041844, "electrocardiographic device": 9.520441892933018, "ongoing rhythm": 7.635246515022862, "key secondary": 7.422989813300176, "outcomes include": 8.01797756645451, "include cognitive": 8.191848839997071, "cognitive function": 8.355835584391686, "initial diagnosis": 8.191848839997071, "prevent cardiovascular": 8.931948929008138, "complications associated": 9.181922482685199, "cardiac nurse": 7.422989813300176, "term ventricular": 8.01797756645451, "care providers": 7.635246515022862, "managing clinically": 8.511001466296774, "significant gastrointestinal": 9.624996450667128, "units accustomed": 8.01797756645451, "often asked": 6.944975542925487, "possible causes": 7.832953288875434, "subspecialty groups": 8.511001466296774, "dependent increase": 8.355835584391686, "leading causes": 7.635246515022862, "hospitalisation among": 8.798342187639646, "worldwide increase": 8.355835584391686, "advanced phase": 7.635246515022862, "called end": 6.672566775728865, "steadily growing": 8.01797756645451, "failure fall": 7.193870284774465, "functional classification": 9.29923091812682, "advanced structural": 8.511001466296774, "structural heart": 8.01797756645451, "pronounced symptoms": 8.511001466296774, "minimal physical": 8.01797756645451, "physical exertion": 8.191848839997071, "maximal medical": 7.832953288875434, "treatment according": 8.511001466296774, "mortality rate": 7.635246515022862, "requires special": 8.01797756645451, "special therapeutic": 8.511001466296774, "every attempt": 7.422989813300176, "correct reversible": 8.355835584391686, "reversible causes": 8.191848839997071, "poor patient": 7.193870284774465, "myocardial ischaemia": 8.658247192583133, "valvular regurgitation": 8.931948929008138, "describe current": 8.01797756645451, "current strategies": 8.355835584391686, "potent inhibition": 8.191848839997071, "type ca2": 6.035843815994525, "variant associated": 8.355835584391686, "influx via": 6.672566775728865, "via l": 4.700994494168267, "type voltage": 7.193870284774465, "channels supports": 8.191848839997071, "plateau phase": 7.422989813300176, "action potentials": 8.191848839997071, "monomeric g": 6.944975542925487, "g proteins": 6.672566775728865, "regulates ventricular": 8.798342187639646, "action potential": 8.01797756645451, "potential duration": 8.355835584391686, "coupling gain": 7.422989813300176, "inhibit cardiac": 7.832953288875434, "cardiac l": 6.3717330906226675, "channel activity": 8.01797756645451, "potential dysfunction": 8.798342187639646, "naturally occurring": 8.511001466296774, "occurring rad": 7.422989813300176, "rad variant": 6.944975542925487, "even eliminates": 7.832953288875434, "inhibitory actions": 8.355835584391686, "channel isoforms": 8.01797756645451, "isoforms known": 7.635246515022862, "murine equivalent": 8.191848839997071, "human rad": 6.3717330906226675, "inhibits l": 6.672566775728865, "type currents": 7.422989813300176, "currents conducted": 8.355835584391686, "cav1.3 channels": 7.832953288875434, "channels as": 6.944975542925487, "% inhibition": 7.193870284774465, "gating movement": 7.832953288875434, "differentially impair": 8.798342187639646, "described modes": 7.832953288875434, "inhibit l": 6.3717330906226675, "dependent processes": 8.511001466296774, "processes per": 7.422989813300176, "per se": 5.217618485351048, "rule out": 6.035843815994525, "decreased expression": 8.658247192583133, "altered regulation": 8.355835584391686, "young adult": 6.944975542925487, "severe anemia": 7.422989813300176, "ethically complex": 8.191848839997071, "complex situations": 8.355835584391686, "involving families": 8.355835584391686, "religious beliefs": 8.191848839997071, "beliefs preclude": 8.01797756645451, "involving young": 7.832953288875434, "legal majority": 7.635246515022862, "face decisions": 7.635246515022862, "decisions about": 7.832953288875434, "this month": 6.672566775728865, "complexities overlapped": 9.05964189305739, "old jehovah": 6.944975542925487, "sickle cell": 6.944975542925487, "cell disease": 7.193870284774465, "threatening anemia": 8.355835584391686, "doctors urgently": 8.01797756645451, "urgently recommend": 8.355835584391686, "recommend blood": 7.832953288875434, "young woman": 6.944975542925487, "family adamantly": 8.01797756645451, "adamantly refuse": 8.01797756645451, "doctors let": 6.944975542925487, "common inpatient": 8.01797756645451, "inpatient medical": 8.191848839997071, "medical conditions": 8.355835584391686, "public reporting": 8.01797756645451, "quality aims": 7.193870284774465, "patients select": 7.832953288875434, "select better": 7.422989813300176, "better hospitals": 8.01797756645451, "individual quality": 8.355835584391686, "identifying superior": 8.658247192583133, "inferior hospitals": 8.355835584391686, "hospitals based": 7.832953288875434, "outcome performance": 8.511001466296774, "combine structure": 8.191848839997071, "empirically derived": 8.511001466296774, "derived composite": 8.191848839997071, "quality measure": 7.832953288875434, "composite measure": 8.191848839997071, "measure predicts": 8.01797756645451, "predicts future": 7.832953288875434, "explains variance": 8.191848839997071, "future hospital": 7.832953288875434, "hospital mortality": 8.355835584391686, "using national": 7.635246515022862, "national medicare": 8.191848839997071, "care hospital": 7.422989813300176, "ranked hospitals": 8.01797756645451, "existing quality": 8.01797756645451, "quality indicators": 8.355835584391686, "including mortality": 8.511001466296774, "future ami": 6.672566775728865, "performance using": 8.191848839997071, "composite measures": 8.355835584391686, "existing measures": 8.191848839997071, "explaining variation": 8.658247192583133, "future mortality": 8.01797756645451, "predicting future": 8.191848839997071, "hyperkalemia caused": 8.511001466296774, "influences efficacy": 8.511001466296774, "assessed hyperkalemia": 8.798342187639646, "african americans": 8.191848839997071, "ischemic hf": 6.944975542925487, "class iv": 6.035843815994525, "higher estimated": 8.01797756645451, "less hypertension": 8.191848839997071, "infarction compared": 8.511001466296774, "potassium increased": 8.511001466296774, "treatment interaction": 8.798342187639646, "remained higher": 7.832953288875434, "attain maximal": 7.635246515022862, "maximal spironolactone": 8.931948929008138, "spironolactone dose": 8.511001466296774, "higher rates": 7.193870284774465, "achieved study": 7.635246515022862, "study drug": 6.672566775728865, "drug dose": 6.3717330906226675, "spironolactone reduced": 8.931948929008138, "exhibited less": 7.635246515022862, "less hyperkalemia": 8.191848839997071, "spironolactone compared": 9.05964189305739, "derive less": 6.944975542925487, "less clinical": 7.422989813300176, "these hypothesis": 8.01797756645451, "generating findings": 8.511001466296774, "targeted peptides": 8.191848839997071, "targeted antioxidant": 8.658247192583133, "protective peptides": 8.511001466296774, "proteomic remodeling": 8.658247192583133, "improved label": 7.635246515022862, "free shotgun": 7.193870284774465, "shotgun proteomics": 8.355835584391686, "proteomics approach": 8.511001466296774, "tac)-induced heart": 8.355835584391686, "associated signaling": 8.658247192583133, "pathway changes": 7.832953288875434, "changes using": 7.422989813300176, "using ingenuity": 7.832953288875434, "proteins significantly": 8.931948929008138, "top pathways": 7.193870284774465, "intermediate metabolism": 9.05964189305739, "citrate cycle": 7.422989813300176, "concomitant treatment": 8.798342187639646, "failure phenotypes": 8.355835584391686, "mitochondrial damage": 8.658247192583133, "damage induced": 7.635246515022862, "mitochondrial proteome": 8.931948929008138, "proteome changes": 8.01797756645451, "% protection": 7.193870284774465, "nonmitochondrial protein": 9.181922482685199, "protein changes": 7.832953288875434, "this included": 7.422989813300176, "included significant": 8.658247192583133, "significant amelioration": 9.181922482685199, "analysis noted": 7.635246515022862, "modest effects": 7.635246515022862, "partial attenuation": 8.511001466296774, "cytoskeleton pathways": 8.798342187639646, "significantly protected": 9.05964189305739, "metabolic pathways": 8.355835584391686, "pathways essentially": 8.658247192583133, "study elucidates": 8.01797756645451, "pathways significantly": 8.931948929008138, "induced proteomic": 8.191848839997071, "proteomic alterations": 8.798342187639646, "perturbed mitochondrial": 9.05964189305739, "upstream signal": 7.832953288875434, "pathway alterations": 8.511001466296774, "potential clinical": 8.355835584391686, "peptide drugs": 7.422989813300176, "treatment heart": 7.832953288875434, "reducing length": 7.832953288875434, "stay increase": 7.422989813300176, "increase rehospitalization": 9.411955803365045, "medicare fee": 7.193870284774465, "beneficiaries discharged": 9.181922482685199, "skilled nursing": 7.832953288875434, "nursing facilities": 8.355835584391686, "hospitals nationwide": 8.658247192583133, "beneficiaries associated": 9.181922482685199, "rehospitalization derived": 9.29923091812682, "hospital claims": 7.832953288875434, "claims using": 7.193870284774465, "policy led": 6.672566775728865, "immediate declines": 8.355835584391686, "day decrease": 7.193870284774465, "absolute increase": 8.191848839997071, "= 0.03": 5.217618485351048, "urinary tract": 7.422989813300176, "tract infection": 7.832953288875434, "individuals hospitalized": 9.181922482685199, "ami without": 6.944975542925487, "day reduction": 7.422989813300176, "hospital length": 7.832953288875434, "consistently associated": 9.05964189305739, "higher rate": 6.944975542925487, "urgent need": 6.944975542925487, "reduce costs": 7.193870284774465, "undergoing procedures": 8.798342187639646, "medically managed": 8.191848839997071, "managed diseases": 8.01797756645451, "well understood": 7.832953288875434, "inpatient data": 7.635246515022862, "care hospitals": 7.635246515022862, "divided physicians": 8.355835584391686, "quintiles according": 8.511001466296774, "used patient": 7.193870284774465, "level regression": 8.01797756645451, "costs across": 7.193870284774465, "across volume": 7.422989813300176, "hospital characteristics": 9.181922482685199, "examined physician": 8.355835584391686, "volume within": 7.422989813300176, "within strata": 7.422989813300176, "physician specialty": 8.511001466296774, "physicians had": 7.635246515022862, "volume hospitals": 8.01797756645451, "higher readmission": 8.355835584391686, "volume institutions": 8.511001466296774, "among noncardiologist": 8.798342187639646, "noncardiologist physicians": 9.411955803365045, "clinician expertise": 8.511001466296774, "neurohormone known": 8.355835584391686, "affect electrolytes": 8.511001466296774, "major clinical": 7.635246515022862, "trials designed": 7.832953288875434, "analyze clinical": 8.01797756645451, "outcomes using": 7.635246515022862, "symptomatic chronic": 8.511001466296774, "mortality significantly": 9.05964189305739, "significantly compared": 8.931948929008138, "standard therapy": 8.01797756645451, "beta blockade": 7.422989813300176, "another study": 7.422989813300176, "infarction patients": 8.511001466296774, "patients randomized": 8.511001466296774, "antagonist eplerenone": 8.798342187639646, "these trial": 6.944975542925487, "trial results": 7.422989813300176, "results provide": 7.832953288875434, "improving survival": 8.355835584391686, "based management": 8.01797756645451, "contemporary therapeutic": 9.181922482685199, "substantial improvement": 9.05964189305739, "limited evidence": 8.01797756645451, "available specifically": 8.931948929008138, "thus examined": 7.422989813300176, "examined changes": 8.01797756645451, "large idiopathic": 8.01797756645451, "cardiomyopathy cohort": 8.798342187639646, "cohort systematically": 8.798342187639646, "systematically followed": 9.05964189305739, "53\u00b112 years": 6.944975542925487, "32\u00b110 %": 5.65563804923464, "including negative": 8.355835584391686, "negative coronary": 8.191848839997071, "enrollment periods": 8.355835584391686, "failure treatment": 8.191848839997071, "treatment eras": 7.635246515022862, "receiving angiotensin": 8.798342187639646, "angiotensin receptors": 8.798342187639646, "receptors blockers": 8.355835584391686, "final evaluation": 8.01797756645451, "evaluation increased": 8.658247192583133, "toward enrollment": 8.191848839997071, "severe left": 6.944975542925487, "point including": 7.832953288875434, "including death": 7.832953288875434, "failure related": 7.832953288875434, "recent enrollment": 8.191848839997071, "enrollment period": 8.191848839997071, "period represented": 8.355835584391686, "powerful independent": 8.658247192583133, "each period": 6.944975542925487, "% risk": 5.217618485351048, "risk reduction": 7.635246515022862, "reduction versus": 8.01797756645451, "reflecting marked": 8.191848839997071, "marked decreases": 8.01797756645451, "related mortality": 8.191848839997071, "based treatment": 7.832953288875434, "dramatic improvement": 8.658247192583133, "controlled randomized": 8.798342187639646, "real world": 6.672566775728865, "tailored follow": 7.832953288875434, "term continuity": 7.832953288875434, "indeterminable anaerobic": 9.181922482685199, "maximal cardiopulmonary": 9.05964189305739, "always identified": 8.191848839997071, "prognostic meaning": 8.355835584391686, "prospectively followed": 8.931948929008138, "dedicated hf": 7.193870284774465, "stable clinical": 7.832953288875434, "clinical conditions": 8.511001466296774, "underwent clinical": 8.355835584391686, "test investigations": 8.511001466296774, "study enrollment": 8.01797756645451, "maximal exercise": 8.01797756645451, "anaerobic metabolism": 8.658247192583133, "peak respiratory": 8.01797756645451, "respiratory quotient": 8.658247192583133, "quotient \u22641.05": 7.635246515022862, "urgent cardiac": 7.635246515022862, "multivariable logistic": 8.931948929008138, "logistic analysis": 8.191848839997071, "resulted significantly": 8.931948929008138, "reduced peak": 7.193870284774465, "higher metabolic": 8.01797756645451, "score value": 6.944975542925487, "powerful prognostic": 8.511001466296774, "prognostic composite": 8.658247192583133, "composite hf": 7.193870284774465, "multivariable analysis": 8.931948929008138, "% pred": 5.217618485351048, "ventilatory efficiency": 8.931948929008138, "efficiency slope": 8.01797756645451, "at nonidentification": 8.658247192583133, "prognosis also": 7.635246515022862, "secondary study": 7.832953288875434, "identify at": 6.944975542925487, "often occurs": 7.193870284774465, "prognostic role": 7.832953288875434, "failure mortality": 8.191848839997071, "joint associations": 8.355835584391686, "associations among": 8.355835584391686, "among cardiorespiratory": 9.05964189305739, "additive effect": 7.832953288875434, "increasing number": 8.191848839997071, "versus unfit": 7.193870284774465, "men without": 6.944975542925487, "disease underwent": 8.191848839997071, "baseline examination": 8.658247192583133, "measures included": 8.191848839997071, "included body": 7.422989813300176, "maximal treadmill": 8.191848839997071, "treadmill exercise": 8.355835584391686, "specific low": 7.193870284774465, "high crf": 6.035843815994525, "deaths occurred": 7.832953288875434, "ratios across": 7.422989813300176, "across high": 6.944975542925487, "low crf": 5.65563804923464, "obese body": 6.672566775728865, "index categories": 8.01797756645451, "when grouped": 7.193870284774465, "fit compared": 7.193870284774465, "overweight body": 7.832953288875434, "index strata": 7.193870284774465, "obese men": 6.3717330906226675, "within men": 6.672566775728865, "men matched": 6.944975542925487, "fit men": 5.65563804923464, "factors present": 7.832953288875434, "moderate level": 7.635246515022862, "presumably decreasing": 8.798342187639646, "mitochondrial energy": 8.658247192583133, "energy production": 8.191848839997071, "production precede": 8.355835584391686, "overload hypertrophy": 8.658247192583133, "significant alterations": 9.05964189305739, "metabolism precede": 8.355835584391686, "hypertrophied heart": 8.511001466296774, "hypertrophy secondary": 8.798342187639646, "abdominal aortic": 8.01797756645451, "energy substrate": 8.01797756645451, "substrate metabolism": 8.658247192583133, "isolated working": 8.01797756645451, "working hearts": 7.635246515022862, "hearts obtained": 7.832953288875434, "mice subjected": 7.635246515022862, "progressive development": 9.05964189305739, "vivo assessment": 7.832953288875434, "via echocardiography": 8.658247192583133, "demonstrated diastolic": 8.931948929008138, "dysfunction by": 7.635246515022862, "% ejection": 6.672566775728865, "marked cardiac": 7.635246515022862, "stimulated rates": 8.01797756645451, "glucose oxidation": 8.191848839997071, "membrane translocation": 8.931948929008138, "glucose transporter": 8.511001466296774, "overall atp": 6.944975542925487, "production rates": 8.01797756645451, "decreased at": 7.193870284774465, "mitochondrial oxidation": 9.05964189305739, "fatty acids": 6.944975542925487, "myocardial glycolysis": 8.798342187639646, "glycolysis rates": 8.01797756645451, "reduced mitochondrial": 8.798342187639646, "mitochondrial complex": 8.798342187639646, "complex v": 6.3717330906226675, "v activity": 6.672566775728865, "oxidative metabolism": 8.658247192583133, "early metabolic": 7.832953288875434, "metabolic changes": 8.191848839997071, "energy deficit": 7.635246515022862, "guide health": 7.193870284774465, "service planning": 8.01797756645451, "relevant health": 7.832953288875434, "service provision": 8.191848839997071, "provision related": 8.191848839997071, "well delineated": 7.832953288875434, "systematic search": 8.191848839997071, "reduced gross": 7.422989813300176, "gross income": 7.193870284774465, "heterogeneous region": 8.658247192583133, "nondeveloped countries": 8.931948929008138, "including lower": 7.832953288875434, "raised blood": 7.193870284774465, "blood glucose": 7.422989813300176, "glucose levels": 7.635246515022862, "systemic hypertension": 8.798342187639646, "main etiologies": 7.832953288875434, "alcohol related": 7.832953288875434, "main cause": 6.672566775728865, "awful paradox": 7.422989813300176, "added factors": 7.422989813300176, "lower gross": 6.944975542925487, "gross national": 7.635246515022862, "national income": 7.832953288875434, "income per": 6.672566775728865, "new strategies": 7.635246515022862, "previously linked": 8.191848839997071, "individuals aged": 8.01797756645451, "renal chloride": 7.635246515022862, "chloride channel": 8.01797756645451, "channel gene": 7.193870284774465, "total cholesterol": 8.191848839997071, "novel finding": 7.422989813300176, "partly explain": 7.635246515022862, "reported greater": 8.01797756645451, "failure linked": 7.635246515022862, "requires confirmation": 8.798342187639646, "ambient air": 6.944975542925487, "recognised risk": 7.832953288875434, "important trigger": 8.191848839997071, "colleagues provide": 8.355835584391686, "new systematic": 7.635246515022862, "common disorder": 7.832953288875434, "disorder associated": 8.511001466296774, "high morbidity": 7.635246515022862, "elderly people": 7.635246515022862, "pollution experienced": 8.798342187639646, "industrial areas": 8.01797756645451, "aggravate cardiovascular": 9.181922482685199, "cardiac overexpression": 8.931948929008138, "exacerbates heart": 8.191848839997071, "key regulator": 7.422989813300176, "cytoskeletal actin": 8.355835584391686, "actin dynamics": 7.635246515022862, "previously demonstrated": 9.05964189305739, "cardiac mena": 7.193870284774465, "deletion produced": 8.191848839997071, "produced cardiac": 8.01797756645451, "conduction abnormalities": 9.181922482685199, "expression correlates": 8.798342187639646, "precise role": 7.193870284774465, "cardiac pathophysiology": 9.05964189305739, "evaluated mice": 7.635246515022862, "cardiac myocyte": 7.832953288875434, "specific mena": 7.422989813300176, "cardiac pathology": 8.191848839997071, "morphologically comparable": 9.411955803365045, "type littermates": 8.01797756645451, "mildly increased": 8.01797756645451, "increased heart": 7.832953288875434, "heart mass": 6.672566775728865, "transgenic mice": 7.832953288875434, "particularly susceptible": 9.181922482685199, "animals experienced": 8.511001466296774, "experienced pronounced": 8.931948929008138, "pronounced decreases": 8.658247192583133, "heart dilatation": 8.01797756645451, "levels eliminated": 8.191848839997071, "eliminated cardiac": 8.355835584391686, "preclude post": 7.422989813300176, "tac cardiac": 6.944975542925487, "cardiac functional": 8.355835584391686, "functional deterioration": 9.181922482685199, "findings indicate": 8.191848839997071, "increased levels": 8.01797756645451, "fare worse": 6.672566775728865, "mechanical support": 8.355835584391686, "support devices": 7.832953288875434, "considerable number": 8.511001466296774, "patients eventually": 8.511001466296774, "eventually reach": 8.01797756645451, "diagnostic procedure": 8.658247192583133, "alternative treatments": 8.931948929008138, "slow progression": 8.01797756645451, "palliative care": 7.832953288875434, "accurate recognition": 8.658247192583133, "advanced disease": 8.01797756645451, "overall management": 8.355835584391686, "failure requires": 8.01797756645451, "multiple disciplines": 8.658247192583133, "collaboration among": 8.511001466296774, "among cardiologists": 8.511001466296774, "cardiovascular surgeons": 9.05964189305739, "medical staff": 7.422989813300176, "staff responsible": 8.191848839997071, "patient care": 7.193870284774465, "physicians experienced": 8.931948929008138, "distributed evenly": 8.355835584391686, "equitable access": 8.01797756645451, "made regarding": 7.635246515022862, "regarding appropriate": 8.798342187639646, "appropriate referrals": 8.798342187639646, "patient circulation": 8.511001466296774, "present consensus": 8.191848839997071, "consensus report": 8.01797756645451, "experienced centers": 8.511001466296774, "patients irrespective": 8.798342187639646, "disease phase": 7.422989813300176, "healthcare staff": 8.01797756645451, "raise awareness": 7.832953288875434, "provide information": 8.511001466296774, "information regarding": 8.798342187639646, "regarding conditions": 8.658247192583133, "other antihyperglycemic": 9.05964189305739, "recent postmarketing": 8.658247192583133, "postmarketing trials": 8.658247192583133, "trials produced": 7.832953288875434, "produced conflicting": 8.658247192583133, "conflicting results": 8.511001466296774, "hospitalized heart": 8.355835584391686, "dipeptidyl peptidase-4": 8.931948929008138, "creating uncertainty": 8.658247192583133, "user cohort": 6.944975542925487, "health insurance": 8.01797756645451, "health system": 7.422989813300176, "system data": 6.944975542925487, "data partners": 7.422989813300176, "patients aged": 7.422989813300176, "initiated therapy": 8.191848839997071, "generation sulfonylureas": 9.181922482685199, "acting insulin": 7.635246515022862, "insulin products": 8.01797756645451, "codes 402.x1": 7.193870284774465, "principal discharge": 8.511001466296774, "discharge diagnosis": 8.511001466296774, "saxagliptin users": 8.191848839997071, "sitagliptin users": 8.191848839997071, "users contributed": 8.191848839997071, "pairwise comparisons": 8.658247192583133, "study drugs": 6.944975542925487, "disease risk": 7.193870284774465, "risk score": 6.672566775728865, "versus sitagliptin": 8.355835584391686, "stratified hazard": 8.191848839997071, "matched analyses": 8.01797756645451, "also similar": 7.193870284774465, "without prior": 7.422989813300176, "prior cardiovascular": 8.658247192583133, "subgroup defined": 8.01797756645451, "highest drs": 6.944975542925487, "residual confounding": 8.658247192583133, "short follow": 7.193870284774465, "sitagliptin compared": 8.658247192583133, "selected antihyperglycemic": 9.411955803365045, "improving physician": 8.511001466296774, "guideline recommendations": 9.29923091812682, "review protocol": 7.832953288875434, "remains suboptimal": 8.355835584391686, "identify implementation": 9.05964189305739, "improve physician": 8.191848839997071, "clear evidence": 7.635246515022862, "benefits outweigh": 8.191848839997071, "use american": 7.193870284774465, "literature search": 8.191848839997071, "include prospective": 8.511001466296774, "prospective studies": 8.511001466296774, "evaluating implementation": 9.29923091812682, "implementation interventions": 9.624996450667128, "interventions aimed": 8.511001466296774, "improving uptake": 8.01797756645451, "extract data": 7.193870284774465, "classify interventions": 8.931948929008138, "interventions according": 9.05964189305739, "systems level": 7.422989813300176, "common underlying": 8.191848839997071, "underlying characteristics": 9.411955803365045, "financial incentives": 8.658247192583133, "include proportion": 8.355835584391686, "recommended pharmacological": 9.520441892933018, "device consideration": 8.658247192583133, "provided self": 7.422989813300176, "care education": 7.635246515022862, "provided left": 7.422989813300176, "function assessment": 8.511001466296774, "include clinical": 8.01797756645451, "common elements": 7.832953288875434, "failing interventions": 8.798342187639646, "contextual framework": 8.658247192583133, "results narratively": 8.511001466296774, "pool results": 7.193870284774465, "briefing reports": 8.01797756645451, "patient perceptions": 8.511001466296774, "qualitative study": 8.191848839997071, "determine patient": 8.191848839997071, "patient awareness": 8.191848839997071, "grounded theory": 7.832953288875434, "analyze interview": 8.191848839997071, "interview data": 7.635246515022862, "predominately male": 8.355835584391686, "patients identified": 8.511001466296774, "identified three": 8.01797756645451, "felt implantable": 8.01797756645451, "significant deterioration": 9.29923091812682, "sound mind": 6.672566775728865, "patients wished": 7.832953288875434, "previously established": 8.931948929008138, "established preferences": 9.05964189305739, "most patients": 7.422989813300176, "consider deactivation": 8.798342187639646, "never turn": 6.672566775728865, "preferences identified": 8.931948929008138, "study support": 7.422989813300176, "include information": 8.511001466296774, "within broader": 7.635246515022862, "broader discussions": 8.511001466296774, "life treatment": 7.635246515022862, "treatment preferences": 8.798342187639646, "patients determine": 8.355835584391686, "deactivation preferences": 9.181922482685199, "patients experiencing": 8.798342187639646, "experiencing distressing": 9.181922482685199, "distressing implantable": 9.05964189305739, "defibrillator shocks": 8.658247192583133, "carotid baroreflex": 8.355835584391686, "baroreflex activation": 8.798342187639646, "activation therapy": 8.355835584391686, "decreased parasympathetic": 9.29923091812682, "activity contribute": 8.511001466296774, "bat results": 6.944975542925487, "centrally mediated": 8.355835584391686, "mediated reduction": 8.355835584391686, "sympathetic outflow": 8.511001466296774, "increased parasympathetic": 9.29923091812682, "chronic stable": 7.635246515022862, "stable guideline": 8.01797756645451, "directed medical": 8.01797756645451, "enrolled at": 6.944975542925487, "receive ongoing": 7.832953288875434, "gdmt alone": 6.672566775728865, "primary safety": 7.635246515022862, "safety end": 6.672566775728865, "related major": 7.422989813300176, "efficacy end": 7.193870284774465, "minute hall": 6.944975542925487, "hall walk": 6.3717330906226675, "free rate": 6.3717330906226675, "confidence bound": 8.01797756645451, "bound 91.4": 6.672566775728865, "patients assigned": 8.191848839997071, "group patients": 7.635246515022862, "experienced improvements": 9.181922482685199, "distance walked": 7.832953288875434, "\u00b1 13.2": 5.217618485351048, "points vs.": 6.672566775728865, "class ranking": 7.422989813300176, "bat significantly": 8.191848839997071, "reduced n": 6.3717330906226675, "toward fewer": 7.193870284774465, "fewer days": 6.672566775728865, "days hospitalized": 8.191848839997071, "improves functional": 8.511001466296774, "failure hospitalizations": 9.181922482685199, "preliminary report": 8.355835584391686, "using cardiopulmonary": 8.798342187639646, "testing guide": 7.422989813300176, "guide exercise": 7.635246515022862, "standard clinical": 8.191848839997071, "rare using": 6.672566775728865, "prescribe exercise": 8.355835584391686, "performed symptom": 8.191848839997071, "symptom limited": 7.832953288875434, "limited maximal": 7.832953288875434, "maximal cpet": 7.193870284774465, "randomly divided": 8.01797756645451, "control without": 7.832953288875434, "exercise patients": 8.191848839997071, "patients used": 7.422989813300176, "used \u03b450%w": 6.672566775728865, "\u03b450%w intensity": 7.832953288875434, "x12 w.": 5.217618485351048, "w rehabilitation": 8.01797756645451, "evaluated functions": 8.511001466296774, "groups patients": 7.832953288875434, "exercise duration": 8.191848839997071, "minutes walking": 7.832953288875434, "nosignificant changes": 8.798342187639646, "guiding exercise": 8.01797756645451, "failure affects": 7.832953288875434, "affects nearly": 7.635246515022862, "newer imaging": 7.422989813300176, "imaging techniques": 8.355835584391686, "hfpef patients": 7.635246515022862, "completely normal": 8.191848839997071, "reduced long": 7.193870284774465, "long axis": 6.3717330906226675, "axis function": 7.422989813300176, "subtle changes": 7.635246515022862, "older women": 6.944975542925487, "other cardiovascular": 8.658247192583133, "often nonspecific": 8.191848839997071, "primary symptoms": 8.01797756645451, "fluid retention": 7.832953288875434, "single diagnostic": 8.191848839997071, "diagnostic test": 7.832953288875434, "assessment remains": 8.355835584391686, "thorough medical": 8.01797756645451, "medical history": 7.832953288875434, "classify patients": 8.191848839997071, "patients according": 8.355835584391686, "functional assessment": 8.798342187639646, "standing blood": 7.635246515022862, "valvular disease": 8.01797756645451, "pulmonary congestion": 8.658247192583133, "jugular venous": 7.635246515022862, "peripheral oedema": 8.191848839997071, "oedema allows": 7.422989813300176, "allows assessment": 8.191848839997071, "volume status": 7.422989813300176, "failure nurses": 7.635246515022862, "local cardiology": 8.01797756645451, "cardiology services": 8.511001466296774, "reduce mortality": 8.01797756645451, "regular physical": 8.01797756645451, "activity controls": 8.191848839997071, "controls acquired": 8.191848839997071, "acquired cardiovascular": 9.05964189305739, "generally associated": 8.658247192583133, "exercise extend": 7.832953288875434, "extend well": 6.944975542925487, "cardiovascular system": 8.798342187639646, "recent evidence": 7.832953288875434, "exercise prevents": 8.191848839997071, "prevents cell": 7.422989813300176, "cell senescence": 7.832953288875434, "active individuals": 8.355835584391686, "developing certain": 8.355835584391686, "certain malignancies": 8.658247192583133, "malignancies including": 8.931948929008138, "including cancer": 8.01797756645451, "exercise regularly": 8.355835584391686, "regularly extend": 8.01797756645451, "even lower": 6.672566775728865, "lower volumes": 7.422989813300176, "recommendations confer": 8.931948929008138, "confer health": 7.422989813300176, "health benefits": 7.832953288875434, "highly relevant": 7.832953288875434, "established cardiac": 8.511001466296774, "cardiac disease": 7.832953288875434, "disease including": 8.191848839997071, "including heart": 7.832953288875434, "rare with.estimates": 8.511001466296774, "with.estimates ranging": 8.931948929008138, "congenital abnormalities": 9.181922482685199, "nontraumatic death": 8.355835584391686, "aged recreational": 8.191848839997071, "recreational athletes": 8.798342187639646, "cardiac deaths": 7.635246515022862, "deaths occur": 7.193870284774465, "advocate pre": 7.193870284774465, "participation screening": 9.05964189305739, "detect congenital": 8.191848839997071, "congenital accessory": 8.658247192583133, "accessory pathways": 8.355835584391686, "ion channelopathies": 8.511001466296774, "frequently abnormal": 8.511001466296774, "older athletes": 7.635246515022862, "limited value": 7.422989813300176, "value given": 6.944975542925487, "overwhelming contribution": 9.29923091812682, "assisted training": 8.191848839997071, "small pilot": 6.944975542925487, "assess robot": 7.193870284774465, "\u00ae system": 6.035843815994525, "% completed": 6.944975542925487, "week aerobic": 7.193870284774465, "aerobic training": 8.01797756645451, "training period": 7.832953288875434, "trainings per": 7.422989813300176, "integrated dynamic": 8.355835584391686, "dynamic resistance": 8.355835584391686, "lower limbs": 6.944975542925487, "underwent testing": 8.191848839997071, "combined training": 8.191848839997071, "training resulted": 8.191848839997071, "peak work": 6.3717330906226675, "work rate": 6.3717330906226675, "oxygen pulse": 7.193870284774465, "life assessment": 7.832953288875434, "assessment indicated": 8.658247192583133, "indicated better": 8.01797756645451, "better well": 6.944975542925487, "combined aerobic": 8.01797756645451, "training intervention": 8.798342187639646, "augmented feedback": 8.355835584391686, "feedback resulted": 8.191848839997071, "muscle strength": 7.832953288875434, "larger studies": 7.635246515022862, "psychosocial factors": 8.658247192583133, "influence adherence": 8.511001466296774, "exercise adherence": 8.355835584391686, "completed surveys": 8.191848839997071, "assess social": 7.422989813300176, "perceived social": 8.01797756645451, "support score": 7.422989813300176, "exercise score": 7.635246515022862, "indicated higher": 8.01797756645451, "higher levels": 7.422989813300176, "higher btes": 6.944975542925487, "btes indicated": 7.635246515022862, "months correlated": 8.191848839997071, "r= 0.13": 5.65563804923464, "higher exercise": 7.832953288875434, "time associated": 7.832953288875434, "randomization group": 8.511001466296774, "borderline association": 8.931948929008138, "increasing btes": 7.832953288875434, "ratio 1.25": 6.672566775728865, "interval 0.99": 7.422989813300176, "care group": 6.672566775728865, "ratio 0.83": 6.672566775728865, "interval 0.66": 7.422989813300176, "poor social": 6.944975542925487, "high barriers": 7.422989813300176, "greater impact": 7.635246515022862, "training improves": 8.191848839997071, "perceived barriers": 8.355835584391686, "facilitate individualized": 9.29923091812682, "individualized approaches": 9.29923091812682, "implement exercise": 8.355835584391686, "training therapy": 8.01797756645451, "blocker hypo": 7.193870284774465, "blockers reduce": 7.832953288875434, "standardized exercise": 8.798342187639646, "exercise protocol": 8.191848839997071, "respiratory gas": 7.832953288875434, "gas analysis": 7.193870284774465, "patients participated": 8.798342187639646, "care programme": 7.635246515022862, "programme aiming": 8.01797756645451, "achieve guideline": 8.191848839997071, "target doses": 7.193870284774465, "hr<70 bpm": 6.3717330906226675, "hr<70 versus": 7.193870284774465, "similar dose": 7.193870284774465, "significantly larger": 8.658247192583133, "larger hr": 6.3717330906226675, "17\u00b122 versus": 7.193870284774465, "significantly higher": 8.658247192583133, "lower resting": 7.422989813300176, "aggressive dose": 7.832953288875434, "many patients": 7.422989813300176, "little hr": 6.3717330906226675, "unidirectional left": 8.511001466296774, "reduce elevated": 7.832953288875434, "elevated left": 7.422989813300176, "pressure improve": 8.01797756645451, "potential efficacy": 8.355835584391686, "therapeutic left": 8.01797756645451, "aged \u226518": 6.035843815994525, "canadian special": 8.01797756645451, "special access": 7.635246515022862, "access programme": 8.01797756645451, "shunt implants": 7.635246515022862, "transseptal catheterisation": 9.520441892933018, "transoesophageal echocardiographic": 10.183399668273621, "echocardiographic guidance": 9.411955803365045, "general anaesthesia": 8.511001466296774, "echocardiography evaluations": 9.624996450667128, "shunt implantation": 8.355835584391686, "enrolled ten": 7.193870284774465, "successfully implanted": 8.931948929008138, "procedural adverse": 8.355835584391686, "month showed": 7.193870284774465, "recorded improvements": 8.798342187639646, "sd 6\u00b72": 5.217618485351048, "[ 12\u00b79": 5.217618485351048, "sd 9\u00b78": 5.217618485351048, "test distance": 7.422989813300176, "pulmonary resistance": 8.658247192583133, "no patient": 6.672566775728865, "incessant ventricular": 8.798342187639646, "tachycardia storm": 8.191848839997071, "months post": 6.944975542925487, "man experience": 7.635246515022862, "implanted left": 7.635246515022862, "interatrial shunt": 8.191848839997071, "shunt demonstrates": 8.355835584391686, "demonstrates initial": 8.658247192583133, "initial safety": 7.635246515022862, "early beneficial": 8.01797756645451, "beneficial clinical": 8.511001466296774, "haemodynamic outcomes": 8.798342187639646, "further large": 7.422989813300176, "scale randomised": 8.01797756645451, "randomised studies": 8.355835584391686, "study paradigm": 7.635246515022862, "paradigm shift": 7.635246515022862, "crucial problem": 7.832953288875434, "current cardiology": 8.355835584391686, "major development": 8.191848839997071, "first results": 7.422989813300176, "neprilysin inhibitors": 8.798342187639646, "considered hopeful": 8.355835584391686, "dual inhibition": 7.832953288875434, "neprilysin blocks": 8.191848839997071, "blocks renin": 7.193870284774465, "concurrently supports": 8.798342187639646, "supports natural": 8.01797756645451, "natural vasodilatory": 8.658247192583133, "diuretic effect": 7.832953288875434, "scale prospective": 8.191848839997071, "prospective randomized": 8.931948929008138, "randomized multicenter": 8.931948929008138, "multicenter trial": 8.191848839997071, "trial paradigm": 7.635246515022862, "stabilized chronic": 8.355835584391686, "elevated bnp": 7.193870284774465, "pro bnp": 5.65563804923464, "group treated": 7.422989813300176, "consistent also": 7.832953288875434, "specified subgroup": 8.355835584391686, "subgroup analyses": 8.191848839997071, "including quality": 8.191848839997071, "typical adverse": 7.832953288875434, "dual ras": 6.035843815994525, "neprilysin inhibition": 8.798342187639646, "time become": 6.944975542925487, "stable chronic": 7.635246515022862, "dysfunction treatment": 8.798342187639646, "significantly contributed": 9.29923091812682, "study sites": 6.944975542925487, "quality work": 7.193870284774465, "work provided": 7.422989813300176, "failure among": 7.422989813300176, "older persons": 7.422989813300176, "primary symptom": 7.832953288875434, "chronic hfpef": 7.422989813300176, "major determinant": 8.191848839997071, "reduced quality": 7.832953288875434, "factorial trial": 7.832953288875434, "trial conducted": 7.832953288875434, "urban academic": 7.635246515022862, "academic medical": 8.01797756645451, "medical center": 7.635246515022862, "initially screened": 8.355835584391686, "screened participants": 8.798342187639646, "older obese": 6.944975542925487, "obese participants": 8.355835584391686, "declined participation": 8.931948929008138, "attention control": 8.191848839997071, "control consisted": 8.191848839997071, "telephone calls": 7.832953288875434, "capacity measured": 8.191848839997071, "score range": 6.944975542925487, "higher scores": 7.422989813300176, "scores indicate": 7.832953288875434, "indicate worse": 7.635246515022862, "worse heart": 6.944975542925487, "enrolled participants": 8.798342187639646, "participants completed": 8.931948929008138, "exercise attendance": 8.511001466296774, "diet adherence": 7.635246515022862, "by main": 5.65563804923464, "main effects": 7.193870284774465, "effects analysis": 8.01797756645451, "kg body": 5.65563804923464, "joint effect": 7.193870284774465, "significant change": 8.355835584391686, "total score": 6.944975542925487, "main effect": 6.944975542925487, "-1 unit": 5.65563804923464, "-6 units": 6.035843815994525, "positively correlated": 8.798342187639646, "percent lean": 7.193870284774465, "thigh muscle": 7.193870284774465, "intermuscular fat": 8.191848839997071, "fat ratio": 6.3717330906226675, "related serious": 7.832953288875434, "serious adverse": 7.832953288875434, "weight decreased": 8.01797756645451, "among obese": 6.944975542925487, "clinically stable": 8.191848839997071, "training increased": 8.355835584391686, "neither intervention": 8.658247192583133, "assist system": 7.422989813300176, "provide long": 7.193870284774465, "term support": 7.193870284774465, "centrifugal flow": 8.01797756645451, "flow pump": 6.3717330906226675, "enhanced hemocompatibility": 9.411955803365045, "levitated rotor": 7.832953288875434, "wide blood": 6.672566775728865, "flow paths": 6.672566775728865, "artificial pulse": 8.01797756645451, "multicenter study": 8.191848839997071, "support)-derived performance": 9.624996450667128, "fraction \u2264": 6.672566775728865, "without inotropes": 8.191848839997071, "optimal medical": 7.832953288875434, "patients continued": 8.355835584391686, "% received": 6.672566775728865, "received transplants": 8.658247192583133, "% died": 5.217618485351048, "% performance": 7.422989813300176, "levitated lvas": 7.635246515022862, "predicted survival": 8.355835584391686, "key adverse": 6.944975542925487, "events included": 7.832953288875434, "included reoperation": 8.658247192583133, "driveline infection": 8.511001466296774, "debilitating stroke": 8.511001466296774, "pump exchanges": 7.635246515022862, "pump malfunctions": 8.191848839997071, "pump thrombosis": 7.832953288875434, "hemolysis events": 8.01797756645451, "life scores": 6.944975542925487, "scores showed": 7.422989813300176, "showed progressive": 8.355835584391686, "sustained improvement": 8.798342187639646, "levitated centrifugal": 8.798342187639646, "flow chronic": 7.193870284774465, "favorable adverse": 8.191848839997071, "event profile": 7.422989813300176, "improved quality": 8.01797756645451, "based program": 7.422989813300176, "program designed": 8.01797756645451, "influence medical": 8.191848839997071, "medical resource": 8.01797756645451, "adjusted survival": 8.191848839997071, "projecting long": 7.832953288875434, "term costs": 6.672566775728865, "valid approach": 7.635246515022862, "extrapolating short": 8.511001466296774, "based simulation": 8.01797756645451, "simulation tool": 7.832953288875434, "tool designed": 7.422989813300176, "integrate data": 7.635246515022862, "laboratory characteristics": 9.411955803365045, "based medications": 8.191848839997071, "generate predicted": 8.355835584391686, "predicted outcomes": 8.355835584391686, "survival projections": 8.658247192583133, "modified seattle": 8.01797756645451, "modeled using": 7.422989813300176, "using relationships": 8.511001466296774, "evaluate parallel": 8.191848839997071, "study designs": 7.422989813300176, "hypothetical programs": 8.798342187639646, "simulations consist": 8.511001466296774, "virtual cohorts": 7.832953288875434, "cohorts used": 7.193870284774465, "generate estimates": 8.355835584391686, "incremental cost": 8.01797756645451, "effectiveness ratios": 8.658247192583133, "user inputs": 6.944975542925487, "model demonstrated": 8.355835584391686, "demonstrated acceptable": 9.05964189305739, "acceptable internal": 8.511001466296774, "external validity": 8.191848839997071, "replicating resource": 8.658247192583133, "survival estimates": 8.355835584391686, "programs across": 7.832953288875434, "scenarios demonstrate": 8.798342187639646, "term improvements": 8.191848839997071, "based treatments": 8.01797756645451, "demonstrate good": 8.01797756645451, "good long": 6.3717330906226675, "term value": 6.672566775728865, "provides researchers": 8.658247192583133, "conducting long": 7.832953288875434, "term cost": 6.3717330906226675, "effectiveness analyses": 8.931948929008138, "debilitating chronic": 8.658247192583133, "upcoming years": 7.635246515022862, "years due": 6.3717330906226675, "demographic changes": 8.511001466296774, "essential role": 7.635246515022862, "supporting patients": 8.511001466296774, "nursing interventions": 8.798342187639646, "nursing actions": 7.832953288875434, "enhancing medical": 8.191848839997071, "pathophysiologic state": 8.931948929008138, "ultimately reduce": 8.191848839997071, "optimize quality": 8.01797756645451, "rates between": 3.711494906650088, "observed between": 4.008988783227255, "adiponectin at": 3.817623257511431, "adiponectin during": 4.177917792195843, "prognosis is": 3.5969351423872324, "recommends against": 4.177917792195843, "confounded by": 3.711494906650088, "effects are": 3.4724877714627436, "single most": 3.4724877714627436, "stratification is": 4.095924419998536, "evaluated before": 4.008988783227255, "estimates was": 3.711494906650088, "shocks during": 3.711494906650088, "sex were": 3.0179219079972626, "study other": 3.4724877714627436, "dopamine had": 3.5969351423872324, "nesiritide had": 3.817623257511431, "function when": 3.711494906650088, "reveal how": 3.3362833878644325, "nucleolin as": 3.5969351423872324, "structure by": 3.5969351423872324, "mechanisms by": 3.711494906650088, "abundance during": 4.008988783227255, "expression during": 4.095924419998536, "surprisingly had": 4.008988783227255, "shared between": 3.817623257511431, "interventions during": 4.329123596291566, "attenuated after": 4.008988783227255, "evident only": 3.5969351423872324, "mortality between": 4.095924419998536, "relations between": 4.095924419998536, "requires further": 4.008988783227255, "correlations between": 4.329123596291566, "remained when": 3.711494906650088, "modest when": 3.4724877714627436, "monitoring after": 4.008988783227255, "strategies have": 3.916476644437717, "apoptosis during": 4.008988783227255, "dogs during": 3.4724877714627436, "fragmentation by": 4.008988783227255, "dogs only": 3.1858665453113337, "become more": 3.4724877714627436, "dysfunction is": 3.817623257511431, "requirements were": 4.095924419998536, "blockers at": 3.4724877714627436, "uptitration after": 4.095924419998536, "spironolactone more": 4.255500733148387, "blockers after": 3.817623257511431, "levels between": 3.817623257511431, "patients above": 3.817623257511431, "level had": 3.1858665453113337, "article by": 3.3362833878644325, "evaluated how": 3.711494906650088, "impairment at": 3.711494906650088, "documented by": 3.711494906650088, "physician at": 3.5969351423872324, "hypothesize that": 4.008988783227255, "seen by": 2.82781902461732, "catheterization during": 4.465974464504069, "dyn s": 2.3504972470841334, "circulation had": 3.916476644437717, "therapy were": 3.5969351423872324, "production by": 3.711494906650088, "profiled by": 3.4724877714627436, "improvement by": 3.817623257511431, "mechanism how": 3.711494906650088, "inclusion through": 4.095924419998536, "survival at": 3.4724877714627436, "levels at": 3.1858665453113337, "survival had": 3.5969351423872324, "disease by": 3.3362833878644325, "parameters between": 4.177917792195843, "incidence over": 3.817623257511431, "support after": 3.711494906650088, "insertion are": 3.711494906650088, "shock after": 3.4724877714627436, "support at": 3.3362833878644325, "outcome at": 3.3362833878644325, "year when": 3.1858665453113337, "transplantation be": 4.177917792195843, "failure as": 3.3362833878644325, "complications after": 4.255500733148387, "implantation are": 4.008988783227255, "budget are": 3.3362833878644325, "bivp during": 3.4724877714627436, "taken at": 3.0179219079972626, "correlated against": 4.177917792195843, "analyzed by": 3.4724877714627436, "reported that": 3.711494906650088, "improve such": 3.5969351423872324, "man had": 2.82781902461732, "obtained by": 3.4724877714627436, "flow by": 2.82781902461732, "systolic as": 3.4724877714627436, "improve after": 3.711494906650088, "considered because": 4.177917792195843, "symptom as": 3.3362833878644325, "surgery by": 3.3362833878644325, "observation at": 3.817623257511431, "motion by": 3.1858665453113337, "regurgitation as": 4.008988783227255, "disappeared after": 4.095924419998536, "suggested that": 3.817623257511431, "demonstrates that": 4.095924419998536, "grouped by": 3.3362833878644325, "fraction was": 3.5969351423872324, "egfr was": 3.0179219079972626, "associations between": 4.329123596291566, "differences between": 4.255500733148387, "rates by": 3.0179219079972626, "interaction by": 3.817623257511431, "bb at": 2.3504972470841334, "obtained during": 3.916476644437717, "examined as": 3.4724877714627436, "shortening by": 3.711494906650088, "transient only": 3.817623257511431, "index by": 3.0179219079972626, "response after": 3.817623257511431, "echocardiography before": 4.529820946528695, "echocardiograms at": 4.177917792195843, "hospitalization during": 4.465974464504069, "injury during": 3.711494906650088, "perfusion by": 3.5969351423872324, "observed by": 3.4724877714627436, "eds between": 3.4724877714627436, "eds had": 2.82781902461732, "hospitalized at": 3.916476644437717, "required at": 3.4724877714627436, "paralleled by": 3.711494906650088, "velocity over": 3.711494906650088, "velocities during": 4.095924419998536, "correlated more": 3.916476644437717, "performance only": 4.008988783227255, "risk when": 3.1858665453113337, "generated by": 3.5969351423872324, "relationship as": 3.916476644437717, "affected by": 3.4724877714627436, "ischemia after": 3.817623257511431, "covering over": 3.711494906650088, "calculated at": 3.711494906650088, "surgery was": 3.4724877714627436, "hypoalbuminemia before": 4.465974464504069, "prognosis after": 3.916476644437717, "insufficiency after": 4.255500733148387, "encountered after": 4.095924419998536, "seems more": 3.3362833878644325, "revision by": 3.4724877714627436, "replacement is": 3.817623257511431, "mortality was": 3.711494906650088, "life was": 3.0179219079972626, "travelled during": 4.008988783227255, "obtained at": 3.4724877714627436, "indices were": 3.5969351423872324, "factors at": 3.3362833878644325, "complicated by": 3.817623257511431, "revealed by": 3.4724877714627436, "prolapse through": 4.008988783227255, "patient had": 3.4724877714627436, "stratified by": 3.711494906650088, "disease such": 3.5969351423872324, "risk after": 3.3362833878644325, "significant when": 4.008988783227255, "death as": 3.0179219079972626, "disease at": 3.3362833878644325, "therapy is": 3.3362833878644325, "report that": 3.4724877714627436, "known as": 3.0179219079972626, "mir-25 by": 3.1858665453113337, "reveal that": 3.4724877714627436, "subjects over": 3.711494906650088, "controlled by": 3.711494906650088, "action through": 3.817623257511431, "differ at": 3.1858665453113337, "manifested as": 3.711494906650088, "cancer between": 3.817623257511431, "hospitalization through": 4.529820946528695, "contact before": 3.817623257511431, "also be": 2.82781902461732, "identified as": 3.711494906650088, "risk as": 2.82781902461732, "pool by": 2.82781902461732, "survival between": 4.008988783227255, "visits as": 3.1858665453113337, "readmissions as": 3.916476644437717, "needs at": 3.0179219079972626, "discharges at": 3.711494906650088, "rate after": 3.3362833878644325, "% having": 3.0179219079972626, "% after": 2.82781902461732, "discrepancy between": 4.255500733148387, "often had": 3.1858665453113337, "changes at": 3.3362833878644325, "times below": 3.4724877714627436, "quantified by": 3.711494906650088, "cohort as": 3.1858665453113337, "treatment had": 3.711494906650088, "determined by": 3.711494906650088, "rats after": 3.3362833878644325, "development at": 3.817623257511431, "assessed at": 3.4724877714627436, "strips before": 3.711494906650088, "groups were": 3.4724877714627436, "fraction during": 3.916476644437717, "strain as": 3.1858665453113337, "failure during": 3.817623257511431, "benefit over": 3.5969351423872324, "reviewed by": 3.4724877714627436, "duration is": 3.4724877714627436, "benefit when": 3.5969351423872324, "needs further": 3.711494906650088, "management between": 4.177917792195843, "improvement after": 4.095924419998536, "constants through": 4.095924419998536, "results further": 3.916476644437717, "resistin as": 3.4724877714627436, "probability after": 4.095924419998536, "improved only": 3.711494906650088, "rhythm at": 3.1858665453113337, "h after": 2.82781902461732, "contents by": 3.4724877714627436, "doxorubicin against": 4.255500733148387, "rats as": 2.82781902461732, "relation between": 4.008988783227255, "infarction after": 4.008988783227255, "events after": 3.5969351423872324, "stroke was": 3.3362833878644325, "events during": 3.711494906650088, "workload during": 3.916476644437717, "complex where": 3.711494906650088, "remodelling is": 3.817623257511431, "made at": 2.82781902461732, "method has": 3.3362833878644325, "phenotype had": 3.711494906650088, "peptides at": 3.4724877714627436, "like other": 3.3362833878644325, "measured at": 3.4724877714627436, "provided by": 3.4724877714627436, "care by": 2.82781902461732, "outcomes through": 4.008988783227255, "conditions such": 3.916476644437717, "occur through": 3.711494906650088, "interplay between": 4.095924419998536, "achieved through": 4.008988783227255, "protected against": 4.095924419998536, "thereby re": 3.3362833878644325, "mri during": 3.3362833878644325, "paced at": 3.0179219079972626, "performed during": 4.008988783227255, "respiration before": 4.177917792195843, "minutes after": 3.711494906650088, "values before": 3.711494906650088, "also had": 3.0179219079972626, "detected by": 3.4724877714627436, "increase by": 3.4724877714627436, "echocardiography as": 4.255500733148387, "increase above": 3.817623257511431, "patients were": 3.711494906650088, "increase during": 3.916476644437717, "features such": 3.711494906650088, "initiated by": 3.5969351423872324, "effect is": 3.1858665453113337, "fraction after": 3.817623257511431, "distinguish between": 4.255500733148387, "activity by": 3.4724877714627436, "imaging when": 3.5969351423872324, "serve as": 3.0179219079972626, "activity as": 3.4724877714627436, "washout was": 3.4724877714627436, "activity after": 3.817623257511431, "nonprescribing as": 4.095924419998536, "blockers are": 3.5969351423872324, "tone by": 2.82781902461732, "improved by": 3.4724877714627436, "interval between": 4.008988783227255, "velocity at": 3.4724877714627436, "mediated by": 3.4724877714627436, "time by": 2.82781902461732, "undertaken at": 3.711494906650088, "improvement between": 4.255500733148387, "rate during": 3.4724877714627436, "exercise as": 3.4724877714627436, "reflected by": 3.5969351423872324, "rule had": 3.0179219079972626, "indication is": 3.711494906650088, "older have": 3.3362833878644325, "stimulated by": 3.711494906650088, "enhanced by": 3.4724877714627436, "desensitizes against": 4.329123596291566, "mechanism during": 4.008988783227255, "safe when": 3.1858665453113337, "subgroups at": 3.5969351423872324, "hrqol as": 3.0179219079972626, "driven by": 3.1858665453113337, "microstructure at": 4.095924419998536, "warrant further": 3.916476644437717, "medicine as": 3.4724877714627436, "indicated that": 3.817623257511431, "enzymes over": 3.5969351423872324, "treatment have": 3.817623257511431, "experience between": 4.177917792195843, "operation was": 3.711494906650088, "occurred after": 3.817623257511431, "oxygenation as": 3.817623257511431, "became again": 3.5969351423872324, "applied during": 3.817623257511431, "support is": 3.3362833878644325, "data are": 3.0179219079972626, "ami between": 3.4724877714627436, "therapy during": 3.817623257511431, "supplementation during": 4.465974464504069, "rehabilitation is": 4.095924419998536, "functions after": 3.916476644437717, "unclear how": 3.4724877714627436, "created by": 3.3362833878644325, "used as": 2.82781902461732, "signaling by": 3.5969351423872324, "control during": 3.817623257511431, "produced while": 3.817623257511431, "produced during": 3.916476644437717, "recovery had": 3.5969351423872324, "concluded that": 3.817623257511431, "produced by": 3.4724877714627436, "drugs have": 3.3362833878644325, "comorbidities such": 4.177917792195843, "imbalance as": 3.5969351423872324, "group until": 3.4724877714627436, "continued until": 3.916476644437717, "regulated by": 3.5969351423872324, "occur after": 3.4724877714627436, "triggered by": 3.5969351423872324, "readmission after": 4.095924419998536, "continuity further": 4.177917792195843, "hospital between": 4.008988783227255, "readmission over": 4.008988783227255, "patient at": 3.3362833878644325, "readmission during": 4.177917792195843, "visits over": 3.4724877714627436, "settings other": 3.817623257511431, "persist through": 3.916476644437717, "demonstrated up": 3.916476644437717, "binding by": 3.3362833878644325, "mutant as": 3.1858665453113337, "ecgs at": 2.82781902461732, "expressed as": 3.5969351423872324, "calculated as": 3.711494906650088, "group during": 3.5969351423872324, "system by": 3.1858665453113337, "therapy are": 3.4724877714627436, "therefore have": 3.817623257511431, "mirnas as": 3.1858665453113337, "filling during": 3.817623257511431, "spectroscopy as": 3.916476644437717, "subjects had": 3.5969351423872324, "supported as": 3.5969351423872324, "stored at": 3.1858665453113337, "plasma by": 3.1858665453113337, "proteolysis between": 4.255500733148387, "epitopes as": 3.4724877714627436, "volume at": 3.1858665453113337, "delivered as": 3.5969351423872324, "evaluated as": 3.5969351423872324, "patients during": 3.916476644437717, "raloxifene between": 4.177917792195843, "thickness as": 3.5969351423872324, "diameter were": 3.711494906650088, "performance by": 3.817623257511431, "blockade at": 3.4724877714627436, "smoked more": 3.4724877714627436, "differ between": 3.817623257511431, "similar when": 3.5969351423872324, "events as": 3.1858665453113337, "established that": 4.008988783227255, "admitted between": 4.008988783227255, "appropriate out": 3.916476644437717, "patient by": 3.3362833878644325, "shown that": 3.3362833878644325, "variability have": 4.008988783227255, "substrate after": 3.916476644437717, "turbulence as": 3.711494906650088, "angiography is": 3.817623257511431, "provide more": 3.5969351423872324, "considered only": 3.916476644437717, "revascularization is": 4.329123596291566, "carried out": 3.4724877714627436, "selected out": 3.5969351423872324, "visits during": 3.711494906650088, "groups after": 3.5969351423872324, "controls during": 3.916476644437717, "technology has": 3.817623257511431, "race as": 2.82781902461732, "significantly more": 4.177917792195843, "blacks had": 3.3362833878644325, "rhythm more": 3.4724877714627436, "persist after": 3.711494906650088, "af at": 2.3504972470841334, "counted as": 3.3362833878644325, "control as": 3.3362833878644325, "therapy by": 3.3362833878644325, "asked about": 3.4724877714627436, "topic so": 3.0179219079972626, "characterised by": 4.008988783227255, "failure at": 3.3362833878644325, "population has": 3.817623257511431, "currents by": 3.4724877714627436, "gain through": 3.5969351423872324, "conducted by": 3.5969351423872324, "indicating that": 3.916476644437717, "inhibition by": 3.711494906650088, "conclude that": 3.711494906650088, "disease has": 3.4724877714627436, "assess how": 3.3362833878644325, "treated at": 3.3362833878644325, "measures at": 3.4724877714627436, "race by": 2.82781902461732, "differ by": 3.1858665453113337, "attenuation by": 3.817623257511431, "changed after": 3.711494906650088, "noted above": 3.4724877714627436, "essentially were": 4.008988783227255, "policy as": 3.1858665453113337, "complications had": 4.095924419998536, "implicated as": 3.711494906650088, "very few": 3.0179219079972626, "devices at": 3.3362833878644325, "cardiomyopathy during": 4.399171093819823, "finding has": 3.4724877714627436, "investigations at": 4.095924419998536, "point was": 3.1858665453113337, "examination between": 4.255500733148387, "quantified as": 3.711494906650088, "categories were": 3.916476644437717, "achieving at": 3.5969351423872324, "overload as": 3.4724877714627436, "resistance by": 3.711494906650088, "evidenced by": 3.5969351423872324, "pathophysiology is": 4.177917792195843, "shortening as": 3.711494906650088, "hypertrophy after": 4.095924419998536, "turning off": 3.4724877714627436, "discovered that": 3.916476644437717, "indicate that": 3.711494906650088, "worse when": 3.3362833878644325, "managed by": 3.3362833878644325, "country has": 3.4724877714627436, "progress has": 3.5969351423872324, "connection between": 4.177917792195843, "results about": 3.711494906650088, "uncertainty about": 4.095924419998536, "identified by": 3.711494906650088, "recorded as": 3.4724877714627436, "guidelines as": 3.711494906650088, "education at": 3.5969351423872324, "explore why": 3.4724877714627436, "findings through": 4.008988783227255, "occur between": 3.711494906650088, "stages where": 3.5969351423872324, "wished further": 3.817623257511431, "deactivation at": 3.916476644437717, "discussions about": 4.095924419998536, "shocks at": 3.1858665453113337, "min after": 3.1858665453113337, "changes were": 3.5969351423872324, "patients have": 3.711494906650088, "confirmed that": 3.817623257511431, "symptoms are": 3.5969351423872324, "services as": 3.4724877714627436, "individuals are": 3.916476644437717, "expectancy by": 3.711494906650088, "exercise below": 3.817623257511431, "athletes under": 3.817623257511431, "death during": 3.5969351423872324, "athletes more": 3.711494906650088, "strength by": 3.4724877714627436, "need further": 3.5969351423872324, "indicated more": 3.817623257511431, "training had": 3.5969351423872324, "explained by": 3.5969351423872324, "analysis at": 3.4724877714627436, "baseline as": 3.4724877714627436, "dose after": 3.3362833878644325, "latter had": 3.3362833878644325, "higher when": 3.4724877714627436, "hr was": 2.608809242675524, "observed after": 3.817623257511431, "baseline had": 3.5969351423872324, "better when": 3.4724877714627436, "target as": 3.1858665453113337, "study at": 3.0179219079972626, "enrolled under": 3.817623257511431, "done after": 3.3362833878644325, "guidance under": 3.817623257511431, "evaluations at": 3.817623257511431, "bleeding at": 3.4724877714627436, "died after": 3.3362833878644325, "treated by": 3.3362833878644325, "excluded by": 3.4724877714627436, "adherence was": 3.711494906650088, "intervention had": 4.008988783227255, "life as": 2.82781902461732, "hemocompatibility by": 4.329123596291566, "risk by": 2.82781902461732, "demonstrate how": 3.916476644437717, "treatments are": 3.817623257511431, "settings have": 3.711494906650088, "actions have": 3.5969351423872324, "heart": 1530.1737078517708, "patients": 1804.717300982363, "failure": 1580.750834761082, "%": 76.86446977621368, "hf": 396.0440513198173, "/": 26.813187131237328, "cardiac": 523.1465195542042, "p": 25.025641322488173, "study": 366.6775705451248, "ventricular": 493.09326354770957, "risk": 289.0585951817624, "exercise": 404.40153567163316, "results": 370.44429222486895, "associated": 423.7079902587829, "mortality": 404.6050512545394, "ejection": 368.18647277566606, "treatment": 375.93225234673736, "left": 238.16799743849438, "fraction": 350.07894132768246, "ci": 122.02438337961938, "outcomes": 325.93556606370436, "=": 14.712877041243047, "clinical": 304.81011270772353, "disease": 274.29844538788007, "therapy": 265.8149883140281, "compared": 271.61297171975366, "hr": 93.12387152655162, "reduced": 243.19243611708953, "function": 256.52336217976733, "increased": 267.612789806152, "ratio": 197.44176875506722, "group": 195.09127150798307, "\u00b1": 11.412792471244607, "methods": 220.56988392015097, "years": 183.3387852725624, "patient": 217.74206489553364, "rate": 156.74304104926554, "systolic": 232.37998691578923, "myocardial": 253.55753747769685, "chf": 124.05238437796298, "lv": 80.27919959185485, "may": 120.78784794696396, "conclusions": 253.4916073167803, "care": 144.5292975908812, "chronic": 197.94733172321241, "dysfunction": 243.07414400239205, "death": 164.53480729588935, "hfpef": 162.1843100488052, "background": 230.20355376264584, "acute": 159.83381280172108, "end": 109.36197043846737, "analysis": 196.16492401982208, "hazard": 169.57260077390907, "follow": 166.96379153123354, "cardiovascular": 244.3278884807316, "using": 148.08132656630042, "significant": 215.2942418306901, "n": 8.387714948746035, "higher": 159.13736380320697, "functional": 203.51328665973037, "this": 122.13743458384327, "preserved": 187.96612617336868, "data": 120.10181067411254, "hospitalization": 227.15564537738757, "high": 118.06618676438183, "index": 136.32884033087973, "used": 116.03056285465111, "baseline": 172.02154875584398, "among": 133.9783430837956, "significantly": 211.55520967905503, "control": 161.18568440318725, "versus": 146.09331758982935, "diastolic": 175.22265999212337, "low": 89.77475185247322, "quality": 152.70222732933527, "right": 126.9268513425432, "age": 88.1424836369737, "pressure": 159.94986112385493, "model": 124.57635409545907, "events": 135.65808061912725, "levels": 135.65808061912725, "health": 135.65808061912725, "volume": 135.65808061912725, "lower": 122.22585684837495, "studies": 144.21877025548332, "use": 83.24567899047516, "ml": 54.5898557224613, "time": 103.81681939626678, "changes": 141.390951230866, "confidence": 166.81416939322162, "trial": 115.17436510712254, "new": 79.98114255947614, "renal": 115.17436510712254, "\u03b2": 6.600169139996881, "rates": 110.47337061295427, "cause": 110.47337061295427, "management": 156.80531922962834, "outcome": 132.90749415701404, "however": 130.07967513239672, "interval": 138.82440776787408, "type": 93.63869984761317, "hospital": 135.80648585987683, "association": 156.26194971582345, "and": 73.45206969747808, "day": 73.45206969747808, "effects": 124.42403708316208, "groups": 114.78760667772306, "increase": 132.78856395187955, "cohort": 112.17879743504753, "induced": 121.59621805854476, "survival": 129.77064204388228, "receptor": 129.77064204388228, "life": 85.49620420869029, "severe": 109.56998819237201, "class": 96.37038713044947, "support": 115.94058000931012, "ii": 43.88596244354732, "crt": 65.29072861998051, "pulmonary": 124.24879526714201, "dose": 79.38933247949812, "effect": 101.74356046434544, "ms": 41.745183787764525, "based": 89.31889538919707, "hypertension": 136.68353541071482, "term": 77.3537085697674, "also": 77.3537085697674, "treated": 107.45712293545816, "infarction": 123.442485350984, "mass": 75.31808466003669, "long": 75.31808466003669, "models": 96.5259419789944, "reduction": 117.87706217651935, "peak": 75.31808466003669, "primary": 104.62930391084085, "training": 111.66311059589871, "improvement": 128.4820475441215, "evidence": 108.64518868790145, "coronary": 108.64518868790145, "medical": 101.80148488622352, "year": 73.28246075030596, "atrial": 93.91713273631886, "randomized": 120.10620196311957, "development": 125.00955977265878, "early": 84.61790089502881, "mean": 73.28246075030596, "mitral": 93.91713273631886, "included": 105.62726677990419, "months": 91.30832349364334, "trials": 91.30832349364334, "improved": 105.62726677990419, "impact": 91.30832349364334, "well": 71.24683684057524, "score": 82.26740364794468, "assessed": 102.60934487190693, "probnp": 88.69951425096782, "nt": 36.393237148307534, "participants": 122.2957948411659, "capacity": 102.60934487190693, "body": 67.1755890211138, "factors": 93.31802781237157, "without": 93.31802781237157, "showed": 86.09070500829229, "respectively": 118.69885969877868, "similar": 93.31802781237157, "angiotensin": 114.59209645827053, "median": 86.09070500829229, "common": 83.48189576561677, "adverse": 90.49020878775424, "role": 65.13996511138308, "kg": 34.25245849252474, "developed": 101.94772944996268, "min": 52.232582895984415, "diabetes": 96.5735010559124, "expression": 106.76106841166184, "e": 4.400112759997921, "congestive": 103.42478502379741, "non": 50.6003146804849, "conclusion": 103.42478502379741, "performed": 98.76186290465135, "related": 87.66238976313691, "first": 72.86541465960813, "major": 70.514917412524, "identified": 100.08850163593297, "vs": 32.11167983674194, "l": 4.12510571249805, "ef": 32.11167983674194, "demonstrated": 107.90805427161698, "mice": 61.06871729192164, "at": 32.11167983674194, "natriuretic": 100.70214537241957, "found": 68.16442016543986, "population": 96.75221824806854, "vs.": 47.33577824948588, "remodeling": 96.75221824806854, "one": 47.33577824948588, "device": 75.6554680375902, "adjusted": 87.51973533192061, "total": 65.81392291835573, "evaluated": 89.20426326871734, "blood": 65.81392291835573, "assist": 73.04665879491468, "within": 73.04665879491468, "measures": 84.50181342392335, "change": 73.04665879491468, "older": 65.81392291835573, "days": 56.997469472460196, "status": 73.04665879491468, "b": 3.7125951412482454, "prognostic": 90.07965147233968, "symptoms": 81.48389151592609, "including": 86.01839672340601, "ischemic": 81.48389151592609, "adults": 70.43784955223914, "defibrillator": 100.21036247955237, "objective": 86.01839672340601, "period": 70.43784955223914, "effective": 86.01839672340601, "ed": 28.900511853067748, "per": 44.07124181848685, "measured": 78.46596960792883, "decreased": 82.83253017809467, "review": 67.82904030956362, "test": 52.92622165299875, "interventions": 96.49886757290228, "human": 61.11292842418747, "advanced": 78.46596960792883, "blockers": 78.46596960792883, "peptide": 73.52329464005032, "bnp": 42.43897360298734, "response": 78.46596960792883, "safety": 65.2202310668881, "improve": 70.695475615433, "hospitalized": 89.92337855968081, "surgery": 70.695475615433, "less": 50.89059774326803, "important": 79.64666363278334, "level": 58.76243117710334, "protein": 70.695475615433, "artery": 65.2202310668881, "lvef": 50.89059774326803, "factor": 65.2202310668881, "readmission": 86.81219428656858, "blocker": 70.695475615433, "visits": 65.2202310668881, "underwent": 79.64666363278334, "activity": 75.44804769993156, "valve": 58.76243117710334, "post": 50.89059774326803, "system": 62.61142182421258, "diagnosis": 76.460797087472, "practice": 72.4301257919343, "implantable": 83.33970651510585, "devices": 67.86765659081568, "potential": 76.460797087472, "strategies": 80.07080130874638, "c": 3.3000845699984405, "flow": 48.85497383353731, "therapeutic": 83.33970651510585, "lvad": 48.85497383353731, "arterial": 72.4301257919343, "mitochondrial": 89.07587775960211, "diet": 48.85497383353731, "design": 60.00261258153705, "resynchronization": 94.20626165996632, "two": 37.5421689564888, "cardiomyopathy": 87.80533492276291, "placebo": 65.03983756619836, "hypertrophy": 79.86721874364311, "gene": 46.819349923806584, "implantation": 82.72950827490635, "cox": 37.5421689564888, "physician": 73.27493054216067, "mm": 24.618954541502156, "rv": 24.618954541502156, "onset": 54.06143668293507, "subjects": 69.41220388393704, "af": 24.618954541502156, "guideline": 70.08906399684935, "cardioverter": 79.13257313251911, "current": 62.21201854158104, "fibrillation": 79.13257313251911, "admission": 70.08906399684935, "recent": 57.39380333886153, "weeks": 51.71093943585093, "assessment": 73.39823453301751, "nyha": 44.78372601407587, "metoprolol": 73.39823453301751, "assess": 54.784994096186004, "followed": 63.376360067942514, "terminal": 63.376360067942514, "p<0.001": 59.38419951696372, "observed": 63.376360067942514, "echocardiography": 84.18876444777236, "prognosis": 66.903197451538, "benefit": 59.38419951696372, "york": 42.74810210434514, "setting": 59.38419951696372, "point": 49.360442188766804, "difference": 70.06195114515309, "due": 34.27763252548977, "performance": 72.92224320071762, "discharge": 66.903197451538, "could": 49.360442188766804, "beta": 42.74810210434514, "inhibition": 70.06195114515309, "rats": 42.74810210434514, "pasp": 42.74810210434514, "rhythm": 54.784994096186004, "cad": 34.27763252548977, "objectives": 66.72566775728865, "mr": 21.40778655782796, "elevated": 60.35843815994525, "defined": 56.5563804923464, "characteristics": 78.32953288875433, "regression": 66.72566775728865, "specific": 60.35843815994525, "proteins": 60.35843815994525, "normal": 52.17618485351048, "0.001": 47.00994494168267, "+": 2.7500704749987004, "three": 47.00994494168267, "likely": 52.17618485351048, "relationship": 71.93870284774465, "month": 47.00994494168267, "these": 47.00994494168267, "iii": 32.645364309990256, "m(2": 32.645364309990256, "improves": 60.35843815994525, "echocardiographic": 81.91848839997071, "correlated": 63.389384369424214, "moderate": 57.34051625194799, "addition": 57.34051625194799, "efficacy": 57.34051625194799, "value": 44.65944769459853, "cells": 44.65944769459853, "after": 44.65944769459853, "hfref": 44.65944769459853, "race": 38.6768542848837, "stage": 44.65944769459853, "stroke": 49.56737561083496, "estimated": 57.34559781560401, "stable": 46.95856636815943, "occurred": 54.322594343950726, "limited": 50.90074244311176, "multivariate": 64.74483256297019, "dependent": 57.34559781560401, "transplant": 60.05310098155979, "ami": 29.380827878991234, "spironolactone": 68.71721863520575, "men": 29.380827878991234, "case": 36.64123037515298, "hg": 19.267007902045165, "diagnostic": 60.05310098155979, "inhibitors": 60.05310098155979, "muscle": 46.95856636815943, "t1": 19.267007902045165, "paf": 29.380827878991234, "medicare": 51.304672435953464, "dilated": 48.07292341849444, "present": 48.07292341849444, "cell": 34.60560646542226, "better": 44.34975712548391, "predictors": 56.71681759369535, "identify": 51.304672435953464, "decrease": 51.304672435953464, "sex": 27.74855966349172, "independent": 59.03229211486664, "mg": 18.196618574153767, "via": 27.74855966349172, "reduce": 44.34975712548391, "findings": 51.304672435953464, "isolated": 51.304672435953464, "composite": 54.159731270292674, "odds": 34.60560646542226, "resistance": 56.71681759369535, "cost": 34.60560646542226, "effectiveness": 63.095413413051496, "standard": 51.304672435953464, "program": 48.07292341849444, "signaling": 54.159731270292674, "insulin": 48.07292341849444, "event": 37.607955953346135, "large": 37.607955953346135, "across": 41.740947882808385, "individuals": 55.5598043434039, "no": 17.12622924626237, "mild": 32.56998255569154, "provide": 45.24510439387712, "evaluate": 48.2867505279562, "examined": 48.2867505279562, "transplantation": 62.66362631100347, "controlled": 53.38053420583092, "independently": 59.38391850640141, "cardiomyocytes": 61.0819721201829, "consecutive": 55.5598043434039, "determine": 50.97386472498134, "activation": 53.38053420583092, "ratios": 41.740947882808385, "or": 17.12622924626237, "testing": 45.24510439387712, "novel": 37.607955953346135, "report": 41.740947882808385, "oxygen": 41.740947882808385, "qrs": 26.116291447992207, "aortic": 41.740947882808385, "sd": 17.12622924626237, "prospective": 52.08731657194115, "pro": 24.484023232492696, "even": 30.53435864596082, "guidelines": 50.044250817966486, "filling": 42.4172853692598, "benefits": 45.26882861995894, "suggest": 42.4172853692598, "research": 45.26882861995894, "0.01": 30.53435864596082, "hearts": 39.13213864013286, "enrolled": 45.26882861995894, "differences": 52.08731657194115, "remained": 45.26882861995894, "different": 47.787998179670005, "beneficial": 50.044250817966486, "co": 16.05583991837097, "women": 35.257458706262, "analyses": 45.26882861995894, "stress": 39.13213864013286, "therefore": 47.787998179670005, "range": 35.257458706262, "velocity": 45.26882861995894, "future": 39.13213864013286, "receiving": 47.787998179670005, "sympathetic": 52.08731657194115, "action": 39.13213864013286, "matched": 42.4172853692598, "resistin": 45.26882861995894, "dnx": 24.484023232492696, "conditions": 46.70796743010205, "surgical": 42.250906711961676, "endothelial": 48.614828800478406, "during": 36.52332939745734, "plasma": 36.52332939745734, "either": 36.52332939745734, "mechanism": 44.60213163435867, "ventricle": 44.60213163435867, "anemia": 36.52332939745734, "physicians": 46.70796743010205, "recommendations": 54.83067302212804, "vascular": 42.250906711961676, "male": 28.498734736230098, "chromatin": 44.60213163435867, "structure": 44.60213163435867, "known": 32.906961459177865, "intervention": 50.35709199342126, "0.02": 28.498734736230098, "interaction": 48.614828800478406, "morbidity": 44.60213163435867, "values": 36.52332939745734, "fontan": 36.52332939745734, "self": 28.498734736230098, "duration": 42.250906711961676, "complications": 51.96092869310123, "reasons": 39.58946634464248, "derived": 39.58946634464248, "kidney": 36.52332939745734, "egfr": 28.498734736230098, "scores": 36.52332939745734, "bb": 14.985450590479573, "measurement": 48.614828800478406, "hyperkalemia": 50.35709199342126, "ivabradine": 46.70796743010205, "obese": 32.906961459177865, "users": 32.906961459177865, "hospitals": 41.416265089047336, "overall": 36.76164732002516, "improvements": 46.76015685103402, "fat": 21.21948680149367, "controls": 39.23298480396441, "biomarkers": 43.371684042237625, "weight": 33.91452015478181, "relative": 39.23298480396441, "as": 13.915061262588175, "inappropriate": 48.24943378645114, "evaluation": 43.371684042237625, "revealed": 39.23298480396441, "vo2": 21.21948680149367, "calculated": 43.371684042237625, "according": 41.416265089047336, "criteria": 39.23298480396441, "greater": 36.76164732002516, "incidence": 41.416265089047336, "ras": 21.21948680149367, "recommended": 45.14234102901567, ".001": 26.463110826499374, "mediated": 39.23298480396441, "dilatation": 43.371684042237625, "procedures": 43.371684042237625, "prediction": 43.371684042237625, "medication": 43.371684042237625, "number": 33.91452015478181, "strain": 33.91452015478181, "need": 26.463110826499374, "dialysis": 39.23298480396441, "measure": 36.76164732002516, "sst2": 26.463110826499374, "sham": 26.463110826499374, "length": 33.91452015478181, "tac": 21.21948680149367, "undergoing": 43.371684042237625, "aged": 26.463110826499374, "frailty": 36.76164732002516, "doxorubicin": 45.14234102901567, "carvedilol": 43.371684042237625, "variability": 45.14234102901567, "nursing": 36.76164732002516, "rad": 21.21948680149367, "four": 24.427486916768654, "g": 1.6500422849992202, "strength": 36.21506289596715, "potentially": 41.66985325755292, "costs": 28.2059669650096, "emergency": 38.230398543736, "et": 12.844671934696777, "single": 31.30571091210629, "glomerular": 40.03540065437319, "filtration": 40.03540065437319, "serum": 28.2059669650096, "growth": 31.30571091210629, "examine": 33.93382829540784, "proportional": 43.16322170864679, "sought": 31.30571091210629, "all": 19.587218585994155, "readmissions": 43.16322170864679, "recently": 36.21506289596715, "provided": 36.21506289596715, "pump": 24.427486916768654, "heartmate": 38.230398543736, "cardiopulmonary": 46.9977197332526, "often": 28.2059669650096, "variables": 38.230398543736, "declined": 36.21506289596715, "retrospective": 44.537938879801054, "phenotype": 38.230398543736, "adherence": 38.230398543736, "hdl": 19.587218585994155, "phosphorylation": 46.9977197332526, "investigate": 41.66985325755292, "aimed": 28.2059669650096, "week": 24.427486916768654, "overload": 36.21506289596715, "history": 33.93382829540784, "st2": 19.587218585994155, "aldosterone": 41.66985325755292, "tapse": 28.2059669650096, "young": 28.2059669650096, "rehabilitation": 45.81147909013717, "drugs": 28.2059669650096, "channel": 33.93382829540784, "mi": 12.844671934696777, "pde2": 24.427486916768654, "prior": 25.855469717925466, "stimulation": 38.19736548609018, "doppler": 31.10600927079052, "prevalence": 36.69911726650876, "impaired": 33.19714098796989, "adult": 25.855469717925466, "target": 28.696901669430765, "systematic": 36.69911726650876, "combined": 33.19714098796989, "appropriate": 38.19736548609018, "area": 22.391863007037934, "meta": 22.391863007037934, "peripheral": 36.69911726650876, "dopamine": 33.19714098796989, "main": 22.391863007037934, "0.05": 22.391863007037934, "secondary": 35.044531998424674, "improving": 35.044531998424674, "global": 28.696901669430765, "abnormal": 33.19714098796989, "mouse": 25.855469717925466, "remains": 31.10600927079052, "longitudinal": 39.566286566259556, "usual": 25.855469717925466, "genes": 25.855469717925466, "mrna": 22.391863007037934, "failing": 31.10600927079052, "pathways": 33.19714098796989, "healthy": 31.10600927079052, "pathophysiology": 43.08124308881489, "develop": 31.10600927079052, "wall": 22.391863007037934, "annular": 31.10600927079052, "thus": 22.391863007037934, "questionnaire": 40.826443973150965, "kccq": 22.391863007037934, "adjustment": 36.69911726650876, "reverse": 31.10600927079052, "would": 25.855469717925466, "adrenergic": 36.69911726650876, "pathway": 31.10600927079052, "cases": 25.855469717925466, "hospitalizations": 44.098876615499805, "coupling": 33.19714098796989, "crf": 17.954950370494643, "antagonist": 36.69911726650876, "metabolic": 35.044531998424674, "trastuzumab": 38.19736548609018, "dash": 22.391863007037934, "resonance": 35.044531998424674, "investigated": 39.566286566259556, "markers": 31.10600927079052, "animals": 31.10600927079052, "unclear": 28.2781902461732, "tissue": 26.08809242675524, "alterations": 34.72487771462744, "composition": 34.72487771462744, "energy": 26.08809242675524, "free": 20.35623909730721, "poor": 20.35623909730721, "iron": 20.35623909730721, "short": 23.504972470841334, "small": 23.504972470841334, "and/or": 26.08809242675524, "many": 20.35623909730721, "ambulatory": 33.362833878644324, "predictor": 31.85866545311334, "nesiritide": 33.362833878644324, "diuretic": 30.179219079972626, "multicenter": 34.72487771462744, "systems": 28.2781902461732, "exhibited": 31.85866545311334, "transcription": 37.11494906650088, "circulating": 34.72487771462744, "r": 1.3750352374993502, "approaches": 33.362833878644324, "pacing": 26.08809242675524, "samples": 28.2781902461732, "safe": 20.35623909730721, "deaths": 26.08809242675524, "registry": 30.179219079972626, "ability": 28.2781902461732, "predict": 28.2781902461732, "subgroups": 31.85866545311334, "children": 30.179219079972626, "possible": 30.179219079972626, "distance": 30.179219079972626, "molecular": 31.85866545311334, "optimal": 28.2781902461732, "parameters": 33.362833878644324, "wk": 10.70389327891398, "shortening": 33.362833878644324, "mva": 16.322682154995128, "mellitus": 30.179219079972626, "considered": 33.362833878644324, "available": 31.85866545311334, "complex": 28.2781902461732, "va": 10.70389327891398, "esrd": 20.35623909730721, "contractile": 34.72487771462744, "pre": 16.322682154995128, "antagonists": 34.72487771462744, "shown": 23.504972470841334, "blockade": 30.179219079972626, "progression": 34.72487771462744, "given": 23.504972470841334, "compliance": 33.362833878644324, "contribute": 33.362833878644324, "several": 28.2781902461732, "converting": 33.362833878644324, "enzyme": 26.08809242675524, "metabolism": 33.362833878644324, "magnetic": 30.179219079972626, "cv": 10.70389327891398, "inflammatory": 35.969351423872325, "tone": 20.35623909730721, "eplerenone": 33.362833878644324, "$": 1.3750352374993502, "vad": 16.322682154995128, "inv": 16.322682154995128, "psoriasis": 31.85866545311334, "aas": 16.322682154995128, "mena": 20.35623909730721, "national": 27.161297171975363, "largely": 25.45037122155588, "monitoring": 30.026550490779893, "requiring": 28.672798907802004, "show": 18.32061518757649, "admitted": 27.161297171975363, "loss": 18.32061518757649, "increasing": 30.026550490779893, "underlying": 30.026550490779893, "general": 25.45037122155588, "presence": 27.161297171975363, "cardiology": 30.026550490779893, "requires": 27.161297171975363, "strategy": 27.161297171975363, "agents": 23.479283184079716, "reference": 28.672798907802004, "consistent": 30.026550490779893, "made": 18.32061518757649, "frequently": 30.026550490779893, "department": 30.026550490779893, "enrollment": 30.026550490779893, "stratification": 34.35860931760288, "multivariable": 33.40345415985079, "analyzed": 27.161297171975363, "reviewed": 27.161297171975363, "particularly": 32.372416281485094, "points": 23.479283184079716, "mechanisms": 30.026550490779893, "scale": 21.154475223757203, "little": 23.479283184079716, "altered": 25.45037122155588, "resulted": 27.161297171975363, "differential": 32.372416281485094, "average": 25.45037122155588, "following": 28.672798907802004, "approach": 27.161297171975363, "uptitration": 31.252389943164694, "hemodynamic": 31.252389943164694, "occur": 21.154475223757203, "hypothesized": 32.372416281485094, "randomly": 27.161297171975363, "imaging": 25.45037122155588, "predictive": 30.026550490779893, "obtained": 27.161297171975363, "sensitivity": 31.252389943164694, "hypertensive": 32.372416281485094, "infusion": 27.161297171975363, "targets": 25.45037122155588, "preoperative": 32.372416281485094, "economic": 27.161297171975363, "rs": 9.633503951022583, "variation": 28.672798907802004, "reported": 27.161297171975363, "size": 18.32061518757649, "diagnosed": 28.672798907802004, "summary": 25.45037122155588, "camp": 18.32061518757649, "drug": 18.32061518757649, "sudden": 23.479283184079716, "ea": 9.633503951022583, "inhibitor": 28.672798907802004, "albumin": 25.45037122155588, "physical": 27.161297171975363, "stay": 18.32061518757649, "result": 23.479283184079716, "abnormalities": 33.40345415985079, "programs": 27.161297171975363, "pathological": 32.372416281485094, "cardiotoxicity": 34.35860931760288, "administration": 34.35860931760288, "center": 23.479283184079716, "catheter": 27.161297171975363, "indicated": 28.672798907802004, "key": 14.690413939495617, "scn5a": 21.154475223757203, "mmol": 18.32061518757649, "testosterone": 32.372416281485094, "autonomic": 28.672798907802004, "eh": 9.633503951022583, "la": 9.633503951022583, "saxagliptin": 31.252389943164694, "sitagliptin": 31.252389943164694, "deactivation": 32.372416281485094, "trends": 20.870473941404192, "suggests": 24.1433752639781, "led": 13.058145723996104, "cachexia": 24.1433752639781, "tested": 20.870473941404192, "fm": 8.563114623131185, "correlation": 27.77990217170195, "p<0.05": 20.870473941404192, "alone": 18.803977976673067, "leading": 22.62255219693856, "importance": 26.69026710291546, "treatments": 26.69026710291546, "databases": 25.48693236249067, "unknown": 22.62255219693856, "needed": 20.870473941404192, "selected": 24.1433752639781, "0.83": 16.28499127784577, "cumulative": 26.69026710291546, "hazards": 22.62255219693856, "therapies": 25.48693236249067, "diseases": 24.1433752639781, "measurements": 28.77548113909786, "admissions": 26.69026710291546, "good": 16.28499127784577, "myocardium": 26.69026710291546, "injury": 20.870473941404192, "younger": 22.62255219693856, "fewer": 18.803977976673067, "seen": 16.28499127784577, "classification": 30.54098606009145, "seven": 18.803977976673067, "iv": 8.563114623131185, "studied": 22.62255219693856, "walk": 16.28499127784577, "medications": 27.77990217170195, "0.0001": 20.870473941404192, "predicting": 26.69026710291546, "required": 24.1433752639781, "useful": 20.870473941404192, "old": 13.058145723996104, "laboratory": 26.69026710291546, "biventricular": 29.691959253200704, "approximately": 29.691959253200704, "lack": 16.28499127784577, "cs": 8.563114623131185, "successful": 26.69026710291546, "0.70": 16.28499127784577, "clinic": 20.870473941404192, "outpatients": 27.77990217170195, "vivo": 16.28499127784577, "minutes": 22.62255219693856, "kinase": 20.870473941404192, "consumption": 27.77990217170195, "maximal": 22.62255219693856, "elastance": 25.48693236249067, "importantly": 27.77990217170195, "moreover": 24.1433752639781, "plus": 16.28499127784577, "comorbidities": 29.691959253200704, "aor": 13.058145723996104, "atp": 13.058145723996104, "stent": 18.803977976673067, "mechanical": 26.69026710291546, "experienced": 27.77990217170195, "dietary": 22.62255219693856, "yet": 13.058145723996104, "\u03b4": 1.1000281899994802, "depression": 26.69026710291546, "aerobic": 22.62255219693856, "worsening": 25.48693236249067, "biological": 26.69026710291546, "0.85": 16.28499127784577, "expressed": 25.48693236249067, "irs1": 16.28499127784577, "irs2": 16.28499127784577, "cancer": 20.870473941404192, "initiative": 26.69026710291546, "trend": 18.803977976673067, "ecct": 16.28499127784577, "mapping": 22.62255219693856, "phase": 18.803977976673067, "titin": 18.803977976673067, "zsf1": 16.28499127784577, "resting": 22.62255219693856, "pd": 8.563114623131185, "sodium": 20.870473941404192, "multiple": 24.1433752639781, "anthracycline": 29.691959253200704, "ablation": 24.1433752639781, "nicorandil": 26.69026710291546, "targeting": 25.48693236249067, "variants": 24.1433752639781, "contextual": 26.69026710291546, "preferences": 27.77990217170195, "biomedical": 26.69026710291546, "pyridostigmine": 30.54098606009145, "dyssynchronous": 30.54098606009145, "uptake": 20.870473941404192, "rule": 16.28499127784577, "membrane": 24.1433752639781, "ecmo": 16.28499127784577, "f": 1.1000281899994802, "kit+": 16.28499127784577, "sample": 18.26166469872867, "attention": 22.301065817179335, "caused": 18.26166469872867, "peptides": 21.125453355980838, "additional": 23.353983715051026, "purpose": 19.79473317232124, "observational": 25.980464346550615, "both": 14.249367368115049, "highly": 18.26166469872867, "strongly": 21.125453355980838, "further": 19.79473317232124, "double": 18.26166469872867, "enhanced": 21.125453355980838, "added": 16.453480729588932, "quantify": 21.125453355980838, "regarding": 22.301065817179335, "d": 0.9625246662495451, "ie": 7.4927252952397865, "subsequent": 23.353983715051026, "experience": 23.353983715051026, "eo": 7.4927252952397865, "basis": 16.453480729588932, "examination": 24.307414400239203, "metrics": 19.79473317232124, "centers": 19.79473317232124, "absolute": 21.125453355980838, "percent": 19.79473317232124, "0.50": 14.249367368115049, "implanted": 22.301065817179335, "sts": 11.42587750849659, "inclusion": 22.301065817179335, "renin": 16.453480729588932, "accompanied": 24.307414400239203, "work": 14.249367368115049, "include": 19.79473317232124, "documented": 23.353983715051026, "determined": 23.353983715051026, "percentage": 23.353983715051026, "intervals": 22.301065817179335, "symptomatic": 24.307414400239203, "circulation": 24.307414400239203, "circulatory": 24.307414400239203, "minute": 18.26166469872867, "diuretics": 22.301065817179335, "protective": 23.353983715051026, "production": 23.353983715051026, "survivors": 22.301065817179335, "furthermore": 24.307414400239203, "especially": 23.353983715051026, "salt": 14.249367368115049, "established": 24.307414400239203, "fibrosis": 21.125453355980838, "t": 0.9625246662495451, "biomarker": 22.301065817179335, "various": 19.79473317232124, "incident": 21.125453355980838, "auc": 11.42587750849659, "shock": 16.453480729588932, "stenosis": 21.125453355980838, "reversed": 21.125453355980838, "ring": 14.249367368115049, "regurgitation": 25.980464346550615, "leaflet": 19.79473317232124, "plasty": 18.26166469872867, "degenerative": 25.17854599671063, "later": 16.453480729588932, "another": 19.79473317232124, "postoperative": 25.980464346550615, "resulting": 22.301065817179335, "angiography": 24.307414400239203, "etiology": 21.125453355980838, "causes": 18.26166469872867, "second": 18.26166469872867, "inpatient": 22.301065817179335, "city": 14.249367368115049, "ca(2": 14.249367368115049, "0.98": 14.249367368115049, "potassium": 22.301065817179335, "community": 22.301065817179335, "crucial": 19.79473317232124, "negative": 21.125453355980838, "brain": 16.453480729588932, "form": 14.249367368115049, "ischemia": 21.125453355980838, "lad": 11.42587750849659, "hypoalbuminemia": 27.41533651106402, "ai": 7.4927252952397865, "idiopathic": 23.353983715051026, "walking": 19.79473317232124, "alternative": 24.307414400239203, "lvet": 14.249367368115049, "partially": 22.301065817179335, "aim": 11.42587750849659, "signalling": 23.353983715051026, "frequency": 22.301065817179335, "investigating": 25.980464346550615, "produced": 21.125453355980838, "collagen": 21.125453355980838, "lean": 14.249367368115049, "gls": 11.42587750849659, "refractory": 23.353983715051026, "still": 16.453480729588932, "rehospitalization": 28.67147093998975, "remodelling": 24.307414400239203, "minnesota": 22.301065817179335, "deficit": 19.79473317232124, "np": 7.4927252952397865, "parasympathetic": 27.41533651106402, "aspects": 19.79473317232124, "ar": 7.4927252952397865, "hrqol": 16.453480729588932, "hgb": 11.42587750849659, "skeletal": 21.125453355980838, "mt": 7.4927252952397865, "gastrointestinal": 28.062921482590784, "s1pr1": 16.453480729588932, "receptors": 22.301065817179335, "hct": 11.42587750849659, "neprilysin": 23.353983715051026, "bleeding": 21.125453355980838, "btes": 14.249367368115049, "remain": 15.652855456053144, "cc": 6.422335967348388, "nps": 9.793609292997077, "play": 12.213743458384327, "ffm": 9.793609292997077, "inflammation": 21.581610854323394, "prospectively": 22.268969439900527, "least": 14.1029834825048, "combination": 20.83492662877646, "american": 18.107531447983575, "recommendation": 22.905739545068585, "hemoglobin": 20.017700327186596, "dl": 6.422335967348388, "1.8": 9.793609292997077, "intravenous": 20.83492662877646, "agent": 14.1029834825048, "settings": 18.107531447983575, "icd": 9.793609292997077, "min/1.73": 18.107531447983575, "hours": 14.1029834825048, "open": 12.213743458384327, "processes": 19.115199271868, "implementation": 22.905739545068585, "nurses": 15.652855456053144, "proteomics": 20.017700327186596, "myocyte": 16.96691414770392, "dna": 9.793609292997077, "recipients": 20.017700327186596, "bundle": 15.652855456053144, "branch": 15.652855456053144, "block": 14.1029834825048, "0.87": 12.213743458384327, "reductions": 20.017700327186596, "0.92": 12.213743458384327, "involved": 18.107531447983575, "cfus": 12.213743458384327, "implications": 21.581610854323394, "metric": 15.652855456053144, "cms": 9.793609292997077, "0.67": 12.213743458384327, "tm": 6.422335967348388, "hm": 6.422335967348388, "1.08": 12.213743458384327, "statistically": 22.268969439900527, "reducing": 18.107531447983575, "investigation": 22.268969439900527, "tachycardia": 20.83492662877646, "fully": 14.1029834825048, "western": 16.96691414770392, "activated": 19.115199271868, "pathogenesis": 21.581610854323394, "lvads": 14.1029834825048, "received": 18.107531447983575, "]": 0.8250211424996101, "0.54": 12.213743458384327, "associations": 21.581610854323394, "female": 15.652855456053144, "pg": 6.422335967348388, "article": 16.96691414770392, "elderly": 16.96691414770392, "protocol": 18.107531447983575, "classified": 20.017700327186596, "coefficient": 20.83492662877646, "1.7": 9.793609292997077, "decreases": 19.115199271868, "systemic": 18.107531447983575, "catheterization": 23.4988598666263, "central": 16.96691414770392, "comparison": 20.017700327186596, "facilitate": 20.017700327186596, "gender": 15.652855456053144, "0.004": 14.1029834825048, "unique": 15.652855456053144, "ec": 6.422335967348388, "iiib": 12.213743458384327, "demonstrate": 20.83492662877646, "cutoff": 15.652855456053144, "died": 12.213743458384327, "experimental": 21.581610854323394, "ang": 9.793609292997077, "oxidative": 19.115199271868, "atherosclerosis": 23.4988598666263, "ctnt": 12.213743458384327, "fit": 9.793609292997077, "continuous": 20.017700327186596, "provides": 18.107531447983575, "favorable": 19.115199271868, "btt": 9.793609292997077, "bivp": 12.213743458384327, "understanding": 22.268969439900527, "analyze": 16.96691414770392, "delay": 14.1029834825048, "occlusion": 19.115199271868, "indices": 16.96691414770392, "linear": 15.652855456053144, "opening": 16.96691414770392, "dynamic": 16.96691414770392, "confirmed": 19.115199271868, "cm2": 9.793609292997077, "continuity": 20.017700327186596, "modestly": 18.107531447983575, "restriction": 20.83492662877646, "hfpsi": 14.1029834825048, "validated": 19.115199271868, "1.73": 12.213743458384327, "kansas": 15.652855456053144, "intermediate": 21.581610854323394, "cxl-1020": 18.107531447983575, "0.96": 12.213743458384327, "newly": 14.1029834825048, "excluded": 18.107531447983575, "2.5": 9.793609292997077, "fold": 12.213743458384327, "angiogenesis": 21.581610854323394, "vegf": 12.213743458384327, "worse": 14.1029834825048, "acf": 9.793609292997077, "0.63": 12.213743458384327, "individual": 20.017700327186596, "bottleneck": 20.017700327186596, "proximal": 18.107531447983575, "lcx": 9.793609292997077, "reserve": 16.96691414770392, "ees": 9.793609292997077, "differ": 15.652855456053144, "marked": 15.652855456053144, "subgroup": 18.107531447983575, "procedure": 19.115199271868, "youngest": 18.107531447983575, "black": 14.1029834825048, "categories": 20.017700327186596, "1.00": 12.213743458384327, "assigned": 18.107531447983575, "tools": 14.1029834825048, "icu": 9.793609292997077, "previously": 20.017700327186596, "embolism": 18.107531447983575, "interquartile": 22.268969439900527, "tnf": 9.793609292997077, "vasopressin": 20.83492662877646, "hand2": 14.1029834825048, "linked": 15.652855456053144, "targeted": 18.107531447983575, "induction": 19.115199271868, "breast": 15.652855456053144, "toward": 15.652855456053144, "aims": 12.213743458384327, "0.99": 12.213743458384327, "modification": 21.581610854323394, "beat": 12.213743458384327, "lbbb": 12.213743458384327, "retn": 12.213743458384327, "sinus": 14.1029834825048, "state": 14.1029834825048, "clinically": 20.017700327186596, "records": 16.96691414770392, "tool": 12.213743458384327, "contribution": 21.581610854323394, "designed": 18.107531447983575, "bets": 12.213743458384327, "prevention": 20.017700327186596, "na+": 9.793609292997077, "channels": 18.107531447983575, "upr": 9.793609292997077, "downregulation": 22.905739545068585, "balance": 16.96691414770392, "diameter": 18.107531447983575, "goal": 12.213743458384327, "states": 15.652855456053144, "pilot": 14.1029834825048, "five": 12.213743458384327, "partial": 16.96691414770392, "extracorporeal": 22.905739545068585, "applied": 16.96691414770392, "fes": 9.793609292997077, "social": 15.652855456053144, "sdqt": 12.213743458384327, "ch": 6.422335967348388, "aac": 9.793609292997077, "bat": 9.793609292997077, "barriers": 18.107531447983575, "pneumonia": 15.92933272655667, "decline": 14.1390951230866, "problems": 15.089609539986313, "progress": 15.089609539986313, "cross": 11.752486235420667, "hypothesis": 16.681416939322162, "progressive": 17.36243885731372, "distribution": 17.984675711936163, "dual": 10.178119548653605, "countries": 15.92933272655667, "increases": 15.92933272655667, "signs": 11.752486235420667, "stiffness": 15.92933272655667, "pressures": 15.92933272655667, "literature": 16.681416939322162, "medline": 14.1390951230866, "arrhythmia": 16.681416939322162, "transfusion": 17.36243885731372, "grade": 11.752486235420667, "strong": 13.04404621337762, "aggressive": 16.681416939322162, "indication": 16.681416939322162, "outpatient": 16.681416939322162, "conducted": 15.92933272655667, "obstructive": 17.36243885731372, "1.2": 8.161341077497564, "0.77": 10.178119548653605, "decongestion": 17.984675711936163, "neither": 14.1390951230866, "sites": 11.752486235420667, "relevance": 15.92933272655667, "participating": 18.55747453325044, "nucleolin": 15.92933272655667, "profile": 14.1390951230866, "modest": 13.04404621337762, "impairment": 16.681416939322162, "receive": 14.1390951230866, "previous": 15.089609539986313, "revascularization": 20.479622099992678, "contemporary": 17.984675711936163, "severely": 15.089609539986313, "0.04": 10.178119548653605, "1.02": 10.178119548653605, "cpcs": 10.178119548653605, "process": 14.1390951230866, "office": 13.04404621337762, "highest": 14.1390951230866, "between": 14.1390951230866, "measuring": 15.92933272655667, "rm": 5.35194663945699, "growing": 14.1390951230866, "discharged": 16.681416939322162, "january": 14.1390951230866, "relevant": 15.089609539986313, "validity": 15.089609539986313, "comparisons": 17.36243885731372, "participation": 18.55747453325044, "understood": 16.681416939322162, "bax": 8.161341077497564, "treating": 15.089609539986313, "replacement": 17.36243885731372, "ras-": 10.178119548653605, "0.81": 10.178119548653605, "burden": 13.04404621337762, "inhospital": 16.681416939322162, "explored": 15.089609539986313, "pediatric": 15.92933272655667, "involving": 15.92933272655667, "international": 18.55747453325044, "1.3": 8.161341077497564, "1.6": 8.161341077497564, "distinct": 15.089609539986313, "final": 11.752486235420667, "hdl(nyha": 15.089609539986313, "quantified": 16.681416939322162, "done": 10.178119548653605, "curve": 11.752486235420667, "loading": 14.1390951230866, "simple": 13.04404621337762, "ans": 8.161341077497564, "fractional": 16.681416939322162, "lung": 10.178119548653605, "reclassification": 20.044943916136276, "described": 15.92933272655667, "over": 10.178119548653605, "statistical": 17.36243885731372, "interestingly": 18.55747453325044, "dt": 5.35194663945699, "june": 10.178119548653605, "varying": 14.1390951230866, "synchrony": 15.92933272655667, "mixed": 11.752486235420667, "anterior": 15.089609539986313, "man": 8.161341077497564, "edge": 10.178119548653605, "wave": 10.178119548653605, "lesions": 14.1390951230866, "clear": 11.752486235420667, "discussed": 15.92933272655667, "symptom": 14.1390951230866, "repeated": 15.089609539986313, "direct": 13.04404621337762, "indicative": 16.681416939322162, "most": 10.178119548653605, "collected": 15.92933272655667, "university": 16.681416939322162, "epidemiology": 17.984675711936163, "comparable": 16.681416939322162, "domains": 14.1390951230866, "internal": 15.089609539986313, "reliability": 17.36243885731372, "concentrations": 19.088116287557156, "family": 13.04404621337762, "doses": 11.752486235420667, "affect": 13.04404621337762, "ng": 5.35194663945699, "achieved": 15.089609539986313, "hno": 8.161341077497564, "usefulness": 16.681416939322162, "here": 10.178119548653605, "contractility": 18.55747453325044, "3.1": 8.161341077497564, "0.97": 10.178119548653605, "initial": 14.1390951230866, "5.0": 8.161341077497564, "covariates": 16.681416939322162, "0.91": 10.178119548653605, "perfusion": 15.92933272655667, "influences": 16.681416939322162, "eds": 8.161341077497564, "driven": 13.04404621337762, "xo": 5.35194663945699, "rat": 8.161341077497564, "absence": 14.1390951230866, "extracellular": 18.55747453325044, "attenuation": 17.36243885731372, "possibly": 15.089609539986313, "force": 11.752486235420667, "vessel": 13.04404621337762, "feasible": 15.089609539986313, "relation": 15.089609539986313, "twice": 11.752486235420667, "0.002": 11.752486235420667, "programme": 15.92933272655667, "nordic": 13.04404621337762, "centre": 13.04404621337762, "parallel": 15.089609539986313, "promising": 15.92933272655667, "milliseconds": 17.984675711936163, "completed": 15.92933272655667, "recovery": 15.089609539986313, "information": 17.36243885731372, "populations": 17.36243885731372, "expected": 15.089609539986313, "responses": 15.92933272655667, "site": 10.178119548653605, "full": 10.178119548653605, "chemotherapy": 17.984675711936163, "mediterranean": 18.55747453325044, "p<0.0001": 15.089609539986313, "part": 10.178119548653605, "thirty": 13.04404621337762, "p<0.01": 13.04404621337762, "p=0.03": 13.04404621337762, "preliminary": 17.36243885731372, "suggesting": 16.681416939322162, "dd": 5.35194663945699, "\u2265": 0.6875176187496751, "extent": 13.04404621337762, "majority": 15.089609539986313, "appears": 14.1390951230866, "hum": 8.161341077497564, "maintenance": 17.36243885731372, "assisted": 15.089609539986313, "cabg": 10.178119548653605, "maladaptive": 17.36243885731372, "activating": 16.681416939322162, "pharmacologic": 18.55747453325044, "like": 10.178119548653605, "poc": 8.161341077497564, "consultation": 17.984675711936163, "haemodynamic": 17.984675711936163, "jq1": 8.161341077497564, "contrast": 15.089609539986313, "subunit": 14.1390951230866, "late": 10.178119548653605, "emd": 8.161341077497564, "myofiber": 15.089609539986313, "thickness": 15.92933272655667, "united": 13.04404621337762, "options": 14.1390951230866, "wrf": 8.161341077497564, "endpoint": 15.089609539986313, "resource": 15.089609539986313, "chm": 8.161341077497564, "lyso": 10.178119548653605, ".05": 8.161341077497564, "acs": 8.161341077497564, "oxygenation": 17.36243885731372, "concurrent": 16.681416939322162, "regulation": 16.681416939322162, "divided": 14.1390951230866, "ecmo+vad": 15.089609539986313, "coupled": 14.1390951230866, "urgent": 13.04404621337762, "familiar": 15.089609539986313, "qt": 5.35194663945699, "qtv": 8.161341077497564, "hnorm": 11.752486235420667, "mirnas": 13.04404621337762, "service": 14.1390951230866, "infection": 15.92933272655667, "q66p": 10.178119548653605, "tta": 8.161341077497564, "tgtetmena": 15.92933272655667, "discussions": 17.36243885731372, "athletes": 15.089609539986313, "psss": 10.178119548653605, "bpm": 8.161341077497564, "lvas": 10.178119548653605, "real": 8.142495638922885, "neurohormonal": 14.845979626600352, "society": 11.31127609846928, "college": 11.31127609846928, "acp": 6.529072861998052, "published": 12.743466181245335, "july": 8.142495638922885, "cochrane": 12.07168763198905, "harms": 9.401988988336534, "venous": 10.435236970702096, "thromboembolic": 15.270493030045724, "includes": 12.07168763198905, "erythropoiesis": 15.270493030045724, "stimulating": 13.889951085850974, "embase": 10.435236970702096, "syndrome": 12.07168763198905, "few": 6.529072861998052, "help": 8.142495638922885, "defibrillators": 15.270493030045724, "al": 4.281557311565592, "authors": 11.31127609846928, "focused": 11.31127609846928, "ahf": 6.529072861998052, "essential": 12.743466181245335, "evaluating": 13.34513355145773, "eligible": 12.07168763198905, "estimates": 12.743466181245335, "1.56": 8.142495638922885, "1.71": 8.142495638922885, "0.73": 8.142495638922885, "reliable": 12.07168763198905, "0.005": 9.401988988336534, "blind": 9.401988988336534, "m2": 4.281557311565592, "america": 11.31127609846928, "hour": 8.142495638922885, "0.13": 8.142495638922885, "nurse": 9.401988988336534, "focus": 9.401988988336534, "practices": 12.743466181245335, "extend": 10.435236970702096, "\u00ae": 0.5500140949997401, "cellular": 12.07168763198905, "tests": 9.401988988336534, "deficits": 12.07168763198905, "defects": 11.31127609846928, "shift": 9.401988988336534, "reports": 11.31127609846928, "diseased": 12.07168763198905, "automatic": 12.743466181245335, "bypass": 10.435236970702096, "percutaneous": 14.38774056954893, "decompensated": 14.845979626600352, "world": 9.401988988336534, "\u226550": 6.529072861998052, "moderately": 13.34513355145773, "1.01": 8.142495638922885, "evident": 11.31127609846928, "0.86": 8.142495638922885, "0.03": 8.142495638922885, "progenitor": 13.34513355145773, "every": 9.401988988336534, "units": 9.401988988336534, "recorded": 12.07168763198905, "noted": 9.401988988336534, "generally": 12.743466181245335, "correlations": 14.38774056954893, "careful": 11.31127609846928, "network": 11.31127609846928, "context": 11.31127609846928, "home": 8.142495638922885, "programmes": 13.34513355145773, "hh": 4.281557311565592, "twenty": 10.435236970702096, "significance": 14.38774056954893, "1.18": 8.142495638922885, "hospitalisations": 16.03595513290902, "apoptosis": 12.743466181245335, "bcl-2": 9.401988988336534, "taken": 9.401988988336534, "dogs": 8.142495638922885, "method": 10.435236970702096, "unchanged": 12.743466181245335, "positive": 12.07168763198905, "become": 10.435236970702096, "when": 8.142495638922885, "technique": 12.743466181245335, "ref": 6.529072861998052, "0.36": 8.142495638922885, "0.32": 8.142495638922885, "predicts": 12.07168763198905, "borderline": 13.34513355145773, "2.7": 6.529072861998052, "adjusting": 12.743466181245335, "presentation": 14.38774056954893, "canadian": 12.07168763198905, "application": 13.889951085850974, "cognitive": 12.743466181245335, "relationships": 14.845979626600352, "presenting": 13.34513355145773, "liver": 9.401988988336534, "hemodynamically": 15.665906577750867, "saf": 6.529072861998052, "fifty": 9.401988988336534, "predominantly": 14.845979626600352, "pf": 4.281557311565592, "2.8": 6.529072861998052, "by": 4.281557311565592, "output": 10.435236970702096, "0.008": 9.401988988336534, "prescribed": 13.34513355145773, "enos": 8.142495638922885, "successfully": 14.38774056954893, "specificity": 13.889951085850974, "confirm": 11.31127609846928, "hhd": 6.529072861998052, "uninephrectomy": 15.270493030045724, "eight": 9.401988988336534, "might": 9.401988988336534, "transition": 13.34513355145773, "decades": 11.31127609846928, "aric": 8.142495638922885, "net": 6.529072861998052, "excellent": 12.743466181245335, "evaluations": 13.889951085850974, "twist": 9.401988988336534, "ste": 6.529072861998052, "pigs": 8.142495638922885, "initiated": 12.743466181245335, "echocardiograms": 15.665906577750867, "basal": 9.401988988336534, "contributions": 14.845979626600352, "annuloplasty": 14.38774056954893, "disappeared": 13.889951085850974, "gradient": 12.07168763198905, "restricted": 13.34513355145773, "vary": 8.142495638922885, "routinely": 12.743466181245335, "um": 4.281557311565592, "rt": 4.281557311565592, "date": 8.142495638922885, "cohorts": 11.31127609846928, "collaboration": 14.845979626600352, "constructed": 13.889951085850974, "q": 0.5500140949997401, "exists": 10.435236970702096, "soluble": 11.31127609846928, "daily": 9.401988988336534, "conscious": 12.743466181245335, "creatinine": 13.34513355145773, "crude": 9.401988988336534, "3.5": 6.529072861998052, "contributes": 13.889951085850974, "ad": 4.281557311565592, "enhancement": 13.889951085850974, "efficiency": 13.34513355145773, "o2": 4.281557311565592, "transmitral": 13.889951085850974, "pcwp": 8.142495638922885, "e'septal": 12.07168763198905, "separate": 12.07168763198905, "5.1": 6.529072861998052, "antiarrhythmic": 15.270493030045724, "prevent": 11.31127609846928, "timing": 10.435236970702096, "antiplatelet": 14.38774056954893, "stenting": 12.07168763198905, "infarcted": 12.743466181245335, "reversible": 13.34513355145773, "cf": 4.281557311565592, "invasive": 12.07168763198905, "\u226570": 6.529072861998052, "fatal": 9.401988988336534, "compare": 11.31127609846928, "grip": 8.142495638922885, "ph": 4.281557311565592, "deterioration": 14.845979626600352, "atrium": 10.435236970702096, "copd": 8.142495638922885, "mdc": 6.529072861998052, "ranging": 11.31127609846928, "healthcare": 13.34513355145773, "perceived": 12.743466181245335, "battery": 11.31127609846928, "frail": 9.401988988336534, "1.24": 8.142495638922885, "spontaneous": 13.889951085850974, "occurs": 10.435236970702096, "intolerance": 13.889951085850974, "mineralocorticoid": 16.383697679994143, "components": 13.34513355145773, "dko": 6.529072861998052, "content": 11.31127609846928, "1.05": 8.142495638922885, "i": 0.5500140949997401, "descriptive": 13.889951085850974, "assessments": 13.889951085850974, "changed": 11.31127609846928, "matrix": 10.435236970702096, "1.03": 8.142495638922885, "times": 9.401988988336534, "rest": 8.142495638922885, "influence": 12.743466181245335, "p=0.04": 10.435236970702096, "prolonged": 12.743466181245335, "p=0.02": 10.435236970702096, "n=11": 8.142495638922885, "specifically": 14.38774056954893, "sensitive": 12.743466181245335, "univariate": 13.34513355145773, "\u2264": 0.5500140949997401, "morphology": 13.34513355145773, "srd": 6.529072861998052, "brachial": 12.07168763198905, "stimulated": 13.34513355145773, "vitro": 9.401988988336534, "success": 11.31127609846928, "larger": 10.435236970702096, "phosphocreatine": 15.665906577750867, "perturbations": 14.845979626600352, "web": 6.529072861998052, "logistic": 12.07168763198905, "congenital": 13.34513355145773, "poorly": 10.435236970702096, "investigations": 15.270493030045724, "erk1/2": 10.435236970702096, "adaptive": 12.07168763198905, "transduction": 14.38774056954893, "proportion": 13.34513355145773, "unit": 8.142495638922885, "predicted": 12.743466181245335, "describe": 12.07168763198905, "routine": 11.31127609846928, "guide": 9.401988988336534, "developing": 13.34513355145773, "bromodomain": 13.889951085850974, "signal": 10.435236970702096, "epigenetic": 13.34513355145773, "substantial": 13.889951085850974, "constriction": 14.38774056954893, "breathing": 12.743466181245335, "pulse": 9.401988988336534, "sequence": 12.07168763198905, "means": 9.401988988336534, "age-": 8.142495638922885, "123)i": 9.401988988336534, "haplotype": 12.743466181245335, "\u03b22": 4.281557311565592, "irrespective": 14.38774056954893, "vagal": 9.401988988336534, "insight": 11.31127609846928, "electrical": 13.34513355145773, "represented": 13.889951085850974, "additive": 12.07168763198905, "wasting": 11.31127609846928, "million": 11.31127609846928, "cgmp": 8.142495638922885, "overexpression": 15.270493030045724, "explore": 11.31127609846928, "canada": 10.435236970702096, "skm": 6.529072861998052, "vo2max": 10.435236970702096, "dcm": 6.529072861998052, "enzymes": 11.31127609846928, "[": 0.5500140949997401, "update": 10.435236970702096, "problem": 11.31127609846928, "beck": 8.142495638922885, "inventory": 12.743466181245335, "living": 10.435236970702096, "explant": 11.31127609846928, "tgf": 6.529072861998052, "pb": 4.281557311565592, "lead": 8.142495638922885, "rabbits": 11.31127609846928, "\u03b21ar": 8.142495638922885, "actions": 11.31127609846928, "translational": 14.845979626600352, "pka": 6.529072861998052, "antibodies": 13.34513355145773, "wild": 8.142495638922885, "hfvt(+": 10.435236970702096, "0\u00b701": 8.142495638922885, "consensus": 12.743466181245335, "supports": 12.07168763198905, "forms": 9.401988988336534, "lvh": 6.529072861998052, "rwt": 6.529072861998052, "madit": 9.401988988336534, "0.64": 8.142495638922885, "bisphosphonates": 15.665906577750867, "alendronate": 13.889951085850974, "sr": 4.281557311565592, "pad": 6.529072861998052, "ongoing": 11.31127609846928, "public": 10.435236970702096, "degs": 8.142495638922885, "telehealth": 13.34513355145773, "beneficiaries": 14.845979626600352, "buddy": 9.401988988336534, "pna": 6.529072861998052, "unfit": 9.401988988336534, "glucose": 11.31127609846928, "c'd": 6.529072861998052, "clcnka": 10.435236970702096, "air": 6.529072861998052, "pollution": 12.743466181245335, "hhf": 6.529072861998052, "gdmt": 8.142495638922885, "paradigm": 12.07168763198905, "qol": 6.529072861998052, "magnetically": 14.38774056954893, "levitated": 12.743466181245335, "database": 9.053765723991788, "created": 8.48345707385196, "board": 7.0514917412524, "talk": 6.1068717291921635, "expenditure": 10.41746331438823, "suggested": 9.557599635934, "x": 0.41251057124980506, "ray": 4.896804646498539, "absorptiometry": 11.452869772534292, "dxa": 4.896804646498539, "diabetic": 9.053765723991788, "proanp": 7.826427728026572, "adiponectin": 10.41746331438823, "inversely": 9.557599635934, "bmi": 4.896804646498539, "1.35": 6.1068717291921635, "latter": 7.826427728026572, "pronounced": 10.008850163593298, "critical": 9.053765723991788, "invasively": 10.008850163593298, "deficiency": 10.008850163593298, "language": 9.053765723991788, "tolerance": 9.557599635934, "clinicians": 10.008850163593298, "trigger": 8.48345707385196, "threshold": 9.557599635934, "sources": 8.48345707385196, "transfusions": 10.790805427161697, "extracted": 9.557599635934, "protocols": 9.557599635934, "limitations": 10.41746331438823, "mainly": 7.826427728026572, "serious": 8.48345707385196, "remote": 7.826427728026572, "pharmacological": 11.74942993331315, "search": 7.826427728026572, "worldwide": 9.557599635934, "financial": 9.557599635934, "component": 9.557599635934, "modern": 7.826427728026572, "heterogeneous": 11.134484719950263, "searched": 9.053765723991788, "1.38": 6.1068717291921635, "shocks": 7.826427728026572, "enhance": 8.48345707385196, "preserve": 9.053765723991788, "march": 7.0514917412524, "1:1": 4.896804646498539, "urine": 7.0514917412524, "cystatin": 9.053765723991788, "0.06": 6.1068717291921635, "similarly": 9.557599635934, "beyond": 7.826427728026572, "involves": 9.053765723991788, "thereby": 8.48345707385196, "fundamental": 10.41746331438823, "gross": 7.0514917412524, "differentiation": 11.74942993331315, "validation": 10.008850163593298, "ies": 4.896804646498539, "ic": 3.211167983674194, "comprised": 9.557599635934, "0.003": 7.0514917412524, "pattern": 8.48345707385196, "twofold": 8.48345707385196, "attenuated": 10.008850163593298, "categorized": 10.41746331438823, "0.90": 6.1068717291921635, "1.20": 6.1068717291921635, "cd34+vegfr2": 10.41746331438823, "0.25": 6.1068717291921635, "0.09": 6.1068717291921635, "0.69": 6.1068717291921635, "choice": 7.826427728026572, "acr": 4.896804646498539, "medicaid": 9.053765723991788, "remaining": 9.557599635934, "extreme": 8.48345707385196, "agreement": 9.557599635934, "principal": 9.557599635934, "way": 4.896804646498539, "needs": 7.0514917412524, "supplemented": 10.790805427161697, "hand": 6.1068717291921635, "cri": 4.896804646498539, "0.55": 6.1068717291921635, "0.49": 6.1068717291921635, "exclusion": 9.557599635934, "acceptable": 10.008850163593298, "rapid": 7.0514917412524, "caspase-3": 9.557599635934, "septum": 7.826427728026572, "biopsies": 9.053765723991788, "fragmentation": 11.134484719950263, "tunel": 7.0514917412524, "paced": 7.0514917412524, "assay": 7.0514917412524, "exchange": 9.053765723991788, "widely": 7.826427728026572, "fractions": 9.557599635934, "immediately": 10.41746331438823, "0.60": 6.1068717291921635, "1.09": 6.1068717291921635, "accounting": 10.008850163593298, "childhood": 9.557599635934, "advances": 9.053765723991788, "intubated": 9.557599635934, "revision": 9.053765723991788, "codes": 7.0514917412524, "visit": 7.0514917412524, "2.4": 4.896804646498539, "traditional": 10.41746331438823, "characterized": 11.134484719950263, "svr": 4.896804646498539, "asymptomatic": 10.790805427161697, "0.8": 4.896804646498539, "features": 9.053765723991788, "recognized": 10.008850163593298, "hart": 6.1068717291921635, "mwt": 4.896804646498539, "1.63": 6.1068717291921635, "density": 8.48345707385196, "lipoprotein": 10.41746331438823, "rationale": 9.557599635934, "exerts": 7.826427728026572, "hdl(healthy": 10.41746331438823, "bound": 7.0514917412524, "k": 0.41251057124980506, "determination": 11.134484719950263, "best": 6.1068717291921635, "knowledge": 9.557599635934, "combining": 9.557599635934, "compensated": 10.41746331438823, "troponin": 9.053765723991788, "prevalent": 9.557599635934, "characteristic": 11.452869772534292, "integrated": 10.008850163593298, "discrimination": 11.452869772534292, "temporary": 9.557599635934, "insertion": 9.557599635934, "cardiogenic": 10.41746331438823, "centrimag": 9.557599635934, "rvad": 6.1068717291921635, "demographics": 10.790805427161697, "eligibility": 10.41746331438823, "requirement": 10.41746331438823, "bridge": 7.826427728026572, "types": 7.0514917412524, "heartware": 9.557599635934, "systematically": 11.452869772534292, "simulation": 10.008850163593298, "policy": 7.826427728026572, "currently": 9.557599635934, "limits": 7.826427728026572, "regions": 8.48345707385196, "sufficient": 10.008850163593298, "regardless": 10.008850163593298, "carefully": 9.557599635934, "adequate": 9.053765723991788, "rvpo": 6.1068717291921635, "materials": 9.557599635934, "ivc": 4.896804646498539, "avd": 4.896804646498539, "vvd": 4.896804646498539, "radial": 7.826427728026572, "apex": 6.1068717291921635, "noninvasive": 10.41746331438823, "tethering": 9.557599635934, "muscles": 8.48345707385196, "prolapse": 9.053765723991788, "4.4": 4.896804646498539, "fig": 4.896804646498539, "started": 8.48345707385196, "rheumatic": 9.557599635934, "closure": 8.48345707385196, "indications": 10.41746331438823, "severity": 9.053765723991788, "reached": 8.48345707385196, "statistics": 10.008850163593298, "kaplan": 7.826427728026572, "meier": 7.0514917412524, "rank": 6.1068717291921635, "rare": 6.1068717291921635, "valid": 7.0514917412524, "terms": 7.0514917412524, "\u03b1": 0.41251057124980506, "responsiveness": 11.452869772534292, "attributable": 10.790805427161697, "taking": 7.826427728026572, "\u226435": 4.896804646498539, "equivalent": 10.008850163593298, "lowest": 7.826427728026572, "p=0.001": 8.48345707385196, "donor": 7.0514917412524, "inotropic": 9.557599635934, "pure": 6.1068717291921635, "solely": 7.826427728026572, "myocytes": 9.053765723991788, "rise": 6.1068717291921635, "equally": 8.48345707385196, "power": 7.0514917412524, "robust": 7.826427728026572, "cm": 3.211167983674194, "selecting": 9.557599635934, "risks": 7.0514917412524, "prevents": 9.053765723991788, "bisoprolol": 10.008850163593298, "vehicle": 8.48345707385196, "capillary": 9.557599635934, "responsible": 10.41746331438823, "medium": 7.826427728026572, "1.16": 6.1068717291921635, "0.79": 6.1068717291921635, "repeat": 7.826427728026572, "oxidase": 8.48345707385196, "respiration": 10.41746331438823, "allopurinol": 10.41746331438823, "depressed": 9.557599635934, "annulus": 8.48345707385196, "estimating": 10.008850163593298, "systole": 8.48345707385196, "diastole": 9.053765723991788, "0.71": 6.1068717291921635, "detecting": 9.557599635934, "tricuspid": 9.557599635934, "echo": 6.1068717291921635, "hundred": 8.48345707385196, "line": 6.1068717291921635, "/\u2265": 3.211167983674194, "shows": 7.0514917412524, "animal": 7.826427728026572, "formed": 7.826427728026572, "descending": 10.008850163593298, "collateral": 10.008850163593298, "complete": 9.053765723991788, "mostly": 7.826427728026572, "selective": 9.557599635934, "reduces": 8.48345707385196, "afterload": 9.557599635934, "represents": 10.008850163593298, "substudy": 9.053765723991788, "arm": 4.896804646498539, "sv": 3.211167983674194, "institution": 10.41746331438823, "concentration": 11.134484719950263, "normalization": 11.134484719950263, "safely": 7.826427728026572, "0.42": 6.1068717291921635, "0.3": 4.896804646498539, "superior": 9.053765723991788, "complicating": 10.790805427161697, "precapillary": 10.790805427161697, "tonometry": 9.557599635934, "carries": 8.48345707385196, "shorter": 8.48345707385196, "identifying": 10.41746331438823, "other": 7.0514917412524, "norepinephrine": 11.452869772534292, "brief": 7.0514917412524, "arrest": 7.826427728026572, "retest": 7.826427728026572, "tug": 4.896804646498539, "error": 7.0514917412524, "ra": 3.211167983674194, "nbdmard": 8.48345707385196, "propensity": 10.008850163593298, "0.45": 6.1068717291921635, "people": 7.826427728026572, "undertaken": 10.008850163593298, "others": 7.826427728026572, "abc": 4.896804646498539, "habc": 6.1068717291921635, "white": 7.0514917412524, "1.13": 6.1068717291921635, "nervous": 8.48345707385196, "nfat": 6.1068717291921635, "mir-25": 7.826427728026572, "embryonic": 9.557599635934, "integrate": 9.557599635934, "mutant": 7.826427728026572, "overexpressing": 11.452869772534292, "murine": 7.826427728026572, "micrornas": 9.557599635934, "mammalian": 9.557599635934, "past": 6.1068717291921635, "hallmark": 9.053765723991788, "h": 0.41251057124980506, "diminished": 10.008850163593298, "exposure": 9.053765723991788, "prevented": 9.557599635934, "december": 9.053765723991788, "insurance": 9.557599635934, "describes": 9.557599635934, "1.11": 6.1068717291921635, "version": 8.48345707385196, "1.34": 6.1068717291921635, "last": 6.1068717291921635, "cardioprotective": 12.026966349681764, "subset": 7.826427728026572, "matching": 9.053765723991788, "contributing": 10.790805427161697, "p=0.035": 8.48345707385196, "0.1": 4.896804646498539, "chart": 7.0514917412524, "postcontrast": 10.790805427161697, "technology": 10.008850163593298, "p=0.01": 7.826427728026572, "chelation": 9.557599635934, "verify": 7.826427728026572, "prolongation": 10.790805427161697, "2.1": 4.896804646498539, "hypophosphorylation": 12.76650219944516, "obesity": 8.48345707385196, "segment": 8.48345707385196, "contributed": 10.41746331438823, "referred": 9.053765723991788, "hospitalisation": 11.74942993331315, "sa": 3.211167983674194, "containing": 10.008850163593298, "separately": 10.008850163593298, "ecg": 4.896804646498539, "0.88": 6.1068717291921635, "broader": 8.48345707385196, "delayed": 8.48345707385196, "series": 7.826427728026572, "initiation": 10.008850163593298, "6.0": 4.896804646498539, "origin": 7.826427728026572, "certain": 8.48345707385196, "0.4": 4.896804646498539, "stimuli": 8.48345707385196, "humans": 7.826427728026572, "effectively": 10.41746331438823, "anti": 6.1068717291921635, "together": 9.053765723991788, "ultrastructural": 11.74942993331315, "affecting": 9.557599635934, "1.06": 6.1068717291921635, "medicine": 9.053765723991788, "detect": 7.826427728026572, "sustaining": 10.008850163593298, "ultimately": 10.008850163593298, "opposing": 9.053765723991788, "engage": 7.826427728026572, "perspective": 10.41746331438823, "recruited": 9.557599635934, "delivery": 9.053765723991788, "services": 9.053765723991788, "standardized": 10.790805427161697, "consequence": 10.41746331438823, "bet": 4.896804646498539, "implicated": 10.008850163593298, "downstream": 10.008850163593298, "phenylephrine": 11.134484719950263, "tissues": 8.48345707385196, "transverse": 10.008850163593298, "operated": 9.053765723991788, "networks": 9.053765723991788, "mri": 4.896804646498539, "tidal": 7.0514917412524, "swine": 7.0514917412524, "1.0": 4.896804646498539, "kilogram": 9.053765723991788, "indicate": 9.053765723991788, "scarce": 7.826427728026572, "functions": 9.557599635934, "fluid": 7.0514917412524, "challenging": 10.41746331438823, "truncated": 9.557599635934, "exposed": 8.48345707385196, "perk": 6.1068717291921635, "concomitant": 10.41746331438823, "pathophysiologic": 12.026966349681764, "pah": 4.896804646498539, "represent": 9.557599635934, "0.66": 6.1068717291921635, "declines": 9.053765723991788, "indicating": 10.008850163593298, "mibg": 6.1068717291921635, "correlates": 10.008850163593298, "periods": 8.48345707385196, "prescribing": 10.41746331438823, "interviews": 10.008850163593298, "nonprescribing": 11.452869772534292, "clinician": 9.557599635934, "augmented": 9.557599635934, "electromechanical": 12.287773259995607, "handling": 9.053765723991788, "dynamics": 9.053765723991788, "protection": 10.008850163593298, "exertional": 10.008850163593298, "controlling": 10.41746331438823, "congestion": 10.008850163593298, "tolvaptan": 9.557599635934, "increasingly": 10.790805427161697, "regulated": 9.557599635934, "transfer": 9.053765723991788, "assays": 7.826427728026572, "emphasis": 9.053765723991788, "5.5": 4.896804646498539, "principle": 9.557599635934, "scales": 7.826427728026572, "qu\u00e9bec": 7.826427728026572, "expenditures": 10.790805427161697, "utilization": 10.41746331438823, "reversal": 9.053765723991788, "sarcomeric": 10.008850163593298, "microstructure": 11.452869772534292, "erc": 4.896804646498539, "reach": 7.0514917412524, "adjunctive": 10.008850163593298, "special": 8.48345707385196, "cpt": 4.896804646498539, "ah": 3.211167983674194, "lp": 3.211167983674194, "pla2": 6.1068717291921635, ".02": 4.896804646498539, "proven": 7.826427728026572, "interpretation": 11.452869772534292, "oht": 4.896804646498539, "consultations": 11.134484719950263, "abdominal": 9.557599635934, "cpr": 4.896804646498539, "intensive": 9.557599635934, "2.2": 4.896804646498539, "feasibility": 10.41746331438823, "apparent": 9.053765723991788, "positively": 10.008850163593298, "emotional": 9.557599635934, "walked": 7.826427728026572, "molecule": 9.053765723991788, "pvf": 4.896804646498539, "carotid": 8.48345707385196, "anticoagulants": 11.452869772534292, "anticoagulation": 11.74942993331315, "intestinal": 10.008850163593298, "overview": 9.053765723991788, "unilateral": 10.008850163593298, "baroreflex": 10.008850163593298, "domain": 7.826427728026572, "normalized": 10.008850163593298, "atropine": 9.053765723991788, "sphingosine-1": 11.134484719950263, "phosphate": 9.557599635934, "regulatory": 10.008850163593298, "saw": 4.896804646498539, "unfamiliar": 10.008850163593298, "subunits": 9.053765723991788, "myosin": 7.826427728026572, "binding": 8.48345707385196, "ri\u03b1": 4.896804646498539, "ser83": 7.0514917412524, "hfvt(-": 7.826427728026572, "rr": 3.211167983674194, "adrenoceptor": 10.790805427161697, "genetic": 8.48345707385196, "foundation": 10.008850163593298, "education": 9.557599635934, "region": 7.826427728026572, "schfi": 7.0514917412524, "v.6.2": 7.0514917412524, "cfi": 4.896804646498539, "rmsea": 7.0514917412524, "fragments": 9.557599635934, "concentric": 10.008850163593298, "raloxifene": 10.008850163593298, "strata": 7.826427728026572, "ca(2+)-pump": 10.41746331438823, "suboptimal": 10.008850163593298, "specialty": 9.557599635934, "screening": 9.557599635934, "atherosclerotic": 11.74942993331315, "differentially": 11.452869772534292, "fee": 4.896804646498539, "demographic": 10.41746331438823, "east": 6.1068717291921635, "consist": 8.48345707385196, "managing": 9.053765723991788, "valvular": 9.053765723991788, "rgk": 4.896804646498539, "q65p": 6.1068717291921635, "ss20": 6.1068717291921635, "actin": 7.0514917412524, "glycolysis": 10.008850163593298, "six": 4.896804646498539, "anaerobic": 9.557599635934, "overweight": 10.008850163593298, "subjected": 9.557599635934, "capita": 7.826427728026572, "sh": 3.211167983674194, "professionals": 11.134484719950263, "antihyperglycemic": 12.287773259995607, "pioglitazone": 10.790805427161697, "sulfonylureas": 11.134484719950263, "cpg": 4.896804646498539, "cpet": 6.1068717291921635, "robot": 7.0514917412524, "hscrp": 7.0514917412524, "interatrial": 10.41746331438823, "shunt": 7.0514917412524, "arni": 6.1068717291921635, "caloric": 8.48345707385196, "mlhf": 6.1068717291921635, "seattle": 8.48345707385196, "decade": 5.217618485351048, "dedicated": 6.3717330906226675, "measurable": 6.672566775728865, "some": 4.071247819461442, "considerable": 7.193870284774465, "initiatives": 6.944975542925487, "areas": 4.700994494168267, "adipose": 5.65563804923464, "cachectic": 6.3717330906226675, "regard": 5.217618485351048, "inverse": 5.65563804923464, "proadm": 5.217618485351048, "unaltered": 6.3717330906226675, "steadily": 6.035843815994525, "hence": 4.700994494168267, "european": 6.035843815994525, "definition": 6.672566775728865, "relaxation": 6.672566775728865, "english": 5.65563804923464, "library": 5.65563804923464, "grading": 5.65563804923464, "recommends": 6.672566775728865, "weak": 4.071247819461442, "uncertain": 6.3717330906226675, "registries": 6.672566775728865, "lists": 4.700994494168267, "selection": 6.3717330906226675, "extraction": 6.672566775728865, "synthesis": 6.3717330906226675, "0.94": 4.071247819461442, "0.61": 4.071247819461442, "13.0": 4.071247819461442, "offered": 5.65563804923464, "supporting": 6.672566775728865, "consistently": 7.193870284774465, "alleviate": 6.3717330906226675, "warrants": 6.035843815994525, "epidemic": 6.035843815994525, "resources": 6.3717330906226675, "conducting": 6.672566775728865, "icds": 4.071247819461442, "cinahl": 5.217618485351048, "reviewers": 6.3717330906226675, "1.45": 4.071247819461442, "1.25": 4.071247819461442, "1.15": 4.071247819461442, "1.54": 4.071247819461442, "1.79": 4.071247819461442, "1.59": 4.071247819461442, "rose": 4.071247819461442, "\u03bcg": 2.140778655782796, "bolus": 4.700994494168267, "optimization": 7.193870284774465, "september": 6.3717330906226675, "north": 4.700994494168267, "active": 5.217618485351048, "coprimary": 6.3717330906226675, "0.11": 4.071247819461442, "0.16": 4.071247819461442, "0.10": 4.071247819461442, ".49": 3.264536430999026, "lessons": 5.65563804923464, "multisite": 6.3717330906226675, "reveal": 5.217618485351048, "involvement": 6.944975542925487, "meeting": 5.65563804923464, "requirements": 7.193870284774465, "identifies": 6.672566775728865, "regulator": 6.3717330906226675, "plasticity": 6.672566775728865, "antecedent": 6.672566775728865, "genomic": 5.65563804923464, "alter": 4.700994494168267, "changing": 6.035843815994525, "developmental": 7.422989813300176, "quantitative": 7.193870284774465, "subproteome": 6.944975542925487, "demonstrating": 7.422989813300176, "extensive": 6.3717330906226675, "knockdown": 6.3717330906226675, "nearly": 5.217618485351048, "abolished": 6.3717330906226675, "surprisingly": 7.193870284774465, "lacking": 5.65563804923464, "displayed": 6.3717330906226675, "perturbed": 6.3717330906226675, "complementary": 7.422989813300176, "modeling": 6.035843815994525, "syndromes": 6.3717330906226675, "1.88": 4.071247819461442, "0.51": 4.071247819461442, "survey": 5.217618485351048, "israel": 5.217618485351048, "mildly": 5.217618485351048, "0.40": 4.071247819461442, "repair": 5.217618485351048, "serial": 5.217618485351048, "0.2": 3.264536430999026, "relations": 6.3717330906226675, "applications": 7.193870284774465, "ppr": 3.264536430999026, "california": 6.672566775728865, "planning": 6.035843815994525, "deciles": 5.65563804923464, "0.84": 4.071247819461442, "decile": 5.217618485351048, "produce": 5.65563804923464, "rankings": 6.035843815994525, "consideration": 7.422989813300176, "deliver": 5.65563804923464, "meet": 4.071247819461442, "unplanned": 6.3717330906226675, "electronic": 6.672566775728865, "randomised": 6.672566775728865, "rcts": 4.071247819461442, "structured": 6.672566775728865, "telephone": 6.3717330906226675, "delivered": 6.3717330906226675, "contact": 5.65563804923464, "met": 3.264536430999026, "reaching": 6.035843815994525, "trended": 5.65563804923464, "0.76": 4.071247819461442, "packages": 6.035843815994525, "canine": 5.217618485351048, "interventricular": 8.01797756645451, "weekly": 5.217618485351048, "blot": 4.071247819461442, "caspase": 5.65563804923464, "apoptotic": 6.3717330906226675, "detected": 6.035843815994525, "driveline": 6.3717330906226675, "redo": 4.071247819461442, "sternotomy": 6.672566775728865, "extubated": 6.3717330906226675, "periprocedural": 7.635246515022862, "uptitrations": 7.193870284774465, "correction": 6.672566775728865, "0.93": 4.071247819461442, "0.39": 4.071247819461442, "get": 3.264536430999026, "presents": 6.035843815994525, "recognition": 6.944975542925487, "infancy": 5.65563804923464, "intended": 6.035843815994525, "rather": 5.217618485351048, "already": 5.65563804923464, "methodology": 6.944975542925487, "ninth": 4.700994494168267, "r(2": 3.264536430999026, "intubation": 6.672566775728865, "perform": 5.65563804923464, "0.7": 3.264536430999026, "augment": 5.65563804923464, "retention": 6.3717330906226675, "covered": 5.65563804923464, "feet": 4.071247819461442, "0.018": 4.700994494168267, "indicators": 6.672566775728865, "promotes": 6.035843815994525, "restoration": 6.944975542925487, "properties": 6.672566775728865, "nitric": 5.217618485351048, "oxide": 4.700994494168267, "respective": 6.672566775728865, "ser(1177": 6.035843815994525, "thr(495": 5.65563804923464, "pkc": 3.264536430999026, "\u03b2ii": 3.264536430999026, "malondialdehyde": 7.832953288875434, "proteome": 6.035843815994525, "shotgun": 5.65563804923464, "triggered": 6.3717330906226675, "amount": 5.217618485351048, "dyspnea": 5.65563804923464, ".002": 4.071247819461442, "phenotypes": 6.672566775728865, "upregulated": 6.944975542925487, "communities": 6.944975542925487, "largest": 5.65563804923464, "former": 5.217618485351048, "smoking": 5.65563804923464, "receiver": 6.035843815994525, "operating": 6.3717330906226675, "10.4": 4.071247819461442, "adding": 5.217618485351048, "aucs": 4.071247819461442, "consisting": 6.672566775728865, "conjunction": 6.944975542925487, "should": 5.217618485351048, "ineligible": 6.672566775728865, "destination": 6.944975542925487, "frequent": 6.035843815994525, "longer": 5.217618485351048, "conclude": 6.035843815994525, "budget": 5.217618485351048, "gaps": 4.071247819461442, "mandatory": 6.3717330906226675, "porcine": 5.65563804923464, "variable": 6.035843815994525, "accordingly": 6.944975542925487, "tracking": 6.035843815994525, "nine": 4.071247819461442, "inferior": 6.035843815994525, "snared": 5.217618485351048, "establish": 6.3717330906226675, "midpapillary": 7.193870284774465, "regional": 6.035843815994525, "circumferential": 7.832953288875434, "base": 4.071247819461442, "apical": 5.217618485351048, "septal": 5.217618485351048, "chest": 4.700994494168267, "develops": 6.035843815994525, "restricting": 6.944975542925487, "posteriorly": 6.944975542925487, "displaced": 6.3717330906226675, "papillary": 6.3717330906226675, "acting": 5.217618485351048, "third": 4.700994494168267, "sound": 4.700994494168267, "resection": 6.3717330906226675, "anastomosis": 6.944975542925487, "equation": 6.035843815994525, "\u00d7": 0.27500704749987004, "integral": 6.035843815994525, "utilized": 6.035843815994525, "murmurs": 5.65563804923464, "organic": 5.65563804923464, "lesion": 5.217618485351048, "possibility": 6.944975542925487, "4.6": 3.264536430999026, "observation": 6.944975542925487, "degree": 5.217618485351048, "fixed": 4.700994494168267, "demonstrates": 7.193870284774465, "set": 3.264536430999026, "veterans": 6.035843815994525, "start": 4.700994494168267, "curves": 5.217618485351048, "log": 3.264536430999026, "danish": 5.217618485351048, "grouped": 5.65563804923464, "forty": 4.700994494168267, "uncontrolled": 7.193870284774465, "commonly": 6.035843815994525, "cronbach": 6.035843815994525, "consistency": 6.944975542925487, "seems": 4.700994494168267, "member": 5.217618485351048, "titrated": 6.035843815994525, "0.53": 4.071247819461442, "1.19": 4.071247819461442, "p=0.18": 5.217618485351048, "nitroxyl": 6.035843815994525, "instability": 6.944975542925487, "sarcomere": 6.3717330906226675, "transient": 6.3717330906226675, "cyclase": 5.65563804923464, "isoproterenol": 7.422989813300176, "multiparametric": 7.832953288875434, "create": 5.217618485351048, "dimension": 6.3717330906226675, "cm(2": 4.071247819461442, "\u226535": 3.264536430999026, "0.95": 4.071247819461442, "undergo": 5.65563804923464, "l.": 2.140778655782796, "diverse": 5.65563804923464, "enhancing": 6.3717330906226675, "surgically": 6.672566775728865, "untreated": 6.3717330906226675, "act": 3.264536430999026, "injected": 6.035843815994525, "encoding": 6.035843815994525, "flk": 3.264536430999026, "histological": 7.193870284774465, "do": 2.140778655782796, "1.95": 4.071247819461442, "released": 6.035843815994525, "21.9": 4.071247819461442, "xanthine": 6.035843815994525, "ros": 3.264536430999026, "cardiomyocyte": 7.422989813300176, "maximum": 5.65563804923464, "explain": 5.65563804923464, "assessing": 6.3717330906226675, "wedge": 4.700994494168267, "velocities": 6.672566775728865, "e'lateral": 6.3717330906226675, "estimation": 6.672566775728865, "0.82": 4.071247819461442, "emean": 4.700994494168267, "likelihood": 6.672566775728865, "s'lateral": 6.3717330906226675, "4.5": 3.264536430999026, "plane": 4.700994494168267, "excursion": 6.3717330906226675, "abstract": 6.035843815994525, "basic": 4.700994494168267, "fiber": 4.700994494168267, "generated": 6.3717330906226675, "tracked": 5.65563804923464, "downward": 6.035843815994525, "nonsurvivors": 7.193870284774465, "along": 4.700994494168267, "shifted": 5.65563804923464, "step": 4.071247819461442, "forward": 5.65563804923464, "affected": 6.035843815994525, "modulated": 6.3717330906226675, "necessary": 6.3717330906226675, "patterns": 6.035843815994525, "occluded": 6.035843815994525, "pulsatile": 6.3717330906226675, "modulates": 6.3717330906226675, "markedly": 6.035843815994525, "indicator": 6.3717330906226675, "decreasing": 6.672566775728865, "nutrition": 6.3717330906226675, "insufficiency": 7.422989813300176, "encountered": 6.944975542925487, "framingham": 6.672566775728865, "failed": 5.217618485351048, "bioprosthetic": 7.422989813300176, "transcatheter": 7.422989813300176, "postoperatively": 7.832953288875434, "restoring": 6.3717330906226675, "offer": 4.700994494168267, "conventional": 7.193870284774465, "oldest": 5.217618485351048, "ethnicity": 6.3717330906226675, "nonadherence": 7.193870284774465, "intake": 5.217618485351048, "radiological": 7.193870284774465, "0.049": 4.700994494168267, "11.4": 4.071247819461442, "6mwt": 4.071247819461442, "125.6": 4.700994494168267, "2.3": 3.264536430999026, "depressive": 6.672566775728865, "anxiety": 5.65563804923464, "0.014": 4.700994494168267, "experiencing": 7.193870284774465, "unfavorable": 6.944975542925487, "dobutamine": 6.672566775728865, "furosemide": 6.672566775728865, "myxoma": 5.217618485351048, "myxomas": 5.65563804923464, "located": 5.65563804923464, "arteries": 6.035843815994525, "presented": 6.3717330906226675, "timed": 4.700994494168267, "up": 2.140778655782796, "&": 0.27500704749987004, "go": 2.140778655782796, "icc": 3.264536430999026, "kappa": 4.700994494168267, "minimal": 5.65563804923464, "seconds": 5.65563804923464, "define": 5.217618485351048, "rheumatoid": 6.672566775728865, "arthritis": 6.3717330906226675, "elevations": 6.672566775728865, "treat": 4.700994494168267, "stratified": 6.672566775728865, "oral": 4.071247819461442, "loop": 4.071247819461442, "2.17": 4.071247819461442, "1.30": 4.071247819461442, "facilities": 6.672566775728865, "satisfaction": 7.193870284774465, "sustainability": 7.635246515022862, "participant": 6.944975542925487, "completion": 6.672566775728865, "aging": 4.700994494168267, "gill": 4.071247819461442, "1.36": 4.071247819461442, "competing": 6.3717330906226675, "sub": 3.264536430999026, "appropriately": 7.422989813300176, ".006": 4.071247819461442, "excessive": 6.3717330906226675, "avp": 3.264536430999026, "deleterious": 6.944975542925487, "helix": 4.700994494168267, "bhlh": 4.071247819461442, "otherwise": 6.3717330906226675, "conversely": 6.672566775728865, "induce": 5.217618485351048, "knockout": 6.035843815994525, "p38": 3.264536430999026, "insights": 6.035843815994525, "ranged": 5.217618485351048, "1.17": 4.071247819461442, "1.26": 4.071247819461442, "coding": 5.217618485351048, "nontrastuzumab": 7.635246515022862, "1.50": 4.071247819461442, "1.33": 4.071247819461442, "stop": 4.071247819461442, "food": 4.071247819461442, "0.89": 4.071247819461442, "quartiles": 6.3717330906226675, "nonsignificant": 7.635246515022862, "concept": 5.65563804923464, "0.35": 4.071247819461442, "1.48": 4.071247819461442, "2.14": 4.071247819461442, "add": 3.264536430999026, "ten": 3.264536430999026, "extended": 6.035843815994525, "expand": 5.217618485351048, "pool": 4.071247819461442, "donors": 5.217618485351048, "typically": 6.3717330906226675, "examining": 6.3717330906226675, "assignment": 6.672566775728865, "select": 5.217618485351048, "characterize": 7.193870284774465, "connecticut": 6.944975542925487, "19.1": 4.071247819461442, ".01": 3.264536430999026, "only": 4.071247819461442, "accumulation": 7.193870284774465, "estimate": 6.035843815994525, "confirmatory": 7.193870284774465, "sixty": 4.700994494168267, "choices": 5.65563804923464, "arrhythmias": 6.944975542925487, "t2": 2.140778655782796, "remarkable": 6.672566775728865, "recommend": 6.3717330906226675, "\u226430": 3.264536430999026, "blinded": 5.65563804923464, "0.58": 4.071247819461442, "deposition": 6.672566775728865, "wistar": 5.217618485351048, "isoforms": 6.035843815994525, "allows": 5.217618485351048, "persistent": 6.672566775728865, "besides": 5.65563804923464, "defibrillation": 7.635246515022862, "usually": 5.65563804923464, "ecgs": 4.071247819461442, "panel": 4.700994494168267, "\u2265160": 4.071247819461442, "peritoneal": 6.672566775728865, "resistant": 6.3717330906226675, "consequences": 7.193870284774465, "almost": 5.217618485351048, "0.007": 4.700994494168267, "0.78": 4.071247819461442, "9.2": 3.264536430999026, "worsened": 6.035843815994525, "consumed": 6.035843815994525, "techniques": 6.672566775728865, "pairs": 4.700994494168267, "2.0": 3.264536430999026, "humanized": 6.3717330906226675, "transgenic": 6.672566775728865, "expressing": 6.672566775728865, "retn(-/-": 6.035843815994525, "macrophages": 6.944975542925487, "dramatic": 6.035843815994525, "elevation": 6.3717330906226675, "link": 4.071247819461442, "standing": 6.035843815994525, "1.81": 4.071247819461442, "cardioprotection": 8.01797756645451, "cancers": 5.65563804923464, "obtain": 5.217618485351048, "adenine": 5.65563804923464, "nucleotides": 6.944975542925487, "contents": 6.035843815994525, "creatine": 6.035843815994525, "grafting": 6.035843815994525, "swedish": 5.65563804923464, "confounders": 6.944975542925487, "became": 5.217618485351048, "introduced": 6.672566775728865, "paediatric": 6.672566775728865, "transplants": 6.944975542925487, "pathology": 6.3717330906226675, "adaptation": 6.672566775728865, "example": 5.65563804923464, "raf": 3.264536430999026, "mek1/2": 5.217618485351048, "scaffold": 6.035843815994525, "determining": 6.944975542925487, "typical": 5.65563804923464, "each": 4.071247819461442, "never": 4.700994494168267, "residents": 6.3717330906226675, "therapeutics": 7.193870284774465, "calcium": 5.65563804923464, "adenosine": 6.3717330906226675, "neutral": 5.65563804923464, "appear": 5.217618485351048, "monitor": 5.65563804923464, "frame": 4.700994494168267, "advantage": 6.3717330906226675, "expansion": 6.3717330906226675, "reporting": 6.3717330906226675, "acetyl": 5.217618485351048, "activate": 6.035843815994525, "histone": 5.65563804923464, "readers": 5.65563804923464, "rna": 3.264536430999026, "pol": 3.264536430999026, "protected": 6.3717330906226675, "transcriptional": 7.832953288875434, "nuclear": 5.65563804923464, "\u03bab": 2.140778655782796, "promoting": 6.3717330906226675, "quantification": 7.635246515022862, "1.5": 3.264536430999026, "9.4": 3.264536430999026, "breath": 5.217618485351048, "cornerstone": 6.944975542925487, "detection": 6.3717330906226675, "challenges": 6.672566775728865, "unfolded": 6.035843815994525, "regulates": 6.3717330906226675, "splicing": 6.035843815994525, "v": 0.27500704749987004, "voltage": 5.65563804923464, "gated": 4.700994494168267, "generating": 6.672566775728865, "stem": 4.071247819461442, "angii": 4.700994494168267, "hypoxia": 5.65563804923464, "kv4.3": 4.700994494168267, "splice": 5.217618485351048, "describing": 6.672566775728865, "conflicting": 6.944975542925487, "distinguish": 6.944975542925487, "temporal": 6.035843815994525, "nonselective": 7.193870284774465, "hemostasis": 6.672566775728865, "label": 4.700994494168267, "arg16": 4.700994494168267, "gln27": 4.700994494168267, "gly16": 4.700994494168267, "glu27": 4.700994494168267, "8)": 2.140778655782796, "washout": 5.65563804923464, "von": 3.264536430999026, "willebrand": 6.672566775728865, "taxonomy": 6.035843815994525, "providing": 6.3717330906226675, "slow": 4.071247819461442, "acetylcholinesterase": 8.658247192583133, "sympathovagal": 7.422989813300176, "methylatropine": 7.635246515022862, "propranolol": 6.944975542925487, "surviving": 6.3717330906226675, "geometry": 6.035843815994525, "conduction": 6.672566775728865, "local": 4.700994494168267, "extending": 6.3717330906226675, "mechanistically": 7.832953288875434, "4.2": 3.264536430999026, "mets": 4.071247819461442, "simultaneous": 7.193870284774465, "exertion": 6.035843815994525, "derive": 5.217618485351048, "derivation": 6.672566775728865, "undergone": 6.3717330906226675, "institutions": 7.193870284774465, "electrocardiographic": 8.658247192583133, "\u22652": 2.140778655782796, "tobacco": 5.65563804923464, "4.8": 3.264536430999026, "\u22651": 2.140778655782796, "savings": 5.65563804923464, "japan": 4.700994494168267, "americans": 6.3717330906226675, "accurate": 6.035843815994525, "phosphodiesterase-2": 8.511001466296774, "cyclic": 5.217618485351048, "monophosphate": 7.422989813300176, "microscopy": 6.672566775728865, "ca2(+": 4.700994494168267, "restored": 6.035843815994525, "amplitude": 6.3717330906226675, "hypertrophic": 7.193870284774465, "specified": 6.3717330906226675, "discontinuation": 7.832953288875434, "hrqol.": 5.217618485351048, "province": 6.035843815994525, "offset": 5.217618485351048, "noncardiovascular": 8.191848839997071, "manage": 5.217618485351048, "rich": 4.071247819461442, "cocoa": 4.700994494168267, "t2d": 3.264536430999026, "detrimental": 6.944975542925487, "epicatechin": 6.944975542925487, "treadmill": 6.3717330906226675, "dapc": 4.071247819461442, "chinese": 5.65563804923464, "herbal": 5.217618485351048, "retrieved": 6.3717330906226675, "volunteers": 6.672566775728865, "biosynthetic": 7.193870284774465, "catabolic": 6.3717330906226675, "activities": 6.672566775728865, ".07": 3.264536430999026, "marginally": 6.672566775728865, "slope": 4.700994494168267, "gain": 4.071247819461442, "pathophysiological": 8.355835584391686, "bridged": 5.65563804923464, "inotropes": 6.3717330906226675, "operation": 6.3717330906226675, "occurring": 6.3717330906226675, "posterior": 6.3717330906226675, "situation": 6.3717330906226675, "team": 4.071247819461442, "half": 4.071247819461442, "discussion": 6.672566775728865, "promise": 5.65563804923464, "australian": 6.672566775728865, "administrative": 7.635246515022862, "fatality": 6.035843815994525, "occurrence": 6.672566775728865, "supplementation": 7.832953288875434, "attrition": 6.3717330906226675, "incremental": 6.944975542925487, "shuttle": 5.65563804923464, "muscular": 6.035843815994525, "zung": 4.071247819461442, "transforming": 7.193870284774465, "yield": 4.700994494168267, "affects": 5.65563804923464, "explants": 6.035843815994525, "epithelial": 6.672566775728865, "mesenchymal": 6.944975542925487, "pluripotency": 7.193870284774465, "periodic": 6.035843815994525, "originally": 6.672566775728865, "cycle": 4.700994494168267, "oscillations": 7.193870284774465, "much": 4.071247819461442, "imbalance": 6.3717330906226675, "nutritional": 6.944975542925487, "denervation": 6.944975542925487, "nonpace": 5.65563804923464, "pace": 4.071247819461442, "spectral": 6.035843815994525, "narrow": 5.217618485351048, "wide": 4.071247819461442, "dyssynchrony": 7.193870284774465, "msec": 4.071247819461442, "randomization": 7.422989813300176, "6.4": 3.264536430999026, "supported": 6.3717330906226675, "smaller": 5.65563804923464, "steady": 5.217618485351048, "continued": 6.3717330906226675, "ensure": 5.217618485351048, "ratings": 5.65563804923464, "noc": 3.264536430999026, "top": 3.264536430999026, "incorporating": 7.422989813300176, "advancement": 6.944975542925487, "highlighting": 7.193870284774465, "reciprocal": 6.672566775728865, "kinase-2": 6.035843815994525, "agonist": 5.65563804923464, "physiological": 7.422989813300176, "43.6": 4.071247819461442, "persist": 5.65563804923464, "rii\u03b1": 4.071247819461442, "c\u03b1": 2.140778655782796, "ser77": 4.700994494168267, "modulation": 6.672566775728865, "repolarization": 7.635246515022862, "vt": 2.140778655782796, "esmolol": 5.65563804923464, "isoprenaline": 7.193870284774465, "sdrr": 4.071247819461442, "haematopoietic": 7.635246515022862, "genotyped": 6.3717330906226675, "2\u00b79": 3.264536430999026, "0\u00b705": 4.071247819461442, "transporter": 6.944975542925487, "working": 5.65563804923464, "definitions": 6.944975542925487, "lcz696": 5.217618485351048, "valsartan": 6.3717330906226675, "threatening": 6.944975542925487, "disorder": 6.035843815994525, "partly": 5.217618485351048, "guided": 5.217618485351048, "discuss": 5.65563804923464, "condition": 6.3717330906226675, "raas": 4.071247819461442, "newer": 4.700994494168267, "acquired": 6.035843815994525, "psychometric": 7.193870284774465, "6.2": 3.264536430999026, "cfa": 3.264536430999026, "construct": 6.3717330906226675, "alphalisa": 6.3717330906226675, "immunoassays": 7.193870284774465, "n-": 2.140778655782796, "terminally": 6.672566775728865, "leu3": 4.071247819461442, "nonterminal": 6.944975542925487, "epitopes": 6.035843815994525, "generation": 6.672566775728865, "eccentric": 6.3717330906226675, "cr": 2.140778655782796, "\u22640.42": 4.700994494168267, "1,790": 4.700994494168267, "1.1": 3.264536430999026, "0.48": 4.071247819461442, "nationwide": 6.672566775728865, "1.07": 4.071247819461442, "etidronate": 6.672566775728865, "refill": 5.217618485351048, "order": 4.700994494168267, "phospholamban": 7.422989813300176, "heavy": 4.700994494168267, "chain": 4.700994494168267, "stages": 5.217618485351048, "rotterdam": 6.3717330906226675, "cvd": 3.264536430999026, "ankle": 4.700994494168267, "south": 4.700994494168267, "dakota": 5.217618485351048, "transitions": 6.944975542925487, "reflecting": 6.672566775728865, "substrate": 6.3717330906226675, "turbulence": 6.672566775728865, "computed": 6.035843815994525, "directed": 6.035843815994525, "framework": 6.3717330906226675, "individualized": 7.635246515022862, "enrichment": 6.672566775728865, "0.74": 4.071247819461442, "blacks": 5.217618485351048, "providers": 6.3717330906226675, "europe": 5.217618485351048, "expectancy": 6.672566775728865, "aha": 3.264536430999026, "currents": 6.035843815994525, "variant": 5.65563804923464, "inhibit": 5.65563804923464, "cav1.2": 5.217618485351048, "cav1.3": 5.217618485351048, "jehovah": 5.65563804923464, "witness": 5.65563804923464, "preclude": 6.035843815994525, "provision": 6.3717330906226675, "decisions": 6.3717330906226675, "doctors": 5.65563804923464, "performers": 6.672566775728865, "worst": 4.700994494168267, "quintile": 6.035843815994525, "existing": 6.035843815994525, "explained": 6.3717330906226675, "1.39": 4.071247819461442, "aldactone": 6.3717330906226675, "aa": 2.140778655782796, "9.7": 3.264536430999026, "hypokalemia": 6.944975542925487, "5.6": 3.264536430999026, "proteomic": 6.3717330906226675, "ingenuity": 6.3717330906226675, "cytoskeleton": 7.193870284774465, "ss31": 4.071247819461442, "uti": 3.264536430999026, "managed": 5.65563804923464, "cared": 4.700994494168267, "strongest": 6.3717330906226675, "cardiologists": 7.422989813300176, "playing": 5.65563804923464, "organization": 7.193870284774465, "powerful": 6.035843815994525, "p<001": 4.700994494168267, "finding": 5.65563804923464, "respiratory": 6.944975542925487, "ci=0.94": 5.65563804923464, "nonidentification": 8.191848839997071, "cardiorespiratory": 8.191848839997071, "fitness": 5.65563804923464, "joint": 4.700994494168267, "precede": 5.65563804923464, "oxidation": 6.3717330906226675, "latin": 4.700994494168267, "income": 5.217618485351048, "fever": 4.700994494168267, "etiologies": 6.672566775728865, "rs10927887": 6.672566775728865, "snp": 3.264536430999026, "cholesterol": 6.944975542925487, "urban": 4.700994494168267, "enabled": 5.65563804923464, "staff": 4.700994494168267, "country": 5.65563804923464, "access": 5.217618485351048, "awareness": 6.3717330906226675, "dpp-4": 4.700994494168267, "user": 4.071247819461442, "drs": 3.264536430999026, "conduct": 5.65563804923464, "dissemination": 7.422989813300176, "classify": 6.035843815994525, "organisation": 7.193870284774465, "cpgs": 4.071247819461442, "communicate": 6.944975542925487, "neurological": 7.193870284774465, "intensity": 6.3717330906226675, "w": 0.27500704749987004, "axis": 4.071247819461442, "gait": 4.071247819461442, "lokomat": 5.65563804923464, "quadriceps": 6.672566775728865, "il6": 3.264536430999026, "psychosocial": 7.193870284774465, "r=": 2.140778655782796, "achieve": 5.65563804923464, "hr<70": 4.700994494168267, "shunting": 6.035843815994525, "proof": 4.700994494168267, "transoesophageal": 8.01797756645451, "thrombosis": 6.672566775728865, "p=0\u00b7016": 5.65563804923464, "centrifugal": 6.944975542925487, "debilitating": 7.193870284774465, "modified": 6.035843815994525, "generate": 6.035843815994525, "projections": 6.944975542925487, "simulations": 6.944975542925487, "efforts": 2.82781902461732, "mpsms": 2.3504972470841334, "60,000": 2.608809242675524, "translating": 3.4724877714627436, "81,000": 2.608809242675524, "averted": 2.82781902461732, "2010\u20132011": 3.1858665453113337, "ulcers": 2.608809242675524, "actually": 3.0179219079972626, "respect": 2.82781902461732, "lipolysis": 3.1858665453113337, "a-": 1.070389327891398, "neurohormones": 3.711494906650088, "adipokines": 3.3362833878644325, "takes": 2.3504972470841334, "place": 2.3504972470841334, "midregional": 3.4724877714627436, "adrenomedullin": 3.817623257511431, "0.5": 1.632268215499513, "correlate": 3.1858665453113337, "38\u201354": 2.3504972470841334, "figure": 2.608809242675524, "description": 3.4724877714627436, "reassessed": 3.3362833878644325, "april": 2.3504972470841334, "exacerbation": 3.5969351423872324, "cerebrovascular": 3.916476644437717, "audience": 3.0179219079972626, "anemic": 2.608809242675524, "deficient": 3.1858665453113337, "grades": 2.608809242675524, "restrictive": 3.4724877714627436, "red": 1.632268215499513, "technical": 3.1858665453113337, "advisors": 3.0179219079972626, "liberal": 2.82781902461732, "1.42": 2.035623909730721, "i2": 1.070389327891398, "16.8": 2.035623909730721, "0.032": 2.3504972470841334, "moderate-": 3.1858665453113337, "thromboembolism": 3.916476644437717, "confounded": 3.3362833878644325, "come": 2.035623909730721, "thresholds": 3.3362833878644325, "seem": 2.035623909730721, "conditioning": 3.5969351423872324, "stemming": 3.0179219079972626, "nonischemic": 3.4724877714627436, "cardiomyopathies": 4.008988783227255, "continues": 3.1858665453113337, "problematic": 3.4724877714627436, "inroads": 2.82781902461732, "armamentarium": 3.711494906650088, "eventual": 3.0179219079972626, "resort": 2.608809242675524, "serially": 3.0179219079972626, "keep": 2.035623909730721, "busy": 2.035623909730721, "prompting": 3.1858665453113337, "ways": 2.035623909730721, "deal": 2.035623909730721, "comments": 3.0179219079972626, "enriching": 3.1858665453113337, "identification": 3.817623257511431, "collins": 2.82781902461732, "categorization": 3.817623257511431, "perhaps": 2.82781902461732, "citations": 3.1858665453113337, "addressed": 3.1858665453113337, "random": 2.608809242675524, "10,420": 2.608809242675524, "257,692": 2.82781902461732, "proved": 2.608809242675524, "1.37": 2.035623909730721, "1.43": 2.035623909730721, "1.72": 2.035623909730721, "2.34": 2.035623909730721, "3.44": 2.035623909730721, "rigorously": 3.3362833878644325, "hypotheses": 3.3362833878644325, "allocation": 3.3362833878644325, "2:1": 1.632268215499513, "pooled": 2.608809242675524, "-714": 2.035623909730721, ".59": 1.632268215499513, "0.12": 2.035623909730721, "0.18": 2.035623909730721, "-0.08": 2.3504972470841334, ".72": 1.632268215499513, "-618": 2.035623909730721, "0.07": 2.035623909730721, "-0.04": 2.3504972470841334, "-0.13": 2.3504972470841334, ".36": 1.632268215499513, "reflective": 3.3362833878644325, "multihospital": 3.711494906650088, "promote": 2.82781902461732, "adoption": 3.0179219079972626, "leaders": 2.82781902461732, "adopting": 3.0179219079972626, "questions": 3.1858665453113337, "issues": 2.608809242675524, "organizations": 3.711494906650088, "profoundly": 3.3362833878644325, "transformed": 3.4724877714627436, "utilizing": 3.1858665453113337, "voluntary": 3.1858665453113337, "testimonies": 3.4724877714627436, "conversations": 3.711494906650088, "magnet": 2.608809242675524, "preceding": 3.1858665453113337, "coordinate": 3.3362833878644325, "accessibility": 3.711494906650088, "altering": 3.0179219079972626, "subproteomes": 3.5969351423872324, "accompany": 3.1858665453113337, "recapitulates": 3.711494906650088, "conserved": 3.1858665453113337, "detergent": 3.1858665453113337, "abundance": 3.1858665453113337, "conservation": 3.5969351423872324, "acid": 2.035623909730721, "characterization": 4.008988783227255, "morpholino": 3.3362833878644325, "morphological": 3.711494906650088, "fish": 2.035623909730721, "chamber": 2.82781902461732, "patterning": 3.3362833878644325, "ostensibly": 3.3362833878644325, "looping": 2.82781902461732, "involve": 2.82781902461732, "bone": 2.035623909730721, "morphogenetic": 3.711494906650088, "rrna": 2.035623909730721, "heterochromatic": 3.916476644437717, "zebrafish": 3.1858665453113337, "orchestrate": 3.4724877714627436, "reprogramming": 3.711494906650088, "shared": 2.608809242675524, "1,045": 2.3504972470841334, "comprising": 3.3362833878644325, "3.21": 2.035623909730721, "1.67": 2.035623909730721, "electrocardiogram": 4.095924419998536, "0.62": 2.035623909730721, "1,620": 2.3504972470841334, "conferred": 3.1858665453113337, "\u226475": 1.632268215499513, "1.49": 2.035623909730721, "consenting": 3.3362833878644325, "outgrowth": 3.1858665453113337, "colony": 2.608809242675524, "forming": 2.82781902461732, "cd34": 2.035623909730721, "vegfr2": 2.608809242675524, "cd133": 2.3504972470841334, "cfu": 1.632268215499513, "0.28": 2.035623909730721, "nondiabetic": 3.4724877714627436, "m": 0.13750352374993502, "preventable": 3.4724877714627436, "statewide": 3.1858665453113337, "nonpublic": 3.1858665453113337, "file": 2.035623909730721, "computing": 3.1858665453113337, "pay": 1.632268215499513, "placed": 2.608809242675524, "specialised": 3.4724877714627436, "fourteen": 3.0179219079972626, "psycinfo": 3.0179219079972626, "searching": 3.1858665453113337, "articles": 3.0179219079972626, "contemporaneous": 3.916476644437717, "telemonitoring": 3.817623257511431, "24/7": 2.035623909730721, "machine": 2.82781902461732, "interface": 3.1858665453113337, "statitistical": 3.711494906650088, "credible": 3.0179219079972626, "tm24/7": 2.608809242675524, "0.20": 2.035623909730721, "rendered": 3.0179219079972626, "where": 2.3504972470841334, "expressions": 3.4724877714627436, "rtq": 1.632268215499513, "pcr": 1.632268215499513, "beagle": 2.608809242675524, "autopsy": 2.82781902461732, "transiently": 3.4724877714627436, "band": 2.035623909730721, "numbers": 2.82781902461732, "favour": 2.608809242675524, "attributed": 3.3362833878644325, "sternal": 2.82781902461732, "sparing": 2.82781902461732, "curative": 3.0179219079972626, "quick": 2.3504972470841334, "avoids": 2.608809242675524, "malfunctioning": 3.817623257511431, "nominal": 2.82781902461732, "strokes": 2.82781902461732, "pef": 1.632268215499513, "assesses": 3.0179219079972626, "\u226540": 1.632268215499513, "\u226510": 1.632268215499513, "0.22": 2.035623909730721, "0.31": 2.035623909730721, "0.027": 2.3504972470841334, "0.65": 2.035623909730721, "0.101": 2.3504972470841334, "neurohumoral": 3.5969351423872324, "relates": 2.82781902461732, "99,930": 2.608809242675524, "40%-49": 2.608809242675524, "compute": 2.82781902461732, "clustering": 3.3362833878644325, "47,025": 2.608809242675524, "13,950": 2.608809242675524, "38,955": 2.608809242675524, "greatest": 3.0179219079972626, "smallest": 3.0179219079972626, "1,259": 2.3504972470841334, "1,113": 2.3504972470841334, "heterogeneity": 3.711494906650088, ".47": 1.632268215499513, "adolescence": 3.4724877714627436, "practitioners": 3.711494906650088, "room": 2.035623909730721, "encounter": 3.1858665453113337, "undiagnosed": 3.4724877714627436, "palliation": 3.3362833878644325, "practical": 3.1858665453113337, "online": 2.608809242675524, "material": 3.0179219079972626, "read": 2.035623909730721, "dodson": 2.608809242675524, "interest": 3.0179219079972626, "subsequently": 3.5969351423872324, "intubations": 3.4724877714627436, "hypothesize": 3.4724877714627436, "suburban": 3.0179219079972626, "jersey": 2.608809242675524, "student": 2.82781902461732, "cis": 1.632268215499513, "2,374,428": 3.1858665453113337, "32,036": 2.608809242675524, "21%-30": 2.608809242675524, "3.6": 1.632268215499513, "31%-68": 2.608809242675524, "annual": 2.608809242675524, "constituted": 3.4724877714627436, "classes": 2.82781902461732, "1,680": 2.3504972470841334, "1,960": 2.3504972470841334, "dyn": 1.632268215499513, "cm(5)/m(2": 3.1858665453113337, "texture": 2.82781902461732, "nodularity": 3.3362833878644325, "derangement": 3.4724877714627436, "portal": 2.608809242675524, "counseling": 3.3362833878644325, "1,080": 2.3504972470841334, "3.45": 2.035623909730721, "3.05": 2.035623909730721, "2.81": 2.035623909730721, "0.013": 2.3504972470841334, "2.61": 2.035623909730721, "3.06": 2.035623909730721, "\u22653": 1.070389327891398, "morbidities": 3.4724877714627436, "2.11": 2.035623909730721, "1.94": 2.035623909730721, "1.90": 2.035623909730721, "ecs": 1.632268215499513, "incubated": 3.1858665453113337, "ser(660": 2.82781902461732, "p70s6k": 2.608809242675524, "ser(411": 2.82781902461732, "particles": 3.1858665453113337, "profiled": 3.0179219079972626, "lc": 1.070389327891398, "incubation": 3.3362833878644325, "p70s6": 2.3504972470841334, "prescriptive": 3.5969351423872324, "71.1": 2.035623909730721, "10.3": 2.035623909730721, "64.26": 2.3504972470841334, "11.42": 2.3504972470841334, "72.83": 2.3504972470841334, "11.07": 2.3504972470841334, "85.9": 2.035623909730721, "39.1": 2.035623909730721, "0.639": 2.3504972470841334, ".044": 2.035623909730721, "nephrectomy": 3.4724877714627436, "c57bl/6": 2.82781902461732, "reproducible": 3.5969351423872324, "perioperative": 3.711494906650088, "gtpase": 2.608809242675524, "rac1": 2.035623909730721, "projected": 3.1858665453113337, "coming": 2.608809242675524, "antihypertensive": 4.008988783227255, "nri": 1.632268215499513, "0.040": 2.3504972470841334, "0.057": 2.3504972470841334, "nris": 2.035623909730721, "50.7": 2.035623909730721, "54.7": 2.035623909730721, "simpler": 2.82781902461732, "incorporated": 3.5969351423872324, "historically": 3.5969351423872324, "hybrid": 2.608809242675524, "operative": 3.1858665453113337, "11.9": 2.035623909730721, "91.8": 2.035623909730721, "rvads": 2.3504972470841334, "explanted": 3.1858665453113337, "95.2": 2.035623909730721, "88.2": 2.035623909730721, "scientific": 3.3362833878644325, "historical": 3.3362833878644325, "tend": 2.035623909730721, "mutually": 3.0179219079972626, "exclusive": 3.1858665453113337, "infrastructure": 3.817623257511431, "necessitating": 3.711494906650088, "speckle": 2.82781902461732, "vena": 2.035623909730721, "cava": 2.035623909730721, "atrioventricular": 4.008988783227255, "rotations": 3.1858665453113337, "rotation": 3.0179219079972626, "variations": 3.3362833878644325, "surrogates": 3.3362833878644325, "reflect": 2.82781902461732, "postsystolic": 3.5969351423872324, "4/6": 1.632268215499513, "holosystolic": 3.5969351423872324, "murmur": 2.608809242675524, "120/70": 2.608809242675524, "p3": 1.070389327891398, "chordal": 2.82781902461732, "ruptures": 3.0179219079972626, "triangular": 3.3362833878644325, "physio": 2.608809242675524, "edwards": 2.82781902461732, "lifesciences": 3.5969351423872324, "irvine": 2.608809242675524, "ca": 1.070389327891398, "sized": 2.3504972470841334, "1a": 1.070389327891398, "concerns": 3.0179219079972626, "191/104": 2.82781902461732, "3/6": 1.632268215499513, "audible": 2.82781902461732, "8.4": 1.632268215499513, "1b": 1.070389327891398, "branches": 3.0179219079972626, "motions": 2.82781902461732, "respond": 2.82781902461732, "consequently": 3.5969351423872324, "vasodilators": 3.5969351423872324, "140/80": 2.608809242675524, "disappearance": 3.711494906650088, "1c": 1.070389327891398, "motion": 2.608809242675524, "considerably": 3.5969351423872324, "insignificant": 3.711494906650088, "configurations": 3.817623257511431, "subvalvular": 3.4724877714627436, "opposed": 2.82781902461732, "michigan": 3.0179219079972626, "1,536": 2.3504972470841334, "externally": 3.3362833878644325, "ann": 1.632268215499513, "arbor": 2.3504972470841334, "affairs": 2.82781902461732, "arbitrary": 3.1858665453113337, "urea": 2.035623909730721, "nitrogen": 3.0179219079972626, "flutter": 2.82781902461732, "concordance": 3.4724877714627436, "0.71/0.68/0.74": 3.817623257511431, "8%/12%/12": 3.1858665453113337, "57%/58%/79": 3.3362833878644325, "uses": 2.035623909730721, "readily": 2.82781902461732, "allocate": 3.0179219079972626, "specialized": 3.4724877714627436, "progresses": 3.3362833878644325, "egfr)-group": 3.4724877714627436, "\u226560": 1.632268215499513, "1.3/1000": 3.0179219079972626, "p=0.049": 2.82781902461732, "p=0.016": 2.82781902461732, "dichotomized": 3.5969351423872324, "ef\u2264": 1.632268215499513, "ef\u226550": 2.3504972470841334, "criterion": 3.1858665453113337, "spearman": 3.0179219079972626, "anova": 2.3504972470841334, "covariate": 3.1858665453113337, "r=-0.62": 2.82781902461732, "r=-0.55": 2.82781902461732, "p=0.27": 2.608809242675524, "category": 3.0179219079972626, "25=13.8": 2.82781902461732, "50=59.1": 2.82781902461732, "75=73.8": 2.82781902461732, "100=77.8": 3.0179219079972626, "p=0.37": 2.608809242675524, "\u03b1=0.96": 2.608809242675524, "\u22650.69": 2.3504972470841334, "subdomains": 3.3362833878644325, "offers": 2.608809242675524, "replicate": 3.1858665453113337, "establishment": 3.711494906650088, "interleukin": 3.4724877714627436, "s)st2": 2.3504972470841334, "hoc": 1.632268215499513, "regimen": 2.82781902461732, "succinate": 3.1858665453113337, "p=0.003": 2.82781902461732, "those": 2.3504972470841334, "2.08": 2.035623909730721, "6.77": 2.035623909730721, "exerted": 2.82781902461732, "angeli": 2.608809242675524, "lusitropic": 3.3362833878644325, "vasodilator": 3.4724877714627436, "chemical": 3.0179219079972626, "cogeneration": 3.5969351423872324, "nitrite": 2.82781902461732, "myoctyes": 3.0179219079972626, "intact": 2.608809242675524, "converts": 3.0179219079972626, "inactive": 3.0179219079972626, "cxl-1051": 3.0179219079972626, "t1/2": 2.035623909730721, "dependently": 3.4724877714627436, "\u03bcmol": 2.035623909730721, "\u224830": 1.632268215499513, "guanylate": 3.1858665453113337, "unlike": 2.608809242675524, "anesthetized": 3.5969351423872324, "microembolization": 4.095924419998536, "tachypacing": 3.4724877714627436, "venoarterial": 3.5969351423872324, "dilation": 3.0179219079972626, "minimally": 3.1858665453113337, "65\u00b112": 2.3504972470841334, "\u226515": 1.632268215499513, "57\u00b122": 2.3504972470841334, "n=161": 2.3504972470841334, "-7": 1.070389327891398, "10.0": 2.035623909730721, "cm(2)/m(2": 3.1858665453113337, "allowed": 2.82781902461732, "transplantations": 4.008988783227255, "implantations": 3.711494906650088, "helpful": 2.82781902461732, "kaiser": 2.608809242675524, "permanente": 3.3362833878644325, "northern": 3.0179219079972626, "meq": 1.632268215499513, "2,538": 2.3504972470841334, "1.44": 2.035623909730721, "compensatory": 3.5969351423872324, "neoangiogenesis": 3.916476644437717, "diameters": 3.1858665453113337, "akt": 1.632268215499513, "synthase": 3.0179219079972626, "comparing": 3.1858665453113337, "proangiogenic": 3.711494906650088, "intravenously": 3.711494906650088, "adenoviral": 3.3362833878644325, "vector": 2.608809242675524, "decoy": 2.3504972470841334, "adenovirus": 3.3362833878644325, "b.": 1.070389327891398, "counteracted": 3.5969351423872324, "n=44": 2.035623909730721, "76.4": 2.035623909730721, "54.5": 2.035623909730721, "61.8": 2.035623909730721, "1.10\u20131.23": 3.1858665453113337, "73.6": 2.035623909730721, "1.83\u20132.07": 3.1858665453113337, "22.0": 2.035623909730721, "44.9": 2.035623909730721, "16.3": 2.035623909730721, "0.73\u20130.90": 3.1858665453113337, "35.3": 2.035623909730721, "0.73\u20130.86": 3.1858665453113337, "0.61\u20130.78": 3.1858665453113337, "30.2": 2.035623909730721, "0.61\u20130.74": 3.1858665453113337, "24.3": 2.035623909730721, "0.76\u20130.91": 3.1858665453113337, "18.1": 2.035623909730721, "0.70\u20130.85": 3.1858665453113337, "preserves": 3.1858665453113337, "vo": 1.070389327891398, "aortocaval": 3.3362833878644325, "fistula": 2.82781902461732, "demand": 2.608809242675524, "bioenergetics": 3.711494906650088, "sprague": 2.82781902461732, "dawley": 2.608809242675524, "mg\u00b7kg(-1)\u00b7day(-1": 4.008988783227255, "\u22657": 1.070389327891398, "flux": 2.035623909730721, "analyzer": 3.0179219079972626, "paralleled": 3.3362833878644325, "diminishing": 3.4724877714627436, "myofilament": 3.4724877714627436, "unreliable": 3.3362833878644325, "sided": 2.3504972470841334, "transthoracic": 3.711494906650088, "0.41": 2.035623909730721, "e'mean": 2.608809242675524, "0.72": 2.035623909730721, "elateral": 3.0179219079972626, "eseptal": 2.82781902461732, "s'septal": 3.0179219079972626, "width": 2.3504972470841334, "0.15": 2.035623909730721, "\u22644.5": 2.035623909730721, "0.38": 2.035623909730721, "carrying": 3.0179219079972626, "two-": 2.035623909730721, "threefold": 3.1858665453113337, "disclosing": 3.3362833878644325, "ninety": 2.608809242675524, "20.8": 2.035623909730721, "mo": 1.070389327891398, "collinearity": 3.5969351423872324, "retained": 3.0179219079972626, "follows": 2.82781902461732, "mmhg": 2.035623909730721, "4.1": 1.632268215499513, "resolution": 3.3362833878644325, "efficient": 3.1858665453113337, "one-": 2.035623909730721, "coated": 2.608809242675524, "polytetrafluoroethylene": 4.529820946528695, "tube": 2.035623909730721, "shape": 2.3504972470841334, "circumflex": 3.3362833878644325, "mid": 1.632268215499513, "infarct": 2.82781902461732, "positron": 3.0179219079972626, "emission": 3.0179219079972626, "tomography": 3.3362833878644325, "covering": 3.0179219079972626, "competitive": 3.4724877714627436, "unloads": 2.82781902461732, "resistive": 3.1858665453113337, "7.5": 1.632268215499513, "cuff": 2.035623909730721, "ivabradine-": 3.4724877714627436, "unloading": 3.1858665453113337, "\u22653.5": 2.035623909730721, "93.2": 2.035623909730721, "82.4": 2.035623909730721, "88.4": 2.035623909730721, "75.2": 2.035623909730721, "0.521": 2.3504972470841334, "0.290": 2.3504972470841334, "0.934": 2.3504972470841334, "0.029": 2.3504972470841334, "92.6": 2.035623909730721, "63.6": 2.035623909730721, "65.0": 2.035623909730721, "correcting": 3.3362833878644325, "hepatic": 2.82781902461732, "instituting": 3.4724877714627436, "algorithms": 3.3362833878644325, "de": 1.070389327891398, "novo": 2.035623909730721, "thoratec": 3.0179219079972626, "corp": 2.035623909730721, "pleasanton": 3.3362833878644325, "calif": 2.3504972470841334, "hvad": 2.035623909730721, "intl": 2.035623909730721, "inc": 1.632268215499513, "dacron": 2.608809242675524, "patch": 2.3504972470841334, "repairs": 2.82781902461732, "multiorgan": 3.3362833878644325, "sepsis": 2.608809242675524, "oversewing": 3.3362833878644325, "difficult": 3.1858665453113337, "alternatives": 3.5969351423872324, "charm": 2.3504972470841334, "candesartan": 3.4724877714627436, "adhere": 2.608809242675524, "referent": 3.0179219079972626, "0.186": 2.3504972470841334, "ages": 2.035623909730721, "divergent": 3.1858665453113337, "striking": 3.0179219079972626, "counterparts": 3.5969351423872324, "nonfatal": 3.0179219079972626, "discordant": 3.3362833878644325, "62.4": 2.035623909730721, "26.9": 2.035623909730721, "59.4": 2.035623909730721, "57.0": 2.035623909730721, "71.3": 2.035623909730721, "travelled": 3.1858665453113337, "158.5": 2.3504972470841334, "118.5": 2.3504972470841334, "155.5": 2.3504972470841334, "0.026": 2.3504972470841334, "-1.7": 2.035623909730721, "waist": 2.3504972470841334, "circumference": 3.711494906650088, "modality": 3.0179219079972626, "leads": 2.3504972470841334, "shortens": 3.0179219079972626, "biologic": 3.0179219079972626, "reconstructed": 3.711494906650088, "25th-75th": 3.1858665453113337, "percentiles": 3.4724877714627436, ".032": 2.035623909730721, "tonometric": 3.3362833878644325, "entry": 2.3504972470841334, "natremia": 3.0179219079972626, "shortened": 3.1858665453113337, "complicated": 3.4724877714627436, "benign": 2.608809242675524, "tumors": 2.608809242675524, "rarely": 2.608809242675524, "embolize": 3.0179219079972626, "vasculature": 3.4724877714627436, "massive": 2.82781902461732, "removal": 2.82781902461732, "embolectomy": 3.4724877714627436, "causing": 2.82781902461732, "stenotic": 3.0179219079972626, "physiology": 3.3362833878644325, "obstructed": 3.3362833878644325, "tactics": 2.82781902461732, "hypothermic": 3.4724877714627436, "uneventful": 3.3362833878644325, "organ": 2.3504972470841334, "sectional": 3.1858665453113337, "environment": 3.4724877714627436, "n=235": 2.3504972470841334, "70y": 1.632268215499513, "77y": 1.632268215499513, "25.6kg": 2.608809242675524, "22.8": 2.035623909730721, "29.4kg": 2.608809242675524, "n=95": 2.035623909730721, "n=68": 2.035623909730721, "n=72": 2.035623909730721, "applicable": 3.3362833878644325, "assessors": 3.1858665453113337, "intraclass": 3.3362833878644325, "detectable": 3.3362833878644325, ".85": 1.632268215499513, ".98": 1.632268215499513, "coefficients": 3.5969351423872324, "3.00": 2.035623909730721, "-4.94s": 2.608809242675524, "p<.01": 2.3504972470841334, "mdc95": 2.3504972470841334, "mdc95%%": 2.82781902461732, "true": 2.035623909730721, "starting": 3.0179219079972626, "tumor": 2.3504972470841334, "necrosis": 3.0179219079972626, "tnf)\u03b1": 2.3504972470841334, "recurrent": 3.1858665453113337, "us": 1.070389327891398, "methotrexate": 3.5969351423872324, "enter": 2.3504972470841334, "switched": 3.0179219079972626, "modifying": 3.1858665453113337, "antirheumatic": 3.711494906650088, "glucocorticoid": 3.817623257511431, "dosage": 2.608809242675524, "1.14": 2.035623909730721, "but": 1.632268215499513, "10.50": 2.3504972470841334, "p=0.036": 2.82781902461732, "glucocorticoids": 3.916476644437717, "1\u22645": 1.632268215499513, "1.85": 2.035623909730721, "\u22655": 1.070389327891398, "2.19": 2.035623909730721, "nbdmards": 3.0179219079972626, "climate": 2.82781902461732, "nhs": 1.632268215499513, "behavioural": 3.4724877714627436, "challenge": 3.1858665453113337, "participatory": 3.711494906650088, "showing": 2.82781902461732, "minor": 2.3504972470841334, "anecdotal": 3.1858665453113337, "commissioning": 3.711494906650088, "hospital-": 3.1858665453113337, "7.1": 1.632268215499513, "11.7": 2.035623909730721, "3.47": 2.035623909730721, "linearly": 3.0179219079972626, "1.55": 2.035623909730721, "0.010": 2.3504972470841334, "reclassified": 3.5969351423872324, "13.4": 2.035623909730721, "0.073": 2.3504972470841334, "0.021": 2.3504972470841334, "0.125": 2.3504972470841334, "8.3": 1.632268215499513, "interruption": 3.5969351423872324, "secretion": 3.1858665453113337, "arginine": 3.0179219079972626, "physiologic": 3.4724877714627436, "cooperate": 3.1858665453113337, "reactivate": 3.3362833878644325, "aberrant": 3.0179219079972626, "reactivation": 3.5969351423872324, "intricately": 3.4724877714627436, "driving": 2.82781902461732, "ill": 1.632268215499513, "calcineurin": 3.4724877714627436, "express": 2.82781902461732, "dhand": 2.3504972470841334, "conditional": 3.4724877714627436, "fetal": 2.3504972470841334, "antagomir": 3.1858665453113337, "evoked": 2.608809242675524, "sensitized": 3.3362833878644325, "manner": 2.608809242675524, "cascades": 3.0179219079972626, "postnatal": 3.1858665453113337, "hungary": 2.82781902461732, "neuro": 2.3504972470841334, "hormonal": 3.0179219079972626, "neglected": 3.1858665453113337, "p38alpha": 3.0179219079972626, "mapk": 2.035623909730721, "links": 2.3504972470841334, "substrates": 3.3362833878644325, "regulating": 3.3362833878644325, "hyperinsulinemia": 4.008988783227255, "akt\u2192forkhead": 3.5969351423872324, "box": 1.632268215499513, "o-1": 1.632268215499513, "p38\u03b1": 2.035623909730721, "mitogen": 2.82781902461732, "neonatal": 3.0179219079972626, "revealing": 3.1858665453113337, "ncdr": 2.035623909730721, "pinnacle": 3.0179219079972626, "innovation": 3.3362833878644325, "excellence": 3.3362833878644325, "contraindications": 4.095924419998536, "hierarchical": 3.5969351423872324, "unadjusted": 3.3362833878644325, "prescription": 3.5969351423872324, "75%-89": 2.608809242675524, "83%-95": 2.608809242675524, "66%-85": 2.608809242675524, "addressing": 3.3362833878644325, "adjuvant": 3.0179219079972626, "manifested": 3.3362833878644325, "coverage": 3.0179219079972626, "seer": 2.035623909730721, "texas": 2.3504972470841334, "9,535": 2.3504972470841334, "2,203": 2.3504972470841334, "23.1": 2.035623909730721, "entire": 2.608809242675524, "29.4": 2.035623909730721, "18.9": 2.035623909730721, "1.75": 2.035623909730721, "1.53": 2.035623909730721, "2.10": 2.035623909730721, "1.82": 2.035623909730721, "2.48": 2.035623909730721, "1.68": 2.035623909730721, "trastuzumb": 3.3362833878644325, "plays": 2.3504972470841334, "postmenopausal": 3.817623257511431, "august": 2.608809242675524, "questionnaires": 3.817623257511431, "behaviors": 3.1858665453113337, "calculate": 3.1858665453113337, "43.1": 2.035623909730721, "trend=0.08": 3.3362833878644325, "1.04": 2.035623909730721, "1.21": 2.035623909730721, "trend=0.01": 3.3362833878644325, "vegetables": 3.3362833878644325, "nuts": 2.035623909730721, "whole": 2.3504972470841334, "grain": 2.3504972470841334, "evaluable": 3.1858665453113337, "23.7": 2.035623909730721, "18.6": 2.035623909730721, "31.8": 2.035623909730721, "univariable": 3.4724877714627436, "2.33": 2.035623909730721, "log2": 2.035623909730721, "amino": 2.3504972470841334, "statistic": 3.1858665453113337, "comorbidity": 3.4724877714627436, "paucity": 2.82781902461732, "prespecified": 3.5969351423872324, "18.5": 2.035623909730721, "66.6": 2.035623909730721, "53.2": 2.035623909730721, "46.4": 2.035623909730721, "24.6": 2.035623909730721, "61.6": 2.035623909730721, "listing": 2.82781902461732, "determinants": 3.5969351423872324, "discharges": 3.3362833878644325, "79.9": 2.035623909730721, "45.9": 2.035623909730721, "27.5": 2.035623909730721, ".024": 2.035623909730721, "19.6": 2.035623909730721, "46.9": 2.035623909730721, "eighty": 2.608809242675524, "cardiologist": 3.5969351423872324, "practitioner": 3.5969351423872324, "drawn": 2.3504972470841334, "discrepancy": 3.4724877714627436, "incompletely": 3.5969351423872324, "thought": 2.82781902461732, "pathobiology": 3.5969351423872324, "suspected": 3.1858665453113337, "n=100": 2.3504972470841334, "entered": 2.82781902461732, "22.9\u00b15.0": 3.0179219079972626, "p=0.046": 2.82781902461732, "388.3": 2.3504972470841334, "n=9": 1.632268215499513, "tissuefaxs": 3.3362833878644325, "r=0.98": 2.608809242675524, "r=-0.36": 2.82781902461732, "r=0.28": 2.608809242675524, "thalassaemia": 3.5969351423872324, "regimens": 3.0179219079972626, "remove": 2.608809242675524, "efficiently": 3.4724877714627436, "reverses": 3.0179219079972626, "n=177": 2.3504972470841334, "n=431": 2.3504972470841334, "core": 2.035623909730721, "off": 1.632268215499513, "p=0.06": 2.608809242675524, "-6.7": 2.035623909730721, "21.1": 2.035623909730721, "17.6": 2.035623909730721, "50.5": 2.035623909730721, "42.4": 2.035623909730721, "0.26": 2.035623909730721, "p=0.012": 2.82781902461732, "p=0.047": 2.82781902461732, "kyoto": 2.3504972470841334, "euthanization": 3.711494906650088, "linking": 2.82781902461732, "tension": 2.82781902461732, "fpassive)-sarcomere": 4.255500733148387, "strips": 2.608809242675524, "kcl": 1.632268215499513, "ki": 1.070389327891398, "unanchors": 3.1858665453113337, "fpassive": 3.0179219079972626, "discerned": 3.1858665453113337, "obvious": 2.82781902461732, "strip": 2.3504972470841334, "\u00b180": 1.632268215499513, "s3991": 2.3504972470841334, "elastic": 2.82781902461732, "n2bus": 2.3504972470841334, "s12884": 2.608809242675524, "pevk": 2.035623909730721, "span": 2.035623909730721, "mechanics": 3.1858665453113337, "1.121": 2.3504972470841334, "1.023": 2.3504972470841334, "1.228": 2.3504972470841334, "p=0.014": 2.82781902461732, "outperformed": 3.5969351423872324, "0.043": 2.3504972470841334, "p=0.022": 2.82781902461732, "parameter": 3.1858665453113337, "stronger": 3.0179219079972626, "raft": 2.035623909730721, "pacemaker": 3.1858665453113337, "electrocardiographers": 4.399171093819823, "0.52": 2.035623909730721, "0.29": 2.035623909730721, "p=0.033": 2.82781902461732, "p=0.155": 2.82781902461732, "pre-": 2.035623909730721, "24.5": 2.035623909730721, "9/10": 2.035623909730721, "ckd": 1.632268215499513, "0.016": 2.3504972470841334, "edema": 2.3504972470841334, "3.2": 1.632268215499513, "36.7": 2.035623909730721, "0.019": 2.3504972470841334, "criteriabased": 3.711494906650088, "tolerated": 3.1858665453113337, "easily": 2.608809242675524, "treatable": 3.1858665453113337, "pdrelated": 3.1858665453113337, "viable": 2.608809242675524, "option": 2.608809242675524, "deferred": 3.0179219079972626, "heterogenous": 3.5969351423872324, "+3.1": 2.035623909730721, "+9.2": 2.035623909730721, "9.5": 1.632268215499513, "0.038": 2.3504972470841334, "0.047": 2.3504972470841334, "compelling": 3.3362833878644325, "thirteen": 3.0179219079972626, "mmol/2100": 3.1858665453113337, "kcal": 2.035623909730721, "parametrized": 3.5969351423872324, "formalism": 3.1858665453113337, "yields": 2.608809242675524, "viscoelastic": 3.5969351423872324, "passive": 2.82781902461732, "constants": 3.1858665453113337, "inflow": 2.608809242675524, "contours": 3.0179219079972626, "wilcoxon": 3.0179219079972626, "signed": 2.608809242675524, "p=0.12": 2.608809242675524, "c=24.3": 2.608809242675524, "5.3": 1.632268215499513, "22.7": 2.035623909730721, "8.1": 1.632268215499513, "k=252": 2.3504972470841334, "s(2": 1.632268215499513, "p=0.007": 2.82781902461732, "ea=1.5": 2.608809242675524, "mediator": 3.0179219079972626, "monocytes": 3.1858665453113337, "responsive": 3.3362833878644325, "connected": 3.1858665453113337, "exhibits": 3.0179219079972626, "underlies": 3.1858665453113337, "remarkably": 3.3362833878644325, "25mg": 2.035623909730721, "ip": 1.070389327891398, "littermate": 3.3362833878644325, "adhesion": 3.0179219079972626, "hretn": 2.3504972470841334, "intriguingly": 3.5969351423872324, "implicate": 3.1858665453113337, "precipitating": 3.711494906650088, "probability": 3.4724877714627436, "relating": 3.0179219079972626, "single-": 2.82781902461732, "pharmaceutically": 4.008988783227255, "3.17": 2.035623909730721, "0.24": 2.035623909730721, "maintaining": 3.4724877714627436, "pharmaceuticals": 3.916476644437717, "ameliorates": 3.4724877714627436, "neoplastic": 3.3362833878644325, "orally": 2.608809242675524, "sacrificed": 3.3362833878644325, "rapidly": 2.82781902461732, "excised": 2.82781902461732, "cytochrome": 3.3362833878644325, "bcl2": 2.035623909730721, "alleviating": 3.4724877714627436, "decrement": 3.1858665453113337, "interfere": 3.1858665453113337, "cytotoxic": 3.1858665453113337, "solid": 2.3504972470841334, "ehrlich": 2.82781902461732, "carcinoma": 3.1858665453113337, "antitumor": 3.1858665453113337, "36,284": 2.608809242675524, "sweden": 2.608809242675524, "\u226490": 1.632268215499513, "2,462": 2.3504972470841334, "1.76": 2.035623909730721, "2.25": 2.035623909730721, "enormous": 3.0179219079972626, "atheromatous": 3.5969351423872324, "amenable": 3.0179219079972626, "cardiomyopathic": 3.916476644437717, "principally": 3.4724877714627436, "comprise": 3.0179219079972626, "contracting": 3.4724877714627436, "ventricles": 3.3362833878644325, "aetiologies": 3.4724877714627436, "particular": 3.3362833878644325, "topics": 2.608809242675524, "debate": 2.608809242675524, "concern": 2.82781902461732, "myocarditis": 3.4724877714627436, "malignant": 3.1858665453113337, "scaffolds": 3.1858665453113337, "humoral": 2.82781902461732, "workload": 3.0179219079972626, "mediate": 2.82781902461732, "paradoxically": 3.711494906650088, "notable": 2.82781902461732, "signalosome": 3.4724877714627436, "drives": 2.608809242675524, "assembly": 3.0179219079972626, "kinases": 2.82781902461732, "sequential": 3.3362833878644325, "effector": 3.0179219079972626, "molecules": 3.1858665453113337, "field": 2.3504972470841334, "capable": 2.82781902461732, "selectively": 3.4724877714627436, "potentiating": 3.5969351423872324, "amyloidosis": 3.4724877714627436, "atypical": 3.0179219079972626, "deals": 2.3504972470841334, "cardiomyiopathy": 3.916476644437717, "angina": 2.608809242675524, "inducible": 3.1858665453113337, "amyloidotic": 3.4724877714627436, "myeloma": 2.82781902461732, "osteomedullary": 3.817623257511431, "biopsy": 2.608809242675524, "strengths": 3.1858665453113337, "utility": 2.82781902461732, "southeastern": 3.5969351423872324, "exhaustion": 3.3362833878644325, "slowness": 3.0179219079972626, "unintentional": 3.711494906650088, "lb": 1.070389327891398, "0.75": 2.035623909730721, "0.687": 2.3504972470841334, "0.700": 2.3504972470841334, "ascertained": 3.4724877714627436, "ascertain": 3.1858665453113337, "learning": 3.0179219079972626, "shaping": 2.82781902461732, "disappointments": 3.916476644437717, "sensitizing": 3.4724877714627436, "endothelin": 3.3362833878644325, "relax": 2.3504972470841334, "astronaut": 3.1858665453113337, "pronto": 2.608809242675524, "highlighted": 3.4724877714627436, "learned": 2.82781902461732, "outline": 2.82781902461732, "perspectives": 3.5969351423872324, "sufficiently": 3.5969351423872324, "accelerate": 3.3362833878644325, "throughput": 3.3362833878644325, "disposition": 3.4724877714627436, "redesigned": 3.3362833878644325, "take": 2.035623909730721, "faster": 2.608809242675524, "turnaround": 3.3362833878644325, "rethinking": 3.3362833878644325, "operationalized": 3.916476644437717, "publicly": 3.0179219079972626, "penalties": 3.1858665453113337, "motivate": 3.0179219079972626, "halts": 2.3504972470841334, "hyperacetylation": 4.008988783227255, "now": 1.632268215499513, "anand": 2.3504972470841334, "lysine": 2.608809242675524, "reader": 2.608809242675524, "precedes": 3.0179219079972626, "neuronal": 3.0179219079972626, "stressors": 3.1858665453113337, "cascade": 2.82781902461732, "converges": 3.1858665453113337, "interplay": 3.1858665453113337, "writer": 2.608809242675524, "acetyltransferases": 4.177917792195843, "erasers": 2.82781902461732, "deacetylases": 3.5969351423872324, "displaces": 3.1858665453113337, "suppression": 3.4724877714627436, "polymerase": 3.3362833878644325, "neurohormonally": 3.916476644437717, "nanomolar": 3.1858665453113337, "blocked": 2.82781902461732, "brd4": 2.035623909730721, "profiling": 3.1858665453113337, "cultured": 3.0179219079972626, "abrogated": 3.1858665453113337, "experiments": 3.4724877714627436, "toxicity": 3.0179219079972626, "detailed": 3.0179219079972626, "tac-": 2.035623909730721, "suppresses": 3.3362833878644325, "causal": 2.608809242675524, "nf": 1.070389327891398, "gata4": 2.3504972470841334, "pause": 2.3504972470841334, "release": 2.82781902461732, "implicates": 3.3362833878644325, "biology": 2.82781902461732, "manipulation": 3.5969351423872324, "abrogate": 3.0179219079972626, "multiacquisition": 4.008988783227255, "yorkshire": 3.1858665453113337, "pacemakers": 3.3362833878644325, "ventricularly": 3.711494906650088, "beats": 2.3504972470841334, "scanned": 2.82781902461732, "scanner": 2.82781902461732, "gadolinium": 3.3362833878644325, "chelate": 2.82781902461732, "scans": 2.3504972470841334, "trichrome": 3.1858665453113337, "blue": 2.035623909730721, "histologic": 3.3362833878644325, "histologically": 3.817623257511431, "5.4": 1.632268215499513, "proposed": 3.0179219079972626, "diffuse": 2.82781902461732, "holding": 2.82781902461732, "inoperable": 3.3362833878644325, "broad": 2.3504972470841334, "assumption": 3.3362833878644325, "3.0": 1.632268215499513, "hemodynamics": 3.5969351423872324, "1-": 1.070389327891398, "3-": 1.070389327891398, "2.56": 2.035623909730721, "2.84": 2.035623909730721, "interesting": 3.4724877714627436, "concepts": 3.0179219079972626, "evolving": 3.0179219079972626, "stand": 2.3504972470841334, "consumes": 3.0179219079972626, "portion": 2.82781902461732, "commoner": 3.0179219079972626, "lifesaving": 3.3362833878644325, "poses": 2.3504972470841334, "nonfunctional": 3.711494906650088, "trapped": 2.82781902461732, "endoplasmic": 3.4724877714627436, "reticulum": 3.1858665453113337, "electric": 3.0179219079972626, "pluripotent": 3.4724877714627436, "hipsc": 2.3504972470841334, "activators": 3.3362833878644325, "overexpress": 3.4724877714627436, "effectors": 3.1858665453113337, "er": 1.070389327891398, "calreticulin": 3.5969351423872324, "chop": 2.035623909730721, "exogenous": 3.1858665453113337, "destabilized": 3.5969351423872324, "mrnas": 2.3504972470841334, "cation": 2.608809242675524, "m7": 1.070389327891398, "trpm7": 2.3504972470841334, "entirely": 3.0179219079972626, "transcript": 3.3362833878644325, "receives": 3.0179219079972626, "etiologic": 3.1858665453113337, "intrinsic": 3.1858665453113337, "concentrating": 3.711494906650088, "behind": 2.608809242675524, "circumstances": 3.711494906650088, "provoke": 2.82781902461732, "decompensation": 3.817623257511431, "olmsted": 2.82781902461732, "county": 2.608809242675524, "2,596": 2.3504972470841334, "ever": 2.035623909730721, "st": 1.070389327891398, "mis": 1.632268215499513, "killip": 2.608809242675524, "comorbid": 3.0179219079972626, "yielded": 2.82781902461732, "early-": 2.608809242675524, "mix": 1.632268215499513, "iodobenzylguanidine": 4.255500733148387, "serve": 2.3504972470841334, "coagulability": 3.711494906650088, "crossover": 3.1858665453113337, "masked": 2.608809242675524, "homozygous": 3.3362833878644325, "equipotent": 3.3362833878644325, "dosages": 2.82781902461732, "12.9": 2.035623909730721, "3.9": 1.632268215499513, "22.1": 2.035623909730721, "priorities": 3.3362833878644325, "nontreatment": 3.5969351423872324, "notes": 2.3504972470841334, "caring": 2.608809242675524, "42%-58": 2.608809242675524, "11%-17": 2.608809242675524, "cited": 2.3504972470841334, "50%-70": 2.608809242675524, "64%-70": 2.608809242675524, "comanagement": 3.5969351423872324, "32%-35": 2.608809242675524, "15%-24": 2.608809242675524, "belief": 2.608809242675524, "12%-20": 2.608809242675524, "thirds": 2.608809242675524, "documentation": 3.711494906650088, "evolution": 3.1858665453113337, "neurotransmission": 4.095924419998536, "elicited": 3.0179219079972626, "os": 1.070389327891398, "tachycardic": 3.4724877714627436, "bradycardic": 3.4724877714627436, "conductance": 3.4724877714627436, "ligation": 3.0179219079972626, "attenuating": 3.4724877714627436, "mechanistic": 3.4724877714627436, "computational": 3.711494906650088, "behavior": 3.0179219079972626, "sheet": 2.3504972470841334, "orientation": 3.4724877714627436, "slowed": 2.608809242675524, "depolarization": 3.817623257511431, "nonfailing": 3.3362833878644325, "electromechanics": 4.008988783227255, "combinations": 3.5969351423872324, "simulated": 3.1858665453113337, "deranged": 3.0179219079972626, "culprit": 2.82781902461732, "insignificantly": 3.916476644437717, "slows": 2.3504972470841334, "depresses": 3.1858665453113337, "stretch": 2.82781902461732, "lateral": 2.82781902461732, "giving": 2.608809242675524, "skinfold": 3.0179219079972626, "comprehensive": 3.711494906650088, "display": 2.82781902461732, "3.09": 2.035623909730721, "2.18": 2.035623909730721, "4.45": 2.035623909730721, "2.90": 2.035623909730721, "2.00": 2.035623909730721, "4.12": 2.035623909730721, "coexist": 2.82781902461732, "interrelated": 3.5969351423872324, "surrogate": 3.1858665453113337, "catabolism": 3.3362833878644325, "5.7": 1.632268215499513, "1.9": 1.632268215499513, "14.0": 2.035623909730721, "6.1": 1.632268215499513, "17.0": 2.035623909730721, "3.3": 1.632268215499513, "load": 2.035623909730721, "corrected": 3.1858665453113337, "chronotropic": 3.5969351423872324, "slower": 2.608809242675524, "0.34": 2.035623909730721, "reflected": 3.1858665453113337, "prove": 2.3504972470841334, "shortness": 3.1858665453113337, "actrn12610001087044": 4.255500733148387, "controversial": 3.711494906650088, "validate": 3.0179219079972626, "exclude": 2.82781902461732, "waves": 2.3504972470841334, "3.8": 1.632268215499513, "nondiabetes": 3.4724877714627436, "\u226555": 1.632268215499513, "\u226565": 1.632268215499513, "dyslipidemia": 3.5969351423872324, "accurately": 3.3362833878644325, "eliminate": 3.1858665453113337, "avoidance": 3.1858665453113337, "japanese": 3.0179219079972626, "hyponatremia": 3.5969351423872324, "administered": 3.5969351423872324, "relieve": 2.82781902461732, "widespread": 3.3362833878644325, "modulate": 3.0179219079972626, "herein": 2.608809242675524, "failure.(1": 3.3362833878644325, "becoming": 3.0179219079972626, "subject": 2.82781902461732, "blunts": 2.608809242675524, "guanosine": 3.1858665453113337, "pde": 1.632268215499513, "superfamily": 3.4724877714627436, "property": 3.0179219079972626, "able": 2.035623909730721, "hydrolysis": 3.3362833878644325, "mediating": 3.1858665453113337, "immunoblotting": 3.817623257511431, "radioenzymatic-": 3.916476644437717, "fluorescence": 3.5969351423872324, "video": 2.3504972470841334, "epifluorescence": 3.916476644437717, "~2": 1.070389327891398, "catecholamine": 3.711494906650088, "infusions": 3.1858665453113337, "hydrolytic": 3.3362833878644325, "blunted": 2.82781902461732, "desensitizes": 3.5969351423872324, "constitute": 3.3362833878644325, "defense": 2.82781902461732, "antagonizing": 3.5969351423872324, "drive": 2.3504972470841334, "intracellular": 3.711494906650088, "antiadrenergic": 3.817623257511431, "reason": 2.608809242675524, "underuse": 3.0179219079972626, "fear": 2.035623909730721, "inducing": 3.0179219079972626, "efficacious": 3.4724877714627436, "monitored": 3.1858665453113337, "medicines": 3.1858665453113337, "nct00232180": 3.4724877714627436, "annually": 3.0179219079972626, "intention": 3.1858665453113337, "subscales": 3.1858665453113337, "rhythm-": 2.82781902461732, "payer": 2.3504972470841334, "minimization": 3.5969351423872324, "ontario": 2.82781902461732, "costing": 2.82781902461732, "accounted": 3.1858665453113337, "cardioversions": 3.817623257511431, "21-$96": 2.608809242675524, "1124-$1522": 3.3362833878644325, "diagnoses": 3.1858665453113337, "72,764": 2.608809242675524, "61,575-$85,145": 3.817623257511431, "78,767": 2.608809242675524, "67,101-$92,139": 3.817623257511431, "restorative": 3.4724877714627436, "associate": 3.1858665453113337, "taub": 2.035623909730721, "ramirez": 2.82781902461732, "sanchez": 2.82781902461732, "ciaraldi": 3.0179219079972626, "perkins": 2.82781902461732, "murphy": 2.608809242675524, "naviaux": 2.82781902461732, "hogan": 2.3504972470841334, "ceballos": 3.0179219079972626, "maisel": 2.608809242675524, "henry": 2.3504972470841334, "clin": 2.035623909730721, "trans": 2.3504972470841334, "sci": 1.632268215499513, "immunohistochemistry": 4.329123596291566, "electron": 3.0179219079972626, "dystrophin": 3.3362833878644325, "ordinated": 3.1858665453113337, "fashion": 2.82781902461732, "myofibre": 3.0179219079972626, "regeneration": 3.5969351423872324, "~24": 1.632268215499513, "warrant": 2.82781902461732, "rigorous": 3.0179219079972626, "pubmed": 2.608809242675524, "5.88": 2.035623909730721, "3.92": 2.035623909730721, "7.85": 2.035623909730721, "-2.78": 2.3504972470841334, "-5.15": 2.3504972470841334, "-0.42": 2.3504972470841334, "resolved": 3.0179219079972626, "ethnic": 2.608809242675524, "platelet": 3.0179219079972626, "sex-": 2.035623909730721, "apparently": 3.3362833878644325, "acetyltransferase": 4.095924419998536, "dithiothreitol": 3.817623257511431, "dtt]-insensitive": 4.008988783227255, "cdp": 1.632268215499513, "choline": 2.82781902461732, "alkyl-2": 2.82781902461732, "sn": 1.070389327891398, "glycerol": 3.0179219079972626, "cholinephosphotransferase": 4.64961545906341, "isoenzymes": 3.3362833878644325, "acetylhydrolase": 3.916476644437717, "phospholipase": 3.711494906650088, "a2": 1.070389327891398, "leukocytes": 3.3362833878644325, ".1": 1.070389327891398, "downregulated": 3.711494906650088, ".004": 2.035623909730721, "feature": 2.82781902461732, "prognostically": 3.817623257511431, "accepted": 3.0179219079972626, "ven": 1.632268215499513, "vco2": 2.035623909730721, "oscillatory": 3.4724877714627436, "ventilation": 3.4724877714627436, "eov": 1.632268215499513, "co2": 1.632268215499513, "petco2": 2.608809242675524, "underlie": 3.0179219079972626, "aforementioned": 3.817623257511431, "encouraged": 3.3362833878644325, "purposes": 3.0179219079972626, "orthotopic": 3.3362833878644325, "institutional": 3.711494906650088, "vads": 2.035623909730721, "0.015": 2.3504972470841334, "require": 2.82781902461732, "cent": 2.035623909730721, "operations": 3.3362833878644325, "infrequent": 3.3362833878644325, "resuscitation": 3.711494906650088, "thrombotic": 3.3362833878644325, "obstruction": 3.4724877714627436, "course": 2.608809242675524, "unstable": 3.0179219079972626, "decided": 2.82781902461732, "extra": 2.3504972470841334, "corporeal": 3.1858665453113337, "transferred": 3.4724877714627436, "und": 1.632268215499513, "bridging": 3.0179219079972626, "reperfusion": 3.4724877714627436, "relies": 2.608809242675524, "cardiography": 3.5969351423872324, "hold": 2.035623909730721, "20,812": 2.608809242675524, "australia": 3.1858665453113337, "contention": 3.3362833878644325, "28.1": 2.035623909730721, "16.5": 2.035623909730721, "0.44": 2.035623909730721, "20.5": 2.035623909730721, "15.9": 2.035623909730721, "11.0": 2.035623909730721, "encouraging": 3.4724877714627436, "intramuscular": 3.711494906650088, "67.2": 2.035623909730721, "10.7": 2.035623909730721, "2.6": 1.632268215499513, "nmol": 2.035623909730721, "allocated": 3.1858665453113337, "recruitment": 3.4724877714627436, "injections": 3.3362833878644325, "-1.3": 2.035623909730721, "leg": 1.632268215499513, "rated": 2.3504972470841334, "21.61": 2.3504972470841334, "8.68": 2.035623909730721, "6.43": 2.035623909730721, ".017": 2.035623909730721, "6.66": 2.035623909730721, ".015": 2.035623909730721, "6.25": 2.035623909730721, ".019": 2.035623909730721, "11.98": 2.3504972470841334, "0.249": 2.3504972470841334, ".622": 2.035623909730721, "tendency": 3.0179219079972626, "3.066": 2.3504972470841334, ".091": 2.035623909730721, "realized": 3.0179219079972626, "instance": 3.0179219079972626, "candidates": 3.3362833878644325, "suffer": 2.608809242675524, "progenitors": 3.4724877714627436, "elucidate": 3.1858665453113337, "scar": 2.035623909730721, "shams": 2.3504972470841334, "inhibiting": 3.3362833878644325, "smad": 2.035623909730721, "2/3": 1.632268215499513, "marker": 2.608809242675524, "nanog": 2.3504972470841334, "optimizing": 3.3362833878644325, "pulseless": 3.1858665453113337, "60s": 1.632268215499513, "permanent": 3.1858665453113337, "8-": 1.070389327891398, "incidentally": 3.5969351423872324, "ascending": 3.1858665453113337, "bp": 1.070389327891398, "profound": 3.0179219079972626, "paco2": 2.3504972470841334, "cerebral": 3.0179219079972626, "bodies": 2.608809242675524, "concluded": 3.1858665453113337, "originating": 3.4724877714627436, "generator": 3.1858665453113337, "clarity": 2.82781902461732, "multisystem": 3.4724877714627436, "dysbalance": 3.3362833878644325, "apart": 2.3504972470841334, "permeability": 3.5969351423872324, "absorption": 3.3362833878644325, "sonographic": 3.4724877714627436, "disturbed": 3.1858665453113337, "barrier": 2.82781902461732, "anabolic": 3.0179219079972626, "highlights": 3.3362833878644325, "carbohydrates": 3.711494906650088, "water": 2.3504972470841334, "micronutrients": 3.817623257511431, "feeding": 2.82781902461732, "gut": 1.632268215499513, "fragment": 3.0179219079972626, "roles": 2.3504972470841334, "great": 2.3504972470841334, "unfavourable": 3.5969351423872324, "indistinct": 3.3362833878644325, "elucidated": 3.3362833878644325, "chronically": 3.4724877714627436, "instrumented": 3.5969351423872324, "zealand": 2.82781902461732, "innervated": 3.3362833878644325, "hrv": 1.632268215499513, "lf": 1.070389327891398, "withdrawal": 3.3362833878644325, "bradycardia": 3.4724877714627436, "exacerbated": 3.4724877714627436, "ne": 1.070389327891398, "capability": 3.3362833878644325, "turned": 2.608809242675524, "stopped": 2.82781902461732, "futility": 3.0179219079972626, "19.4": 2.035623909730721, "28.7": 2.035623909730721, "25.2": 2.035623909730721, "1.57": 2.035623909730721, "p=0.15": 2.608809242675524, "11.1": 2.035623909730721, "2.93": 2.035623909730721, "comparative": 3.4724877714627436, "mandate": 2.82781902461732, "accountable": 3.4724877714627436, "terminologies": 3.711494906650088, "makes": 2.3504972470841334, "validating": 3.3362833878644325, "science": 2.82781902461732, "beta1": 2.3504972470841334, "\u03b21": 1.070389327891398, "adenylyl": 3.0179219079972626, "triggers": 3.0179219079972626, "desensitization": 3.916476644437717, "classic": 2.82781902461732, "paradigms": 3.1858665453113337, "\u03b21ars": 2.3504972470841334, "s1pr1s": 2.608809242675524, "simply": 2.608809242675524, "uncovered": 3.1858665453113337, "hek": 1.632268215499513, "interact": 3.0179219079972626, "postischemic": 3.5969351423872324, "produces": 3.0179219079972626, "counterbalance": 3.817623257511431, "overstimulation": 3.916476644437717, "alberta": 2.82781902461732, "alive": 2.3504972470841334, "69.2": 2.035623909730721, "9.0": 1.632268215499513, "physician(s": 3.4724877714627436, "exclusively": 3.4724877714627436, "62.9": 2.035623909730721, "account": 2.82781902461732, "nonetheless": 3.4724877714627436, "halt": 2.035623909730721, "ser23/24": 3.0179219079972626, "catalytic": 3.1858665453113337, "ser96": 2.3504972470841334, "thr197": 2.608809242675524, "ri": 1.070389327891398, "isoelectric": 3.4724877714627436, "focusing": 3.0179219079972626, "blots": 2.3504972470841334, "monoclonal": 3.3362833878644325, "fluo": 2.035623909730721, "phosphomimic": 3.5969351423872324, "kd": 1.070389327891398, "wt": 1.070389327891398, "displays": 3.0179219079972626, "prone": 2.3504972470841334, "signifies": 3.1858665453113337, "lability": 3.0179219079972626, "structurally": 3.5969351423872324, "surface": 2.82781902461732, "fluctuations": 3.5969351423872324, "genuine": 2.82781902461732, "susceptibility": 3.817623257511431, "primarily": 3.1858665453113337, "anthracyclines": 3.817623257511431, "polymorphisms": 3.711494906650088, "candidate": 3.1858665453113337, "homeostasis": 3.4724877714627436, "oxidant": 2.82781902461732, "defence": 2.82781902461732, "nested": 2.608809242675524, "hope": 2.035623909730721, "survived": 3.0179219079972626, "sampling": 3.0179219079972626, "source": 2.608809242675524, "allogeneic": 3.3362833878644325, "autologous": 3.3362833878644325, "seventy": 2.82781902461732, "germline": 3.0179219079972626, "females": 2.82781902461732, "radiation": 3.1858665453113337, "4\u00b77": 1.632268215499513, "nad(p)h": 2.82781902461732, "rac2": 2.035623909730721, "rs13058338": 3.3362833878644325, "7508t\u2192a": 2.82781902461732, "2\u00b78": 1.632268215499513, "hfe": 1.632268215499513, "rs1799945": 3.1858665453113337, "63c\u2192g": 2.3504972470841334, "2\u00b75": 1.632268215499513, "efflux": 2.608809242675524, "abcc2": 2.3504972470841334, "rs8187710": 3.1858665453113337, "1515g\u2192a": 2.82781902461732, "4\u00b73": 1.632268215499513, "0\u00b779": 2.035623909730721, "0\u00b767": 2.035623909730721, "0\u00b769": 2.035623909730721, "complicity": 3.3362833878644325, "moves": 2.3504972470841334, "exemplify": 3.1858665453113337, "propose": 2.82781902461732, "distinctive": 3.4724877714627436, "universal": 3.1858665453113337, "uniform": 2.82781902461732, "nomenclature": 3.5969351423872324, "view": 2.035623909730721, "foster": 2.608809242675524, "collaborative": 3.711494906650088, "conjoint": 3.0179219079972626, "effort": 2.608809242675524, "preventing": 3.3362833878644325, "breakdown": 3.1858665453113337, "composed": 3.0179219079972626, "prodrug": 2.82781902461732, "beginning": 3.1858665453113337, "stabilize": 3.1858665453113337, "summarizes": 3.3362833878644325, "principles": 3.3362833878644325, "progressed": 3.3362833878644325, "purely": 2.608809242675524, "interconnected": 3.817623257511431, "accumulating": 3.5969351423872324, "window": 2.608809242675524, "shortcomings": 3.5969351423872324, "dearth": 2.608809242675524, "summarize": 3.1858665453113337, "uniquely": 3.0179219079972626, "capture": 2.82781902461732, "strict": 2.608809242675524, "standards": 3.1858665453113337, "multimarker": 3.4724877714627436, "fastest": 2.82781902461732, "subclass": 3.0179219079972626, "indicates": 3.1858665453113337, "noncoding": 3.1858665453113337, "rnas": 2.035623909730721, "regulate": 3.0179219079972626, "untranslated": 3.5969351423872324, "messenger": 3.1858665453113337, "degradation": 3.4724877714627436, "repression": 3.3362833878644325, "give": 2.035623909730721, "look": 2.035623909730721, "namely": 2.608809242675524, "endopeptidase": 3.711494906650088, "vasopeptidase": 3.711494906650088, "subpulmonary": 3.5969351423872324, "exhibit": 2.82781902461732, "sixteen": 2.82781902461732, "30\u00b12": 2.035623909730721, "calf": 2.035623909730721, "31)p": 2.035623909730721, "spectroscopy": 3.5969351423872324, "tertiary": 3.0179219079972626, "referral": 3.0179219079972626, "1.9\u00b10.1": 2.82781902461732, "66\u00b13": 2.035623909730721, "appendicular": 3.5969351423872324, "z": 0.13750352374993502, "-1.46\u00b10.22": 3.3362833878644325, "poorer": 2.608809242675524, "max": 1.632268215499513, "r=0.67": 2.608809242675524, "p=0.004": 2.82781902461732, "-1.47\u00b10.21": 3.3362833878644325, "4/16": 2.035623909730721, "sarcopenic": 3.3362833878644325, "-2.0": 2.035623909730721, "9/16": 2.035623909730721, "\u2265-2.0": 2.3504972470841334, "constant": 3.0179219079972626, "postexercise": 3.5969351423872324, "resynthesis": 3.4724877714627436, "1.48\u00b10.13": 3.1858665453113337, "2.40\u00b10.33": 3.1858665453113337, "min(-1": 2.608809242675524, "questioned": 3.3362833878644325, "italy": 2.3504972470841334, "original": 3.0179219079972626, "exploratory": 3.4724877714627436, "dimensions": 3.3362833878644325, ".92": 1.632268215499513, ".95": 1.632268215499513, ".99": 1.632268215499513, "contrasting": 3.4724877714627436, "nonstandardized": 3.916476644437717, "misdiagnosis": 3.5969351423872324, "stored": 2.608809242675524, "-80": 1.632268215499513, "\u00b0": 0.13750352374993502, "enriched": 3.0179219079972626, "immunoprecipitation": 4.255500733148387, "spectrometric": 3.711494906650088, "customized": 3.3362833878644325, "homogeneous": 3.4724877714627436, "sandwich": 3.0179219079972626, "spectrometry": 3.5969351423872324, "processed": 3.1858665453113337, "proteolysis": 3.4724877714627436, "pro2": 2.035623909730721, "gly4": 2.035623909730721, "pro6": 2.035623909730721, "gly7": 2.035623909730721, "pro75": 2.3504972470841334, "arg76": 2.3504972470841334, "termini": 2.82781902461732, "nonglycosylated": 3.916476644437717, "immunoreactive": 3.817623257511431, "immunodetection": 3.916476644437717, "next": 2.035623909730721, "avoiding": 3.0179219079972626, "glycosylated": 3.5969351423872324, "-3.2": 2.035623909730721, "-5.4": 2.035623909730721, "-1.1": 2.035623909730721, "-1.5": 2.035623909730721, "-0.5": 2.035623909730721, "idealized": 3.1858665453113337, "14.2": 2.035623909730721, "denotes": 2.82781902461732, "pathophysiologically": 4.329123596291566, "antitachycardia": 3.916476644437717, "endpoints": 3.1858665453113337, "tachyarrhythmias": 4.008988783227255, "3.4": 1.632268215499513, "0.009": 2.3504972470841334, "0.80": 2.035623909730721, "nct00180271": 3.4724877714627436, "denmark": 2.82781902461732, "307.026": 2.82781902461732, "4.9": 1.632268215499513, "alendronate-": 3.5969351423872324, "etidronate-": 3.4724877714627436, "3.7": 1.632268215499513, "bisphophonates": 3.817623257511431, "1.41": 2.035623909730721, "analysed": 3.0179219079972626, "bisphosphonate": 3.817623257511431, "subcellular": 3.4724877714627436, "reversibility": 3.711494906650088, "epinephrine": 3.4724877714627436, "sarcoplasmic": 3.5969351423872324, "reticular": 3.1858665453113337, "ca(2+)-uptake": 3.711494906650088, "myofibrillar": 3.5969351423872324, "ca(2+)-stimulated": 4.095924419998536, "atpase": 2.608809242675524, "unaffected": 3.3362833878644325, "catecholamines": 3.817623257511431, "inconsistent": 3.5969351423872324, "embedded": 3.0179219079972626, "subclinical": 3.4724877714627436, "uv": 1.070389327891398, "8,009": 2.3504972470841334, "smoked": 2.608809242675524, "intima": 2.608809242675524, "media": 2.3504972470841334, "1.02\u00b10.18": 3.1858665453113337, "1.02\u00b10.16": 3.1858665453113337, "share": 2.3504972470841334, "0.9": 1.632268215499513, "quartile": 3.0179219079972626, "nationally": 3.3362833878644325, "considerations": 3.817623257511431, "project": 2.82781902461732, "150,000": 2.82781902461732, "rural": 2.3504972470841334, "implemented": 3.4724877714627436, "urbanized": 3.1858665453113337, "midwestern": 3.3362833878644325, "extensively": 3.4724877714627436, "identical": 3.1858665453113337, "fractal": 2.82781902461732, "scaling": 2.82781902461732, "exponent": 3.0179219079972626, "somewhat": 3.0179219079972626, "stems": 2.3504972470841334, "underperfusion": 3.817623257511431, "renin-": 2.608809242675524, "nephropathy": 3.4724877714627436, "ultrasonography": 3.916476644437717, "tomographic": 3.4724877714627436, "preferred": 3.1858665453113337, "lipid": 2.3504972470841334, "lowering": 3.0179219079972626, "cessation": 3.1858665453113337, "preventive": 3.3362833878644325, "angioplasty": 3.4724877714627436, "coral": 2.3504972470841334, "concrete": 3.0179219079972626, "unsuitable": 3.3362833878644325, "unsuccessful": 3.5969351423872324, "plans": 2.3504972470841334, "bioinformatic": 3.711494906650088, "microarray": 3.3362833878644325, "reveals": 2.82781902461732, "discover": 3.0179219079972626, "gse9128": 2.82781902461732, "downloaded": 3.3362833878644325, "omnibus": 2.82781902461732, "processing": 3.3362833878644325, "carried": 2.82781902461732, "r.": 1.070389327891398, "cluster": 2.82781902461732, "globally": 3.0179219079972626, "observe": 2.82781902461732, "interactors": 3.4724877714627436, "osprey": 2.608809242675524, "overlapping": 3.4724877714627436, "cytoscape": 3.1858665453113337, "david": 2.3504972470841334, "programmed": 3.3362833878644325, "northwest": 3.1858665453113337, "1,767": 2.3504972470841334, "demonstration": 3.711494906650088, "clinics": 2.82781902461732, "integrates": 3.3362833878644325, "binomial": 3.0179219079972626, ".03": 1.632268215499513, "quarterly": 3.1858665453113337, "-0.054": 2.608809242675524, "-0.010": 2.608809242675524, ".005": 2.035623909730721, "interactions": 3.5969351423872324, "socioeconomic": 3.711494906650088, "whites": 2.608809242675524, "1.46": 2.035623909730721, "1.77": 2.035623909730721, "1.58": 2.035623909730721, "1.27": 2.035623909730721, "1.96": 2.035623909730721, ".5": 1.070389327891398, "modifiable": 3.3362833878644325, "conceptually": 3.5969351423872324, "side": 2.035623909730721, "maintain": 3.0179219079972626, "randomize": 3.1858665453113337, "3,000": 2.3504972470841334, "cha\u2082ds\u2082vasc": 3.4724877714627436, "mandated": 3.0179219079972626, "nights": 2.608809242675524, "spent": 2.3504972470841334, "counted": 2.82781902461732, "know": 2.035623909730721, "grown": 2.3504972470841334, "faced": 2.3504972470841334, "uncommon": 3.0179219079972626, "housed": 2.608809242675524, "accustomed": 3.3362833878644325, "asked": 2.3504972470841334, "array": 2.3504972470841334, "complication": 3.5969351423872324, "topic": 2.3504972470841334, "partner": 2.82781902461732, "subspecialty": 3.5969351423872324, "called": 2.608809242675524, "fall": 2.035623909730721, "abcd": 2.035623909730721, "acc)/american": 3.711494906650088, "characterised": 3.711494906650088, "structural": 3.3362833878644325, "attempt": 2.82781902461732, "correct": 2.82781902461732, "ischaemia": 3.1858665453113337, "tachy-": 2.608809242675524, "bradyarrhythmias": 4.008988783227255, "potent": 2.608809242675524, "ca2": 1.632268215499513, "influx": 2.608809242675524, "plateau": 2.82781902461732, "potentials": 3.3362833878644325, "excitation": 3.3362833878644325, "contraction": 3.4724877714627436, "rem": 1.632268215499513, "rem2": 2.035623909730721, "gem": 1.632268215499513, "kir": 1.632268215499513, "monomeric": 3.1858665453113337, "naturally": 3.1858665453113337, "eliminates": 3.3362833878644325, "inhibitory": 3.3362833878644325, "inhibits": 3.0179219079972626, "potently": 3.0179219079972626, "attenuates": 3.3362833878644325, "gating": 2.608809242675524, "movement": 3.0179219079972626, "substitution": 3.5969351423872324, "impair": 2.608809242675524, "modes": 2.3504972470841334, "se": 1.070389327891398, "mistargeting": 3.5969351423872324, "ethically": 3.1858665453113337, "situations": 3.3362833878644325, "pediatrics": 3.3362833878644325, "families": 3.0179219079972626, "whose": 2.3504972470841334, "religious": 3.1858665453113337, "beliefs": 2.82781902461732, "legal": 2.3504972470841334, "face": 2.035623909730721, "ethics": 2.608809242675524, "rounds": 2.608809242675524, "complexities": 3.5969351423872324, "overlapped": 3.3362833878644325, "sickle": 2.608809242675524, "going": 2.3504972470841334, "urgently": 3.0179219079972626, "woman": 2.3504972470841334, "adamantly": 3.1858665453113337, "refuse": 2.608809242675524, "let": 1.632268215499513, "die": 1.632268215499513, "is": 1.070389327891398, "combine": 2.82781902461732, "empirically": 3.4724877714627436, "explains": 3.0179219079972626, "variance": 3.0179219079972626, "n=1,203,595": 3.4724877714627436, "n=625,595": 3.1858665453113337, "n=1,234,299": 3.4724877714627436, "ranked": 2.608809242675524, "chosen": 2.608809242675524, "1.61": 2.035623909730721, "dying": 2.3504972470841334, "explaining": 3.3362833878644325, "african": 2.82781902461732, "n=120": 2.3504972470841334, "n=1543": 2.608809242675524, "rales": 2.3504972470841334, "4.29\u00b10.5": 3.0179219079972626, "4.55\u00b10.49": 3.1858665453113337, "4.32\u00b10.54": 3.1858665453113337, "4.31\u00b10.49": 3.1858665453113337, "throughout": 3.3362833878644325, "attain": 2.608809242675524, "13.9": 2.035623909730721, "5.8": 1.632268215499513, "potassium>5.5": 3.711494906650088, "p<0.046": 2.82781902461732, "potassium<3.5": 3.711494906650088, "17.9": 2.035623909730721, "interaction=0.032": 4.095924419998536, "seemed": 2.608809242675524, "antioxidant": 3.4724877714627436, "szeto": 2.3504972470841334, "schiller": 3.0179219079972626, "ss": 1.070389327891398, "tac)-induced": 3.5969351423872324, "mapped": 2.608809242675524, "gluconeogenesis": 3.916476644437717, "citrate": 2.82781902461732, "ameliorated": 3.4724877714627436, "damage": 2.608809242675524, "nonmitochondrial": 4.008988783227255, "amelioration": 3.5969351423872324, "essentially": 3.4724877714627436, "elucidates": 3.3362833878644325, "upstream": 3.0179219079972626, "does": 2.035623909730721, "skilled": 2.82781902461732, "thousand": 3.0179219079972626, "2,101,481": 3.1858665453113337, "claims": 2.608809242675524, "quasi": 2.3504972470841334, "experiment": 3.3362833878644325, "immediate": 3.1858665453113337, "0.30": 2.035623909730721, "2.82": 2.035623909730721, "1.60": 2.035623909730721, "urinary": 2.82781902461732, "tract": 2.3504972470841334, "medically": 3.1858665453113337, "quintiles": 3.1858665453113337, "8.9": 1.632268215499513, "25.8": 2.035623909730721, "21.5": 2.035623909730721, "p<0001": 2.608809242675524, "finally": 2.82781902461732, "p=0.002": 2.82781902461732, "internists": 3.3362833878644325, "10.6": 2.035623909730721, "weakest": 2.82781902461732, "6.7": 1.632268215499513, "p=0.485": 2.82781902461732, "noncardiologist": 3.916476644437717, "expertise": 3.1858665453113337, "antagonism": 3.3362833878644325, "neurohormone": 3.5969351423872324, "electrolytes": 3.5969351423872324, "very": 2.035623909730721, "ephesus": 2.82781902461732, "tuscany": 2.82781902461732, "53\u00b112": 2.3504972470841334, "32\u00b110": 2.3504972470841334, "fulfilling": 3.3362833878644325, "8.8\u00b16.3": 2.82781902461732, "subdivided": 3.3362833878644325, "eras": 2.035623909730721, "n=66": 2.035623909730721, "n=102": 2.3504972470841334, "n=197": 2.3504972470841334, "n=238": 2.3504972470841334, "n=142": 2.3504972470841334, "n=71": 2.035623909730721, "noncardiac": 3.3362833878644325, "n=22": 2.035623909730721, "n=36": 2.035623909730721, "0.14": 2.035623909730721, "replicated": 3.3362833878644325, "emphasizing": 3.4724877714627436, "tailored": 3.0179219079972626, "indeterminable": 3.817623257511431, "always": 2.608809242675524, "meaning": 2.82781902461732, "achievement": 3.4724877714627436, "quotient": 3.0179219079972626, "\u22641.05": 2.3504972470841334, "3.01": 2.035623909730721, "4.98": 2.035623909730721, "90.54": 2.3504972470841334, "pred": 2.035623909730721, "hr]=0.977": 3.1858665453113337, "ci]=0.97": 3.0179219079972626, "ventilatory": 3.4724877714627436, "hr=1.02": 2.82781902461732, "ci=1.01": 2.82781902461732, "hr=0.931": 3.0179219079972626, "ci=0.87": 2.82781902461732, "hr=0.948": 3.0179219079972626, "hr=0.990": 3.0179219079972626, "ci=0.98": 2.82781902461732, "hr=0.967": 3.0179219079972626, "hr=1.41": 2.82781902461732, "ci=1.06": 2.82781902461732, "1.89": 2.035623909730721, "hr=1.459": 3.0179219079972626, "ci=1.09": 2.82781902461732, "1.10": 2.035623909730721, "inability": 3.1858665453113337, "cooper": 2.608809242675524, "19.8\u00b110.4": 3.1858665453113337, "3.97": 2.035623909730721, "3.71": 2.035623909730721, "upper": 2.3504972470841334, "p<0.002": 2.82781902461732, "p\u22640.02": 2.608809242675524, "counseled": 3.1858665453113337, "achieving": 3.1858665453113337, "presumably": 3.3362833878644325, "hypertrophied": 3.711494906650088, "evidenced": 3.1858665453113337, "translocation": 3.711494906650088, "lactate": 2.82781902461732, "fatty": 2.3504972470841334, "acids": 2.3504972470841334, "reality": 2.82781902461732, "adequacy": 3.0179219079972626, "delineated": 3.3362833878644325, "website": 2.82781902461732, "nondeveloped": 3.5969351423872324, "raised": 2.608809242675524, "chagas": 2.608809242675524, "alcohol": 2.82781902461732, "6.3": 1.632268215499513, "varies": 2.608809242675524, "awful": 2.3504972470841334, "paradox": 2.82781902461732, "scenario": 3.0179219079972626, "polymorphism": 3.5969351423872324, "p.": 1.070389327891398, "arg83gly": 3.0179219079972626, "renastur": 3.0179219079972626, "caucasian": 3.1858665453113337, "ka": 1.070389327891398, "chloride": 3.0179219079972626, "min./1.73": 3.1858665453113337, "ldl": 1.632268215499513, "gg": 1.070389327891398, "genotype": 3.0179219079972626, "or=1.65": 2.82781902461732, "ci=1.04": 2.82781902461732, "2.62": 2.035623909730721, "confirmation": 3.5969351423872324, "ambient": 2.82781902461732, "recognised": 3.3362833878644325, "lancet": 2.608809242675524, "anoop": 2.3504972470841334, "shah": 2.035623909730721, "colleagues": 3.3362833878644325, "aware": 2.3504972470841334, "industrial": 3.3362833878644325, "aggravate": 3.1858665453113337, "exacerbates": 3.4724877714627436, "cytoskeletal": 3.5969351423872324, "deletion": 3.0179219079972626, "precise": 2.82781902461732, "functionally": 3.5969351423872324, "morphologically": 3.916476644437717, "littermates": 3.4724877714627436, "susceptible": 3.4724877714627436, "turning": 2.82781902461732, "discovered": 3.3362833878644325, "normalizing": 3.4724877714627436, "eliminated": 3.3362833878644325, "fare": 2.035623909730721, "eventually": 3.3362833878644325, "spite": 2.3504972470841334, "developments": 3.5969351423872324, "palliative": 3.3362833878644325, "vital": 2.3504972470841334, "disciplines": 3.4724877714627436, "communication": 3.711494906650088, "surgeons": 3.0179219079972626, "distributed": 3.4724877714627436, "evenly": 2.608809242675524, "equitable": 3.1858665453113337, "referrals": 3.1858665453113337, "strengthen": 3.3362833878644325, "connection": 3.3362833878644325, "certified": 3.1858665453113337, "raise": 2.3504972470841334, "turkey": 2.608809242675524, "postmarketing": 3.711494906650088, "dipeptidyl": 3.3362833878644325, "peptidase-4": 3.4724877714627436, "creating": 3.0179219079972626, "uncertainty": 3.4724877714627436, "partners": 3.0179219079972626, "u.s.": 2.035623909730721, "mini": 2.035623909730721, "sentinel": 3.0179219079972626, "products": 3.0179219079972626, "402.x1": 2.608809242675524, "404.x1": 2.608809242675524, "404.x3": 2.608809242675524, "428.xx": 2.608809242675524, "pairwise": 3.0179219079972626, "drs)-stratified": 3.916476644437717, "0.47": 2.035623909730721, "limitation": 3.3362833878644325, "residual": 3.0179219079972626, "confounding": 3.4724877714627436, "introduction": 3.5969351423872324, "outweigh": 3.0179219079972626, "healthstar": 3.3362833878644325, "campbell": 3.0179219079972626, "joanna": 2.608809242675524, "briggs": 2.608809242675524, "institute": 3.1858665453113337, "reviews": 2.82781902461732, "centres": 2.82781902461732, "extract": 2.82781902461732, "duplicate": 3.1858665453113337, "provider": 3.0179219079972626, "eg": 1.070389327891398, "decision": 3.0179219079972626, "incentives": 3.3362833878644325, "elements": 3.0179219079972626, "redesign": 3.0179219079972626, "synthesise": 3.3362833878644325, "narratively": 3.4724877714627436, "succeed": 2.82781902461732, "fail": 2.035623909730721, "disseminate": 3.4724877714627436, "briefing": 3.0179219079972626, "publications": 3.5969351423872324, "presentations": 3.711494906650088, "perceptions": 3.4724877714627436, "qualitative": 3.4724877714627436, "grounded": 3.0179219079972626, "theory": 2.608809242675524, "collect": 2.82781902461732, "interview": 3.1858665453113337, "toronto": 2.82781902461732, "predominately": 3.711494906650088, "felt": 2.035623909730721, "mind": 2.035623909730721, "wished": 2.608809242675524, "said": 2.035623909730721, "consider": 3.0179219079972626, "undecided": 3.1858665453113337, "adamant": 2.82781902461732, "turn": 2.035623909730721, "implant": 2.82781902461732, "distressing": 3.4724877714627436, "comment": 2.82781902461732, "centrally": 3.1858665453113337, "outflow": 2.82781902461732, "system-": 2.82781902461732, "hall": 2.035623909730721, "97.2": 2.035623909730721, "91.4": 2.035623909730721, "59.6": 2.035623909730721, "13.2": 2.035623909730721, "17.4": 2.035623909730721, "ranking": 2.82781902461732, "0.08": 2.035623909730721, "prescribe": 3.1858665453113337, "china": 2.3504972470841334, "\u03b450%w": 2.3504972470841334, "x12": 1.632268215499513, "w.": 1.070389327891398, "before": 2.608809242675524, "nosignificant": 3.711494906650088, "p>0.05": 2.608809242675524, "guiding": 2.82781902461732, "uk": 1.070389327891398, "completely": 3.3362833878644325, "subtle": 2.608809242675524, "nonspecific": 3.4724877714627436, "breathlessness": 3.817623257511431, "fatigue": 2.82781902461732, "thorough": 3.0179219079972626, "lying": 2.3504972470841334, "auscultation": 3.5969351423872324, "jugular": 2.82781902461732, "oedema": 2.608809242675524, "regular": 2.82781902461732, "hyperlipidaemia": 3.916476644437717, "senescence": 3.3362833878644325, "malignancies": 3.5969351423872324, "prostate": 3.0179219079972626, "colon": 2.3504972470841334, "osteoporosis": 3.5969351423872324, "dementia": 3.0179219079972626, "regularly": 3.1858665453113337, "volumes": 2.82781902461732, "confer": 2.608809242675524, "with.estimates": 3.817623257511431, "50,000": 2.608809242675524, "200,000": 2.82781902461732, "hereditary": 3.3362833878644325, "nontraumatic": 3.5969351423872324, "sport": 2.3504972470841334, "middle": 2.608809242675524, "recreational": 3.5969351423872324, "males": 2.3504972470841334, "esc": 1.632268215499513, "advocate": 3.0179219079972626, "accessory": 3.1858665453113337, "ion": 1.632268215499513, "channelopathies": 3.916476644437717, "overwhelming": 3.5969351423872324, "trainings": 3.1858665453113337, "limbs": 2.3504972470841334, "+233": 2.035623909730721, "il": 1.070389327891398, "+0.5": 2.035623909730721, "+0.2": 2.035623909730721, "6.5": 1.632268215499513, "feedback": 3.0179219079972626, "97.8": 2.035623909730721, "surveys": 2.82781902461732, "r=-0.11": 2.82781902461732, "r=-0.12": 2.82781902461732, "p<0.005": 2.82781902461732, "corresponded": 3.5969351423872324, "implement": 3.1858665453113337, "arguments": 3.1858665453113337, "hypo": 2.035623909730721, "gas": 1.632268215499513, "participated": 3.5969351423872324, "aiming": 2.608809242675524, "value=0.631": 3.4724877714627436, "17\u00b122": 2.3504972470841334, "4\u00b115": 2.035623909730721, "value=0.027": 3.4724877714627436, "17.5\u00b15.5": 3.0179219079972626, "14.4\u00b13.3": 3.0179219079972626, "value=0.038": 3.4724877714627436, "2.0\u00b13.2": 2.82781902461732, "1.2\u00b17.7": 2.82781902461732, "value=0.033": 3.4724877714627436, "unidirectional": 3.817623257511431, "\u226518": 1.632268215499513, "implants": 3.0179219079972626, "transseptal": 3.4724877714627436, "catheterisation": 3.916476644437717, "guidance": 3.0179219079972626, "anaesthesia": 3.4724877714627436, "oct": 1.632268215499513, "procedural": 3.3362833878644325, "shunts": 2.608809242675524, "patent": 2.608809242675524, "migration": 3.1858665453113337, "p=0\u00b70004": 3.0179219079972626, "duke": 2.035623909730721, "6\u00b72": 1.632268215499513, "24\u00b78": 2.035623909730721, "12\u00b79": 2.035623909730721, "44\u00b73": 2.035623909730721, "9\u00b78": 1.632268215499513, "79\u00b71": 2.035623909730721, "13\u00b70": 2.035623909730721, "p=0\u00b70001": 3.0179219079972626, "p=0\u00b7035": 2.82781902461732, "incessant": 3.1858665453113337, "storm": 2.3504972470841334, "warranted": 3.1858665453113337, "hopeful": 2.82781902461732, "at1": 1.632268215499513, "blocks": 2.608809242675524, "aldosteron": 3.3362833878644325, "concurrently": 3.5969351423872324, "natural": 2.82781902461732, "vasodilatory": 3.5969351423872324, "stabilized": 3.3362833878644325, "sacubiltril": 3.4724877714627436, "hypotension": 3.4724877714627436, "interrupt": 3.1858665453113337, "czech": 2.3504972470841334, "republic": 3.0179219079972626, "congratulated": 3.711494906650088, "thanked": 2.82781902461732, "more": 2.035623909730721, "persons": 2.82781902461732, "determinant": 3.4724877714627436, "factorial": 3.1858665453113337, "february": 3.0179219079972626, "november": 3.0179219079972626, "academic": 3.0179219079972626, "initially": 3.1858665453113337, "screened": 3.0179219079972626, "39.3": 2.035623909730721, "consisted": 3.1858665453113337, "calls": 2.3504972470841334, "attendance": 3.3362833878644325, "-1": 1.070389327891398, "-8": 1.070389327891398, ".70": 1.632268215499513, "-6": 1.070389327891398, "-12": 1.632268215499513, ".08": 1.632268215499513, ".003": 2.035623909730721, "thigh": 2.3504972470841334, "intermuscular": 3.711494906650088, "0.27": 2.035623909730721, "hemocompatibility": 4.095924419998536, "rotor": 2.3504972470841334, "paths": 2.3504972470841334, "artificial": 3.3362833878644325, "intermacs": 3.1858665453113337, "interagency": 3.4724877714627436, "mechanically": 3.5969351423872324, "support)-derived": 4.008988783227255, "inotrope": 3.0179219079972626, "listed": 2.608809242675524, "exceeded": 3.0179219079972626, "0.0093": 2.608809242675524, "reoperation": 3.4724877714627436, "rankin": 2.608809242675524, "exchanges": 3.1858665453113337, "malfunctions": 3.5969351423872324, "hemolysis": 3.1858665453113337, "sustained": 3.1858665453113337, "projecting": 3.3362833878644325, "extrapolating": 3.711494906650088, "valuable": 3.0179219079972626, "modeled": 2.82781902461732, "designs": 2.82781902461732, "hypothetical": 3.5969351423872324, "10,000": 2.608809242675524, "virtual": 2.82781902461732, "inputs": 2.608809242675524, "external": 3.0179219079972626, "replicating": 3.4724877714627436, "scenarios": 3.1858665453113337, "functioning": 3.4724877714627436, "researchers": 3.4724877714627436, "upcoming": 3.0179219079972626, "understand": 3.3362833878644325, "deter": 2.3504972470841334, "such": 2.035623909730721, "optimize": 3.0179219079972626}